Hits from PDB	Structure Title	EC number
2DLH	SOLUTION STRUCTURE OF THE SECOND FN3 DOMAIN OF HUMAN RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE DELTA	3.1.3.48
2DM9	CRYSTAL STRUCTURE OF PH1978 FROM PYROCOCCUS HORIKOSHII OT3	3.6.3.14
2DMA	CRYSTAL STRUCTURE OF PH1978 FROM PYROCOCCUS HORIKOSHII OT3 (FORM II)	3.6.3.14
2DN7	SOLUTION STRUCTURES OF THE 6TH FN3 DOMAIN OF HUMAN RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE F	3.1.3.48
2DNJ	DNASE I-INDUCED DNA CONFORMATION. 2 ANGSTROMS STRUCTURE OF A DNASE I-OCTAMER COMPLEX	3.1.21.1
2DNR	SOLUTION STRUCTURE OF RNA BINDING DOMAIN IN SYNAPTOJANIN 1	3.1.3.36
2DO2	DESIGN OF SPECIFIC INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN A GROUP II CYS 49 PHOSPHOLIPASE A2 AND A DESIGNED PENTAPEPTIDE ALA-LEU-ALA-SER-LYS AT 2.6A RESOLUTION	3.1.1.4
2DOI	THE X-RAY CRYSTALLOGRAPHIC STRUCTURE OF THE ANGIOGENESIS INHIBITOR, ANGIOSTATIN, BOUND TO A PEPTIDE FROM THE GROUP A STREPTOCOCCUS PROTEIN PAM	3.4.21.7
2DOJ	CRYSTAL STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH ADENOSINE AT 2.4 A RESOLUTION	3.4.21
2DOK	CRYSTAL STRUCTURE OF THE PIN DOMAIN OF HUMAN EST1A	3.1
2DOO	THE STRUCTURE OF IMP-1 COMPLEXED WITH THE DETECTING REAGENT (DANSYLC4SH) BY A FLUORESCENT PROBE	3.5.2.6
2DOS	STRUCTURAL BASIS FOR THE RECOGNITION OF LYS48-LINKED POLYUBIQUITIN CHAIN BY THE JOSEPHIN DOMAIN OF ATAXIN-3, A PUTATIVE DEUBIQUITINATING ENZYME	3.4.22 3.4.19.12
2DP4	CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PROTEINASE K AND A HUMAN LACTOFERRIN FRAGMENT AT 2.9 A RESOLUTION	3.4.21.64
2DP6	CRYSTAL STRUCTURE OF URACIL-DNA GLYCOSYLASE IN COMPLEX WITH AP:C CONTAINING DNA	3.2.2
2DP8	CARBOHYDRATE RECOGNITION BY LACTOFERRIN: CRYSTAL STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH TRISACCHARIDE AT 2.5 A RESOLUTION	3.4.21
2DPX	CRYSTAL STRUCTURE OF HUMAN RAD GTPASE	3.6.5.2
2DPY	CRYSTAL STRUCTURE OF THE FLAGELLAR TYPE III ATPASE FLII	3.6.3.14 7.1.2.2
2DPZ	STRUCTURE OF THE COMPLEX OF PHOSPHOLIPASE A2 WITH N-(4-HYDROXYPHENYL)- ACETAMIDE AT 2.1 A RESOLUTION	3.1.1.4
2DQ6	CRYSTAL STRUCTURE OF AMINOPEPTIDASE N FROM ESCHERICHIA COLI	3.4.11.2
2DQA	CRYSTAL STRUCTURE OF TAPES JAPONICA LYSOZYME	3.2.1.17
2DQB	CRYSTAL STRUCTURE OF DNTP TRIPHOSPHOHYDROLASE FROM THERMUS THERMOPHILUS HB8, WHICH IS HOMOLOGOUS TO DGTP TRIPHOSPHOHYDROLASE	3.1.5.1
2DQK	CRYSTAL STRUCTURE OF THE COMPLEX OF PROTEINASE K WITH A SPECIFIC LACTOFERRIN PEPTIDE VAL-LEU-LEU-HIS AT 1.93 A RESOLUTION	3.4.21.64
2DQM	CRYSTAL STRUCTURE OF AMINOPEPTIDASE N COMPLEXED WITH BESTATIN	3.4.11.2
2DQS	CRYSTAL STRUCTURE OF THE CALCIUM PUMP WITH AMPPCP IN THE ABSENCE OF CALCIUM	3.6.3.8 7.2.2.10
2DQV	STRUCTURE OF THE C-TERMINAL LOBE OF BOVINE LACTOFERRIN IN COMPLEX WITH GALACTOSE AT 2.7 A RESOLUTION	3.4.21
2DQX	MUTANT BETA-AMYLASE (W55R) FROM SOY BEAN	3.2.1.2
2DQY	CRYSTAL STRUCTURE OF HUMAN CARBOXYLESTERASE IN COMPLEX WITH CHOLATE AND PALMITATE	3.1.1.1 3.1.1.13 3.1.1.56
2DQZ	CRYSTAL STRUCTURE OF HUMAN CARBOXYLESTERASE IN COMPLEX WITH HOMATROPINE, COENZYME A, AND PALMITATE	3.1.1.1 3.1.1.13 3.1.1.56
2DR0	CRYSTAL STRUCTURE OF HUMAN CARBOXYLESTERASE IN COMPLEX WITH TAUROCHOLATE	3.1.1.1 3.1.1.13 3.1.1.56
2DRO	CRYSTAL STRUCTURE OF REDUCING-END-XYLOSE RELEASING EXO-OLIGOXYLANASE D263C MUTANT	3.2.1.156
2DRQ	CRYSTAL STRUCTURE OF REDUCING-END-XYLOSE RELEASING EXO-OLIGOXYLANASE D263G MUTANT	3.2.1.156
2DRR	CRYSTAL STRUCTURE OF REDUCING-END-XYLOSE RELEASING EXO-OLIGOXYLANASE D263N MUTANT	3.2.1.156
2DRS	CRYSTAL STRUCTURE OF REDUCING-END-XYLOSE RELEASING EXO-OLIGOXYLANASE D263S MUTANT	3.2.1.156
2DS9	STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH MANNOSE AT 2.8 A RESOLUTION	3.4.21
2DSB	CRYSTAL STRUCTURE OF HUMAN ADP-RIBOSE PYROPHOSPHATASE NUDT5	3.6.1.13 3.6.1 3.6.1.58 2.7.7.96
2DSC	CRYSTAL STRUCTURE OF HUMAN ADP-RIBOSE PYROPHOSPHATASE NUDT5 IN COMPLEX WITH MAGNESIUM AND ADP-RIBOSE	3.6.1.13 3.6.1 3.6.1.58 2.7.7.96
2DSD	CRYSTAL STRUCTURE OF HUMAN ADP-RIBOSE PYROPHOSPHATASE NUDT5 IN COMPLEX WITH MAGNESIUM AND AMP	3.6.1.13 3.6.1 3.6.1.58 2.7.7.96
2DSF	STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH XYLOSE AT 2.8A RESOLUTION	3.4.21
2DSK	CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF HYPERTHERMOPHILIC CHITINASE FROM PYROCOCCUS FURIOSUS	3.2.1.14
2DSN	CRYSTAL STRUCTURE OF T1 LIPASE	3.1.1.3
2DSO	CRYSTAL STRUCTURE OF D138N MUTANT OF DRP35, A 35KDA DRUG RESPONSIVE PROTEIN FROM STAPHYLOCOCCUS AUREUS	3.1.1.25 3.1.1
2DUA	CRYSTAL STRUCTURE OF PHOSPHONOPYRUVATE HYDROLASE COMPLEX WITH OXALATE AND MG++	3.11.1.3
2DUC	CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE(3CLPRO)	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2DUJ	CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PROTEINASE K AND A SYNTHETIC PEPTIDE LEU-LEU-PHE-ASN-ASP AT 1.67 A RESOLUTION	3.4.21.64
2DUK	CRYSTAL STRUCTURE OF MS0616	3.6.1.52 3.6.1
2DVC	STRUCTURE OF THE BOVINE LACTOFERRIN C-LOBE COMPLEX WITH SUCROSE AT 3.0 A RESOLUTION	3.4.21
2DVN	STRUCTURE OF PH1917 PROTEIN WITH THE COMPLEX OF IMP FROM PYROCOCCUS HORIKOSHII	3.6.1.66
2DVO	STRUCTURE OF PH1917 PROTEIN WITH THE COMPLEX OF ITP FROM PYROCOCCUS HORIKOSHII	3.6.1.66
2DVP	STRUCTURE OF NTPASE FROM PYROCCOUS HORIKOSHII	3.6.1.66
2DW0	CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-1 CRYSTAL)	3.4.24
2DW1	CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-2 CRYSTAL)	3.4.24
2DW2	CRYSTAL STRUCTURE OF VAP2 FROM CROTALUS ATROX VENOM (FORM 2-5 CRYSTAL)	3.4.24
2DW5	CRYSTAL STRUCTURE OF HUMAN PEPTIDYLARGININE DEIMINASE 4 IN COMPLEX WITH N-ALPHA-BENZOYL-N5-(2-FLUORO-1-IMINOETHYL)-L-ORNITHINE AMIDE	3.5.3.15
2DWA	STRUCTURE OF THE COMPLEX OF LACTOFERRIN C-TERMINAL HALF WITH FUCOSE AT 2.07 A RESOLUTION	3.4.21
2DWH	CRYSTAL STRUCTURE OF N-ACETYLGLUCOSAMINE COMPLEX OF BOVINE LACTOFERRIN C-LOBE AT 2.8 A RESOLUTION	3.4.21
2DWI	CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN C-TERMINAL HALF OF BOVINE LACTOFERRIN AND CELLOBIOSE AT 2.2 A RESOLUTION	3.4.21
2DWJ	STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH RAFFINOSE AT 2.3 A RESOLUTION	3.4.21
2DWL	CRYSTAL STRUCTURE OF THE PRIA PROTEIN COMPLEXED WITH OLIGONUCLEOTIDES	3.6.1 3.6.4
2DWM	CRYSTAL STRUCTURE OF THE PRIA PROTEIN COMPLEXED WITH OLIGONUCLEOTIDES	3.6.1 3.6.4
2DWN	CRYSTAL STRUCTURE OF THE PRIA PROTEIN COMPLEXED WITH OLIGONUCLEOTIDES	3.6.4
2DWO	PFKFB3 IN COMPLEX WITH ADP AND PEP	2.7.1.105 3.1.3.46
2DWP	A PSEUDO SUBSTRATE COMPLEX OF 6-PHOSPHOFRUCTO-2-KINASE OF PFKFB	2.7.1.105 3.1.3.46
2DX0	CRYSTAL STRUCTURE OF THE N-TERMINAL SH2 DOMAIN OF MOUSE PHOSPHOLIPASE C-GAMMA 2	3.1.4.11
2DXC	RECOMBINANT THIOCYANATE HYDROLASE, FULLY-MATURED FORM	3.5.5.8
2DXL	GLYCEROPHOSPHODIESTERASE FROM ENTEROBACTER AEROGENES	3.1.4.46 3.1.4.53
2DXN	GLYCEROPHOSPHODIESTERASE FROM ENTEROBACTER AEROGENES	3.1.4.46 3.1.4.53
2DXP	CRYSTAL STRUCTURE OF THE COMPLEX OF THE ARCHAEAL SULFOLOBUS PTP-FOLD PHOSPHATASE WITH PHOSPHOPEPTIDES A-(P)Y-R	3.1.3.48
2DXR	CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN C-TERMINAL HALF OF BOVINE LACTOFERRIN AND SORBITOL AT 2.85 A RESOLUTION	3.4.21
2DXS	CRYSTAL STRUCTURE OF HCV NS5B RNA POLYMERASE COMPLEXED WITH A TETRACYCLIC INHIBITOR	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2DXY	STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH TREHALOSE AT 2.0 A RESOLUTION	3.4.21
2DY7	SOLUTION STRUCTURE OF THE FIRST CHROMODOMAIN OF YEAST CHD1	3.6.1 3.6.4
2DY8	SOLUTION STRUCTURE OF THE SECOND CHROMODOMAIN OF YEAST CHD1	3.6.1 3.6.4
2DYN	DYNAMIN (PLECKSTRIN HOMOLOGY DOMAIN) (DYNPH)	3.6.5.5
2DYU	HELICOBACTER PYLORI FORMAMIDASE AMIF CONTAINS A FINE-TUNED CYSTEINE-GLUTAMATE-LYSINE CATALYTIC TRIAD	3.5.1.49
2DYV	HELICOBACTER PYLORI FORMAMIDASE AMIF CONTAINS A FINE-TUNED CYSTEINE-GLUTAMATE-LYSINE CATALYTIC TRIAD	3.5.1.49
2DYX	STRUCTURE OF THE COMPLEX OF LACTOFERRIN C-LOBE WITH MELIBIOSE AT 2.0 A RESOLUTION	3.4.21
2DZY	CRYSTAL STRUCTURE OF N392A MUTANT OF YEAST BLEOMYCIN HYDROLASE	3.4.22.40
2DZZ	CRYSTAL STRUCTURE OF N392V MUTANT OF YEAST BLEOMYCIN HYDROLASE	3.4.22.40
2E00	CRYSTAL STRUCTURE OF N392L MUTANT OF YEAST BLEOMYCIN HYDROLASE	3.4.22.40
2E01	CRYSTAL STRUCTURE OF H369A MUTANT OF YEAST BLEOMYCIN HYDROLASE	3.4.22.40
2E02	CRYSTAL STRUCTURE OF H369L MUTANT OF YEAST BLEOMYCIN HYDROLASE	3.4.22.40
2E03	CRYSTAL STRUCTURE OF NQ67E MUTANT OF YEAST BLEOMYCIN HYDROLASE	3.4.22.40
2E0L	MUTANT HUMAN RIBONUCLEASE 1 (Q28L, R31L, R32L)	3.1.27.5 4.6.1.18
2E0M	MUTANT HUMAN RIBONUCLEASE 1 (T24L, Q28L, R31L, R32L)	3.1.27.5 4.6.1.18
2E0O	MUTANT HUMAN RIBONUCLEASE 1 (V52L, D53L, N56L, F59L)	3.1.27.5 4.6.1.18
2E0P	THE CRYSTAL STRUCTURE OF CEL44A	3.2.1.4 3.2.1.151
2E0S	CARBOHYDRATE RECOGNITION OF C-TERMINAL HALF OF LACTOFERRIN: CRYSTAL STRUCTURE OF THE COMPLEX OF C-LOBE WITH RHAMNOSE AT 2.15 A RESOLUTION	3.4.21
2E0T	CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF DUAL SPECIFICITY PHOSPHATASE 26, MS0830 FROM HOMO SAPIENS	3.1.3.48 3.1.3.16
2E0W	T391A PRECURSOR MUTANT PROTEIN OF GAMMA-GLUTAMYLTRANSPEPTIDASE FROM ESCHERICHIA COLI	2.3.2.2 3.4.19.13
2E0X	CRYSTAL STRUCTURE OF GAMMA-GLUTAMYLTRANSPEPTIDASE FROM ESCHERICHIA COLI (MONOCLINIC FORM)	2.3.2.2 3.4.19.13
2E0Y	CRYSTAL STRUCTURE OF THE SAMARIUM DERIVATIVE OF MATURE GAMMA-GLUTAMYLTRANSPEPTIDASE FROM ESCHERICHIA COLI	2.3.2.2 3.4.19.13
2E11	THE CRYSTAL STRUCTURE OF XC1258 FROM XANTHOMONAS CAMPESTRIS: A CN-HYDROLASE SUPERFAMILY PROTEIN WITH AN ARSENIC ADDUCT IN THE ACTIVE SITE	3
2E1B	CRYSTAL STRUCTURE OF THE ALAX-M TRANS-EDITING ENZYME FROM PYROCOCCUS HORIKOSHII	6.1.1.7 3.1.1.29
2E1E	CRYSTAL STRUCTURE OF THE HRDC DOMAIN OF HUMAN WERNER SYNDROME PROTEIN, WRN	3.6.1 3.6.4.12 3.1
2E1F	CRYSTAL STRUCTURE OF THE HRDC DOMAIN OF HUMAN WERNER SYNDROME PROTEIN, WRN	3.6.1 3.6.4.12 3.1
2E1P	CRYSTAL STRUCTURE OF PRO-TK-SUBTILISIN	3.4.21.62 3.4.21
2E1S	CRYSTAL STRUCTURE OF THE COMPLEX OF C-TERMINAL HALF OF BOVINE LACTOFERRIN AND ARABINOSE AT 2.7 A RESOLUTION	3.4.21
2E1W	CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE COMPLEXED WITH POTENT INHIBITORS	3.5.4.4
2E25	THE CRYSTAL STRUCTURE OF THE T109S MUTANT OF E. COLI DIHYDROOROTASE COMPLEXED WITH AN INHIBITOR 5-FLUOROOROTATE	3.5.2.3
2E26	CRYSTAL STRUCTURE OF TWO REPEAT FRAGMENT OF REELIN	3.4.21
2E29	SOLUTION STRUCTURE OF THE GUCT DOMAIN FROM HUMAN ATP-DEPENDENT RNA HELICASE DDX50, DEAD BOX PROTEIN 50	3.6.1 3.6.4.13
2E2D	FLEXIBILITY AND VARIABILITY OF TIMP BINDING: X-RAY STRUCTURE OF THE COMPLEX BETWEEN COLLAGENASE-3/MMP-13 AND TIMP-2	3.4.24
2E2K	HELICOBACTER PYLORI FORMAMIDASE AMIF CONTAINS A FINE-TUNED CYSTEINE-GLUTAMATE-LYSINE CATALYTIC TRIAD	3.5.1.49
2E2L	HELICOBACTER PYLORI FORMAMIDASE AMIF CONTAINS A FINE-TUNED CYSTEINE-GLUTAMATE-LYSINE CATALYTIC TRIAD	3.5.1.49
2E3J	THE CRYSTAL STRUCTURE OF EPOXIDE HYDROLASE B (RV1938) FROM MYCOBACTERIUM TUBERCULOSIS AT 2.1 ANGSTROM	3.3.2.3 3.3.2.10
2E3W	X-RAY STRUCTURE OF NATIVE RNASE A	3.1.27.5 4.6.1.18
2E3X	CRYSTAL STRUCTURE OF RUSSELL'S VIPER VENOM METALLOPROTEINASE	3.4.24.58
2E3Z	CRYSTAL STRUCTURE OF INTRACELLULAR FAMILY 1 BETA-GLUCOSIDASE BGL1A FROM THE BASIDIOMYCETE PHANEROCHAETE CHRYSOSPORIUM IN SUBSTRATE-FREE FORM	3.2.1.21
2E40	CRYSTAL STRUCTURE OF INTRACELLULAR FAMILY 1 BETA-GLUCOSIDASE BGL1A FROM THE BASIDIOMYCETE PHANEROCHAETE CHRYSOSPORIUM IN COMPLEX WITH GLUCONOLACTONE	3.2.1.21
2E4L	THERMODYNAMIC AND STRUCTURAL ANALYSIS OF THERMOLABILE RNASE HI FROM SHEWANELLA ONEIDENSIS MR-1	3.1.26.4
2E4T	CRYSTAL STRUCTURE OF CEL44A, GH FAMILY 44 ENDOGLUCANASE FROM CLOSTRIDIUM THERMOCELLUM	3.2.1.4 3.2.1.151
2E52	CRYSTAL STRUCTURAL ANALYSIS OF HINDIII RESTRICTION ENDONUCLEASE IN COMPLEX WITH COGNATE DNA AT 2.0 ANGSTROM RESOLUTION	3.1.21.4
2E5K	SOLUTION STRUCTURE OF SH3 DOMAIN IN SUPPRESSOR OF T-CELL RECEPTOR SIGNALING 1	3.1.3.48
2E5T	C-TERMINAL DOMAIN OF EPSILON SUBUNIT OF F1F0-ATP SYNTHASE FROM THE THERMOPHILIC BACILLUS PS3 IN THE PRESENCE OF ATP CONDITION	3.6.3.14
2E5U	C-TERMINAL DOMAIN OF EPSILON SUBUNIT OF F1F0-ATP SYNTHASE FROM THE THERMOPHILIC BACILLUS PS3	3.6.3.14
2E5X	STRUCTURE OF NUCLEOTIDE TRIPHOSPHATE PYROPHOSPHATASE FROM PYROCOCCUS HORIKOSHII OT3	3.6.1.19 3.6.1.66
2E5Y	EPSILON SUBUNIT AND ATP COMPLEX OF F1F0-ATP SYNTHASE FROM THE THERMOPHILIC BACILLUS PS3	3.6.3.14
2E67	CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN TTHB029 FROM THERMUS THERMOPHILUS HB8	3.5.1
2E69	CRYSTAL STRUCTURE OF THE STATIONARY PHASE SURVIVAL PROTEIN SURE FROM THERMUS THERMOPHILUS HB8 IN COMPLEX WITH SULFATE	3.1.3.5
2E6B	CRYSTAL STRUCTURE OF THE STATIONARY PHASE SURVIVAL PROTEIN SURE FROM THERMUS THERMOPHILUS HB8 IN COMPLEX WITH MAGNESIUM AND TUNGSTATE	3.1.3.5
2E6C	CRYSTAL STRUCTURE OF THE STATIONARY PHASE SURVIVAL PROTEIN SURE FROM THERMUS THERMOPHILUS HB8 COCRYSTALLIZED WITH MANGANESE AND AMP	3.1.3.5
2E6E	CRYSTAL STRUCTURE OF THE STATIONARY PHASE SURVIVAL PROTEIN SURE FROM THERMUS THERMOPHILUS HB8	3.1.3.5
2E6H	CRYSTAL STRUCTURE OF E37A MUTANT OF THE STATIONARY PHASE SURVIVAL PROTEIN SURE FROM THERMUS THERMOPHILUS HB8 COCRYSTALLIZED WITH MANGANESE AND AMP	3.1.3.5
2E6L	STRUCTURE OF MOUSE WRN EXONUCLEASE DOMAIN	3.6.1 3.6.4.12 3.1
2E6M	STRUCTURE OF MOUSE WERNER EXONUCLEASE DOMAIN	3.6.1 3.6.4.12 3.1
2E6N	SOLUTION STRUCTURE OF THE TUDOR DOMAIN OF STAPHYLOCOCCAL NUCLEASE DOMAIN-CONTAINING PROTEIN 1	3.1.31.1
2E7V	CRYSTAL STRUCTURE OF SEA DOMAIN OF TRANSMEMBRANE PROTEASE FROM MUS MUSCULUS	3.4.21
2E7Y	HIGH RESOLUTION STRUCTURE OF T. MARITIMA TRNASE Z	3.1.26.11
2E85	CRYSTAL STRUCTURE OF THE HYDROGENASE 3 MATURATION PROTEASE	3.4 3.4.23.51
2E8I	STRUCTURE OF 6-AMINOHEXANOATE-DIMER HYDROLASE, D1 MUTANT	3.5.1.46
2E8O	SOLUTION STRUCTURE OF THE N-TERMINAL SAM-DOMAIN OF THE SAM DOMAIN AND HD DOMAIN CONTAINING PROTEIN 1 (DENDRITIC CELL-DERIVED IFNG-INDUCED PROTEIN) (DCIP) (MONOCYTE PROTEIN 5) (MOP-5)	3.1.5
2E8Y	CRYSTAL STRUCTURE OF PULLULANASE TYPE I FROM BACILLUS SUBTILIS STR. 168	3.2.1.41
2E8Z	CRYSTAL STRUCTURE OF PULLULANASE TYPE I FROM BACILLUS SUBTILIS STR. 168 COMPLEXED WITH ALPHA-CYCLODEXTRIN	3.2.1.41
2E9B	CRYSTAL STRUCTURE OF PULLULANASE TYPE I FROM BACILLUS SUBTILIS STR. 168 COMPLEXED WITH MALTOSE	3.2.1.41
2E9L	CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC NEUTRAL BETA-GLYCOSYLCERAMIDASE (KLOTHO-RELATED PROTE:KLRP) COMPLEX WITH GLUCOSE AND FATTY ACIDS	3.2.1.21
2E9M	CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC NEUTRAL BETA-GLYCOSYLCERAMIDASE (KLOTHO-RELATED PROTE:KLRP) COMPLEX WITH GALACTOSE AND FATTY ACIDS	3.2.1.21
2E9T	FOOT-AND-MOUTH DISEASE VIRUS RNA-POLYMERASE RNA DEPENDENT IN COMPLEX WITH A TEMPLATE-PRIMER RNA AND 5F-UTP	2.7.7.48 3.4.22.28 3.4.22.46 3.6.1.15
2E9Z	FOOT-AND-MOUTH DISEASE VIRUS RNA-POLYMERASE IN COMPLEX WITH A TEMPLATE- PRIMER RNA, ATP AND UTP	2.7.7.48 3.4.22.28 3.4.22.46 3.6.1.15
2EA1	CRYSTAL STRUCTURE OF RIBONUCLEASE I FROM ESCHERICHIA COLI COMPLEXED WITH GUANYLYL-2(PRIME),5(PRIME)-GUANOSINE	3.1.27.6 4.6.1.21
2EA2	H-METAP2 COMPLEXED WITH A773812	3.4.11.18
2EA3	CRYSTAL STRUCTURE OF CELLULOMONAS BOGORIENSIS CHYMOTRYPSIN	3.4.21
2EA4	H-METAP2 COMPLEXED WITH A797859	3.4.11.18
2EAB	CRYSTAL STRUCTURE OF 1,2-A-L-FUCOSIDASE FROM BIFIDOBACTERIUM BIFIDUM (APO FORM)	3.2.1.63
2EAC	CRYSTAL STRUCTURE OF 1,2-A-L-FUCOSIDASE FROM BIFIDOBACTERIUM BIFIDUM IN COMPLEX WITH DEOXYFUCONOJIRIMYCIN	3.2.1.63
2EAD	CRYSTAL STRUCTURE OF 1,2-A-L-FUCOSIDASE FROM BIFIDOBACTERIUM BIFIDUM IN COMPLEX WITH SUBSTRATE	3.2.1.63
2EAE	CRYSTAL STRUCTURE OF 1,2-A-L-FUCOSIDASE FROM BIFIDOBACTERIUM BIFIDUM IN COMPLEXES WITH PRODUCTS	3.2.1.63
2EAR	P21 CRYSTAL OF THE SR CA2+-ATPASE WITH BOUND TG	3.6.3.8 7.2.2.10
2EAT	CRYSTAL STRUCTURE OF THE SR CA2+-ATPASE WITH BOUND CPA AND TG	3.6.3.8 7.2.2.10
2EAU	CRYSTAL STRUCTURE OF THE SR CA2+-ATPASE WITH BOUND CPA IN THE PRESENCE OF CURCUMIN	3.6.3.8 7.2.2.10
2EB0	CRYSTAL STRUCTURE OF METHANOCOCCUS JANNASCHII PUTATIVE FAMILY II INORGANIC PYROPHOSPHATASE	3.6.1.1
2EB1	CRYSTAL STRUCTURE OF THE C-TERMINAL RNASE III DOMAIN OF HUMAN DICER	3.1.26.3
2EBJ	CRYSTAL STRUCTURE OF PYRROLIDONE CARBOXYL PEPTIDASE FROM THERMUS THERMOPHILUS	3.4.19.3
2EBN	CRYSTAL STRUCTURE OF ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1, AN ALPHA(SLASH)BETA-BARREL ENZYME ADAPTED FOR A COMPLEX SUBSTRATE	3.2.1.96
2EBS	CRYSTAL STRUCTURE ANAALYSIS OF OLIGOXYLOGLUCAN REDUCING-END-SPECIFIC CELLOBIOHYDROLASE (OXG-RCBH) D465N MUTANT COMPLEXED WITH A XYLOGLUCAN HEPTASACCHARIDE	3.2.1.150
2EC0	RNA-DEPENDENT RNA POLYMERASE OF FOOT-AND-MOUTH DISEASE VIRUS IN COMPLEX WITH A TEMPLATE-PRIMER RNA AND ATP	2.7.7.48 3.4.22.28 3.4.22.46 3.6.1.15
2EC9	CRYSTAL STRUCTURE ANALYSIS OF HUMAN FACTOR VIIA , SOULUBLE TISSUE FACTOR COMPLEXED WITH BCX-3607	3.4.21.21
2ECF	CRYSTAL STRUCTURE OF DIPEPTIDYL AMINOPEPTIDASE IV FROM STENOTROPHOMONAS MALTOPHILIA	3.4.14.5
2EDA	CRYSTALLOGRAPHIC AND FLUORESCENCE STUDIES OF THE INTERACTION OF HALOALKANE DEHALOGENASE WITH HALIDE IONS: STUDIES WITH HALIDE COMPOUNDS REVEAL A HALIDE BINDING SITE IN THE ACTIVE SITE	3.8.1.5
2EDC	CRYSTALLOGRAPHIC AND FLUORESCENCE STUDIES OF THE INTERACTION OF HALOALKANE DEHALOGENASE WITH HALIDE IONS: STUDIES WITH HALIDE COMPOUNDS REVEAL A HALIDE BINDING SITE IN THE ACTIVE SITE	3.8.1.5
2EDX	SOLUTION STRUCTURES OF THE FN3 DOMAIN OF HUMAN RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE F	3.1.3.48
2EDY	SOLUTION STRUCTURES OF THE FN3 DOMAIN OF HUMAN RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE F	3.1.3.48
2EE1	SOLUTION STRUCTURES OF THE CHROMO DOMAIN OF HUMAN CHROMODOMAIN HELICASE-DNA-BINDING PROTEIN 4	3.6.1 3.6.4.12
2EE4	SOLUTION STRUCTURE OF THE RHOGAP DOMAIN FROM HUMAN RHO GTPASE ACTIVATING PROTEIN 5 VARIANT	3.6.5.2
2EE5	SOLUTION STRUCTURE OF THE N-TERUMINUS EXTENDED RHOGAP DOMAIN FROM HUMAN RHO GTPASE ACTIVATING PROTEIN 5 VARIANT	3.6.5.2
2EEE	SOLUTION STRUCTURE OF THE A1PP DOMAIN FROM HUMAN PROTEIN C6ORF130	3.5.1 3.2.2
2EEK	CRYSTAL STRUCTURE OF ATLANTIC COD TRYPSIN COMPLEXED WITH BENZAMIDINE	3.4.21.4
2EEP	PROLYL TRIPEPTIDYL AMINOPEPTIDASE COMPLEXED WITH AN INHIBITOR	3.4.14 3.4.14.12
2EEX	CRYSTAL STRUCTURE OF CEL44A, GH FAMILY 44 ENDOGLUCANASE FROM CLOSTRIDIUM THERMOCELLUM	3.2.1.4 3.2.1.151
2EF1	CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN CD38	3.2.2.5 3.2.2.6 2.4.99.20
2EF4	CRYSTAL STRUCTURE OF THE ARGINASE FROM THERMUS THERMOPHILUS	3.5.3.1
2EF5	CRYSTAL STRUCTURE OF THE ARGINASE FROM THERMUS THERMOPHILUS	3.5.3.1
2EG6	THE CRYSTAL STRUCTURE OF THE LIGAND-FREE DIHYDROOROTASE FROM E. COLI	3.5.2.3
2EG7	THE CRYSTAL STRUCTURE OF E. COLI DIHYDROOROTASE COMPLEXED WITH HDDP	3.5.2.3
2EG8	THE CRYSTAL STRUCTURE OF E. COLI DIHYDROOROTASE COMPLEXED WITH 5-FLUOROOROTIC ACID	3.5.2.3
2EG9	CRYSTAL STRUCTURE OF THE TRUNCATED EXTRACELLULAR DOMAIN OF MOUSE CD38	3.2.2.5 3.2.2.6 2.4.99.20
2EGI	CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN(AQ1494) FROM AQUIFEX AEOLICUS	3.1
2EGJ	CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN(AQ1494) FROM AQUIFEX AEOLICUS	3.1
2EGR	CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN(AQ1494) FROM AQUIFEX AEOLICUS	3.1
2EHG	CRYSTAL STRUCTURE OF HYPERTHERMOPHILIC ARCHAEAL RNASE HI	3.1.26.4
2EI6	FACTOR XA IN COMPLEX WITH THE INHIBITOR (-)-CIS-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL)CARBONYL]-1,2-CYCLOHEXANEDIAMINE	3.4.21.6
2EI7	FACTOR XA IN COMPLEX WITH THE INHIBITOR TRANS-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL)CARBONYL]-1,2-CYCLOHEXANEDIAMINE	3.4.21.6
2EI8	FACTOR XA IN COMPLEX WITH THE INHIBITOR (1S,2R,4S)-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-4-(N,N-DIMETHYLCARBAMOYL)-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL)CARBONYL]-1,2-CYCLOHEXANEDIAMINE	3.4.21.6
2EIP	INORGANIC PYROPHOSPHATASE	3.6.1.1
2EJ1	CRYSTAL STRUCTURE OF CEL44A, GH FAMILY 44 ENDOGLUCANASE FROM CLOSTRIDIUM THERMOCELLUM	3.2.1.4 3.2.1.151
2EKI	SOLUTION STRUCTURES OF THE TGS DOMAIN OF HUMAN DEVELOPMENTALLY-REGULATED GTP-BINDING PROTEIN 1	3.6.5
2ENB	CRYSTAL STRUCTURES OF THE BINARY CA2+ AND PDTP COMPLEXES AND THE TERNARY COMPLEX OF THE ASP 21->GLU MUTANT OF STAPHYLOCOCCAL NUCLEASE. IMPLICATIONS FOR CATALYSIS AND LIGAND BINDING	3.1.31.1
2END	CRYSTAL STRUCTURE OF A PYRIMIDINE DIMER SPECIFIC EXCISION REPAIR ENZYME FROM BACTERIOPHAGE T4: REFINEMENT AT 1.45 ANGSTROMS AND X-RAY ANALYSIS OF THE THREE ACTIVE SITE MUTANTS	3.1.25.1 3.2.2.17 4.2.99.18
2ENG	ENDOGLUCANASE V	3.2.1.4
2ENU	MUTANT L121M STRUCTURE OF TTHB049 FROM THERMUS THERMOPHILUS HB8	3.1.3.73
2ENW	MUTANT Y92H STRUCTURE OF TTHB049 FROM THERMUS THERMOPHILUS HB8	3.1.3.73
2ENX	STRUCTURE OF THE FAMILY II INORGANIC PYROPHOSPHATASE FROM STREPTOCOCCUS AGALACTIAE AT 2.8 RESOLUTION	3.6.1.1
2EO0	CRYSTAL STRUCTURE OF HOLLIDAY JUNCTION RESOLVASE ST1444	3.1.22.4
2EO7	CRYSTAL STRUCTURE OF CEL44A, GH FAMILY 44 ENDOGLUCANASE FROM CLOSTRIDIUM THERMOCELLUM	3.2.1.4 3.2.1.151
2EO8	CRYSTAL STRUCTURE OF A MUTANT PYRROLIDONE CARBOXYL PEPTIDASE (A199P) FROM P. FURIOSUS	3.4.19.3
2EOA	STRUCTURAL STUDY OF PROJECT ID TTHB049 FROM THERMUS THERMOPHILUS HB8 (W85H)	3.1.3.73
2EOB	SOLUTION STRUCTURE OF THE SECOND SH2 DOMAIN FROM RAT PLC GAMMA-2	3.1.4.11
2EPB	SOLUTION STRUCTURE OF CHROMO DOMAIN 2 IN CHROMODOMAIN-HELICASE-DNA-BINDING PROTEIN 6	3.6.1 3.6.4.12
2EPE	CRYSTAL STRUCTURE ANALYSIS OF HEN EGG WHITE LYSOZYME GROWN BY CAPILLARY METHOD	3.2.1.17
2EPK	N-ACETYL-B-D-GLUCOSAMINIDASE (GCNA) FROM STREPTOCOCCUS GORDONII	3.2.1.52
2EPL	N-ACETYL-B-D-GLUCOSAMINIDASE (GCNA) FROM STREPTOCOCCUS GORDONII	3.2.1.52
2EPM	N-ACETYL-B-D-GLUCOASMINIDASE (GCNA) FROM STRETOCOCCUS GORDONII	3.2.1.52
2EPN	N-ACETYL-B-D-GLUCOSAMINIDASE (GCNA) FROM STREPTOCOCCUS GORDONII	3.2.1.52
2EPO	N-ACETYL-B-D-GLUCOSAMINIDASE (GCNA) FROM STREPTOCOCCUS GORDONII	3.2.1.52
2EQD	CRYSTAL STRUCTURE OF CEL44A, GH FAMILY 44 ENDOGLUCANASE FROM CLOSTRIDIUM THERMOCELLUM	3.2.1.4 3.2.1.151
2EQE	SOLUTION STRUCTURE OF THE FOURTH A20-TYPE ZINC FINGER DOMAIN FROM HUMAN TUMOR NECROSIS FACTOR, ALPHA-INDUCED PROTEIN3	3 2.3.2 3.4.19.12
2EQF	SOLUTION STRUCTURE OF THE 7TH A20-TYPE ZINC FINGER DOMAIN FROM HUMAN TUMOR NECROSIS FACTOR, ALPHA-INDUCED PROTEIN3	3 2.3.2 3.4.19.12
2EQG	SOLUTION STRUCTURE OF THE FIRST A20-TYPE ZINC FINGER DOMAIN FROM HUMAN TUMOR NECROSIS FACTOR, ALPHA-INDUCED PROTEIN3	3 2.3.2 3.4.19.12
2EQI	SOLUTION STRUCTURE OF THE SH3 DOMAIN FROM PHOSPHOLIPASE C, GAMMA 2	3.1.4.11
2EQL	CRYSTALLOGRAPHIC STUDIES OF A CALCIUM BINDING LYSOZYME FROM EQUINE MILK AT 2.5 ANGSTROMS RESOLUTION	3.2.1.17
2EQS	SOLUTION STRUCTURE OF THE S1 RNA BINDING DOMAIN OF HUMAN ATP-DEPENDENT RNA HELICASE DHX8	3.6.1 3.6.4.13
2ER0	X-RAY STUDIES OF ASPARTIC PROTEINASE-STATINE INHIBITOR COMPLEXES	3.4.23.6 3.4.23.22
2ER6	THE STRUCTURE OF A SYNTHETIC PEPSIN INHIBITOR COMPLEXED WITH ENDOTHIAPEPSIN.	3.4.23.6 3.4.23.22
2ER7	X-RAY ANALYSES OF ASPARTIC PROTEINASES.III. THREE-DIMENSIONAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH A TRANSITION-STATE ISOSTERE INHIBITOR OF RENIN AT 1.6 ANGSTROMS RESOLUTION	3.4.23.6 3.4.23.22
2ER9	X-RAY STUDIES OF ASPARTIC PROTEINASE-STATINE INHIBITOR COMPLEXES.	3.4.23.6 3.4.23.22
2ERO	CRYSTAL STRUCTURE OF VASCULAR APOPTOSIS-INDUCING PROTEIN-1(ORTHORHOMBIC CRYSTAL FORM)	3.4.24
2ERP	CRYSTAL STRUCTURE OF VASCULAR APOPTOSIS-INDUCING PROTEIN-1(INHIBITOR-BOUND FORM)	3.4.24
2ERQ	CRYSTAL STRUCTURE OF VASCULAR APOPTOSIS-INDUCING PROTEIN-1(TETRAGONAL CRYSTAL FORM)	3.4.24
2ERV	CRYSTAL STRUCTURE OF THE OUTER MEMBRANE ENZYME PAGL	3.1.1.77
2ERY	THE CRYSTAL STRUCTURE OF THE RAS RELATED PROTEIN RRAS2 (RRAS2) IN THE GDP BOUND STATE	3.6.5
2ES4	CRYSTAL STRUCTURE OF THE BURKHOLDERIA GLUMAE LIPASE-SPECIFIC FOLDASE IN COMPLEX WITH ITS COGNATE LIPASE	3.1.1.3
2ESB	CRYSTAL STRUCTURE OF HUMAN DUSP18	3.1.3.48 3.1.3.16
2EST	CRYSTALLOGRAPHIC STUDY OF THE BINDING OF A TRIFLUOROACETYL DIPEPTIDE ANILIDE INHIBITOR WITH ELASTASE	3.4.21.36
2ETF	CRYSTAL STRUCTURE OF FULL LENGTH BOTULINUM NEUROTOXIN (TYPE B) LIGHT CHAIN	3.4.24.69
2ETJ	CRYSTAL STRUCTURE OF RIBONUCLEASE HII (EC 3.1.26.4) (RNASE HII) (TM0915) FROM THERMOTOGA MARITIMA AT 1.74 A RESOLUTION	3.1.26.4
2ETL	CRYSTAL STRUCTURE OF UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 (UCH-L1)	3.4.19.12 6
2EUG	CRYSTAL STRUCTURE OF ESCHERICHIA COLI URACIL DNA GLYCOSYLASE AND ITS COMPLEXES WITH URACIL AND GLYCEROL: STRUCTURE AND GLYCOSYLASE MECHANISM REVISITED	3.2.2.3 3.2.2.27
2EVC	CRYSTAL STRUCTURE OF E. COLI. METHIONINE AMINO PEPTIDASE IN COMPLEX WITH 5-(2-(TRIFLUOROMETHYL)PHENYL)FURAN-2-CARBOXYLIC ACID	3.4.11.18
2EVM	CRYSTAL STRUCTURE OF METHIONINE AMINOPEPTIDASE IN COMPLEX WITH 5-(2,5-DICHLOROPHENYL)FURAN-2-CARBOXYLIC ACID	3.4.11.18
2EVO	CRYSTAL STRUCTURE OF METHIONINE AMINO PEPTIDASE IN COMPLEX WITH N-CYCLOPENTYL-N-(THIAZOL-2-YL)OXALAMIDE	3.4.11.18
2EVW	CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH R-CAGED GTP	3.6.5.2
2EW5	STRUCTURE OF HELICOBACTER PYLORI PEPTIDE DEFORMYLASE IN COMPLEX WITH INHIBITOR	3.5.1.88
2EW7	CRYSTAL STRUCTURE OF HELICOBACTER PYLORI PEPTIDE DEFORMYLASE	3.5.1.88
2EW9	SOLUTION STRUCTURE OF APOWLN5-6	3.6.3.4 7.2.2.8
2EWB	THE CRYSTAL STRUCTURE OF BOVINE LENS LEUCINE AMINOPEPTIDASE IN COMPLEX WITH ZOFENOPRILAT	3.4.11.1 3.4.13.23 3.4.11.5
2EWY	CRYSTAL STRUCTURE OF HUMAN BACE2 IN COMPLEX WITH A HYDROXYETHYLENAMINE TRANSITION-STATE INHIBITOR	3.4.23.45
2EX2	CRYSTAL STRUCTURE OF PENICILLIN BINDING PROTEIN 4 (DACB) FROM ESCHERICHIA COLI	3.4.16.4 3.4.99 3.4.21
2EX5	GROUP I INTRON-ENCODED HOMING ENDONUCLEASE I-CEUI COMPLEXED WITH DNA	3.1
2EX6	CRYSTAL STRUCTURE OF PENICILLIN BINDING PROTEIN 4 (DACB) FROM ESCHERICHIA COLI, COMPLEXED WITH AMPICILLIN	3.4.16.4 3.4.99 3.4.21
2EX8	CRYSTAL STRUCTURE OF PENICILLIN BINDING PROTEIN 4 (DACB) FROM ESCHERICHIA COLI, COMPLEXED WITH PENICILLIN-G	3.4.16.4 3.4.99 3.4.21
2EX9	CRYSTAL STRUCTURE OF PENICILLIN BINDING PROTEIN 4 (DACB) FROM ESCHERICHIA COLI, COMPLEXED WITH PENICILLIN-V	3.4.16.4 3.4.99 3.4.21
2EXA	CRYSTAL STRUCTURE OF PENICILLIN BINDING PROTEIN 4 (DACB) FROM ESCHERICHIA COLI, COMPLEXED WITH FAROM	3.4.16.4 3.4.99 3.4.21
2EXB	CRYSTAL STRUCTURE OF PENICILLIN BINDING PROTEIN 4 (DACB) FROM ESCHERICHIA COLI, COMPLEXED WITH FLOMOX	3.4.16.4 3.4.99 3.4.21
2EXH	STRUCTURE OF THE FAMILY43 BETA-XYLOSIDASE FROM GEOBACILLUS STEAROTHERMOPHILUS	3.2.1.37
2EXI	STRUCTURE OF THE FAMILY43 BETA-XYLOSIDASE D15G MUTANT FROM GEOBACILLUS STEAROTHERMOPHILUS	3.2.1.37
2EXJ	STRUCTURE OF THE FAMILY43 BETA-XYLOSIDASE D128G MUTANT FROM GEOBACILLUS STEAROTHERMOPHILUS IN COMPLEX WITH XYLOBIOSE	3.2.1.37
2EXK	STRUCTURE OF THE FAMILY43 BETA-XYLOSIDASE E187G FROM GEOBACILLUS STEAROTHERMOPHILUS IN COMPLEX WITH XYLOBIOSE	3.2.1.37
2EXO	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE BETA-1,4-GLYCANASE CEX FROM CELLULOMONAS FIMI	3.2.1.91 3.2.1.8
2EXZ	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT T22C	3.1.31.1
2EY1	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT T22V	3.1.31.1
2EY2	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT T41C	3.1.31.1
2EY5	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT T41S	3.1.31.1
2EY6	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT T41V	3.1.31.1
2EYF	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT T44V	3.1.31.1
2EYH	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT T62S	3.1.31.1
2EYJ	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT T62V	3.1.31.1
2EYL	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT T82S	3.1.31.1
2EYM	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT T120C	3.1.31.1
2EYO	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT T120S	3.1.31.1
2EYP	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT T120V	3.1.31.1
2EYQ	CRYSTAL STRUCTURE OF ESCHERICHIA COLI TRANSCRIPTION-REPAIR COUPLING FACTOR	3.6.4
2EZ6	CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS RNASE III (D44N) COMPLEXED WITH PRODUCT OF DOUBLE-STRANDED RNA PROCESSING	3.1.26.3
2EZH	SOLUTION NMR STRUCTURE OF THE IGAMMA SUBDOMAIN OF THE MU END DNA BINDING DOMAIN OF MU PHAGE TRANSPOSASE, MINIMIZED AVERAGE STRUCTURE	3.1.22 6.5.1
2EZI	SOLUTION NMR STRUCTURE OF THE IGAMMA SUBDOMAIN OF THE MU END DNA BINDING DOMAIN OF MU PHAGE TRANSPOSASE, 30 STRUCTURES	3.1.22 6.5.1
2EZK	SOLUTION NMR STRUCTURE OF THE IBETA SUBDOMAIN OF THE MU END DNA BINDING DOMAIN OF PHAGE MU TRANSPOSASE, REGULARIZED MEAN STRUCTURE	3.1.22 6.5.1
2EZL	SOLUTION NMR STRUCTURE OF THE IBETA SUBDOMAIN OF THE MU END DNA BINDING DOMAIN OF PHAGE MU TRANSPOSASE, 29 STRUCTURES	3.1.22 6.5.1
2F03	CRYSTAL STRUCTURE OF TETRAMERIC RESTRICTION ENDONUCLEASE SFII IN COMPLEX WITH COGNATE DNA (PARTIAL BOUND FORM)	3.1.21.4
2F0D	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT I92V	3.1.31.1
2F0E	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V23L	3.1.31.1
2F0F	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT L25I	3.1.31.1
2F0G	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V66I	3.1.31.1
2F0H	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V66L	3.1.31.1
2F0I	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT I72L	3.1.31.1
2F0J	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT I72V	3.1.31.1
2F0K	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V23I/L25I	3.1.31.1
2F0L	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V23L/I72L	3.1.31.1
2F0M	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V23L/I72V	3.1.31.1
2F0N	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT L25I/I72L	3.1.31.1
2F0O	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V66I/I72V	3.1.31.1
2F0P	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V66I/V99I	3.1.31.1
2F0Q	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V66L/I92L	3.1.31.1
2F0S	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V66L/I92V	3.1.31.1
2F0T	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V66L/V99I	3.1.31.1
2F0U	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V23I/L25I/I72V	3.1.31.1
2F0V	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V23L/V66L/I72L	3.1.31.1
2F0W	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V23I/L25I/V66L/I72L	3.1.31.1
2F0Z	CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN COMPLEX WITH ZANAMIVIR INHIBITOR	3.2.1.18
2F10	CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN COMPLEX WITH PERAMIVIR INHIBITOR	3.2.1.18
2F11	CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN COMPLEX WITH ISOBUTYL ETHER MIMETIC INHIBITOR	3.2.1.18
2F12	CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN COMPLEX WITH 3- HYDROXYPROPYL ETHER MIMETIC INHIBITOR	3.2.1.18
2F13	CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 IN COMPLEX WITH 2',3'- DIHYDROXYPROPYL ETHER MIMETIC INHIBITOR	3.2.1.18
2F18	GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH (2R,3R,4S)-2-({[(1R)-2-HYDROXY-1-PHENYLETHYL]AMINO}METHYL)PYRROLIDINE-3,4-DIOL	3.2.1.114
2F1A	GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH (2R,3R,4S)-2-({[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}METHYL)PYRROLIDINE-3,4-DIOL	3.2.1.114
2F1B	GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH (2R,3R,4S,5R)-2-({[(1R)-2-HYDROXY-1-PHENYLETHYL]AMINO}METHYL)-5-METHYLPYRROLIDINE-3,4-DIOL	3.2.1.114
2F1G	CATHEPSIN S IN COMPLEX WITH NON-COVALENT 2-(BENZOXAZOL-2-YLAMINO)-ACETAMIDE	3.4.22.27
2F1N	STRUCTURE OF CDTB, THE BIOLOGICALLY ACTIVE SUBUNIT OF CYTOLETHAL DISTENDING TOXIN	3.1
2F1W	CRYSTAL STRUCTURE OF THE TRAF-LIKE DOMAIN OF HAUSP/USP7	3.1.2.15 3.4.19.12
2F1X	CRYSTAL STRUCTURE OF THE TRAF-LIKE DOMAIN OF HAUSP/USP7 BOUND TO A P53 PEPTIDE	3.4.19.12
2F1Y	CRYSTAL STRUCTURE OF THE TRAF-LIKE DOMAIN OF HAUSP/USP7 BOUND TO A MDM2 PEPTIDE	3.4.19.12
2F1Z	CRYSTAL STRUCTURE OF HAUSP	3.1.2.15 3.4.19.12
2F20	X-RAY CRYSTAL STRUCTURE OF PROTEIN BT_1218 FROM BACTEROIDES THETAIOTAOMICRON. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BTR8.	3.4
2F24	CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 E111Q MUTANT	3.2.1.18
2F25	CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 E111Q MUTANT IN COMPLEX WITH DANA INHIBITOR	3.2.1.18
2F26	CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 E111Q-Q112E DOUBLE MUTANT	3.2.1.18
2F27	CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 E111Q-Q112E DOUBLE MUTANT IN COMPLEX WITH DANA INHIBITOR	3.2.1.18
2F28	CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 Q116E MUTANT	3.2.1.18
2F29	CRYSTAL STRUCTURE OF THE HUMAN SIALIDASE NEU2 Q116E MUTANT IN COMPLEX WITH DANA INHIBITOR	3.2.1.18
2F2G	X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT3G16990	3.5.1 3.5.99.2
2F2N	TRICLINIC HEN EGG LYSOZYME CROSS-LINKED BY GLUTARALDEHYDE	3.2.1.17
2F2O	STRUCTURE OF CALMODULIN BOUND TO A CALCINEURIN PEPTIDE: A NEW WAY OF MAKING AN OLD BINDING MODE	3.1.3.16
2F2P	STRUCTURE OF CALMODULIN BOUND TO A CALCINEURIN PEPTIDE: A NEW WAY OF MAKING AN OLD BINDING MODE	3.1.3.16
2F2Q	HIGH RESOLUTION CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT L20R63/A LIGANDED TO GUANIDINIUM ION	3.2.1.17
2F30	TRICLINIC CROSS-LINKED LYSOZYME SOAKED WITH 4.5M UREA	3.2.1.17
2F32	XRAY CRYSTAL STRUCTURE OF LYSOZYME MUTANT L20/R63A LIGANDED TO ETHYLGUANIDINIUM	3.2.1.17
2F3B	MECHANISM OF DISPLACEMENT OF A CATALYTICALLY ESSENTIAL LOOP FROM THE ACTIVE SITE OF FRUCTOSE-1,6-BISPHOSPHATASE	3.1.3.11
2F3C	CRYSTAL STRUCTURE OF INFESTIN 1, A KAZAL-TYPE SERINEPROTEASE INHIBITOR, IN COMPLEX WITH TRYPSIN	3.4.21.4
2F3D	MECHANISM OF DISPLACEMENT OF A CATALYTICALLY ESSENTIAL LOOP FROM THE ACTIVE SITE OF FRUCTOSE-1,6-BISPHOSPHATASE	3.1.3.11
2F3E	CRYSTAL STRUCTURE OF THE BACE COMPLEX WITH AXQ093, A MACROCYCLIC INHIBITOR	3.4.23.46
2F3F	CRYSTAL STRUCTURE OF THE BACE COMPLEX WITH BDF488, A MACROCYCLIC INHIBITOR	3.4.23.46
2F3K	SUBSTRATE ENVELOPE AND DRUG RESISTANCE: CRYSTAL STRUCTURE OF R01 IN COMPLEX WITH WILD-TYPE HIV-1 PROTEASE	3.4.23.16
2F3V	SOLUTION STRUCTURE OF 1-110 FRAGMENT OF STAPHYLOCOCCAL NUCLEASE WITH V66W MUTATION	3.1.31.1
2F3W	SOLUTION STRUCTURE OF 1-110 FRAGMENT OF STAPHYLOCOCCAL NUCLEASE IN 2M TMAO	3.1.31.1
2F43	RAT LIVER F1-ATPASE	3.6.3.14
2F47	XRAY CRYSTAL STRUCTURE OF T4 LYSOZYME MUTANT L20/R63A LIGANDED TO METHYLGUANIDINIUM	3.2.1.17
2F4A	TRICLINIC CROSS-LINKED LYSOZYME SOAKED WITH THIOUREA 1.5M	3.2.1.17
2F4G	TRICLINIC CROSS-LINKED LYSOZYME SOAKED IN BROMOETHANOL 1M	3.2.1.17
2F4M	THE MOUSE PNGASE-HR23 COMPLEX REVEALS A COMPLETE REMODULATION OF THE PROTEIN-PROTEIN INTERFACE COMPARED TO ITS YEAST ORTHOLOGS	3.5.1.52
2F4O	THE MOUSE PNGASE-HR23 COMPLEX REVEALS A COMPLETE REMODULATION OF THE PROTEIN-PROTEIN INTERFACE COMPARED TO ITS YEAST ORTHOLOGS	3.5.1.52
2F4Y	BARNASE CROSS-LINKED WITH GLUTARALDEHYDE	3.1.27
2F55	TWO HEPATITIS C VIRUS NS3 HELICASE DOMAINS COMPLEXED WITH THE SAME STRAND OF DNA	3.6.1 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2F56	BARNASE CROSS-LINKED WITH GLUTARALDEHYDE SOAKED IN 6M UREA	3.1.27
2F5M	CROSS-LINKED BARNASE SOAKED IN BROMO-ETHANOL	3.1.27
2F5N	MUTM CROSSLINKED TO UNDAMAGED DNA SAMPLING A:T BASE PAIR IC1	3.2.2.23 4.2.99.18
2F5O	MUTM CROSSLINKED TO UNDAMAGED DNA SAMPLING G:C BASE PAIR IC3	3.2.2.23 4.2.99.18
2F5P	MUTM CROSSLINKED TO UNDAMAGED DNA SAMPLING A:T BASE PAIR IC2	3.2.2.23 4.2.99.18
2F5Q	CATALYTICALLY INACTIVE (E3Q) MUTM CROSSLINKED TO OXOG:C CONTAINING DNA CC2	3.2.2.23 4.2.99.18
2F5S	CATALYTICALLY INACTIVE (E3Q) MUTM CROSSLINKED TO OXOG:C CONTAINING DNA CC1	3.2.2.23 4.2.99.18
2F5W	CROSS-LINKED BARNASE SOAKED IN 3 M THIOUREA	3.1.27
2F61	CRYSTAL STRUCTURE OF PARTIALLY DEGLYCOSYLATED ACID BETA-GLUCOSIDASE	3.2.1.45 2.4.1 3.2.1
2F6B	STRUCTURAL AND ACTIVE SITE MODIFICATION STUDIES IMPLICATE GLU, TRP AND ARG IN THE ACTIVITY OF XYLANASE FROM ALKALOPHILIC BACILLUS SP. (NCL 87-6-10).	3.2.1.8
2F6D	STRUCTURE OF THE COMPLEX OF A GLUCOAMYLASE FROM SACCHAROMYCOPSIS FIBULIGERA WITH ACARBOSE	3.2.1.3
2F6E	CLOSTRIDIUM DIFFICILE TOXIN A C-TERMINAL FRAGMENT 1 (TCDA-F1)	3.4.22 2.4.1
2F6F	THE STRUCTURE OF THE S295F MUTANT OF HUMAN PTP1B	3.1.3.48
2F6I	CRYSTAL STRUCTURE OF THE CLPP PROTEASE CATALYTIC DOMAIN FROM PLASMODIUM FALCIPARUM	3.4.21.92
2F6T	PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS	3.1.3.48
2F6V	PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS	3.1.3.48
2F6W	PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS	3.1.3.48
2F6Y	PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS	3.1.3.48
2F6Z	PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS	3.1.3.48
2F70	PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS	3.1.3.48
2F71	PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS	3.1.3.48
2F7D	A MUTANT RABBIT CATHEPSIN K WITH A NITRILE INHIBITOR	3.4.22.38
2F7O	GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH MANNOSTATIN A	3.2.1.114
2F7P	GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH BENZYL-MANNOSTATIN A	3.2.1.114
2F7Q	GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH AMINOCYCLOPENTITETROL	3.2.1.114
2F7R	GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH BENZYL-AMINOCYCLOPENTITETROL	3.2.1.114
2F7S	THE CRYSTAL STRUCTURE OF HUMAN RAB27B BOUND TO GDP	3.6.5.2
2F7T	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MOS1 MARINER TRANSPOSASE	3.1
2F7V	STRUCTURE OF ACETYLCITRULLINE DEACETYLASE COMPLEXED WITH ONE CO	3.5.1.16 3.5.1
2F80	HIV-1 PROTEASE MUTANT D30N COMPLEXED WITH INHIBITOR TMC114	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2F81	HIV-1 PROTEASE MUTANT L90M COMPLEXED WITH INHIBITOR TMC114	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2F83	CRYSTAL STRUCTURE AT 2.9 ANGSTROMS RESOLUTION OF HUMAN PLASMA COAGULATION FACTOR XI ZYMOGEN	3.4.21.27
2F8G	HIV-1 PROTEASE MUTANT I50V COMPLEXED WITH INHIBITOR TMC114	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2F8H	STRUCTURE OF ACETYLCITRULLINE DEACETYLASE FROM XANTHOMONAS CAMPESTRIS IN METAL-FREE FORM	3.5.1.16 3.5.1
2F8Q	AN ALKALI THERMOSTABLE F/10 XYLANASE FROM ALKALOPHILIC BACILLUS SP. NG-27	3.2.1.8
2F90	CRYSTAL STRUCTURE OF BISPHOSPHOGLYCERATE MUTASE IN COMPLEX WITH 3-PHOSPHOGLYCERATE AND ALF4-	5.4.2.4 5.4.2.1 3.1.3.13 5.4.2.11
2F91	1.2A RESOLUTION STRUCTURE OF A CRAYFISH TRYPSIN COMPLEXED WITH A PEPTIDE INHIBITOR, SGTI	3.4.21.4
2F96	2.1 A CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA RNASE T (RIBONUCLEASE T)	3.1.13
2F9B	DISCOVERY OF NOVEL HETEROCYCLIC FACTOR VIIA INHIBITORS	3.4.21.21
2F9L	3D STRUCTURE OF INACTIVE HUMAN RAB11B GTPASE	3.6.5.2
2F9M	3D STRUCTURE OF ACTIVE HUMAN RAB11B GTPASE	3.6.5.2
2F9N	CRYSTAL STRUCTURE OF THE RECOMBINANT HUMAN ALPHA I TRYPTASE MUTANT K192Q/D216G IN COMPLEX WITH LEUPEPTIN	3.4.21.59
2F9O	CRYSTAL STRUCTURE OF THE RECOMBINANT HUMAN ALPHA I TRYPTASE MUTANT D216G	3.4.21.59
2F9P	CRYSTAL STRUCTURE OF THE RECOMBINANT HUMAN ALPHA I TRYPTASE MUTANT D216G IN COMPLEX WITH LEUPEPTIN	3.4.21.59
2F9V	HCV NS3 PROTEASE DOMAIN WITH NS4A PEPTIDE AND A KETOAMIDE INHIBITOR WITH P1 AND P2 CYCLOPROPYLALANNINES	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2F9Z	COMPLEX BETWEEN THE CHEMOTAXIS DEAMIDASE CHED AND THE CHEMOTAXIS PHOSPHATASE CHEC FROM THERMOTOGA MARITIMA	3
2FA7	CRYSTAL STRUCTURE OF THE COMPLEX OF BOVINE LACTOFERRIN C-LOBE WITH A PENTASACCHARIDE AT 2.38 A RESOLUTION	3.4.21
2FAV	CRYSTAL STRUCTURE OF SARS MACRO DOMAIN IN COMPLEX WITH ADP-RIBOSE AT 1.8 A RESOLUTION	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2FBA	GLUCOAMYLASE FROM SACCHAROMYCOPSIS FIBULIGERA AT ATOMIC RESOLUTION	3.2.1.3
2FBB	CRYSTAL STRUCTURE ANALYSIS OF HEXAGONAL LYSOZYME	3.2.1.17
2FBD	THE CRYSTALLOGRAPHIC STRUCTURE OF THE DIGESTIVE LYSOZYME 1 FROM MUSCA DOMESTICA AT 1.90 ANG.	3.2.1.17
2FBL	THE CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN NE1496	3.6.1.25
2FBO	CRYSTAL STRUCTURE OF THE TWO TANDEM V-TYPE REGIONS OF VCBP3 (V-REGION-CONTAINING CHITIN BINDING PROTEIN) TO 1.85 A	3.2.1.14
2FBP	STRUCTURE REFINEMENT OF FRUCTOSE-1,6-BISPHOSPHATASE AND ITS FRUCTOSE 2,6-BISPHOSPHATE COMPLEX AT 2.8 ANGSTROMS RESOLUTION	3.1.3.11
2FBT	WRN EXONUCLEASE	2.7.7 3.6.4.12 3.1
2FBV	WRN EXONUCLEASE, MN COMPLEX	2.7.7 3.6.4.12 3.1
2FBX	WRN EXONUCLEASE, MG COMPLEX	2.7.7 3.6.4.12 3.1
2FBY	WRN EXONUCLEASE, EU COMPLEX	2.7.7 3.6.4.12 3.1
2FC0	WRN EXONUCLEASE, MN DGMP COMPLEX	2.7.7 3.6.4.12 3.1
2FCC	CRYSTAL STRUCTURE OF T4 PYRIMIDINE DIMER GLYCOSYLASE (T4-PDG) COVALENTLY COMPLEXED WITH A DNA SUBSTRATE CONTAINING ABASIC SITE	3.1.25.1 3.2.2.17 4.2.99.18
2FCI	STRUCTURAL BASIS FOR THE REQUIREMENT OF TWO PHOSPHOTYROSINES IN SIGNALING MEDIATED BY SYK TYROSINE KINASE	3.1.4.11
2FCO	CRYSTAL STRUCTURE OF BACILLUS STEAROTHERMOPHILUS PRFA-HOLLIDAY JUNCTION RESOLVASE	3.1.22.4
2FD6	STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR IN COMPLEX WITH UROKINASE RECEPTOR AND AN ANTI-UPAR ANTIBODY AT 1.9 A	3.4.21.73
2FDA	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COAGULATION FACTOR XIA IN COMPLEX WITH ALPHA-KETOTHIAZOLE ARGININE DERIVED LIGAND	3.4.21.27
2FDD	CRYSTAL STRUCTURE OF HIV PROTEASE D545701 BOUND WITH GW0385	3.4.23.16
2FDE	WILD TYPE HIV PROTEASE BOUND WITH GW0385	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2FDP	CRYSTAL STRUCTURE OF BETA-SECRETASE COMPLEXED WITH AN AMINO-ETHYLENE INHIBITOR	3.4.23.46
2FE1	CRYSTAL STRUCTURE OF PAE0151 FROM PYROBACULUM AEROPHILUM	3.1
2FE4	THE CRYSTAL STRUCTURE OF HUMAN NEURONAL RAB6B IN ITS INACTIVE GDP-BOUND FORM	3.6.1
2FE8	SARS CORONAVIRUS PAPAIN-LIKE PROTEASE: STRUCTURE OF A VIRAL DEUBIQUITINATING ENZYME	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2FEA	CRYSTAL STRUCTURE OF MTNX PHOSPHATASE FROM BACILLUS SUBTILIS AT 2.00 A RESOLUTION	3.1.3 3.1.3.87
2FEB	NMR SOLUTION STRUCTURE, DYNAMICS AND BINDING PROPERTIES OF THE KRINGLE IV TYPE 8 MODULE OF APOLIPOPROTEIN(A)	3.4.21
2FEK	STRUCTURE OF A PROTEIN TYROSINE PHOSPHATASE	3.1.3.48
2FF1	CRYSTAL STRUCTURE OF TRYPANOSOMA VIVAX NUCLEOSIDE HYDROLASE SOAKED WITH IMMUCILLINH	3.2.2.1
2FF2	CRYSTAL STRUCTURE OF TRYPANOSOMA VIVAX NUCLEOSIDE HYDROLASE CO-CRYSTALLIZED WITH IMMUCILLINH	3.2.2.1
2FFF	OPEN FORM OF A CLASS A TRANSPEPTIDASE DOMAIN	2.4.1.129 3.4.16.4
2FFI	CRYSTAL STRUCTURE OF PUTATIVE 2-PYRONE-4,6-DICARBOXYLIC ACID HYDROLASE FROM PSEUDOMONAS PUTIDA, NORTHEAST STRUCTURAL GENOMICS TARGET PPR23.	3.1.1.57
2FFJ	CRYSTAL STRUCTURE OF A DUF89 FAMILY PROTEIN (AF1104) FROM ARCHAEOGLOBUS FULGIDUS DSM 4304 AT 2.45 A RESOLUTION	3.1.3
2FFQ	THE CRYSTAL STRUCTURE OF HUMAN NEURONAL RAB6B IN ITS ACTIVE GTPGS-BOUND FORM	3.6.1
2FFY	AMPC BETA-LACTAMASE N289A MUTANT IN COMPLEX WITH A BORONIC ACID DEACYLATION TRANSITION STATE ANALOG COMPOUND SM3	3.5.2.6
2FFZ	STRUCTURAL STUDIES EXAMINING THE SUBSTRATE SPECIFICITY PROFILES OF PC-PLCBC PROTEIN VARIANTS	3.1.4.3
2FGE	CRYSTAL STRUCTURE OF PRESEQUENCE PROTEASE PREP FROM ARABIDOPSIS THALIANA	3.4.24
2FGL	AN ALKALI THERMOSTABLE F/10 XYLANASE FROM ALKALOPHILIC BACILLUS SP. NG-27	3.2.1.8
2FGN	STRUCTURAL STUDIES EXAMINING THE SUBSTRATE SPECIFICITY PROFILES OF PC-PLCBC PROTEIN VARIANTS	3.1.4.3
2FGU	X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE T80S VARIANT IN COMPLEX WITH THE INHIBITOR SAQUINAVIR USED TO EXPLORE THE ROLE OF INVARIANT THR80 IN HIV-1 PROTEASE STRUCTURE, FUNCTION, AND VIRAL INFECTIVITY.	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2FGV	X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE T80N VARIANT IN COMPLEX WITH THE INHIBITOR SAQUINAVIR USED TO EXPLORE THE ROLE OF INVARIANT THR80 IN HIV-1 PROTEASE STRUCTURE, FUNCTION, AND VIRAL INFECTIVITY.	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2FGZ	CRYSTAL STRUCTURE ANALYSIS OF APO PULLULANASE FROM KLEBSIELLA PNEUMONIAE	3.2.1.41
2FH6	CRYSTAL STRUCTURE ANALYSIS OF KLEBSIELLA PNEUMONIAE PULLULANASE COMPLEXED WITH GLUCOSE	3.2.1.41
2FH7	CRYSTAL STRUCTURE OF THE PHOSPHATASE DOMAINS OF HUMAN PTP SIGMA	3.1.3.48
2FH8	CRYSTAL STRUCTURE ANALYSIS OF KLEBSIELLA PNEUMONIAE PULLULANASE COMPLEXED WITH ISOMALTOSE	3.2.1.41
2FHB	CRYSTAL STRUCTURE ANALYSIS OF KLEBSIELLA PNEUMONIAE PULLULANASE COMPLEXED WITH MALTOSE	3.2.1.41
2FHF	CRYSTAL STRUCTURE ANALYSIS OF KLEBSIELLA PNEUMONIAE PULLULANASE COMPLEXED WITH MALTOTETRAOSE	3.2.1.41
2FHI	SUBSTRATE ANALOG (IB2) COMPLEX WITH THE HIS 96 ASN SUBSTITUTION OF THE FRAGILE HISTIDINE TRIAD PROTEIN, FHIT	3.6.1.29
2FHM	SOLUTION STRUCTURE OF BACILLUS SUBTILIS ACYLPHOSPHATASE	3.6.1.7
2FHR	TRYPANOSOMA RANGELI SIALIDASE IN COMPLEX WITH 2,3- DIFLUOROSIALIC ACID (COVALENT INTERMEDIATE)	3.2.1.18
2FHX	PSEUDOMONAS AERUGINOSA SPM-1 METALLO-BETA-LACTAMASE	3.5.2.6
2FHY	STRUCTURE OF HUMAN LIVER FPBASE COMPLEXED WITH A NOVEL BENZOXAZOLE AS ALLOSTERIC INHIBITOR	3.1.3.11
2FI3	CRYSTAL STRUCTURE OF A BPTI VARIANT (CYS14->SER, CYS38->SER) IN COMPLEX WITH TRYPSIN	3.4.21.4
2FI4	CRYSTAL STRUCTURE OF A BPTI VARIANT (CYS14->SER) IN COMPLEX WITH TRYPSIN	3.4.21.4
2FI5	CRYSTAL STRUCTURE OF A BPTI VARIANT (CYS38->SER) IN COMPLEX WITH TRYPSIN	3.4.21.4
2FIE	STRUCTURE OF HUMAN LIVER FBPASE COMPLEXED WITH POTENT BENZOXAZOLE ALLOSTERIC INHIBITORS	3.1.3.11
2FIR	CRYSTAL STRUCTURE OF DFPR-VIIA/STF	3.4.21.21
2FIT	FHIT (FRAGILE HISTIDINE TRIAD PROTEIN)	3.6.1.29
2FIV	CRYSTAL STRUCTURE OF FELINE IMMUNODEFICIENCY VIRUS PROTEASE COMPLEXED WITH A SUBSTRATE	3.4.23.16 3.4.23 2.7.7.49 3.1.26.13 3.1.13.2 3.6.1.23 2.7.7 3.1
2FIX	STRUCTURE OF HUMAN LIVER FBPASE COMPLEXED WITH POTENT BENZOXAZOLE ALLOSTERIC INHIBITIORS	3.1.3.11
2FJ0	CRYSTAL STRUCTURE OF JUVENILE HORMONE ESTERASE FROM MANDUCA SEXTA, WITH OTFP COVALENTLY ATTACHED	3.1.1
2FJL	SOLUTION STRUCTURE OF THE SPLIT PH DOMAIN IN PHOSPHOLIPASE C-GAMMA1	3.1.4.11
2FJM	THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 2	3.1.3.48
2FJN	THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 2	3.1.3.48
2FJP	HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH AN INHIBITOR	3.4.14.5
2FJU	ACTIVATED RAC1 BOUND TO ITS EFFECTOR PHOSPHOLIPASE C BETA 2	3.6.5.2
2FJV	RT29 BOUND TO D(CTTAATTCGAATTAAG) IN COMPLEX WITH MMLV RT CATALYTIC FRAGMENT	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
2FJW	D(CTTGAATGCATTCAAG) IN COMPLEX WITH MMLV RT CATALYTIC FRAGMENT	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
2FJX	RT29 BOUND TO D(CTTGAATGCATTCAAG) IN COMPLEX WITH MMLV RT CATALYTIC FRAGMENT	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
2FK6	CRYSTAL STRUCTURE OF RNASE Z/TRNA(THR) COMPLEX	3.1.26.11
2FKB	CRYSTAL STRUCTURE OF A PUTATIVE ENZYME (POSSIBLE NUDIX HYDROLASE) FROM ESCHERICHIA COLI K12	3.6
2FKC	CRYSTAL FORM I OF PRE-REACTIVE COMPLEX OF RESTRICTION ENDONUCLEASE HINP1I WITH COGNATE DNA AND CALCIUM ION	3.1.21.4
2FKH	CRYSTAL FORM II OF PRE-REACTIVE COMPLEX OF RESTRICTION ENDONUCLEASE HINP1I WITH COGNATE DNA AND CALCIUM IONS	3.1.21.4
2FL3	BINARY COMPLEX OF RESTRICTION ENDONUCLEASE HINP1I WITH COGNATE DNA	3.1.21.4
2FLB	DISCOVERY OF A NOVEL HYDROXY PYRAZOLE BASED FACTOR IXA INHIBITOR	3.4.21.21
2FLC	POST-REACTIVE COMPLEX OF RESTRICTION ENDONUCLEASE HINP1I WITH NICKED COGNATE DNA AND MAGNESIUM IONS	3.1.21.4
2FLO	CRYSTAL STRUCTURE OF EXOPOLYPHOSPHATASE (PPX) FROM E. COLI O157:H7	3.6.1.11
2FLR	NOVEL 5-AZAINDOLE FACTOR VIIA INHIBITORS	3.4.21.21
2FLT	THE X-RAY STRUCTURE OF THE CIS-3-CHLOROACRYLIC ACID DEHALOGENASE CIS-CAAD INACTIVATED WITH (R)-OXIRANE-2-CARBOXYLATE	3.8.1
2FM0	CRYSTAL STRUCTURE OF PDE4D IN COMPLEX WITH L-869298	3.1.4.17 3.1.4.53
2FM2	HCV NS3-4A PROTEASE DOMAIN COMPLEXED WITH A KETOAMIDE INHIBITOR, SCH446211	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
2FM5	CRYSTAL STRUCTURE OF PDE4D2 IN COMPLEX WITH INHIBITOR L-869299	3.1.4.17 3.1.4.53
2FM6	ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (NATIVE FORM)	3.5.2.6
2FMB	EIAV PROTEASE COMPLEXED WITH AN INHIBITOR LP-130	3.4.23.16
2FMJ	220-LOOP MUTANT OF STREPTOMYCES GRISEUS TRYPSIN	3.4.21.4
2FN4	THE CRYSTAL STRUCTURE OF HUMAN RAS-RELATED PROTEIN, RRAS, IN THE GDP-BOUND STATE	3.6.5
2FNS	CRYSTAL STRUCTURE OF WILD-TYPE INACTIVE (D25N) HIV-1 PROTEASE COMPLEXED WITH WILD-TYPE HIV-1 NC-P1 SUBSTRATE.	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2FNT	CRYSTAL STRUCTURE OF A DRUG-RESISTANT (V82A) INACTIVE (D25N) HIV-1 PROTEASE COMPLEXED WITH AP2V VARIANT OF HIV-1 NC-P1 SUBSTRATE.	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2FNX	DESIGN OF SPECIFIC PEPTIDE INHIBITORS OF PHOSPHOLIPASE A2 (PLA2): CRYSTAL STRUCTURE OF THE COMPLEX OF PLA2 WITH A HIGHLY POTENT PEPTIDE VAL-ILE-ALA-LYS AT 2.7A RESOLUTION	3.1.1.4
2FO5	CRYSTAL STRUCTURE OF RECOMBINANT BARLEY CYSTEINE ENDOPROTEASE B ISOFORM 2 (EP-B2) IN COMPLEX WITH LEUPEPTIN	3.4.22
2FO9	STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 95% ACETONE	3.4.21.36
2FOA	STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 40/50/10 % BENZENE	3.4.21.36
2FOB	STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 40/50/10 CYCLOHEXANE	3.4.21.36
2FOC	STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 55% DIMETHYLFORMAMIDE	3.4.21.36
2FOD	STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 80% ETHANOL	3.4.21.36
2FOE	STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 80% HEXANE	3.4.21.36
2FOF	STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 80% ISOPROPANOL	3.4.21.36
2FOG	STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 40% TRIFLUOROETHANOL	3.4.21.36
2FOH	STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 40% TRIFLUOROETHANOL	3.4.21.36
2FOJ	THE CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HAUSP/USP7 COMPLEXED WITH P53 PEPTIDE 364-367	3.1.2.15 3.4.19.12
2FOK	STRUCTURE OF RESTRICTION ENDONUCLEASE FOKI	3.1.21.4
2FOM	DENGUE VIRUS NS2B/NS3 PROTEASE	3.4.21.91 3.6.1.15 3.6.4.13
2FOO	THE CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HAUSP/USP7 COMPLEXED WITH P53 PEPTIDE 359-362	3.1.2.15 3.4.19.12
2FOP	THE CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF HAUSP/USP7 COMPLEXED WITH MDM2 PEPTIDE 147-150	3.1.2.15 3.4.19.12
2FOZ	HUMAN ADP-RIBOSYLHYDROLASE 3	3.5.1 3.2.1.143 3.2.2
2FP0	HUMAN ADP-RIBOSYLHYDROLASE 3	3.5.1 3.2.1.143 3.2.2
2FP3	CRYSTAL STRUCTURE OF THE DROSOPHILA INITIATOR CASPASE DRONC	3.4.22
2FP7	WEST NILE VIRUS NS2B/NS3PROTEASE IN COMPLEX WITH BZ-NLE-LYS-ARG-ARG-H	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2FPQ	CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE D LIGHT CHAIN	3.4.24.69
2FPR	CRYSTAL STRUCTURE THE N-TERMINAL DOMAIN OF E. COLI HISB. APO MG MODEL.	3.1.3.15 4.2.1.19
2FPS	CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF E.COLI HISB- APO CA MODEL.	3.1.3.15 4.2.1.19
2FPU	CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF E.COLI HISB- COMPLEX WITH HISTIDINOL	3.1.3.15 4.2.1.19
2FPW	CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF E.COLI HISB- PHOSPHOASPARTATE INTERMEDIATE.	3.1.3.15 4.2.1.19
2FPX	CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF E.COLI HISB- SULFATE COMPLEX.	3.1.3.15 4.2.1.19
2FPZ	HUMAN TRYPTASE WITH 2-AMINO BENZIMIDAZOLE	3.4.21.59
2FQ1	CRYSTAL STRUCTURE OF THE TWO-DOMAIN NON-RIBOSOMAL PEPTIDE SYNTHETASE ENTB CONTAINING ISOCHORISMATE LYASE AND ARYL-CARRIER PROTEIN DOMAINS	3.3.2.1 6.3.2.14
2FQ9	CATHEPSIN S WITH NITRILE INHIBITOR	3.4.22.27
2FQQ	CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (CYS285->ALA, CYS362->ALA, CYS364->ALA, CYS397->ALA) IN COMPLEX WITH 1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE	3.4.22.36
2FR5	CRYSTAL STRUCTURE OF MOUSE CYTIDINE DEAMINASE COMPLEXED WITH TETRAHYDROURIDINE	3.5.4.5
2FR6	CRYSTAL STRUCTURE OF MOUSE CYTIDINE DEAMINASE COMPLEXED WITH CYTIDINE	3.5.4.5
2FRA	HUMAN CATHEPSIN S WITH CRA-27934, A NITRILE INHIBITOR	3.4.22.27
2FRQ	HUMAN CATHEPSIN S WITH INHIBITOR CRA-26871	3.4.22.27
2FS2	STRUCTURE OF THE E. COLI PAAI PROTEIN FROM THE PHYENYLACETIC ACID DEGRADATION OPERON	3.1.2
2FS4	KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C RING	3.4.23.15
2FS8	HUMAN BETA-TRYPTASE II WITH INHIBITOR CRA-29382	3.4.21.59
2FS9	HUMAN BETA TRYPTASE II WITH INHIBITOR CRA-28427	3.4.21.59
2FT2	HUMAN CATHEPSIN S WITH INHIBITOR CRA-29728	3.4.22.27
2FTL	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH BPTI AT 100K	3.4.21.4
2FTM	CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH THE BPTI VARIANT (TYR35->GLY)	3.4.21.4
2FTW	CRYSTAL STRUCTURE OF DIHYDROPYRIMIDINASE FROM DICTYOSTELIUM DISCOIDEUM	3.5.2.2
2FTY	CRYSTAL STRUCTURE OF DIHYDROPYRIMIDINASE FROM SACCHAROMYCES KLUYVERI	3.5.2.2
2FU6	ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (APO FORM)	3.5.2.6
2FU7	ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (CU-SUBSTITUTED FORM)	3.5.2.6
2FU8	ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (D-CAPTOPRIL COMPLEX)	3.5.2.6
2FU9	ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (MP2 INHIBITOR COMPLEX)	3.5.2.6
2FUD	HUMAN CATHEPSIN S WITH INHIBITOR CRA-27566	3.4.22.27
2FUF	CRYSTAL STRUCTURE OF THE SV40 LARGE T ANTIGEN ORIGIN-BINDING DOMAIN	3.6.4
2FUZ	UGL HEXAGONAL CRYSTAL STRUCTURE WITHOUT GLYCINE AND DTT MOLECULES	3.2.1 3.2.1.179
2FV5	CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH IK682	3.4.24.86
2FV9	CRYSTAL STRUCTURE OF TACE IN COMPLEX WITH JMV 390-1	3.4.24.86
2FVC	CRYSTAL STRUCTURE OF NS5B BK STRAIN (DELTA 24) IN COMPLEX WITH A 3-(1,1-DIOXO-2H-(1,2,4)-BENZOTHIADIAZIN-3-YL)-4-HYDROXY-2(1H)-QUINOLINONE	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
2FVH	CRYSTAL STRUCTURE OF RV1848, A UREASE GAMMA SUBUNIT UREA (UREA AMIDOHYDROLASE), FROM MYCOBACTERIUM TUBERCULOSIS	3.5.1.5
2FVK	CRYSTAL STRUCTURE OF DIHYDROPYRIMIDINASE FROM SACCHAROMYCES KLUYVERI IN COMPLEX WITH THE SUBSTRATE DIHYDROURACIL	3.5.2.2
2FVM	CRYSTAL STRUCTURE OF DIHYDROPYRIMIDINASE FROM SACCHAROMYCES KLUYVERI IN COMPLEX WITH THE REACTION PRODUCT N-CARBAMYL-BETA-ALANINE	3.5.2.2
2FVP	A STRUCTURAL STUDY OF THE CA DINUCLEOTIDE STEP IN THE INTEGRASE PROCESSING SITE OF MOLONEY MURINE LEUKEMIA VIRUS	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
2FVQ	A STRUCTURAL STUDY OF THE CA DINUCLEOTIDE STEP IN THE INTEGRASE PROCESSING SITE OF MOLONEY MURINE LEUKEMIA VIRUS	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
2FVR	A STRUCTURAL STUDY OF THE CA DINUCLEOTIDE STEP IN THE INTEGRASE PROCESSING SITE OF MOLONEY MURINE LEUKEMIA VIRUS	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
2FVS	A STRUCTURAL STUDY OF THE CA DINUCLEOTIDE STEP IN THE INTEGRASE PROCESSING SITE OF MOLONEY MURINE LEUKEMIA VIRUS	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
2FVV	HUMAN DIPHOSPHOINOSITOL POLYPHOSPHATE PHOSPHOHYDROLASE 1	3.6.1.52 3.6.1
2FVZ	HUMAN INOSITOL MONOPHOSPHOSPHATASE 2	3.1.3.25
2FWR	STRUCTURE OF ARCHAEOGLOBUS FULGIDIS XPB	3.6.4.12
2FWW	HUMAN BETA-TRYPTASE II COMPLEXED WITH 4-PIPERIDINEBUTYRATE TO MAKE ACYLENZYME	3.4.21.59
2FX4	BOVINE TRYPSIN BOUND BY 4-PIPERIDINEBUTYRATE TO MAKE ACYLENZYME COMPLEX	3.4.21.4
2FX5	PSEUDOMONAS MENDOCINA LIPASE	3.1.1.3
2FX6	BOVINE TRYPSIN COMPLEXED WITH 2-AMINOBENZAMIDAZOLE	3.4.21.4
2FXD	X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE IRM MUTANT COMPLEXED WITH ATAZANAVIR (BMS-232632)	3.4.23.16 2.7.7.49 3.1.26.13
2FXE	X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE CRM MUTANT COMPLEXED WITH ATAZANAVIR (BMS-232632)	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2FXI	ARSENATE REDUCTASE (ARSC FROM PI258) C10S/C15A DOUBLE MUTANT WITH SULFATE IN ITS ACTIVE SITE	1.20.4 3.1.3.48 1.20.4.4
2FXR	HUMAN BETA TRYPTASE II COMPLEXED WITH ACTIVATED KETONE INHIBITOR CRA-29382	3.4.21.59
2FXZ	SOLUTION STRUCTURE OF 97-109 SEGMENT OF STAPHYLOCOCCAL NUCLEASE	3.1.31.1
2FYE	MUTANT HUMAN CATHEPSIN S WITH IRREVERSIBLE INHIBITOR CRA-14013	3.4.22.27
2FYG	CRYSTAL STRUCTURE OF NSP10 FROM SARS CORONAVIRUS	3.4.19.12 3.4.22 3.4.22.69
2FYH	SOLUTION STRUCTURE OF THE 2'-5' RNA LIGASE-LIKE PROTEIN FROM PYROCOCCUS FURIOSUS	3.1.4.58
2FYQ	CRYSTAL STRUCTURE OF THE NORWALK VIRUS PROTEASE	3.6.1.15 3.4.22.66 2.7.7.48
2FYR	CRYSTAL STRUCTURE OF NORWALK VIRUS PROTEASE GROWN IN THE PRESENCE OF AEBSF	3.6.1.15 3.4.22.66 2.7.7.48
2FYV	GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH AN AMINO-SALACINOL CARBOXYLATE ANALOG	3.2.1.114
2FZ4	CRYSTAL STRUCTURE OF THE N-TERMINAL HALF OF ARCHAEOGLOBUS FULGIDUS XPB	3.6.4.12
2FZL	STRUCTURE OF C-TERMINAL DOMAIN OF ARCHAEOGLOBUS FULGIDUS XPB	3.6.4.12
2FZS	CRYSTAL STRUCTURE OF E. COLI CLPP WITH A PEPTIDE CHLOROMETHYL KETONE COVALENTLY BOUND AT THE ACTIVE SITE	3.4.21.92
2FZZ	FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2'-(((3R)-3-HYDROXY-1-PYRROLIDINYL)METHYL)-4-BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6-TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE	3.4.21.6
2G00	FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL)-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1-YL)BENZAMIDE	3.4.21.6
2G06	X-RAY STRUCTURE OF MOUSE PYRIMIDINE 5'-NUCLEOTIDASE TYPE 1, WITH BOUND MAGNESIUM(II)	3.1.3.5 3.1.3.91
2G07	X-RAY STRUCTURE OF MOUSE PYRIMIDINE 5'-NUCLEOTIDASE TYPE 1, PHOSPHO-ENZYME INTERMEDIATE ANALOG WITH BERYLLIUM FLUORIDE	3.1.1.5 3.1.3.5 3.1.3.91
2G08	X-RAY STRUCTURE OF MOUSE PYRIMIDINE 5'-NUCLEOTIDASE TYPE 1, PRODUCT-TRANSITION COMPLEX ANALOG WITH ALUMINUM FLUORIDE	3.1.1.5 3.1.3.5 3.1.3.91
2G09	X-RAY STRUCTURE OF MOUSE PYRIMIDINE 5'-NUCLEOTIDASE TYPE 1, PRODUCT COMPLEX	3.1.1.5 3.1.3.5 3.1.3.91
2G0A	X-RAY STRUCTURE OF MOUSE PYRIMIDINE 5'-NUCLEOTIDASE TYPE 1 WITH LEAD(II) BOUND IN ACTIVE SITE	3.1.1.5 3.1.3.5 3.1.3.91
2G0C	STRUCTURE OF THE RNA BINDING DOMAIN (RESIDUES 404-479) OF THE BACILLUS SUBTILIS YXIN PROTEIN	3.6.1 3.6.4.13
2G0N	THE CRYSTAL STRUCTURE OF THE HUMAN RAC3 IN COMPLEX WITH GDP AND CHLORIDE	3.6.5.2
2G1A	CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE	3.1.3.2
2G1N	KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C" RING"	3.4.23.15
2G1O	KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C" RING"	3.4.23.15
2G1R	KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C RING	3.4.23.15
2G1S	KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C RING	3.4.23.15
2G1Y	KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C" RING"	3.4.23.15
2G20	KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C RING	3.4.23.15
2G21	KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C" RING"	3.4.23.15
2G22	KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C" RING"	3.4.23.15
2G24	KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C" RING"	3.4.23.15
2G26	KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C" RING"	3.4.23.15
2G27	KETOPIPERAZINE-BASED RENIN INHIBITORS: OPTIMIZATION OF THE C" RING"	3.4.23.15
2G2N	CRYSTAL STRUCTURE OF E.COLI TRANSTHYRETIN-RELATED PROTEIN WITH BOUND ZN	3.5.2.17
2G2P	CRYSTAL STRUCTURE OF E.COLI TRANSTHYRETIN-RELATED PROTEIN WITH BOUND ZN AND BR	3.5.2.17
2G2U	CRYSTAL STRUCTURE OF THE SHV-1 BETA-LACTAMASE/BETA-LACTAMASE INHIBITOR PROTEIN (BLIP) COMPLEX	3.5.2.6
2G2W	CRYSTAL STRUCTURE OF THE SHV D104K BETA-LACTAMASE/BETA-LACTAMASE INHIBITOR PROTEIN (BLIP) COMPLEX	3.5.2.6
2G3F	CRYSTAL STRUCTURE OF IMIDAZOLONEPROPIONASE COMPLEXED WITH IMIDAZOLE-4-ACETIC ACID SODIUM SALT, A SUBSTRATE HOMOLOGUE	3.5.2.7
2G3I	STRUCTURE OF S.OLIVACEOVIRIDIS XYLANASE Q88A/R275A MUTANT	3.2.1.8
2G3J	STRUCTURE OF S.OLIVACEOVIRIDIS XYLANASE Q88A/R275A MUTANT	3.2.1.8
2G3M	CRYSTAL STRUCTURE OF THE SULFOLOBUS SOLFATARICUS ALPHA-GLUCOSIDASE MALA	3.2.1.20
2G3N	CRYSTAL STRUCTURE OF THE SULFOLOBUS SOLFATARICUS ALPHA-GLUCOSIDASE MALA IN COMPLEX WITH BETA-OCTYL-GLUCOPYRANOSIDE	3.2.1.20
2G43	STRUCTURE OF THE ZNF UBP DOMAIN FROM DEUBIQUITINATING ENZYME ISOPEPTIDASE T (ISOT)	3.1.2.15 3.4.19.12
2G45	CO-CRYSTAL STRUCTURE OF ZNF UBP DOMAIN FROM THE DEUBIQUITINATING ENZYME ISOPEPTIDASE T (ISOT) IN COMPLEX WITH UBIQUITIN	3.1.2.15 3.4.19.12
2G47	CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH AMYLOID-BETA (1-40)	3.4.24.56
2G48	CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH AMYLIN	3.4.24.56
2G49	CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH GLUCAGON	3.4.24.56
2G4D	CRYSTAL STRUCTURE OF HUMAN SENP1 MUTANT (C603S) IN COMPLEX WITH SUMO-1	3.4.22
2G4F	STRUCTURE OF S.OLIVACEOVIRIDIS XYLANASE Q88A/R275A MUTANT	3.2.1.8
2G4K	ANOMALOUS SUBSTRUCTURE OF HUMAN ADP-RIBOSYLHYDROLASE 3	3.5.1 3.2.1.143 3.2.2
2G4P	ANOMALOUS SUBSTRUCTURE OF LYSOZYME AT PH 4.5	3.2.1.17
2G4Q	ANOMALOUS SUBSTRUCTURE OF LYSOZYME AT PH 8.0	3.2.1.17
2G4T	ANOMALOUS SUBSTRUCTURE OF PORCINE PANCREATIC ELASTASE (NA)	3.4.21.36
2G4U	ANOMALOUS SUBSTRUCTURE OF PORCINE PANCREATIC ELASTAASE (CA)	3.4.21.36
2G4V	ANOMALOUS SUBSTRUCTURE OF PROTEINASE K	3.4.21.64
2G4W	ANOMALOUS SUBSTRUCTURE OF RIBONUCLEASE A (C2)	3.1.27.5 4.6.1.18
2G4X	ANOMALOUS SUBSTRUCTURE OD RIBONUCLEASE A (P3221)	3.1.27.5 4.6.1.18
2G4Z	ANOMALOUS SUBSTRUCTURE OF THERMOLYSIN	3.4.24.27
2G51	ANOMALOUS SUBSTRUCTURE OF TRYPSIN (P1)	3.4.21.4
2G52	ANOMALOUS SUBSTRUCTURE OF TRYPSIN (P21)	3.4.21.4
2G54	CRYSTAL STRUCTURE OF ZN-BOUND HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH INSULIN B CHAIN	3.4.24.56
2G55	ANOMALOUS SUBSTRUCTURE OF TRYPSIN (P3121)	3.4.21.4
2G56	CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH INSULIN B CHAIN	3.4.24.56
2G58	CRYSTAL STRUCTURE OF A COMPLEX OF PHOSPHOLIPASE A2 WITH A DESIGNED PEPTIDE INHIBITOR DEHYDRO-ILE-ALA-ARG-SER AT 0.98 A RESOLUTION	3.1.1.4
2G59	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE FROM HOMO SAPIENS	3.1.3.48
2G5D	CRYSTAL STRUCTURE OF MLTA FROM NEISSERIA GONORRHOEAE MONOCLINIC FORM	3.2.1 4.2.2
2G5N	INDOLE-AMIDINE COMPLEXES WITH BOVINE TRYPSIN	3.4.21.4
2G5P	CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) COMPLEXED WITH CYANOPYRROLIDINE (C5-PRO-PRO) INHIBITOR 21AC	3.4.14.5
2G5T	CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) COMPLEXED WITH CYANOPYRROLIDINE (C5-PRO-PRO) INHIBITOR 21AG	3.4.14.5
2G5V	INDOLE-AMIDINE COMPLEXES WITH BOVINE TRYPSIN	3.4.21.4
2G5X	CRYSTAL STRUCTURE OF LYCHNIN A TYPE 1 RIBOSOME INACTIVATING PROTEIN (RIP)	3.2.2.22
2G63	CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) COMPLEXED WITH CYANOPYRROLIDINE (C5-PRO-PRO) INHIBITOR 24B	3.4.14.5
2G69	STRUCTURE OF UNLIGANDED HIV-1 PROTEASE F53L MUTANT	3.4.23.16
2G6D	HUMAN CATHEPSIN S MUTANT WITH VINYL SULFONE INHIBITOR CRA-14009	3.4.22.27
2G6G	CRYSTAL STRUCTURE OF MLTA FROM NEISSERIA GONORRHOEAE	3.2.1 4.2.2
2G6P	CRYSTAL STRUCTURE OF TRUNCATED (DELTA 1-89) HUMAN METHIONINE AMINOPEPTIDASE TYPE 1 IN COMPLEX WITH PYRIDYL PYRIMIDINE DERIVATIVE	3.4.11.18
2G6V	THE CRYSTAL STRUCTURE OF RIBD FROM ESCHERICHIA COLI	1.1.1.193 3.5.4.26
2G6Z	CRYSTAL STRUCTURE OF HUMAN DUSP5	3.1.3.48 3.1.3.16
2G7C	CLOSTRIDIUM DIFFICILE TOXIN A FRAGMENT BOUND TO AGAL(1,3)BGAL(1,4)BGLCNAC	3.4.22 2.4.1
2G7E	THE 1.6 A CRYSTAL STRUCTURE OF VIBRIO CHOLERAE EXTRACELLULAR ENDONUCLEASE I	3.1.21.1 3.1.21
2G7F	THE 1.95 A CRYSTAL STRUCTURE OF VIBRIO CHOLERAE EXTRACELLULAR ENDONUCLEASE I	3.1.21.1 3.1.21
2G7K	STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN, SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS	3.4.24.69
2G7N	STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS	3.4.24.69
2G7P	STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS	3.4.24.69
2G7Q	STRUCTURE OF THE LIGHT CHAIN OF BOTULINUM NEUROTOXIN SEROTYPE A BOUND TO SMALL MOLECULE INHIBITORS	3.4.24.69
2G7R	X-RAY STRUCTURE OF THE DEATH DOMAIN OF THE HUMAN MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1	3.4.22
2G7Y	HUMAN CATHEPSIN S WITH INHIBITOR CRA-16981	3.4.22.27
2G80	CRYSTAL STRUCTURE OF UTR4 PROTEIN (UNKNOWN TRANSCRIPT 4 PROTEIN) (YEL038W) FROM SACCHAROMYCES CEREVISIAE AT 2.28 A RESOLUTION	3.1.3.77
2G81	CRYSTAL STRUCTURE OF THE BOWMAN-BIRK INHIBITOR FROM VIGNA UNGUICULATA SEEDS IN COMPLEX WITH BETA-TRYPSIN AT 1.55 ANGSTRONS RESOLUTION	3.4.21.4
2G8E	CALPAIN 1 PROTEOLYTIC CORE IN COMPLEX WITH SNJ-1715, A CYCLIC HEMIACETAL-TYPE INHIBITOR	3.4.22.52
2G8F	B. HALODURANS RNASE H CATALYTIC DOMAIN E188A MUTANT IN COMPLEX WITH MG2+ AND RNA/DNA HYBRID (NON-P NICK AT THE ACTIVE SITE)	3.1.26.4
2G8H	B. HALODURANS RNASE H CATALYTIC DOMAIN D192N MUTANT IN COMPLEX WITH MG2+ AND RNA/DNA HYBRID (NON-P NICK AT THE ACTIVE SITE)	3.1.26.4
2G8I	B. HALODURANS RNASE H CATALYTIC DOMAIN D192N MUTANT IN COMPLEX WITH MN2+ AND RNA/DNA HYBRID (NON-P NICK AT THE ACTIVE SITE)	3.1.26.4
2G8J	CALPAIN 1 PROTEOLYTIC CORE IN COMPLEX WITH SNJ-1945, A ALPHA-KETOAMIDE-TYPE INHIBITOR.	3.4.22.52
2G8K	B. HALODURANS RNASE H CATALYTIC DOMAIN D192N MUTANT IN COMPLEX WITH CA2+ AND RNA/DNA HYBRID (NON-P NICK AT THE ACTIVE SITE)	3.1.26.4
2G8L	CRYSTAL STRUCTURE OF A DUF89 FAMILY PROTEIN (PH1575) FROM PYROCOCCUS HORIKOSHII AT 2.04 A RESOLUTION	3.1.3
2G8Q	THE CRYSTAL STRUCTURE OF RNASE A FROM MONOCLINIC CRYSTALS AT 100 K	3.1.27.5 4.6.1.18
2G8R	THE CRYSTAL STRUCTURE OF THE RNASE A- 3-N-PIPERIDINE-4-CARBOXYL-3-DEOXY-ARA-URIDINE COMPLEX	3.1.27.5 4.6.1.18
2G8T	INDOLE-AMIDINE COMPLEXES WITH BOVINE TRYPSIN	3.4.21.4
2G8U	B. HALODURANS RNASE H CATALYTIC DOMAIN D132N MUTANT IN COMPLEX WITH MG2+ AND RNA/DNA HYBRID (NON-P NICK AT THE ACTIVE SITE)	3.1.26.4
2G8V	B. HALODURANS RNASE H CATALYTIC DOMAIN E188A MUTANT IN COMPLEX WITH MG2+ AND RNA/DNA HYBRID (REACTION PRODUCT)	3.1.26.4
2G8W	B. HALODURANS RNASE H CATALYTIC DOMAIN E188A MUTANT IN COMPLEX WITH CA2+ AND RNA/DNA HYBRID	3.1.26.4
2G93	LIGAND RECOGNITION SITE IN C-LOBE OF LACTOFERRIN: CRYSTAL STRUCTURE OF THE COMPLEX OF C-LOBE OF BOVINE LACTOFERRIN WITH METHYL ALPHA-D-MANNOPYRANOSIDE AT 1.9 A RESOLUTION	3.4.21
2G94	CRYSTAL STRUCTURE OF BETA-SECRETASE BOUND TO A POTENT AND HIGHLY SELECTIVE INHIBITOR.	3.4.23.46
2G9D	CRYSTAL STRUCTURE OF SUCCINYLGLUTAMATE DESUCCINYLASE FROM VIBRIO CHOLERAE, NORTHEAST STRUCTURAL GENOMICS TARGET VCR20	3.1 3.5.1.96
2G9F	CRYSTAL STRUCTURE OF INTEIN-TAGGED MOUSE PNGASE C-TERMINAL DOMAIN	3.5.1.52
2G9G	CRYSTAL STRUCTURE OF HIS-TAGGED MOUSE PNGASE C-TERMINAL DOMAIN	3.5.1.52
2G9N	STRUCTURE OF THE DEAD DOMAIN OF HUMAN EUKARYOTIC INITIATION FACTOR 4A, EIF4A	3.6.1 3.6.4.13
2G9O	SOLUTION STRUCTURE OF THE APO FORM OF THE THIRD METAL-BINDING DOMAIN OF ATP7A PROTEIN (MENKES DISEASE PROTEIN)	3.6.3.4 7.2.2.8
2G9Y	STRUCTURE OF S102T E. COLI ALKALINE PHOSPHATASE IN PRESENCE OF PHOSPHATE AT 2.00 A RESOLUTION	3.1.3.1
2GA2	H-METAP2 COMPLEXED WITH A193400	3.4.11.18
2GA3	STRUCTURE OF S102T E. COLI ALKALINE PHOSPHATASE-PHOSPHATE INTERMEDIATE AT 2.20A RESOLUTION	3.1.3.1
2GA4	STX2 WITH ADENINE	3.2.2.22
2GA7	SOLUTION STRUCTURE OF THE COPPER(I) FORM OF THE THIRD METAL-BINDING DOMAIN OF ATP7A PROTEIN (MENKES DISEASE PROTEIN)	3.6.3.4 7.2.2.8
2GAC	T152C MUTANT GLYCOSYLASPARAGINASE FROM FLAVOBACTERIUM MENINGOSEPTICUM	3.5.1.26
2GAE	CRYSTAL STRUCTURE OF MLTA FROM E. COLI	3.2.1 4.2.2
2GAW	WILD TYPE GLYCOSYLASPARAGINASE FROM FLAVOBACTERIUM MENINGOSEPTICUM	3.5.1.26
2GB5	CRYSTAL STRUCTURE OF NADH PYROPHOSPHATASE (EC 3.6.1.22) (1790429) FROM ESCHERICHIA COLI K12 AT 2.30 A RESOLUTION	3.6.1.22 3.6.1
2GBZ	THE CRYSTAL STRUCTURE OF XC847 FROM XANTHOMONAS CAMPESTRIS: A 3-5 OLIGORIBONUCLEASE OF DNAQ FOLD FAMILY WITH A NOVEL OPPOSINGLY-SHIFTED HELIX	3.1
2GC8	STRUCTURE OF A PROLINE SULFONAMIDE INHIBITOR BOUND TO HCV NS5B POLYMERASE	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
2GCF	SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF THE COPPPER(I) ATPASE PACS IN ITS APO FORM	3.6.3 7.2.2.8
2GCH	REFINED CRYSTAL STRUCTURE OF GAMMA-CHYMOTRYPSIN AT 1.9 ANGSTROMS RESOLUTION	3.4.21.1
2GCT	STRUCTURE OF GAMMA-CHYMOTRYPSIN IN THE RANGE PH 2.0 TO PH 10.5 SUGGESTS THAT GAMMA-CHYMOTRYPSIN IS A COVALENT ACYL-ENZYME ADDUCT AT LOW PH	3.4.21.1
2GCU	X-RAY STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT1G53580	3.1.2.6 1.13.11.18
2GD4	CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX	3.4.21.6
2GDD	HUMAN BETA II TRYPTASE WITH INHIBITOR CRA-27592	3.4.21.59
2GDN	CRYSTAL STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS BETA-LACTAMASE	3.5.2.6
2GDT	NMR STRUCTURE OF THE NONSTRUCTURAL PROTEIN 1 (NSP1) FROM THE SARS CORONAVIRUS	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2GEF	CRYSTAL STRUCTURE OF A NOVEL VIRAL PROTEASE WITH A SERINE/LYSINE CATALYTIC DYAD MECHANISM	3.4.21
2GEZ	CRYSTAL STRUCTURE OF POTASSIUM-INDEPENDENT PLANT ASPARAGINASE	3.5.1.1 3.4.19.5
2GFH	CRYSTAL STRUCTURE OF A N-ACETYLNEURAMINIC ACID PHOSPHATASE (NANP) FROM MUS MUSCULUS AT 1.90 A RESOLUTION	3.1.3.29
2GFI	CRYSTAL STRUCTURE OF THE PHYTASE FROM D. CASTELLII AT 2.3 A	3.1.3.8 3.1.3.2
2GFJ	CRYSTAL STRUCTURE OF THE ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (INHIBITOR 1)	3.5.2.6
2GFK	CRYSTAL STRUCTURE OF THE ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (INHIBITOR 2)	3.5.2.6
2GFO	STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 8	3.1.2.15 3.4.19.12
2GFQ	STRUCTURE OF PROTEIN OF UNKNOWN FUNCTION PH0006 FROM PYROCOCCUS HORIKOSHII	3.1.1.96
2GFT	CRYSTAL STRUCTURE OF THE E263A NUCLEOPHILE MUTANT OF BACILLUS LICHENIFORMIS ENDO-BETA-1,4-GALACTANASE IN COMPLEX WITH GALACTOTRIOSE	3.2.1.89
2GG0	NOVEL BACTERIAL METHIONINE AMINOPEPTIDASE INHIBITORS	3.4.11.18
2GG1	NMR SOLUTION STRUCTURE OF DOMAIN III OF THE E-PROTEIN OF TICK-BORNE LANGAT FLAVIVIRUS (INCLUDES RDC RESTRAINTS)	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2GG2	NOVEL BACTERIAL METHIONINE AMINOPEPTIDASE INHIBITORS	3.4.11.18
2GG3	NOVEL BACTERIAL METHIONINE AMINOPEPTIDASE INHIBITORS	3.4.11.18
2GG5	NOVEL BACTERIAL METHIONINE AMINOPEPTIDASE INHIBITORS	3.4.11.18
2GG7	NOVEL BACTERIAL METHIONINE AMINOPEPTIDASE INHIBITORS	3.4.11.18
2GG8	NOVEL BACTERIAL METHIONINE AMINOPEPTIDASE INHIBITORS	3.4.11.18
2GG9	NOVEL BACTERIAL METHIONINE AMINOPEPTIDASE INHIBITORS	3.4.11.18
2GGB	NOVEL BACTERIAL METHIONINE AMINOPEPTIDASE INHIBITORS	3.4.11.18
2GGC	NOVEL BACTERIAL METHIONINE AMINOPEPTIDASE INHIBITORS	3.4.11.18
2GGK	THE MUTANT A302C OF AGROBACTERIUM RADIOBACTER N-CARBAMOYL-D-AMINO-ACID AMIDOHYDROLASE	3.5.1.77
2GGL	THE MUTANT A222C OF AGROBACTERIUM RADIOBACTER N-CARBAMOYL-D-AMINO ACID AMIDOHYDROLASE	3.5.1.77
2GGV	CRYSTAL STRUCTURE OF THE WEST NILE VIRUS NS2B-NS3 PROTEASE, HIS51ALA MUTANT	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2GH4	YTER/D143N/DGALA-RHA	3.2.1 3.2.1.172
2GH6	CRYSTAL STRUCTURE OF A HDAC-LIKE PROTEIN WITH 9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONAN AMIDE BOUND	3.5.1
2GHQ	CTD-SPECIFIC PHOSPHATASE SCP1 IN COMPLEX WITH PEPTIDE C-TERMINAL DOMAIN OF RNA POLYMERASE II	3.1.3.16
2GHT	CTD-SPECIFIC PHOSPHATASE SCP1 IN COMPLEX WITH PEPTIDE FROM C-TERMINAL DOMAIN OF RNA POLYMERASE II	3.1.3.16
2GHU	CRYSTAL STRUCTURE OF FALCIPAIN-2 FROM PLASMODIUM FALCIPARUM	3.4.22
2GI4	SOLUTION STRUCTURE OF THE LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE FROM CAMPYLOBACTER JEJUNI.	3.1.3.48
2GIE	HINCII BOUND TO COGNATE DNA GTTAAC	3.1.21.4
2GIH	Q138F HINCII BOUND TO COGNATE DNA GTCGAC AND CA2+	3.1.21.4
2GIQ	HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE NS5B WITH NNI-2 INHIBITOR	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2GIR	HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE NS5B WITH NNI-1 INHIBITOR	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2GJ8	STRUCTURE OF THE MNME G-DOMAIN IN COMPLEX WITH GDP*ALF4-, MG2+ AND K+	3.6
2GJ9	STRUCTURE OF THE MNME G-DOMAIN IN COMPLEX WITH GDP*ALF4-, MG2+ AND RB+	3.6
2GJA	STRUCTURE OF THE MNME G-DOMAIN IN COMPLEX WITH GDP*ALF4-, MG2+ AND NH4+	3.6
2GJK	STRUCTURAL AND FUNCTIONAL INSIGHTS INTO THE HUMAN UPF1 HELICASE CORE	3.6.1 3.6.4
2GJP	STRUCTURE OF BACILLUS HALMAPALUS ALPHA-AMYLASE, CRYSTALLIZED WITH THE SUBSTRATE ANALOGUE ACARBOSE AND MALTOSE	3.2.1.1 3.2.1.98
2GJR	STRUCTURE OF BACILLUS HALMAPALUS ALPHA-AMYLASE WITHOUT ANY SUBSTRATE ANALOGUES	3.2.1.1 3.2.1.98
2GJT	CRYSTAL STRUCTURE OF THE HUMAN RECEPTOR PHOSPHATASE PTPRO	3.1.3.48
2GJW	RNA RECOGNITION AND CLEAVAGE BY AN SPLICING ENDONUCLEASE	3.1.27.9 4.6.1.16
2GK1	X-RAY CRYSTAL STRUCTURE OF NGT-BOUND HEXA	3.2.1.52
2GK6	STRUCTURAL AND FUNCTIONAL INSIGHTS INTO THE HUMAN UPF1 HELICASE CORE	3.6.1 3.6.4
2GK7	STRUCTURAL AND FUNCTIONAL INSIGHTS INTO THE HUMAN UPF1 HELICASE CORE	3.6.1 3.6.4
2GKL	CRYSTAL STRUCTURE OF THE ZINC CARBAPENEMASE CPHA IN COMPLEX WITH THE INHIBITOR PYRIDINE-2,4-DICARBOXYLATE	3.5.2.6
2GKO	S41 PSYCHROPHILIC PROTEASE	3.4.21.62 3.4.21.14
2GL9	CRYSTAL STRUCTURE OF GLYCOSYLASPARAGINASE-SUBSTRATE COMPLEX	3.5.1.26
2GLF	CRYSTAL STRUCTURE OF AMINIPEPTIDASE (M18 FAMILY) FROM THERMOTOGA MARITIMA	3.4.11
2GLQ	X-RAY STRUCTURE OF HUMAN ALKALINE PHOSPHATASE IN COMPLEX WITH STRONTIUM	3.1.3.1
2GMC	STRUCTURE OF C12-LF11 BOUND TO THE DPC MICELLES	3.4.21
2GMK	CRYSTAL STRUCTURE OF ONCONASE DOUBLE MUTANT WITH SPONTANEOUSLY-ASSEMBLED (AMP) 4 STACK	3.1.27
2GMN	CRYSTAL STRUCTURE OF BJP-1, A SUBCLASS B3 METALLO-BETA-LACTAMASE OF BRADYRHIZOBIUM JAPONICUM	3.5.2.6
2GMT	THREE-DIMENSIONAL STRUCTURE OF CHYMOTRYPSIN INACTIVATED WITH (2S) N-ACETYL-L-ALANYL-L-PHENYLALANYL-CHLOROETHYL KETONE: IMPLICATIONS FOR THE MECHANISM OF INACTIVATION OF SERINE PROTEASES BY CHLOROKETONES	3.4.21.1
2GMW	CRYSTAL STRUCTURE OF D,D-HEPTOSE 1.7-BISPHOSPHATE PHOSPHATASE FROM E. COLI.	3.1.3 3.1.3.82
2GNS	DESIGN OF SPECIFIC PEPTIDE INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN A GROUP II PHOSPHOLIPASE A2 AND A DESIGNED PENTAPEPTIDE ALA- LEU- VAL- TYR- LYS AT 2.3 A RESOLUTION	3.1.1.4
2GO3	CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS LPXC COMPLEXED WITH IMIDAZOLE.	3.5.1 3.5.1.108
2GO4	CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS LPXC COMPLEXED WITH TU-514	3.5.1 3.5.1.108
2GOK	CRYSTAL STRUCTURE OF THE IMIDAZOLONEPROPIONASE FROM AGROBACTERIUM TUMEFACIENS AT 1.87 A RESOLUTION	3.5.2.7
2GON	XRAY STRUCTURE OF GAG133-278	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2GP0	HEPTP CATALYTIC DOMAIN (RESIDUES 44-339), S225D MUTANT	3.1.3.48
2GP9	CRYSTAL STRUCTURE OF THE SLOW FORM OF THROMBIN IN A SELF-INHIBITED CONFORMATION	3.4.21.5
2GPZ	TRANSTHYRETIN-LIKE PROTEIN FROM SALMONELLA DUBLIN	3.5.2.17
2GQ0	CRYSTAL STRUCTURE OF THE MIDDLE DOMAIN OF HTPG, THE E. COLI HSP90	3.6.4.10
2GQ1	CRYSTAL STRUCTURE OF RECOMBINANT TYPE I FRUCTOSE-1,6-BISPHOSPHATASE FROM ESCHERICHIA COLI COMPLEXED WITH SULFATE IONS	3.1.3.11
2GQC	SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF RHOMBOID INTRAMEMBRANE PROTEASE FROM P. AERUGINOSA	3.4.21.105
2GRC	1.5 A STRUCTURE OF BROMODOMAIN FROM HUMAN BRG1 PROTEIN, A CENTRAL ATPASE OF SWI/SNF REMODELING COMPLEX	3.6.1 3.6.4
2GRI	NMR STRUCTURE OF THE SARS-COV NON-STRUCTURAL PROTEIN NSP3A	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2GSE	CRYSTAL STRUCTURE OF HUMAN DIHYDROPYRIMIDINEASE-LIKE 2	3.5.2.2
2GSN	STRUCTURE OF XAC NUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE	3.6.1.9
2GSO	STRUCTURE OF XAC NUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE IN COMPLEX WITH VANADATE	3.6.1.9
2GSP	RIBONUCLEASE T1/2',3'-CGPS AND 3'-GMP, 2 DAYS	3.1.27.3 4.6.1.24
2GSU	STRUCTURE OF XAC NUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE IN COMPLEX WITH AMP	3.6.1.9
2GT2	STRUCTURE OF THE E. COLI GDP-MANNOSE MANNOSYL HYDROLASE	3.6.1
2GT4	CRYSTAL STRUCTURE OF THE Y103F MUTANT OF THE GDP-MANNOSE MANNOSYL HYDROLASE IN COMPLEX WITH GDP-MANNOSE AND MG+2	3.6.1
2GT7	CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PEPTIDASE AT PH 6.0 IN THE SPACE GROUP P21	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2GT8	CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PEPTIDASE (WITH AN ADDITIONAL ALA AT THE N-TERMINUS OF EACH PROTOMER) IN THE SPACE GROUP P43212	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2GTB	CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PEPTIDASE (WITH AN ADDITIONAL ALA AT THE N-TERMINUS OF EACH PROTOMER) INHIBITED BY AN AZA-PEPTIDE EPOXIDE IN THE SPACE GROUP P43212	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2GTH	CRYSTAL STRUCTURE OF THE WILDTYPE MHV CORONAVIRUS NON-STRUCTURAL PROTEIN NSP15	3.6.4.13
2GTI	MUTATION OF MHV CORONAVIRUS NON-STRUCTURAL PROTEIN NSP15 (F307L)	3.6.4.13
2GTQ	CRYSTAL STRUCTURE OF AMINOPEPTIDASE N FROM HUMAN PATHOGEN NEISSERIA MENINGITIDIS	3.4.11.2
2GTX	STRUCTURAL BASIS OF CATALYSIS BY MONONUCLEAR METHIONINE AMINOPEPTIDASE	3.4.11.18
2GU0	CRYSTAL STRUCTURE OF HUMAN ROTAVIRUS NSP2 (GROUP C / BRISTOL STRAIN)	3.6.4
2GU1	CRYSTAL STRUCTURE OF A ZINC CONTAINING PEPTIDASE FROM VIBRIO CHOLERAE	3.4
2GU2	CRYSTAL STRUCTURE OF AN ASPARTOACYLASE FROM RATTUS NORVEGICUS	3.5.1.15
2GU4	E. COLI METHIONINE AMINOPEPTIDASE IN COMPLEX WITH NLEP, 1: 0.5, DI-METALATED	3.4.11.18
2GU5	E. COLI METHIONINE AMINOPEPTIDASE IN COMPLEX WITH NLEP, 1: 1, DI-METALATED	3.4.11.18
2GU6	E. COLI METHIONINE AMINOPEPTIDASE IN COMPLEX WITH NLEP, 1: 2, DI-METALATED	3.4.11.18
2GU7	E. COLI METHIONINE AMINOPEPTIDASE UNLIGANDED, 1:0.5	3.4.11.18
2GUW	CRYSTAL STRUCTURE OF AMP NUCLEOSIDASE FROM SALMONELLA TYPHIMURIUM LT2	3.2.2.4
2GUY	ORTHORHOMBIC CRYSTAL STRUCTURE (SPACE GROUP P21212) OF ASPERGILLUS NIGER ALPHA-AMYLASE AT 1.6 A RESOLUTION	3.2.1.1
2GV0	THE STRUCTURE OF THE ORTHORHOMBIC FORM OF SOFT-SHELLED TURTLE LYSOZYME AT 1.9 ANGSTROMS RESOLUTION	3.2.1.17
2GV1	NMR SOLUTION STRUCTURE OF THE ACYLPHOSPHATASE FROM ESCHAERICHIA COLI	3.6.1.7
2GV6	CRYSTAL STRUCTURE OF MATRIPTASE WITH INHIBITOR CJ-730	3.4.21 3.4.21.109
2GV7	STRUCTURE OF MATRIPTASE IN COMPLEX WITH INHIBITOR CJ-672	3.4.21 3.4.21.109
2GV9	CRYSTAL STRUCTURE OF THE HERPES SIMPLEX VIRUS TYPE 1 DNA POLYMERASE	2.7.7.7 3.1.26.4
2GVF	HCV NS3-4A PROTEASE DOMAIN COMPLEXED WITH A MACROCYCLIC KETOAMIDE INHIBITOR, SCH419021	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2GVH	CRYSTAL STRUCTURE OF ACYL-COA HYDROLASE (15159470) FROM AGROBACTERIUM TUMEFACIENS AT 2.65 A RESOLUTION	3.1.2.20
2GVN	L-ASPARAGINASE FROM ERWINIA CAROTOVORA IN COMPLEX WITH ASPARTIC ACID	3.5.1.1
2GVU	CRYSTAL STRUCTURE OF DIISOPROPYL FLUOROPHOSPHATASE (DFPASE), MUTANT D229N / N120D	3.1.8.2
2GVV	STRUCTURE OF DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) IN COMPLEX WITH DICYCLOPENTYLPHOSPHOROAMIDATE (DCPPA)	3.1.8.2
2GVW	STRUCTURE OF DIISOPROPYL FLUOROPHOSPHATASE (DFPASE) HOLOENZYME (RT)	3.1.8.2
2GVX	STRUCTURE OF DIISOPROPYL FLUOROPHOSPHATASE (DFPASE), MUTANT D229N / N175D	3.1.8.2
2GVY	MONOCLINIC CRYSTAL FORM OF ASPERGILLUS NIGER ALPHA-AMYLASE IN COMPLEX WITH MALTOSE AT 1.8 A RESOLUTION	3.2.1.1
2GWF	STRUCTURE OF A USP8-NRDP1 COMPLEX	3.1.2.15 3.4.19.12
2GWO	CRYSTAL STRUCTURE OF TMDP	3.1.3.48 3.1.3.16
2GX4	CRYSTAL STRUCTURE OF SARS CORONAVIRUS 3CL PROTEASE INHIBITOR COMPLEX	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2GX6	RATIONAL STABILIZATION OF E. COLI RIBOSE BINDING PROTEIN	3.6.3.17
2GXB	CRYSTAL STRUCTURE OF THE ZA DOMAIN BOUND TO Z-RNA	3.5.4 3.5.4.37
2GYU	CRYSTAL STRUCTURE OF MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH HI-6	3.1.1.7
2GYV	CRYSTAL STRUCTURE OF MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH ORTHO-7	3.1.1.7
2GYW	CRYSTAL STRUCTURE OF MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH OBIDOXIME	3.1.1.7
2GZ5	HUMAN TYPE 1 METHIONINE AMINOPEPTIDASE IN COMPLEX WITH OVALICIN AT 1.1 ANG	3.4.11.18
2GZ7	STRUCTURE-BASED DRUG DESIGN AND STRUCTURAL BIOLOGY STUDY OF NOVEL NONPEPTIDE INHIBITORS OF SARS-COV MAIN PROTEASE	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2GZ8	STRUCTURE-BASED DRUG DESIGN AND STRUCTURAL BIOLOGY STUDY OF NOVEL NONPEPTIDE INHIBITORS OF SARS-COV MAIN PROTEASE	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2GZ9	STRUCTURE-BASED DRUG DESIGN AND STRUCTURAL BIOLOGY STUDY OF NOVEL NONPEPTIDE INHIBITORS OF SARS-COV MAIN PROTEASE	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2GZD	CRYSTAL STRUCTURE OF RAB11 IN COMPLEX WITH RAB11-FIP2	3.6.5.2
2GZH	CRYSTAL STRUCTURE OF RAB11 IN COMPLEX WITH RAB11-FAMILY INTERACTING PROTEIN 2	3.6.5.2
2GZR	ENTEROBACTIN AND SALMOCHELIN HYDROLASE IROE	3.1
2GZS	ENTEROBACTIN HYDOLASE IROE COMPLEX WITH DFP	3.1
2H02	STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS	3.1.3.48
2H03	STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS	3.1.3.48
2H04	STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS	3.1.3.48
2H0E	CRYSTAL STRUCTURE OF PUCM IN THE ABSENCE OF SUBSTRATE	3.5.2.17
2H0F	CRYSTAL STRUCTURE OF PUCM IN THE PRESENCE OF 8-AZAXANTHINE	3.5.2.17
2H0J	CRYSTAL STRUCTURE OF PUCM IN THE PRESENCE OF 5,6-DIAMINOURACIL	3.5.2.17
2H0P	NMR STRUCTURE OF THE DENGUE-4 VIRUS ENVELOPE PROTEIN DOMAIN III	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2H0Q	CRYSTAL STRUCTURE OF THE PGM DOMAIN OF THE SUPPRESSOR OF T-CELL RECEPTOR (STS-1)	3.1.3.48
2H0R	STRUCTURE OF THE YEAST NICOTINAMIDASE PNC1P	3.5.1.19
2H0T	CRYSTAL STRUCTURE OF THE M69V E166A DOUBLE MUTANT OF SHV-1 B-LACTAMASE COMPLEXED TO CLAVULANIC ACID	3.5.2.6
2H0Y	CRYSTAL STRUCTURE OF THE M69V E166A DOUBLE MUTANT OF SHV-1 B-LACTAMASE COMPLEXED TO SULBACTAM	3.5.2.6
2H10	CRYSTAL STRUCTURE OF THE M69V E166A DOUBLE MUTANT OF SHV-1 B-LACTAMASE COMPLEXED TO TAZOBACTAM	3.5.2.6
2H1C	CRYSTAL STRUCTURE OF FITACB FROM NEISSERIA GONORRHOEAE	3.1
2H1E	TANDEM CHROMODOMAINS OF BUDDING YEAST CHD1	3.6.1 3.6.4
2H1I	CRYSTAL STRUCTURE OF THE BACILLUS CEREUS CARBOXYLESTERASE	3.1.1.1
2H1J	3.1 A X-RAY STRUCTURE OF PUTATIVE OLIGOENDOPEPTIDASE F: CRYSTALS GROWN BY MICROFLUIDIC SEEDING	3.4.24
2H1N	3.0 A X-RAY STRUCTURE OF PUTATIVE OLIGOENDOPEPTIDASE F: CRYSTALS GROWN BY VAPOR DIFFUSION TECHNIQUE	3.4.24
2H1O	STRUCTURE OF FITAB BOUND TO IR36 DNA FRAGMENT	3.1
2H1U	PORCINE PANCREATIC ELASTASE COMPLEXED WITH METPHELEUGLU AT PH 5.0	3.4.21.36
2H1X	CRYSTAL STRUCTURE OF 5-HYDROXYISOURATE HYDROLASE (FORMERLY KNOWN AS TRP, TRANSTHYRETIN RELATED PROTEIN)	3.5.2.17
2H2D	THE STRUCTURAL BASIS FOR SIRTUIN SUBSTRATE AFFINITY	3.5.1 2.3.1.286
2H2F	THE STRUCTURAL BASIS FOR SIRTUIN SUBSTRATE AFFINITY	3.5.1 2.3.1.286
2H2G	THE STRUCTURAL BASIS OF SIRTUIN SUBSTRATE AFFINITY	3.5.1 2.3.1.286
2H2H	THE STRUCTURAL BASIS OF SIRTUIN SUBSTRATE SPECIFICITY	3.5.1 2.3.1.286
2H2I	THE STRUCTURAL BASIS OF SIRTUIN SUBSTRATE AFFINITY	3.5.1 2.3.1.286
2H2N	CRYSTAL STRUCTURE OF HUMAN SOLUBLE CALCIUM-ACTIVATED NUCLEOTIDASE (SCAN) WITH CALCIUM ION	3.6.1.6
2H2U	CRYSTAL STRUCTURE OF THE E130Y MUTANT OF HUMAN SOLUBLE CALCIUM-ACTIVATED NUCLEOTIDASE (SCAN) WITH CALCIUM ION	3.6.1.6
2H2Z	CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE WITH AUTHENTIC N AND C-TERMINI	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2H3F	SOLUTION STRUCTURE OF THE HIV-1 MA PROTEIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2H3I	SOLUTION STRUCTURE OF THE HIV-1 MYRISTOYLATED MATRIX PROTEIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2H3Q	SOLUTION STRUCTURE OF HIV-1 MYRMA BOUND TO DI-C4-PHOSPHATIDYLINOSITOL-(4,5)-BISPHOSPHATE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2H3V	STRUCTURE OF THE HIV-1 MATRIX PROTEIN BOUND TO DI-C8-PHOSPHATIDYLINOSITOL-(4,5)-BISPHOSPHATE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2H3Z	STRUCTURE OF THE HIV-1 MATRIX PROTEIN BOUND TO DI-C4-PHOSPHATIDYLINOSITOL-(4,5)-BISPHOSPHATE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2H40	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF UNLIGANDED PDE5	3.1.4.35
2H42	CRYSTAL STRUCTURE OF PDE5 IN COMPLEX WITH SILDENAFIL	3.1.4.35
2H44	CRYSTAL STRUCTURE OF PDE5A1 IN COMPLEX WITH ICARISID II	3.1.4.35
2H48	CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (CYS362->ALA, CYS364->ALA, CYS397->ALA) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)	3.4.22.36
2H4C	STRUCTURE OF DABOIATOXIN (HETERODIMERIC PLA2 VENOM)	3.1.1.4
2H4F	SIR2-P53 PEPTIDE-NAD+	3.5.1 2.3.1.286
2H4G	CRYSTAL STRUCTURE OF PTP1B WITH MONOCYCLIC THIOPHENE INHIBITOR	3.1.3.48
2H4H	SIR2 H116Y MUTANT-P53 PEPTIDE-NAD	3.5.1 2.3.1.286
2H4I	CRYSTAL STRUCTURE OF THE COMPLEX OF PROTEOLYTICALLY PRODUCED C-TERMINAL HALF OF BOVINE LACTOFERRIN WITH LACTOSE AT 2.55 A RESOLUTION	3.4.21
2H4J	SIR2-DEACETYLATED PEPTIDE (FROM ENZYMATIC TURNOVER IN CRYSTAL)	3.5.1 2.3.1.286
2H4K	CRYSTAL STRUCTURE OF PTP1B WITH A MONOCYCLIC THIOPHENE INHIBITOR	3.1.3.48
2H4U	CRYSTAL STRUCTURE OF HUMAN THIOESTERASE SUPERFAMILY MEMBER 2 (CASP TARGET)	3.1.2.1 3.1.2 3.1.2.2
2H4V	CRYSTAL STRUCTURE OF THE HUMAN TYROSINE RECEPTOR PHOSPHATASE GAMMA	3.1.3.48
2H4W	CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (GLU390->ASP) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)	3.4.22.36
2H4X	HUMAN BISPHOSPHOGLYCERATE MUTASE COMPLEX WITH 3-PHOSPHOGLYCERATE WITH CRYSTAL GROWTH 90 DAYS	5.4.2.4 5.4.2.1 3.1.3.13 5.4.2.11
2H4Y	CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (ARG286->LYS) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)	3.4.22.36
2H4Z	HUMAN BISPHOSPHOGLYCERATE MUTASE COMPLEXED WITH 2,3-BISPHOSPHOGLYCERATE	5.4.2.4 5.4.2.1 3.1.3.13 5.4.2.11
2H51	CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (GLU390->ASP AND ARG286->LYS) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)	3.4.22.36
2H52	CRYSTAL STRUCTURE OF HUMAN BISPHOSPHOGLYCERATE MUTASE COMPLEX WITH 3-PHOSPHOGLYCERATE (18 DAYS)	5.4.2.4 5.4.2.1 3.1.3.13 5.4.2.11
2H54	CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (THR388->ALA) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)	3.4.22.36
2H56	CRYSTAL STRUCTURE OF DNA-3-METHYLADENINE GLYCOSIDASE (10174367) FROM BACILLUS HALODURANS AT 2.55 A RESOLUTION	3.2.2
2H59	SIR2 H116A-DEACETYLATED P53 PEPTIDE-3'-O-ACETYL ADP RIBOSE	3.5.1 2.3.1.286
2H5C	0.82A RESOLUTION CRYSTAL STRUCTURE OF ALPHA-LYTIC PROTEASE AT PH 5	3.4.21.12
2H5D	0.9A RESOLUTION CRYSTAL STRUCTURE OF ALPHA-LYTIC PROTEASE COMPLEXED WITH A TRANSITION STATE ANALOGUE, MEOSUC-ALA-ALA-PRO-VAL BORONIC ACID	3.4.21.12
2H5I	CRYSTAL STRUCTURE OF CASPASE-3 WITH INHIBITOR AC-DEVD-CHO	3.4.22 3.4.22.56
2H5J	CRYSTAL STRUSTURE OF CASPASE-3 WITH INHIBITOR AC-DMQD-CHO	3.4.22 3.4.22.56
2H5S	SA2-13 PENAM SULFONE COMPLEXED TO WT SHV-1 BETA-LACTAMASE	3.5.2.6
2H5X	RUVA FROM MYCOBACTERIUM TUBERCULOSIS	3.6.1 3.6.4.12
2H5Z	CRYSTALLOGRAPHIC STRUCTURE OF DIGESTIVE LYSOZYME 1 FROM MUSCA DOMESTICA BOUND TO CHITOTETRAOSE AT 1.92 A RESOLUTION	3.2.1.17
2H60	SOLUTION STRUCTURE OF HUMAN BRG1 BROMODOMAIN	3.6.1 3.6.4
2H65	CRYSTAL STRUSTURE OF CASPASE-3 WITH INHIBITOR AC-VDVAD-CHO	3.4.22 3.4.22.56
2H6A	CRYSTAL STRUCTURE OF THE ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (MONO ZINC FORM)	3.5.2.6
2H6M	AN EPISULFIDE CATION (THIIRANIUM RING) TRAPPED IN THE ACTIVE SITE OF HAV 3C PROTEINASE INACTIVATED BY PEPTIDE-BASED KETONE INHIBITORS	3.4.22.28 3.6.1.15 2.7.7.48
2H6S	SECRETED ASPARTIC PROTEINASE (SAP) 3 FROM CANDIDA ALBICANS	3.4.23.24
2H6T	SECRETED ASPARTIC PROTEINASE (SAP) 3 FROM CANDIDA ALBICANS COMPLEXED WITH PEPSTATIN A	3.4.23.24
2H7J	CRYSTAL STRUCTURE OF CATHEPSIN S IN COMPLEX WITH A NONPEPTIDIC INHIBITOR.	3.4.22.27
2H85	CRYSTAL STRUCTURE OF NSP 15 FROM SARS	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2H8C	STRUCTURE OF RUSA D70N IN COMPLEX WITH DNA	3.1.22 3.1.22.4
2H8E	STRUCTURE RUSA D70N	3.1.22 3.1.22.4
2H8G	5'-METHYLTHIOADENOSINE NUCLEOSIDASE FROM ARABIDOPSIS THALIANA	3.2.2.16
2H8N	STRUCTURE OF A GLUTAMINE-RICH DOMAIN FROM HISTONE DEACETYLASE 4	3.5.1.98
2H9H	AN EPISULFIDE CATION (THIIRANIUM RING) TRAPPED IN THE ACTIVE SITE OF HAV 3C PROTEINASE INACTIVATED BY PEPTIDE-BASED KETONE INHIBITORS	3.4.22.28 3.6.1.15 2.7.7.48
2H9J	STRUCTURE OF HEN EGG WHITE LYSOZYME SOAKED WITH NI2-XYLYLBICYCLAM	3.2.1.17
2H9K	STRUCTURE OF HEN EGG WHITE LYSOZYME SOAKED WITH NI-CYCLAM	3.2.1.17
2H9T	CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN IN COMPLEX WITH SURAMIN	3.4.21.5
2H9Y	CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE COMPLEXED WITH M-(N,N,N-TRIMETHYLAMMONIO)TRIFLUOROACETOPHENONE	3.1.1.7
2HA0	CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE COMPLEXED WITH 4-KETOAMYLTRIMETHYLAMMONIUM	3.1.1.7
2HA2	CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE COMPLEXED WITH SUCCINYLCHOLINE	3.1.1.7
2HA3	CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE COMPLEXED WITH CHOLINE	3.1.1.7
2HA4	CRYSTAL STRUCTURE OF MUTANT S203A OF MOUSE ACETYLCHOLINESTERASE COMPLEXED WITH ACETYLCHOLINE	3.1.1.7
2HA5	CRYSTAL STRUCTURE OF MUTANT S203A OF ACETYLCHOLINESTERASE COMPLEXED WITH ACETYLTHIOCHOLINE	3.1.1.7
2HA6	CRYSTAL STRUCTURE OF MUTANT S203A OF MOUSE ACETYLCHOLINESTERASE COMPLEXED WITH SUCCINYLCHOLINE	3.1.1.7
2HA7	CRYSTAL STRUCTURE OF MUTANT S203A OF MOUSE ACETYLCHOLINESTERASE COMPLEXED WITH BUTYRYLTHIOCHOLINE	3.1.1.7
2HAD	CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE: AN ENZYME TO DETOXIFY HALOGENATED ALKANES	3.8.1.5
2HAH	THE STRUCTURE OF FIV 12S PROTEASE IN COMPLEX WITH TL-3	3.4.23.16 2.7.7.49 3.1.13.2 3.1.26.13
2HAI	CRYSTAL STRUCTURE OF HCV NS5B RNA POLYMERASE IN COMPLEX WITH NOVEL CLASS OF DIHYDROPYRONE-CONTAINING INHIBITOR.	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
2HAL	AN EPISULFIDE CATION (THIIRANIUM RING) TRAPPED IN THE ACTIVE SITE OF HAV 3C PROTEINASE INACTIVATED BY PEPTIDE-BASED KETONE INHIBITORS	3.4.22.28 3.6.1.15 2.7.7.48
2HAW	CRYSTAL STRUCTURE OF FAMILY II INORGANIC PYROPHOSPHATASE IN COMPLEX WITH PNP	3.6.1.1
2HB1	CRYSTAL STRUCTURE OF PTP1B WITH MONOCYCLIC THIOPHENE INHIBITOR	3.1.3.48
2HB2	STRUCTURE OF HIV PROTEASE 6X MUTANT IN APO FORM	3.4.23.16
2HB3	WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH POTENT INHIBITOR GRL06579	3.4.23.4
2HB4	STRUCTURE OF HIV PROTEASE NL4-3 IN AN UNLIGANDED STATE	3.4.23.16
2HB5	CRYSTAL STRUCTURE OF THE MOLONEY MURINE LEUKEMIA VIRUS RNASE H DOMAIN	3.1.26.4 3.4.23 2.7.7.49 2.7.7.7 2.7.7 3.1
2HB6	STRUCTURE OF CAENORHABDITIS ELEGANS LEUCINE AMINOPEPTIDASE (LAP1)	3.4.11.1
2HB9	CRYSTAL STRUCTURE OF THE ZINC-BETA-LACTAMASE L1 FROM STENOTROPHOMONAS MALTOPHILIA (INHIBITOR 3)	3.5.2.6
2HBJ	STRUCTURE OF THE YEAST NUCLEAR EXOSOME COMPONENT, RRP6P, REVEALS AN INTERPLAY BETWEEN THE ACTIVE SITE AND THE HRDC DOMAIN	3.1.13
2HBK	STRUCTURE OF THE YEAST NUCLEAR EXOSOME COMPONENT, RRP6P, REVEALS AN INTERPLAY BETWEEN THE ACTIVE SITE AND THE HRDC DOMAIN; PROTEIN IN COMPLEX WITH MN	3.1.13
2HBL	STRUCTURE OF THE YEAST NUCLEAR EXOSOME COMPONENT, RRP6P, REVEALS AN INTERPLAY BETWEEN THE ACTIVE SITE AND THE HRDC DOMAIN; PROTEIN IN COMPLEX WITH MN, ZN, AND AMP	3.1.13
2HBM	STRUCTURE OF THE YEAST NUCLEAR EXOSOME COMPONENT, RRP6P, REVEALS AN INTERPLAY BETWEEN THE ACTIVE SITE AND THE HRDC DOMAIN; PROTEIN IN COMPLEX WITH MN, ZN, AND UMP	3.1.13
2HBQ	CRYSTAL STRUCTURE OF WILDTYPE HUMAN CASPASE-1 IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)	3.4.22.36
2HBR	CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (ARG286->ALA) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)	3.4.22.36
2HBY	CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (GLU390->ALA) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)	3.4.22.36
2HBZ	CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (ARG286->ALA, GLU390->ALA) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)	3.4.22.36
2HC0	STRUCTURE OF HIV PROTEASE 6X MUTANT IN COMPLEX WITH AB-2.	3.4.23.16
2HC1	ENGINEERED CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE HPTPBETA.	3.1.3.48
2HC2	ENGINEERED PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN	3.1.3.48
2HC9	STRUCTURE OF CAENORHABDITIS ELEGANS LEUCINE AMINOPEPTIDASE-ZINC COMPLEX (LAP1)	3.4.11.1
2HCA	CRYSTAL STRUCTURE OF BOVINE LACTOFERRIN C-LOBE LIGANDED WITH GLUCOSE AT 2.8 A RESOLUTION	3.4.21
2HCM	CRYSTAL STRUCTURE OF MOUSE PUTATIVE DUAL SPECIFICITY PHOSPHATASE COMPLEXED WITH ZINC TUNGSTATE, NEW YORK STRUCTURAL GENOMICS CONSORTIUM	3.1.3.16 3.1.3.48
2HCN	CRYSTAL STRUCTURE OF RNA DEPENDENT RNA POLYMERASE DOMAIN FROM WEST NILE VIRUS	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57
2HCS	CRYSTAL STRUCTURE OF RNA DEPENDANT RNA POLYMERASE DOMAIN OF WEST NILE VIRUS	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57
2HCT	ACIDIC RESIDUES AT THE ACTIVE SITES OF CD38 AND ADP-RIBOSYL CYCLASE DETERMINE NAAPD SYNTHESIS AND HYDROLYSIS ACTIVITIES	3.2.2.5 3.2.2.6 2.4.99.20
2HD0	STRUCTURE OF THE CATALYTIC DOMAIN OF HEPATITIS C VIRUS NS2	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2HD1	CRYSTAL STRUCTURE OF PDE9 IN COMPLEX WITH IBMX	3.1.4.35
2HD4	CRYSTAL STRUCTURE OF PROTEINASE K INHIBITED BY A LACTOFERRIN OCTAPEPTIDE GLY-ASP-GLU-GLN-GLY-GLU-ASN-LYS AT 2.15 A RESOLUTION	3.4.21.64
2HD5	USP2 IN COMPLEX WITH UBIQUITIN	3.1.2.15 3.4.19.12
2HDO	CRYSTAL STRUCTURE OF PUTATIVE PHOSPHOGLYCOLATE PHOSPHATASE (NP_784602.1) FROM LACTOBACILLUS PLANTARUM AT 1.50 A RESOLUTION	3.1.3.18 3.6.1.1
2HDQ	AMPC BETA-LACTAMASE IN COMPLEX WITH 2-CARBOXYTHIOPHENE	3.5.2.6
2HDR	AMPC BETA-LACTAMASE IN COMPLEX WITH 4-AMINO-3-HYDROXYBENZOIC ACID	3.5.2.6
2HDS	AMPC BETA-LACTAMASE IN COMPLEX WITH 4-METHANESULFONYLAMINO BENZOIC ACID	3.5.2.6
2HDU	AMPC BETA-LACTAMASE IN COMPLEX WITH 2-ACETAMIDOTHIOPHENE-3-CARBOXYLIC ACID	3.5.2.6
2HEA	CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY	3.2.1.17
2HEB	CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY	3.2.1.17
2HEC	CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY	3.2.1.17
2HED	CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY	3.2.1.17
2HEE	CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY	3.2.1.17
2HEF	CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OF A PROTEIN TO THE CONFORMATIONAL STABILITY	3.2.1.17
2HEG	PHOSPHO-ASPARTYL INTERMEDIATE ANALOGUE OF APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE	3.1.3.2
2HEZ	BIFIDOBACTERIUM LONGUM BILE SALT HYDROLASE	3.5.1.24 3.5.1 3.5.1.74
2HF0	BIFIDOBACTERIUM LONGUM BILE SALT HYDROLASE	3.5.1.24 3.5.1 3.5.1.74
2HF2	DOMAIN SHIFTING CONFIRMS MONOMERIC STRUCTURE OF ESCHERICHIA SUGAR PHOSPHATASE SUPH	3.1.3.23
2HF7	TRANSITION STATE ANALOGUE OF APHA CLASS B ACID PHOSPHATASE/PHOSPHOTRANSFERASE (ALUMINIUM FLUORIDE COMPLEX)	3.1.3.2
2HFZ	CRYSTAL STRUCTURE OF RNA DEPENDENT RNA POLYMERASE DOMAIN FROM WEST NILE VIRUS	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57
2HGT	STRUCTURE OF THE HIRUGEN AND HIRULOG 1 COMPLEXES OF ALPHA-THROMBIN	3.4.21.5
2HH5	CRYSTAL STRUCTURE OF CATHEPSIN S IN COMPLEX WITH A ZINC MEDIATED NON-COVALENT ARYLAMINOETHYL AMIDE	3.4.22.27
2HHA	THE STRUCTURE OF DPP4 IN COMPLEX WITH AN OXADIAZOLE INHIBITOR	3.4.14.5
2HHJ	HUMAN BISPHOSPHOGLYCERATE MUTASE COMPLEXED WITH 2,3-BISPHOSPHOGLYCERATE (15 DAYS)	5.4.2.4 5.4.2.1 3.1.3.13 5.4.2.11
2HHL	CRYSTAL STRUCTURE OF THE HUMAN SMALL CTD PHOSPHATASE 3 ISOFORM 1	3.1.3.16
2HHM	STRUCTURE OF INOSITOL MONOPHOSPHATASE, THE PUTATIVE TARGET OF LITHIUM THERAPY	3.1.3.25 3.1.3.94
2HHN	CATHEPSIN S IN COMPLEX WITH NON COVALENT ARYLAMINOETHYL AMIDE.	3.4.22.27
2HI0	CRYSTAL STRUCTURE OF PUTATIVE PHOSPHOGLYCOLATE PHOSPHATASE (YP_619066.1) FROM LACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS ATCC BAA-365 AT 1.51 A RESOLUTION	3.1.3.18
2HIH	CRYSTAL STRUCTURE OF STAPHYLOCOCCUS HYICUS LIPASE	3.1.1.3 3.1.1.32
2HIM	CRYSTAL STRUCTURE AND ALLOSTERIC REGULATION OF THE CYTOPLASMIC ESCHERICHIA COLI L-ASPARAGINASE I	3.5.1.1
2HIS	CELLULOMONAS FIMI XYLANASE/CELLULASE DOUBLE MUTANT E127A/H205N WITH COVALENT CELLOBIOSE	3.2.1.91 3.2.1.8
2HIZ	CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE (BACE) IN THE PRESENCE OF AN INHIBITOR	3.4.23.46
2HJE	CRYSTAL STRUCTURE OF VIBRIO HARVEYI LUXQ PERIPLASMIC DOMAIN	2.7.13.3 3.1.3
2HJH	CRYSTAL STRUCTURE OF THE SIR2 DEACETYLASE	3.5.1 2.3.1.286
2HJP	CRYSTAL STRUCTURE OF PHOSPHONOPYRUVATE HYDROLASE COMPLEX WITH PHOSPHONOPYRUVATE AND MG++	3.11.1.3
2HJV	STRUCTURE OF THE SECOND DOMAIN (RESIDUES 207-368) OF THE BACILLUS SUBTILIS YXIN PROTEIN	3.6.1 3.6.4.13
2HKP	SUMO PROTEASE ULP1 WITH THE CATALYTIC CYSTEINE OXIDIZED TO A SULFENIC ACID	3.4.22 3.4.22.68
2HKY	NMR SOLUTION STRUCTURE OF HUMAN RNASE 7	3.1.27
2HL6	STRUCTURE OF HOMOLOGOUSLY EXPRESSED FERRULATE ESTERASE OF ASPERGILLUS NIGER IN COMPLEX WITH CAPS	3.1.1.73
2HL8	SUMO PROTEASE ULP1 WITH THE CATALYTIC CYSTEINE OXIDIZED TO A SULFINIC ACID	3.4.22 3.4.22.68
2HL9	SUMO PROTEASE ULP1 WITH THE CATALYTIC CYSTEINE OXIDIZED TO A SULFONIC ACID	3.4.22 3.4.22.68
2HLC	HL COLLAGENASE STRUCTURE AT 1.7A RESOLUTION	3.4.21 3.4.21.49
2HLT	SOLUTION STRUCTURE OF BACILLUS SUBTILIS ACYLPHOSPHATASE	3.6.1.7
2HLU	SOLUTION STRUCTURE OF BACILLUS SUBTILIS ACYLPHOSPHATASE	3.6.1.7
2HM1	CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE (BACE) IN THE PRESENCE OF AN INHIBITOR (2)	3.4.23.46
2HM7	CRYSTAL STRUCTURE ANALYSIS OF THE G84S EST2 MUTANT	3.1.1.1
2HMI	HIV-1 REVERSE TRANSCRIPTASE/FRAGMENT OF FAB 28/DNA COMPLEX	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2HMX	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 MATRIX PROTEIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2HND	CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2HNP	CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE 1B	3.1.3.48
2HNQ	CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE 1B	3.1.3.48
2HNT	CRYSTALLOGRAPHIC STRUCTURE OF HUMAN GAMMA-THROMBIN	3.4.21.5
2HNY	CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2HNZ	CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2HOB	CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE WITH AUTHENTIC N AND C-TERMINI IN COMPLEX WITH A MICHAEL ACCEPTOR N3	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2HOH	RIBONUCLEASE T1 (N9A MUTANT) COMPLEXED WITH 2'GMP	3.1.27.3 4.6.1.24
2HOQ	CRYSTAL STRUCTURE OF THE PROBABLE HALOACID DEHALOGENASE (PH1655) FROM PYROCOCCUS HORIKOSHII OT3	3 3.1.3
2HOW	DIPEPTIDASE (PH0974) FROM PYROCOCCUS HORIKOSHII OT3	3.4
2HP5	CRYSTAL STRUCTURE OF THE OXA-10 W154G MUTANT AT PH 7.0	3.5.2.6
2HP6	CRYSTAL STRUCTURE OF THE OXA-10 W154A MUTANT AT PH 7.5	3.5.2.6
2HP9	CRYSTAL STRUCTURE OF THE OXA-10 W154A MUTANT AT PH 6.0	3.5.2.6
2HPA	STRUCTURAL ORIGINS OF L(+)-TARTRATE INHIBITION OF HUMAN PROSTATIC ACID PHOSPHATASE	3.1.3.2 3.1.3.5
2HPB	CRYSTAL STRUCTURE OF THE OXA-10 W154A MUTANT AT PH 9.0	3.5.2.6
2HPE	COMPARISON OF THE STRUCTURES OF HIV-2 PROTEASE COMPLEXES IN THREE CRYSTAL SPACE GROUPS WITH AN HIV-1 PROTEASE COMPLEX STRUCTURE	3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2HPF	COMPARISON OF THE STRUCTURES OF HIV-2 PROTEASE COMPLEXES IN THREE CRYSTAL SPACE GROUPS WITH AN HIV-1 PROTEASE COMPLEX STRUCTURE	3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2HPJ	CRYSTAL STRUCTURE OF THE PUB DOMAIN OF MOUSE PNGASE	3.5.1.52
2HPL	CRYSTAL STRUCTURE OF THE MOUSE P97/PNGASE COMPLEX	3.5.1.52
2HPO	STRUCTURE OF AMINOPEPTIDASE N FROM E. COLI SUGGESTS A COMPARTMENTALIZED, GATED ACTIVE SITE	3.4.11.2
2HPP	STRUCTURES OF THE NONCOVALENT COMPLEXES OF HUMAN AND BOVINE PROTHROMBIN FRAGMENT 2 WITH HUMAN PPACK-THROMBIN	3.4.21.5
2HPQ	STRUCTURES OF THE NONCOVALENT COMPLEXES OF HUMAN AND BOVINE PROTHROMBIN FRAGMENT 2 WITH HUMAN PPACK-THROMBIN	3.4.21.5
2HPT	CRYSTAL STRUCTURE OF E. COLI PEPN (AMINOPEPTIDASE N)IN COMPLEX WITH BESTATIN	3.4.11.2
2HPZ	CRYSTAL STRUCTURE OF PROTEINASE K COMPLEX WITH A SYNTHETIC PEPTIDE KLKLLVVIRLK AT 1.69 A RESOLUTION	3.4.21.64
2HQE	CRYSTAL STRUCTURE OF HUMAN P100 TUDOR DOMAIN: LARGE FRAGMENT	3.1.31.1
2HQU	HUMAN DUTPASE IN COMPLEX WITH ALPHA,BETA-IMINODUTP AND MAGNESIUM ION	3.6.1.23
2HQX	CRYSTAL STRUCTURE OF HUMAN P100 TUDOR DOMAIN CONSERVED REGION	3.1.31.1
2HR6	CRYSTAL STRUCTURE OF DUTPASE IN COMPLEX WITH SUBSTRATE ANALOGUE DUDP AND MANGANESE	3.6.1.23
2HRM	CRYSTAL STRUCTURE OF DUTPASE COMPLEXED WITH SUBSTRATE ANALOGUE METHYLENE-DUTP	3.6.1.23
2HRR	CRYSTAL STRUCTURE OF HUMAN LIVER CARBOXYLESTERASE 1 (HCE1) IN COVALENT COMPLEX WITH THE NERVE AGENT TABUN (GA)	3.1.1.1 3.1.1.13 3.1.1.56
2HRV	2A CYSTEINE PROTEINASE FROM HUMAN RHINOVIRUS 2	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
2HRW	CRYSTAL STRUCTURE OF PHOSPHONOPYRUVATE HYDROLASE	3.11.1.3
2HS1	ULTRA-HIGH RESOLUTION X-RAY CRYSTAL STRUCTURE OF HIV-1 PROTEASE V32I MUTANT WITH TMC114 (DARUNAVIR) INHIBITOR	3.4.23.16
2HS2	CRYSTAL STRUCTURE OF M46L MUTANT OF HIV-1 PROTEASE COMPLEXED WITH TMC114 (DARUNAVIR)	3.4.23.16
2HS7	MULTIPATTERN RIETVELD REFINEMENT WITH PROTEIN POWDER DATA: AN APPROACH TO HIGHER RESOLUTION	3.2.1.17
2HS9	MULTIPATTERN RIETVELD REFINEMENT WITH PROTEIN POWDER DATA: AN APPROACH TO HIGHER RESOLUTION	3.2.1.17
2HSO	MULTIPATTERN RIETVELD REFINEMENT WITH PROTEIN POWDER DATA: AN APPROACH TO HIGHER RESOLUTION	3.2.1.17
2HSP	SOLUTION STRUCTURE OF THE SH3 DOMAIN OF PHOSPHOLIPASE CGAMMA	3.1.4.11
2HSX	NMR STRUCTURE OF THE NONSTRUCTURAL PROTEIN 1 (NSP1) FROM THE SARS CORONAVIRUS	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2HSZ	CRYSTAL STRUCTURE OF A PREDICTED PHOSPHOGLYCOLATE PHOSPHATASE (HS_0176) FROM HAEMOPHILUS SOMNUS 129PT AT 1.90 A RESOLUTION	3.1.3.18
2HT5	N8 NEURAMINIDASE	3.2.1.18
2HT7	N8 NEURAMINIDASE IN OPEN COMPLEX WITH OSELTAMIVIR	3.2.1.18
2HT8	N8 NEURAMINIDASE IN COMPLEX WITH OSELTAMIVIR	3.2.1.18
2HTQ	N8 NEURAMINIDASE IN COMPLEX WITH ZANAMIVIR	3.2.1.18
2HTR	N8 NEURAMINIDASE IN COMPLEX WITH DANA	3.2.1.18
2HTU	N8 NEURAMINIDASE IN COMPLEX WITH PERAMIVIR	3.2.1.18
2HTV	N4 NEURAMINIDASE	3.2.1.18
2HTW	N4 NEURAMINIDASE IN COMPLEX WITH DANA	3.2.1.18
2HTX	CRYSTAL STRUCTURE ANALYSIS OF HEN EGG WHITE LYSOZYME CROSSLINKED BY POLYMERIZED GLUTARALDEHYDE IN ACIDIC ENVIRONMENT	3.2.1.17
2HU1	CRYSTAL STRUCTURE ANALYSIS OF HEN EGG WHITE LYSZOYME	3.2.1.17
2HU3	PARENT STRUCTURE OF HEN EGG WHITE LYSOZYME GROWN IN ACIDIC PH 4.8. REFINEMENT FOR COMPARISON WITH CROSSLINKED MOLECULES OF LYSOZYME	3.2.1.17
2HU5	BINDING OF INHIBITORS BY ACYLAMINOACYL-PEPTIDASE	3.4.19.1
2HU6	CRYSTAL STRUCTURE OF HUMAN MMP-12 IN COMPLEX WITH ACETOHYDROXAMIC ACID AND A BICYCLIC INHIBITOR	3.4.24.65
2HU7	BINDING OF INHIBITORS BY ACYLAMINOACYL PEPTIDASE	3.4.19.1
2HU8	BINDING OF INHIBITORS BY ACYLAMINOACYL PEPTIDASE	3.4.19.1
2HUB	STRUCTURE OF HEN EGG-WHITE LYSOZYME DETERMINED FROM CRYSTALS GROWN IN PH 7.5	3.2.1.17
2HUC	STRUCTURAL STUDIES EXAMINING THE SUBSTRATE SPECIFICITY PROFILES OF PC-PLCBC PROTEIN VARIANTS	3.1.4.3
2HUK	CRYSTAL STRUCTURE OF T4 LYSOZYME V131C SYNTHETIC DIMER	3.2.1.17
2HUL	CRYSTAL STRUCTURE OF T4 LYSOZYME S44C SYNTHETIC DIMER	3.2.1.17
2HUM	CRYSTAL STRUCTURE OF T4 LYSOZYME D72C SYNTHETIC DIMER	3.2.1.17
2HVL	CRYSTAL STRUCTURE OF THE HEPTP CATALYTIC DOMAIN C270S MUTANT	3.1.3.48
2HVM	HEVAMINE A AT 1.8 ANGSTROM RESOLUTION	3.2.1.14 3.2.1.17
2HVV	CRYSTAL STRUCTURE OF DCMP DEAMINASE FROM STREPTOCOCCUS MUTANS	3.5.4.12
2HVW	CRYSTAL STRUCTURE OF DCMP DEAMINASE FROM STREPTOCOCCUS MUTANS	3.5.4.12
2HVX	DISCOVERY OF POTENT, ORALLY ACTIVE, NONPEPTIDE INHIBITORS OF HUMAN MAST CELL CHYMASE BY USING STRUCTURE-BASED DRUG DESIGN	3.4.21.39
2HW0	NMR SOLUTION STRUCTURE OF THE NUCLEASE DOMAIN FROM THE REPLICATOR INITIATOR PROTEIN FROM PORCINE CIRCOVIRUS PCV2	3.1.21 2.7.7 3.6.1
2HW4	CRYSTAL STRUCTURE OF HUMAN PHOSPHOHISTIDINE PHOSPHATASE	3.1.3 3.9.1.3
2HWB	A COMPARISON OF THE ANTI-RHINOVIRAL DRUG BINDING POCKET IN HRV14 AND HRV1A	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
2HWC	A COMPARISON OF THE ANTI-RHINOVIRAL DRUG BINDING POCKET IN HRV14 AND HRV1A	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
2HWD	A COMPARISON OF THE ANTI-RHINOVIRAL DRUG BINDING POCKET IN HRV14 AND HRV1A	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
2HWE	A COMPARISON OF THE ANTI-RHINOVIRAL DRUG BINDING POCKET IN HRV14 AND HRV1A	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
2HWF	A COMPARISON OF THE ANTI-RHINOVIRAL DRUG BINDING POCKET IN HRV14 AND HRV1A	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
2HWH	HCV NS5B ALLOSTERIC INHIBITOR COMPLEX	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2HWI	HCV NS5B ALLOSTERIC INHIBITOR COMPLEX	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2HWK	CRYSTAL STRUCTURE OF VENEZUELAN EQUINE ENCEPHALITIS ALPHAVIRUS NSP2 PROTEASE DOMAIN	3.4.22
2HWL	CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH FIBRINOGEN GAMMA' PEPTIDE	3.4.21.5
2HWT	NMR SOLUTION STRUCTURE OF THE MASTER-REP PROTEIN NUCLEASE DOMAIN (2-95) FROM THE FABA BEAN NECROTIC YELLOWS VIRUS	3.1.21 2.7.7 3.6.1
2HWW	STRUCTURE OF PIN DOMAIN OF HUMAN SMG6	3.1
2HWX	STRUCTURE OF HUMAN SMG6 E1282C PIN DOMAIN MUTANT.	3.1
2HX5	CRYSTAL STRUCTURE OF A PUTATIVE THIOESTERASE (PMT_2055) FROM PROCHLOROCOCCUS MARINUS STR. MIT 9313 AT 1.50 A RESOLUTION	3.1.2.28
2HX6	SOLUTION STRUCTURE ANALYSIS OF THE PHAGE T4 ENDORIBONUCLEASE REGB	3.1
2HXB	DCTP DEAMINASE-DUTPASE FROM METHANOCALDOCOCCUS JANNASCHII	3.5.4.30
2HXD	BIFUNCTIONAL DCTP DEAMINASE-DUTPASE MUTANT ENZYME VARIANT E145A FROM METHANOCALDOCOCCUS JANNASCHII IN COMPLEX WITH ALPHA,BETA-IMIDO DUTP AND MAGNESIUM	3.5.4.30
2HXM	COMPLEX OF UNG2 AND A SMALL MOLECULE SYNTHETIC INHIBITOR	3.2.2 3.2.2.27
2HXP	CRYSTAL STRUCTURE OF THE HUMAN PHOSPHATASE (DUSP9)	3.1.3.48 3.1.3.16
2HXV	CRYSTAL STRUCTURE OF A DIAMINOHYDROXYPHOSPHORIBOSYLAMINOPYRIMIDINE DEAMINASE/ 5-AMINO-6-(5-PHOSPHORIBOSYLAMINO)URACIL REDUCTASE (TM1828) FROM THERMOTOGA MARITIMA AT 1.80 A RESOLUTION	3.5.4.26 1.1.1.193
2HXY	CRYSTAL STRUCTURE OF HUMAN APO-EIF4AIII	3.6.1 3.6.4.13
2HY1	CRYSTAL STRUCTURE OF RV0805	3.1.4.17 3.1.4.53
2HY3	CRYSTAL STRUCTURE OF THE HUMAN TYROSINE RECEPTOR PHOSPHATE GAMMA IN COMPLEX WITH VANADATE	3.1.3.48
2HYK	THE CRYSTAL STRUCTURE OF AN ENDO-BETA-1,3-GLUCANASE FROM ALKALIPHILIC NOCARDIOPSIS SP.STRAIN F96	3.2.1.39
2HYO	CRYSTAL STRUCTURE OF RV0805 N97A MUTANT	3.1.4.17 3.1.4.53
2HYP	CRYSTAL STRUCTURE OF RV0805 D66A MUTANT	3.1.4.17 3.1.4.53
2HZ6	THE CRYSTAL STRUCTURE OF HUMAN IRE1-ALPHA LUMINAL DOMAIN	2.7.11.1 3.1.26
2HZP	CRYSTAL STRUCTURE OF HOMO SAPIENS KYNURENINASE	3.7.1.3
2HZY	MOUSE FUMARYLACETOACETATE HYDROLASE COMPLEXES WITH A TRANSITION-STATE MIMIC OF THE COMPLETE SUBSTRATE	3.7.1.2
2I03	CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE 4 (DPP IV) WITH POTENT ALKYNYL CYANOPYRROLIDINE (ABT-279)	3.4.14.5
2I0U	CRYSTAL STRUCTURES OF PHOSPHOLIPASES A2 FROM VIPERA NIKOLSKII VENOM REVEALING TRITON X-100 BOUND IN HYDROPHOBIC CHANNEL	3.1.1.4
2I0X	HYPOTHETICAL PROTEIN PF1117 FROM PYROCOCCUS FURIOSUS	3.1
2I1A	A RETROVIRAL PROTEASE-LIKE DOMAIN IN THE EUKARYOTIC PROTEIN DDI1	3.4.23
2I1R	NOVEL THIAZOLONES AS HCV NS5B POLYMERASE INHIBITORS: FURTHER DESIGNS, SYNTHESIS, SAR AND X-RAY COMPLEX STRUCTURE	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2I1V	CRYSTAL STRUCTURE OF PFKFB3 IN COMPLEX WITH ADP AND FRUCTOSE-2,6-BISPHOSPHATE	2.7.1.105 3.1.3.46
2I1Y	CRYSTAL STRUCTURE OF THE PHOSPHATASE DOMAIN OF HUMAN PTP IA-2	3.1.3.48
2I25	CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR PBLA8 VARIABLE DOMAIN IN COMPLEX WITH LYSOZYME	3.2.1.17
2I26	CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR ANCESTRAL VARIABLE DOMAIN IN COMPLEX WITH LYSOZYME	3.2.1.17
2I33	THE STRUCTURE OF THE CLASS C ACID PHOSPHATASE FROM BACILLUS ANTHRACIS	3.1.3.2
2I34	THE CRYSTAL STRUCTURE OF CLASS C ACID PHOSPHATASE FROM BACILLUS ANTHRACIS WITH TUNGSTATE BOUND	3.1.3.2
2I3B	SOLUTION STRUCTURE OF A HUMAN CANCER-RELATED NUCLEOSIDE TRIPHOSPHATASE	3.6.1.15
2I3C	CRYSTAL STRUCTURE OF AN ASPARTOACYLASE FROM HOMO SAPIENS	3.5.1.15
2I3E	SOLUTION STRUCTURE OF CATALYTIC DOMAIN OF GOLDFISH RICH PROTEIN	3.1.4.37
2I3P	K28R MUTANT OF HOMING ENDONUCLEASE I-CREI	3.1
2I3Q	Q44V MUTANT OF HOMING ENDONUCLEASE I-CREI	3.1
2I3R	ENGINEERED CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE HPTPBETA	3.1.3.48
2I3U	STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS	3.1.3.48
2I42	CRYSTAL STRUCTURE OF YERSINIA PROTEIN TYROSINE PHOSPHATASE COMPLEXED WITH VANADATE, A TRANSITION STATE ANALOGUE	3.1.3.48
2I47	CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH INHIBITOR	3.4.24.86
2I4D	CRYSTAL STRUCTURE OF WT HIV-1 PROTEASE WITH GS-8373	3.4.23.16
2I4E	STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS	3.1.3.48
2I4G	STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH A SULFAMIC ACID (SOAKING EXPERIMENT)	3.1.3.48
2I4H	STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN CO-CRYSTALLIZED WITH A SULFAMIC ACID INHIBITOR	3.1.3.48
2I4I	CRYSTAL STRUCTURE OF HUMAN DEAD-BOX RNA HELICASE DDX3X	3.6.1 3.6.4.13
2I4Q	HUMAN RENIN/PF02342674 COMPLEX	3.4.23.15
2I4R	CRYSTAL STRUCTURE OF THE V-TYPE ATP SYNTHASE SUBUNIT F FROM ARCHAEOGLOBUS FULGIDUS. NESG TARGET GR52A.	3.6.3.14
2I4U	HIV-1 PROTEASE WITH TMC-126	3.4.23.16
2I4V	HIV-1 PROTEASE I84V, L90M WITH TMC126	3.4.23.16
2I4W	HIV-1 PROTEASE WT WITH GS-8374	3.4.23.16
2I4X	HIV-1 PROTEASE I84V, L90M WITH GS-8374	3.4.23.16
2I50	SOLUTION STRUCTURE OF UBP-M ZNF-UBP DOMAIN	3.1.2.15 3.4.19.12
2I5D	CRYSTAL STRUCTURE OF HUMAN INOSINE TRIPHOSPHATE PYROPHOSPHATASE	3.6.1.19 3.6.1.9
2I5I	CRYSTAL STRUCTURE OF A PUTATIVE CELLOBIOSE-PHOSPHATE CLEAVAGE PROTEIN (EF3048) FROM ENTEROCOCCUS FAECALIS V583 AT 1.70 A RESOLUTION	3.5.1
2I5J	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DHBNH, AN RNASE H INHIBITOR	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2I5W	STRUCTURE OF HOGG1 CROSSLINKED TO DNA SAMPLING A NORMAL G ADJACENT TO AN OXOG	3.2.2 4.2.99.18
2I5X	ENGINEERING THE PTPBETA CATALYTIC DOMAIN WITH IMPROVED CRYSTALLIZATION PROPERTIES	3.1.3.48
2I65	STRUCTURAL BASIS FOR THE MECHANISTIC UNDERSTANDING HUMAN CD38 CONTROLLED MULTIPLE CATALYSIS	3.2.2.5 3.2.2.6 2.4.99.20
2I66	STRUCTURAL BASIS FOR THE MECHANISTIC UNDERSTANDING HUMAN CD38 CONTROLLED MULTIPLE CATALYSIS	3.2.2.5 3.2.2.6 2.4.99.20
2I67	STRUCTURAL BASIS FOR THE MECHANISTIC UNDERSTANDING HUMAN CD38 CONTROLLED MULTIPLE CATALYSIS	3.2.2.5 3.2.2.6 2.4.99.20
2I6J	CRYSTAL STRUCTURE OF THE COMPLEX OF THE ARCHAEAL SULFOLOBUS PTP-FOLD PHOSPHATASE WITH PHOSPHATE ION	3.1.3.48
2I6M	CRYSTAL STRUCTURE OF THE COMPLEXES OF THE ARCHAEAL SULFOLOBUS PTP-FOLD PHOSPHATASE WITH TUNGSTATE	3.1.3.48
2I6O	CRYSTAL STRUCTURE OF THE COMPLEX OF THE ARCHAEAL SULFOLOBUS PTP-FOLD PHOSPHATASE WITH PHOSPHOPEPTIDES N-G-(P)Y-K-N	3.1.3.48
2I6P	CRYSTAL STRUCTURE OF THE COMPLEX OF THE ARCHAEAL SULFOLOBUS PTP-FOLD PHOSPHATASE WITH PNPP	3.1.3.48
2I6Q	COMPLEMENT COMPONENT C2A	3.4.21.43
2I6S	COMPLEMENT COMPONENT C2A	3.4.21.43
2I6Z	X-RAY DIFFRACTION STUDIES OF ADDUCTS BETWEEN ANTICANCER PLATINUM DRUGS AND HEN EGG WHITE LYSOZYME	3.2.1.17
2I71	CRYSTAL STRUCTURE OF A CONSERVED PROTEIN OF UNKNOWN FUNCTION FROM SULFOLOBUS SOLFATARICUS P2	3.1
2I72	AMPC BETA-LACTAMASE IN COMPLEX WITH 5-DIFORMYLAMINOMETHYL-BENZO[B]THIOPHEN-2-BORONIC ACID	3.5.2.6
2I74	CRYSTAL STRUCTURE OF MOUSE PEPTIDE N-GLYCANASE C-TERMINAL DOMAIN IN COMPLEX WITH MANNOPENTAOSE	3.5.1.52
2I75	CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE N4 (PTPN4)	3.1.3.48
2I7A	DOMAIN IV OF HUMAN CALPAIN 13	3.4.22
2I7D	STRUCTURE OF HUMAN CYTOSOLIC DEOXYRIBONUCLEOTIDASE IN COMPLEX WITH DEOXYURIDINE, ALF4 AND MG2+	3.1.3
2I7T	STRUCTURE OF HUMAN CPSF-73	3.1.27
2I7V	STRUCTURE OF HUMAN CPSF-73	3.1.27
2I8E	STRUCTURE OF SSO1404, A PREDICTED DNA REPAIR-ASSOCIATED PROTEIN FROM SULFOLOBUS SOLFATARICUS P2	3.1
2I8L	SOLUTION STRUCTURE OF AN ENDOPEPTIDASE HYCI FROM ESCHERICHIA COLI	3.4 3.4.23.51
2I8T	GDP-MANNOSE MANNOSYL HYDROLASE-CALCIUM-GDP-MANNOSE COMPLEX	3.6.1
2I8U	GDP-MANNOSE MANNOSYL HYDROLASE-CALCIUM-GDP PRODUCT COMPLEX	3.6.1
2I9A	CRYSTAL STRUCTURE OF THE FREE AMINOTERMINAL FRAGMENT OF UROKINASE TYPE PLASMINOGEN ACTIVATOR (ATF)	3.4.21.73
2I9B	CRYSTAL STRUCTURE OF ATF-UROKINASE RECEPTOR COMPLEX	3.4.21.73
2I9U	CRYSTAL STRUCTURE OF GUANINE DEAMINASE FROM C. ACETOBUTYLICUM WITH BOUND GUANINE IN THE ACTIVE SITE	3.5.4.3
2IAJ	CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH ATP	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2IAO	CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE E37Q MUTANT	3.1.8.2
2IAP	CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE E21Q MUTANT	3.1.8.2
2IAQ	CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE S271A MUTANT	3.1.8.2
2IAR	CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE W244H MUTANT	3.1.8.2
2IAS	CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE W244F MUTANT	3.1.8.2
2IAT	CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE W244L MUTANT	3.1.8.2
2IAU	CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE W244Y MUTANT	3.1.8.2
2IAV	CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE H287A MUTANT	3.1.8.2
2IAW	CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE N175D MUTANT	3.1.8.2
2IAX	CRYSTAL STRUCTURE OF SQUID GANGLION DFPASE D232S MUTANT	3.1.8.2
2IBI	COVALENT UBIQUITIN-USP2 COMPLEX	3.1.2.15 3.4.19.12
2IC3	CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH NONNUCLEOSIDE INHIBITOR HBY 097	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2IC5	CRYSTAL STRUCTURE OF HUMAN RAC3 GROWN IN THE PRESENCE OF GPP(NH)P.	3.6.5.2
2IC8	CRYSTAL STRUCTURE OF GLPG	3.4.21.105
2ICS	CRYSTAL STRUCTURE OF AN ADENINE DEAMINASE	3.5.4.2 3.1.1
2ICU	CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN YEDK FROM ESCHERICHIA COLI	3.4
2ID4	THE 1.9 A STRUCTURE OF KEX2 IN COMPLEX WITH AN AC-R-E-R-K-CHLOROMETHYL KETONE INHIBITOR.	3.4.21.61
2ID8	CRYSTAL STRUCTURE OF PROTEINASE K	3.4.21.64
2IDW	CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017)	3.4.23.16
2IDY	NMR STRUCTURE OF THE SARS-COV NON-STRUCTURAL PROTEIN NSP3A	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2IEH	CRYSTAL STRUCTURE OF HUMAN KINESIN EG5 IN COMPLEX WITH (R)-MON97, A NEW MONASTROL-BASED INHIBITOR THAT BINDS AS (R)-ENANTIOMER	3.6.4.4
2IEN	CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017)	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2IEO	CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A POTENT NON-PEPTIDE INHIBITOR (UIC-94017)	3.4.23.16
2IER	CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS LPXC COMPLEXED WITH URIDINE 5'-DIPHOSPHATE	3.5.1 3.5.1.108
2IES	CRYSTAL STRUCTURE OF AQUIFEX AEOLICUS LPXC COMPLEXED WITH PYROPHOSPHATE	3.5.1 3.5.1.108
2IEY	CRYSTAL STRUCTURE OF MOUSE RAB27B BOUND TO GDP IN HEXAGONAL SPACE GROUP	3.6.5.2
2IEZ	CRYSTAL STRUCTURE OF MOUSE RAB27B BOUND TO GDP IN MONOCLINIC SPACE GROUP	3.6.5.2
2IF0	CRYSTAL STRUCTURE OF MOUSE RAB27B BOUND TO GDP IN MONOCLINIC SPACE GROUP	3.6.5.2
2IFD	CRYSTAL STRUCTURE OF A REMOTE BINDING SITE MUTANT, R492L, OF CDC25B PHOSPHATASE CATALYTIC DOMAIN	3.1.3.48
2IFR	CRYSTAL STRUCTURE OF SCYTALIDO-GLUTAMIC PEPTIDASE WITH A PEPTIDE BASED TRANSITION STATE ANALOG	3.4.23.32
2IFV	CRYSTAL STRUCTURE OF AN ACTIVE SITE MUTANT, C473D, OF CDC25B PHOSPHATASE CATALYTIC DOMAIN	3.1.3.48
2IFW	CRYSTAL STRUCTURE OF SCYTALIDO-GLUTAMIC PEPTIDASE WITH A TRANSITION STATE ANALOG INHIBITOR	3.4.23.32
2IGC	STRUCTURE OF SPIN LABELED T4 LYSOZYME MUTANT T115R1A	3.2.1.17
2IGI	CRYSTAL STRUCTURE OF E. COLI OLIGORIBONUCLEASE	3.1
2IGL	CRYSTAL STRUCTURE OF E. COLI YEDX, A TRANSTHYRETIN RELATED PROTEIN	3.5.2.17
2IGX	ACHIRAL, CHEAP AND POTENT INHIBITORS OF PLASMEPSINS II	3.4.23.39
2IGY	ACHIRAL, CHEAP AND POTENT INHIBITORS OF PLASMEPSINS II	3.4.23.39
2IHL	LYSOZYME (E.C.3.2.1.17) (JAPANESE QUAIL)	3.2.1.17
2IHN	CO-CRYSTAL OF BACTERIOPHAGE T4 RNASE H WITH A FORK DNA SUBSTRATE	3.1.26.4
2IHP	YEAST INORGANIC PYROPHOSPHATASE WITH MAGNESIUM AND PHOSPHATE	3.6.1.1
2IHY	STRUCTURE OF THE STAPHYLOCOCCUS AUREUS PUTATIVE ATPASE SUBUNIT OF AN ATP-BINDING CASSETTE (ABC) TRANSPORTER	3.6.3.34
2IIT	HUMAN DIPEPTIDYL PEPTIDASE 4 IN COMPLEX WITH A DIAZEPAN-2-ONE INHIBITOR	3.4.14.5
2IIV	HUMAN DIPEPTIDYL PEPTIDASE 4 IN COMPLEX WITH A DIAZEPAN-2-ONE INHIBITOR	3.4.14.5
2IJD	CRYSTAL STRUCTURE OF THE POLIOVIRUS PRECURSOR PROTEIN 3CD	3.4.22.28 2.7.7.48 3.4.22.29 3.6.1.15
2IJF	CRYSTAL STRUCTURE OF THE POLIOVIRUS RNA-DEPENDENT RNA POLYMERASE FIDELITY MUTANT 3DPOL G64S	2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28
2IJN	ISOTHIAZOLES AS ACTIVE-SITE INHIBITORS OF HCV NS5B POLYMERASE	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
2IJO	CRYSTAL STRUCTURE OF THE WEST NILE VIRUS NS2B-NS3 PROTEASE COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2IK0	YEAST INORGANIC PYROPHOSPHATASE VARIANT E48D WITH MAGNESIUM AND PHOSPHATE	3.6.1.1
2IK1	YEAST INORGANIC PYROPHOSPHATASE VARIANT Y93F WITH MAGNESIUM AND PHOSPHATE	3.6.1.1
2IK2	YEAST INORGANIC PYROPHOSPHATASE VARIANT D115E WITH MAGNESIUM AND PHOSPHATE	3.6.1.1
2IK4	YEAST INORGANIC PYROPHOSPHATASE VARIANT D117E WITH MAGNESIUM AND PHOSPHATE	3.6.1.1
2IK6	YEAST INORGANIC PYROPHOSPHATASE VARIANT D120E WITH MAGNESIUM AND PHOSPHATE	3.6.1.1
2IK7	YEAST INORGANIC PYROPHOSPHATASE VARIANT D120N WITH MAGNESIUM AND PHOSPHATE	3.6.1.1
2IK9	YEAST INORGANIC PYROPHOSPHATASE VARIANT D152E WITH MAGNESIUM AND PHOSPHATE	3.6.1.1
2IKD	SOLUTION STRUCTURE OF THE FIRST CLIP DOMAIN IN PAP2	3.4.21
2IKE	SOLUTION STRUCTURE OF THE SECOND CLIP DOMAIN IN PAP2	3.4.21
2IKO	CRYSTAL STRUCTURE OF HUMAN RENIN COMPLEXED WITH INHIBITOR	3.4.23.15
2IKQ	CRYSTAL STRUCTURE OF MOUSE STS-1 PGM DOMAIN IN COMPLEX WITH PHOSPHATE	3.1.3.48
2IKU	CRYSTAL STRUCTURE OF HUMAN RENIN COMPLEXED WITH INHIBITORS	3.4.23.15
2IL2	CRYSTAL STRUCTURE OF HUMAN RENIN COMPLEXED WITH INHIBITOR	3.4.23.15
2ILN	CRYSTAL STRUCTURE OF THE BOWMAN-BIRK INHIBITOR FROM SNAIL MEDIC SEEDS IN COMPLEX WITH BOVINE TRYPSIN	3.4.21.4
2ILP	CLOSTRIDIUM BOTULINUM SEROTYPE A LIGHT CHAIN INHIBITED BY 4-CHLOROCINNAMIC HYDROXAMATE	3.4.24.69
2ILX	SOLUTION STRUCTURE OF CATALYTIC DOMAIN OF RAT 2',3'-CYCLIC-NUCLEOTIDE 3'-PHOSPHODIESTERASE (CNP) PROTEIN	3.1.4.37
2ILY	CRYSTAL STRUCTURE OF POLIOVIRUS POLYMERASE COMPLEXED WITH ATP AND MG2+	2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28
2ILZ	CRYSTAL STRUCTURE OF POLIOVIRUS POLYMERASE COMPLEXED WITH GTP AND MN2+	2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28
2IM0	CRYSTAL STRUCTURE OF POLIOVIRUS POLYMERASE COMPLEXED WITH CTP AND MG2+	2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28
2IM1	CRYSTAL STRUCTURE OF POLIOVIRUS POLYMERASE COMPLEXED WITH CTP AND MN2+	2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28
2IM2	CRYSTAL STRUCTURE OF POLIOVIRUS POLYMERASE COMPLEXED WITH UTP AND MG2+	2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28
2IM3	CRYSTAL STRUCTURE OF POLIOVIRUS POLYMERASE COMPLEXED WITH UTP AND MN2+	2.7.7.48 3.4.22.29 3.6.1.15 3.4.22.28
2IMA	CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN INHIBITED BY 2,4-DICHLOROCINNAMIC HYDROXAMATE	3.4.24.69
2IMB	CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN INHIBITED BY L-ARGININE HYDROXAMATE	3.4.24.69
2IMC	CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A LIGHT CHAIN, RESIDUES 1-424	3.4.24.69
2IMG	CRYSTAL STRUCTURE OF DUAL SPECIFICITY PROTEIN PHOSPHATASE 23 FROM HOMO SAPIENS IN COMPLEX WITH LIGAND MALATE ION	3.1.3.48 3.1.3.16
2IMO	CRYSTAL STRUCTURE OF ALLANTOATE AMIDOHYDROLASE FROM ESCHERICHIA COLI AT PH 4.6	3.5.3 3.5.3.9
2IMR	CRYSTAL STRUCTURE OF AMIDOHYDROLASE DR_0824 FROM DEINOCOCCUS RADIODURANS	3.5.4.40
2IMZ	CRYSTAL STRUCTURE OF MTU RECA INTEIN SPLICING DOMAIN	3.1
2IN0	CRYSTAL STRUCTURE OF MTU RECA INTEIN SPLICING DOMAIN	3.1
2IN2	NMR STRUCTURE OF THE APO HUMAN RHINOVIRUS 3C PROTEASE (SEROTYPE 14)	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
2IN8	CRYSTAL STRUCTURE OF MTU RECA INTEIN, SPLICING DOMAIN	3.1
2IN9	CRYSTAL STRUCTURE OF MTU RECA INTEIN, SPLICING DOMAIN	3.1
2IO0	CRYSTAL STRUCTURE OF HUMAN SENP2 IN COMPLEX WITH PRESUMO-2	3.4.22
2IO1	CRYSTAL STRUCTURE OF HUMAN SENP2 IN COMPLEX WITH PRESUMO-3	3.4.22
2IO2	CRYSTAL STRUCTURE OF HUMAN SENP2 IN COMPLEX WITH RANGAP1-SUMO-1	3.4.22
2IO3	CRYSTAL STRUCTURE OF HUMAN SENP2 IN COMPLEX WITH RANGAP1-SUMO-2	3.4.22
2IO7	E. COLI BIFUNCTIONAL GLUTATHIONYLSPERMIDINE SYNTHETASE/AMIDASE INCOMPLEX WITH MG2+ AND AMPPNP	6.3.1.8 3.5.1.78
2IO8	E. COLI BIFUNCTIONAL GLUTATHIONYLSPERMIDINE SYNTHETASE/AMIDASE INCOMPLEX WITH MG2+ AND ADP	6.3.1.8 3.5.1.78
2IO9	E. COLI BIFUNCTIONAL GLUTATHIONYLSPERMIDINE SYNTHETASE/AMIDASE INCOMPLEX WITH MG2+ ,GSH AND ADP	6.3.1.8 3.5.1.78
2IOA	E. COLI BIFUNCTIONAL GLUTATHIONYLSPERMIDINE SYNTHETASE/AMIDASE INCOMPLEX WITH MG2+ AND ADP AND PHOSPHINATE INHIBITOR	6.3.1.8 3.5.1.78
2IOB	E. COLI BIFUNCTIONAL GLUTATHIONYLSPERMIDINE SYNTHETASE/AMIDASE APO PROTEIN	6.3.1.8 3.5.1.78
2IOC	THE CRYSTAL STRUCTURE OF TREX1 EXPLAINS THE 3' NUCLEOTIDE SPECIFICITY AND REVEALS A POLYPROLINE II HELIX FOR PROTEIN PARTENRING	3.1.11.2
2IOF	CRYSTAL STRUCTURE OF PHOSPHONOACETALDEHYDE HYDROLASE WITH SODIUM BOROHYDRIDE-REDUCED SUBSTRATE INTERMEDIATE	3.11.1.1
2IOH	CRYSTAL STRUCTURE OF PHOSPHONOACETALDEHYDE HYDROLASE WITH A K53R MUTATION	3.11.1.1
2IOT	CLAVULANIC ACID BOUND TO ELASTASE	3.4.21.36
2IPB	CRYSTAL STRUCTURE OF T159D MUTANT OF S. TYPHIMURIUM PHON PROTEIN	3.1.3.2
2IPH	X-RAY STRUCTURE AT 1.75 A RESOLUTION OF A NOROVIRUS PROTEASE LINKED TO AN ACTIVE SITE DIRECTED PEPTIDE INHIBITOR	3.4.22 3.6.1.15 3.4.22.66 2.7.7.48
2IPP	CRYSTAL STRUCTURE OF THE TETRAGONAL FORM OF HUMAN LIVER CATHEPSIN B	3.4.22.1
2IQ1	CRYSTAL STRUCTURE OF HUMAN PPM1K	3.1.3.16
2IQ6	CRYSTAL STRUCTURE OF THE AMINOPEPTIDASE FROM VIBRIO PROTEOLYTICUS IN COMPLEXATION WITH LEUCYL-LEUCYL-LEUCINE.	3.4.11.10
2IQ7	CRYSTAL STRUCTURE OF THE POLYGALACTURONASE FROM COLLETOTRICHUM LUPINI AND ITS IMPLICATIONS FOR THE INTERACTION WITH POLYGALACTURONASE-INHIBITING PROTEINS	3.2.1.15
2IQG	CRYSTAL STRUCTURE OF HYDROXYETHYL SECONDARY AMINE-BASED PEPTIDOMIMETIC INHIBITOR OF HUMAN BETA-SECRETASE (BACE)	3.4.23.46
2IRV	CRYSTAL STRUCTURE OF GLPG, A RHOMBOID INTRAMEMBRANE SERINE PROTEASE	3.4.21.105
2IRZ	CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE COMPLEXED WITH INHIBITOR	3.4.23.46
2IS0	CRYSTAL STRUCTURE OF HUMAN BETA-SECRETASE COMPLEXED WITH INHIBITOR	3.4.23.46
2IS1	CRYSTAL STRUCTURE OF UVRD-DNA-SO4 COMPLEX	3.6.1 3.6.4.12
2IS2	CRYSTAL STRUCTURE OF UVRD-DNA BINARY COMPLEX	3.6.1 3.6.4.12
2IS3	CRYSTAL STRUCTURE OF ESCHERICHIA COLI RNASE T	3.1.13
2IS4	CRYSTAL STRUCTURE OF UVRD-DNA-ADPNP TERNARY COMPLEX	3.6.1 3.6.4.12
2IS6	CRYSTAL STRUCTURE OF UVRD-DNA-ADPMGF3 TERNARY COMPLEX	3.6.1 3.6.4.12
2ISD	PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C-DELTA1 FROM RAT	3.1.4.11
2ISE	BOTULINUM NEUROTOXIN A LIGHT CHAIN WT CRYSTAL FORM A	3.4.24.69
2ISG	BOTULINUM NEUROTOXIN A LIGHT CHAIN WT CRYSTAL FORM B	3.4.24.69
2ISH	BOTULINUM NEUROTOXIN A LIGHT CHAIN WT CRYSTAL FORM C	3.4.24.69
2ISI	CRYSTAL STRUCTURE OF APE1 FROM HOMO SAPIENS IN A NEW CRYSTAL FORM COMPLEXED WITH A LIGAND	4.2.99.18 3.1
2ITG	CATALYTIC DOMAIN OF HIV-1 INTEGRASE: ORDERED ACTIVE SITE IN THE F185H CONSTRUCT	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2IU0	CRYSTAL STRUCTURES OF TRANSITION STATE ANALOGUE INHIBITORS OF INOSINE MONOPHOSPHATE CYCLOHYDROLASE	2.1.2.3 3.5.4.10
2IU3	CRYSTAL STRUCTURES OF TRANSITION STATE ANALOGUE INHIBITORS OF INOSINE MONOPHOSPHATE CYCLOHYDROLASE	2.1.2.3 3.5.4.10
2IUC	STRUCTURE OF ALKALINE PHOSPHATASE FROM THE ANTARCTIC BACTERIUM TAB5	3.1.3.1
2IUL	HUMAN TACE G13 MUTANT	3.4.15.1 3.2.1
2IUX	HUMAN TACE MUTANT G1234	3.2.1 3.4.15.1
2IUZ	CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS CHITINASE B1 IN COMPLEX WITH C2-DICAFFEINE	3.2.1.14
2IVH	CRYSTAL STRUCTURE OF THE NUCLEASE DOMAIN OF COLE7 (H545Q MUTANT) IN COMPLEX WITH AN 18-BP DUPLEX DNA	3.1
2IVK	CRYSTAL STRUCTURE OF THE PERIPLASMIC ENDONUCLEASE VVN COMPLEXED WITH A 16-BP DNA	3.1
2IVN	STRUCTURE OF UP1 PROTEIN	3.4.24.57 2.3.1.234
2IVP	STRUCTURE OF UP1 PROTEIN	3.4.24.57 2.3.1.234
2IVY	CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN SSO1404 FROM SULFOLOBUS SOLFATARICUS P2	3.1
2IW0	STRUCTURE OF THE CHITIN DEACETYLASE FROM THE FUNGAL PATHOGEN COLLETOTRICHUM LINDEMUTHIANUM	3.5.1.41
2IW2	CRYSTAL STRUCTURE OF HUMAN PROLIDASE	3.4.13.9
2IWJ	SOLUTION STRUCTURE OF THE ZN COMPLEX OF HIV-2 NCP(23-49) PEPTIDE, ENCOMPASSING PROTEIN CCHC-LINKER, DISTAL CCHC ZN-BINDING MOTIF AND C- TERMINAL TAIL.	3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2IWM	PRECURSOR MUTANT CYS1SER OF PENICILLIN V ACYLASE FROM BACILLUS SPHAERICUS	3.5.1.11
2IX0	RNASE II	3.1.13.1
2IX1	RNASE II D209N MUTANT	3.1.13.1
2IX9	RESPECTIVE ROLE OF PROTEIN FOLDING AND GLYCOSYLATION IN THE THERMAL STABILITY OF RECOMBINANT FERULOYL ESTERASE A	3.1.1.73
2IXA	A-ZYME, N-ACETYLGALACTOSAMINIDASE	3.2.1.49
2IXB	CRYSTAL STRUCTURE OF N-ACETYLGALACTOSAMINIDASE IN COMPLEX WITH GALNAC	3.2.1.49
2IXD	CRYSTAL STRUCTURE OF THE PUTATIVE DEACETYLASE BC1534 FROM BACILLUS CEREUS	3.5.1
2IXS	STRUCTURE OF SDAI RESTRICTION ENDONUCLEASE	3.1.21.4
2IXU	CRYSTAL STRUCTURE OF THE MODULAR CPL-1 ENDOLYSIN COMPLEXED WITH A PEPTIDOGLYCAN ANALOGUE (WILD-TYPE ENDOLYSIN)	3.2.1.17
2IXV	CRYSTAL STRUCTURE OF THE MODULAR CPL-1 ENDOLYSIN COMPLEXED WITH A PEPTIDOGLYCAN ANALOGUE (E94Q MUTANT)	3.2.1.17
2IY0	SENP1 (MUTANT) SUMO1 RANGAP	3.4.22
2IY1	SENP1 (MUTANT) FULL LENGTH SUMO1	3.4.22
2IY9	CRYSTAL STRUCTURE OF THE A-SUBUNIT OF THE AB5 TOXIN FROM E. COLI	3.4.21
2IYC	SENP1 NATIVE STRUCTURE	3.4.22
2IYD	SENP1 COVALENT COMPLEX WITH SUMO-2	3.4.22
2IYE	STRUCTURE OF CATALYTIC CPX-ATPASE DOMAIN COPB-B	3.6.3.10
2IYK	CRYSTAL STRUCTURE OF THE UPF2-INTERACTING DOMAIN OF NONSENSE MEDIATED MRNA DECAY FACTOR UPF1	3.6.1 3.6.4
2IZO	STRUCTURE OF AN ARCHAEAL PCNA1-PCNA2-FEN1 COMPLEX	3.1
2J0E	THREE DIMENSIONAL STRUCTURE AND CATALYTIC MECHANISM OF 6- PHOSPHOGLUCONOLACTONASE FROM TRYPANOSOMA BRUCEI	3.1.1.31
2J0Q	THE CRYSTAL STRUCTURE OF THE EXON JUNCTION COMPLEX AT 3.2 A RESOLUTION	3.6.4.13
2J0S	THE CRYSTAL STRUCTURE OF THE EXON JUNCTION COMPLEX AT 2.2 A RESOLUTION	3.6.4.13
2J0T	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-1 IN COMPLEX WITH THE INHIBITORY DOMAIN OF TIMP-1	3.4.24.7
2J0U	THE CRYSTAL STRUCTURE OF EIF4AIII-BARENTSZ COMPLEX AT 3.0 A RESOLUTION	3.6.4.13
2J13	STRUCTURE OF A FAMILY 4 CARBOHYDRATE ESTERASE FROM BACILLUS ANTHRACIS	3.5.1
2J16	APO & SULPHATE BOUND FORMS OF SDP-1	3.1.3.48
2J17	PTYR BOUND FORM OF SDP-1	3.1.3.48
2J1A	STRUCTURE OF CBM32 FROM CLOSTRIDIUM PERFRINGENS BETA-N- ACETYLHEXOSAMINIDASE GH84C IN COMPLEX WITH GALACTOSE	3.2.1.169
2J1E	HIGH RESOLUTION CRYSTAL STRUCTURE OF CBM32 FROM A N-ACETYL-BETA- HEXOSAMINIDASE IN COMPLEX WITH LACNAC	3.2.1.169
2J1L	CRYSTAL STRUCTURE OF HUMAN RHO-RELATED GTP-BINDING PROTEIN RHOD	3.6.5.2
2J25	PARTIALLY DEGLYCOSYLATED GLUCOCERAMIDASE	3.2.1.45 2.4.1 3.2.1
2J2C	CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC 5'-NUCLEOTIDASE II (NT5C2, CN-II)	3.1.3.5
2J2U	CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX	3.4.21.6
2J30	THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF (PRO)CASPASE-3	3.4.22.56
2J31	THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF(PRO)CASPASE-3	3.4.22.56
2J32	THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF(PRO)CASPASE-3	3.4.22.56
2J33	THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF (PRO)CASPASE-3	3.4.22.56
2J34	CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX	3.4.21.6
2J38	CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX	3.4.21.6
2J3D	NATIVE MONOCLINIC FORM OF TORPEDO ACETYLCHOLINESTERASE	3.1.1.7
2J3E	DIMERIZATION IS IMPORTANT FOR THE GTPASE ACTIVITY OF CHLOROPLAST TRANSLOCON COMPONENTS ATTOC33 AND PSTOC159	3.6.5
2J3Q	TORPEDO ACETYLCHOLINESTERASE COMPLEXED WITH FLUOROPHORE THIOFLAVIN T	3.1.1.7
2J43	ALPHA-GLUCAN RECOGNITION BY FAMILY 41 CARBOHYDRATE-BINDING MODULES FROM STREPTOCOCCAL VIRULENCE FACTORS	3.2.1.41
2J47	BACTEROIDES THETAIOTAOMICRON GH84 O-GLCNACASE IN COMPLEX WITH A IMIDAZOLE-PUGNAC HYBRID INHIBITOR	3.2.1.52 3.2.1.169
2J4C	STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 10MM HGCL2	3.1.1.8
2J4E	THE ITP COMPLEX OF HUMAN INOSINE TRIPHOSPHATASE	3.6.1.19 3.6.1.9
2J4F	TORPEDO ACETYLCHOLINESTERASE - HG HEAVY-ATOM DERIVATIVE	3.1.1.7
2J4G	BACTEROIDES THETAIOTAOMICRON GH84 O-GLCNACASE IN COMPLEX WITH N-BUTYL- THIAZOLINE INHIBITOR	3.2.1.52 3.2.1.169
2J4H	CRYSTAL STRUCTURE OF A H121A ESCHERICHIA COLI DCTP DEAMINASE MUTANT ENZYME	3.5.4.13
2J4I	CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX	3.4.21.6
2J4M	DOUBLE DOCKERIN FROM PIROMYCES EQUI CEL45A	3.2.1.4
2J4N	DOUBLE DOCKERIN FROM PIROMYCES EQUI CEL45A	3.2.1.4
2J4Q	CRYSTAL STRUCTURE OF A E138A ESCHERICHIA COLI DCTP DEAMINASE MUTANT ENZYME IN COMPLEX WITH DTTP	3.5.4.13
2J4T	BIOLOGICAL AND STRUCTURAL FEATURES OF MURINE ANGIOGENIN-4, AN ANGIOGENIC PROTEIN	3.1.27.5 3.1.27
2J5S	STRUCTURAL OF ABDH, A BETA-DIKETONE HYDROLASE FROM THE CYANOBACTERIUM ANABAENA SP. PCC 7120 BOUND TO (S)-3-OXOCYCLOHEXYL ACETIC ACID	3.7.1.7
2J62	STRUCTURE OF A BACTERIAL O-GLCNACASE IN COMPLEX WITH GLCNACSTATIN	3.2.1.169
2J63	CRYSTAL STRUCTURE OF AP ENDONUCLEASE LMAP FROM LEISHMANIA MAJOR	4.2.99.18 3.1
2J65	STRUCTURE OF LPXC FROM AQUIFEX AEOLICUS IN COMPLEX WITH UDP	3.5.1 3.5.1.108
2J67	THE TIR DOMAIN OF HUMAN TOLL-LIKE RECEPTOR 10 (TLR10)	3.2.2.6
2J68	BACTERIAL DYNAMIN-LIKE PROTEIN BDLP, GDP BOUND	3.6.5.5
2J6Y	STRUCTURAL AND FUNCTIONAL CHARACTERISATION OF PARTNER SWITCHING REGULATING THE ENVIRONMENTAL STRESS RESPONSE IN BACILLUS SUBTILIS	3.1.3.3
2J6Z	STRUCTURAL AND FUNCTIONAL CHARACTERISATION OF PARTNER-SWITCHING REGULATING THE ENVIRONMENTAL STRESS RESPONSE IN B. SUBTILIS	3.1.3.3
2J70	STRUCTURAL AND FUNCTIONAL CHARACTERISATION OF PARTNER-SWITCHING REGULATING THE ENVIRONMENTAL STRESS RESPONSE IN B. SUBTILIS	3.1.3.3
2J71	ALPHA-GLUCAN RECOGNITION BY A FAMILY 41 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA PULLULANASE PULA	3.2.1.41
2J72	ALPHA-GLUCAN RECOGNITION BY A FAMILY 41 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA PULLULANASE PULA	3.2.1.41
2J73	ALPHA-GLUCAN RCOGNITION BY A FAMILY 41 CARBOHYDRATE-BINDING MODULE FROM THERMOTOGA MARITIMA PULLULANASE PULA	3.2.1.41
2J74	STRUCTURE OF BETA-1,4-GALACTANASE	3.2.1.89
2J75	BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH NOEUROMYCIN	3.2.1.21
2J77	BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH DEOXYNOJIRIMYCIN	3.2.1.21
2J78	BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH GLUCO- HYDROXIMOLACTAM	3.2.1.21
2J79	BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH GALACTO- HYDROXIMOLACTAM	3.2.1.21
2J7B	BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH GLUCO- TETRAZOLE	3.2.1.21
2J7C	BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH PHENYLAMINOMETHYL-DERIVED GLUCOIMIDAZOLE	3.2.1.21
2J7D	BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH METHOXYCARBONYL-SUBSTITUTED GLUCOIMIDAZOLE	3.2.1.21
2J7E	BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH METHYL ACETATE-SUBSTITUTED GLUCOIMIDAZOLE	3.2.1.21
2J7F	BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH CARBOXYLATE- SUBSTITUTED GLUCOIMIDAZOLE	3.2.1.21
2J7G	BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH METHYL ACETIC ACID-SUBSTITUTED GLUCOIMIDAZOLE	3.2.1.21
2J7H	BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH AZAFAGOMINE	3.2.1.21
2J7K	CRYSTAL STRUCTURE OF THE T84A MUTANT EF-G:GDPCP COMPLEX	3.6.1.48
2J7M	CHARACTERIZATION OF A FAMILY 32 CBM	3.2.1.169
2J7U	DENGUE VIRUS NS5 RNA DEPENDENT RNA POLYMERASE DOMAIN	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2J7V	STRUCTURE OF PBP-A	3.4.16.4
2J7W	DENGUE VIRUS NS5 RNA DEPENDENT RNA POLYMERASE DOMAIN COMPLEXED WITH 3' DGTP	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2J83	ULILYSIN METALLOPROTEASE IN COMPLEX WITH BATIMASTAT.	3.4.24
2J88	HYALURONIDASE IN COMPLEX WITH A MONOCLONAL IGG FAB FRAGMENT	3.2.1.35
2J8F	CRYSTAL STRUCTURE OF THE MODULAR CPL-1 ENDOLYSIN COMPLEXED WITH A PEPTIDOGLYCAN ANALOGUE (E94Q MUTANT IN COMPLEX WITH A DISACCHARIDE- PENTAPEPTIDE)	3.2.1.17
2J8G	CRYSTAL STRUCTURE OF THE MODULAR CPL-1 ENDOLYSIN COMPLEXED WITH A PEPTIDOGLYCAN ANALOGUE (E94Q MUTANT IN COMPLEX WITH A TETRASACCHARIDE- PENTAPEPTIDE)	3.2.1.17
2J8J	SOLUTION STRUCTURE OF THE A4 DOMAIN OF BLOOD COAGULATION FACTOR XI	3.4.21.27
2J8L	FXI APPLE 4 DOMAIN LOOP-OUT CONFORMATION	3.4.21.27
2J8X	EPSTEIN-BARR VIRUS URACIL-DNA GLYCOSYLASE IN COMPLEX WITH UGI FROM PBS-2	3.2.2.3 3.2.2.27
2J8Y	STRUCTURE OF PBP-A ACYL-ENZYME COMPLEX WITH PENICILLIN-G	3.4.16.4
2J92	3C PROTEASE FROM TYPE A10(61) FOOT-AND-MOUTH DISEASE VIRUS - CRYSTAL PACKING MUTANT (K51Q)	3.4.22.28 3.4.22.46 3.6.1.15 2.7.7.48
2J94	CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX	3.4.21.6
2J95	CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX	3.4.21.6
2J97	HUMAN CORONAVIRUS 229E NON STRUCTURAL PROTEIN 9 (NSP9)	3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1
2J98	HUMAN CORONAVIRUS 229E NON STRUCTURAL PROTEIN 9 CYS69ALA MUTANT (NSP9)	3.4.19.12 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1
2J9A	BLLAP IN COMPLEX WITH MICROGININ FR1	3.4.11.1 3.4.11.5 3.4.13.23
2J9J	ATOMIC-RESOLUTION CRYSTAL STRUCTURE OF CHEMICALLY-SYNTHESIZED HIV-1 PROTEASE COMPLEXED WITH INHIBITOR JG-365	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2J9K	ATOMIC-RESOLUTION CRYSTAL STRUCTURE OF CHEMICALLY-SYNTHESIZED HIV-1 PROTEASE COMPLEXED WITH INHIBITOR MVT-101	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2J9N	ROBOTICALLY HARVESTED TRYPSIN COMPLEXED WITH BENZAMIDINE CONTAINING POLYPEPTIDE MEDIATED CRYSTAL CONTACTS	3.4.21.4
2J9O	STRUCTURE OF PBP-A, L158E MUTANT	3.4.16.4
2J9P	CRYSTAL STRUCTURE OF THE BACILLUS SUBTILIS PBP4A, AND ITS COMPLEX WITH A PEPTIDOGLYCAN MIMETIC PEPTIDE.	3.4.16.4
2JA9	STRUCTURE OF THE N-TERMINAL DELETION OF YEAST EXOSOME COMPONENT RRP40	3.1.13
2JAI	DDAH1 COMPLEXED WITH CITRULLINE	3.5.3.18
2JAJ	DDAH1 COMPLEXED WITH L-257	3.5.3.18
2JAL	BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH CYCLOPHELLITOL	3.2.1.21
2JAO	CRYSTAL STRUCTURE OF D12N VARIANT OF MOUSE CYTOSOLIC 5'(3')- DEOXYRIBONUCLEOTIDASE (CDN) IN COMPLEX WITH DEOXYGUANOSINE 5'- MONOPHOSPHATE	3.1.3
2JAR	CRYSTAL STRUCTURE OF D12N VARIANT OF MOUSE CYTOSOLIC 5'(3')- DEOXYRIBONUCLEOTIDASE (CDN) IN COMPLEX WITH DEOXYURIDINE 5'- MONOPHOSPHATE	3.1.3
2JAU	CRYSTAL STRUCTURE OF D41N VARIANT OF HUMAN MITOCHONDRIAL 5'(3')- DEOXYRIBONUCLEOTIDASE (MDN) IN COMPLEX WITH 3'-AZIDOTHYMIDINE 5'- MONOPHOSPHATE	3.1.3
2JAW	CRYSTAL STRUCTURE OF D41N VARIANT OF HUMAN MITOCHONDRIAL 5'(3')- DEOXYRIBONUCLEOTIDASE (MDN) IN COMPLEX WITH 5-BROMOVINYLDEOXYURIDINE 5'-MONOPHOSPHATE	3.1.3
2JAY	PROTEASOME BETA SUBUNIT PRCB FROM MYCOBACTERIUM TUBERCULOSIS	3.4.25.1
2JAZ	CRYSTAL STRUCTURE OF THE MUTANT N560D OF THE NUCLEASE DOMAIN OF COLE7 IN COMPLEX WITH IM7	3.1
2JB0	CRYSTAL STRUCTURE OF THE MUTANT H573A OF THE NUCLEASE DOMAIN OF COLE7 IN COMPLEX WITH IM7	3.1
2JBF	STRUCTURE OF PBP-A, L158E MUTANT. ACYL-ENZYME COMPLEX WITH PENICILLIN- G.	3.4.16.4
2JBG	CRYSTAL STRUCTURE OF THE MUTANT N560A OF THE NUCLEASE DOMAIN OF COLE7 IN COMPLEX WITH IM7	3.1
2JBJ	MEMBRANE-BOUND GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH 2-PMPA (2-PHOSPHONOMETHYL-PENTANEDIOIC ACID)	3.4.17.21
2JBK	MEMBRANE-BOUND GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH QUISQUALIC ACID (QUISQUALATE, ALPHA-AMINO-3,5-DIOXO-1,2,4- OXADIAZOLIDINE-2-PROPANOIC ACID)	3.4.17.21
2JBU	CRYSTAL STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME COMPLEXED WITH CO- PURIFIED PEPTIDES.	3.4.24.56
2JBW	CRYSTAL STRUCTURE OF THE 2,6-DIHYDROXY-PSEUDO-OXYNICOTINE HYDROLASE.	3.7.1 3.7.1.19
2JC0	CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH INHIBITOR SB655264	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2JC1	CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH INHIBITOR SB698223	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2JC4	3'-5' EXONUCLEASE (NEXO) FROM NEISSERIA MENINGITIDIS	3.1.11.2
2JC5	APURINIC APYRIMIDINIC (AP) ENDONUCLEASE (NAPE) FROM NEISSERIA MENINGITIDIS	3.1.11.2
2JC7	THE CRYSTAL STRUCTURE OF THE CARBAPENEMASE OXA-24 REVEALS NEW INSIGHTS INTO THE MECHANISM OF CARBAPENEM-HYDROLYSIS	3.5.2.6
2JC9	CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH ADENOSINE	3.1.3.5
2JCH	STRUCTURAL AND MECHANISTIC BASIS OF PENICILLIN BINDING PROTEIN INHIBITION BY LACTIVICINS	2.4.1.129 3.4.16.4
2JCM	CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH BERYLLIUM TRIFLUORIDE	3.1.3.5
2JDI	GROUND STATE STRUCTURE OF F1-ATPASE FROM BOVINE HEART MITOCHONDRIA (BOVINE F1-ATPASE CRYSTALLISED IN THE ABSENCE OF AZIDE)	3.6.3.14
2JDL	STRUCTURE OF C-TERMINAL REGION OF ACIDIC P2 RIBOSOMAL PROTEIN COMPLEXED WITH TRICHOSANTHIN	3.2.2.22
2JE4	ATOMIC-RESOLUTION CRYSTAL STRUCTURE OF CHEMICALLY-SYNTHESIZED HIV-1 PROTEASE IN COMPLEX WITH JG-365	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2JE5	STRUCTURAL AND MECHANISTIC BASIS OF PENICILLIN BINDING PROTEIN INHIBITION BY LACTIVICINS	2.4.1.129 3.4.16.4
2JE6	STRUCTURE OF A 9-SUBUNIT ARCHAEAL EXOSOME	3.1.13
2JE8	STRUCTURE OF A BETA-MANNOSIDASE FROM BACTEROIDES THETAIOTAOMICRON	3.2.1.25
2JEA	STRUCTURE OF A 9-SUBUNIT ARCHAEAL EXOSOME BOUND TO RNA	3.1.13
2JEB	STRUCTURE OF A 9-SUBUNIT ARCHAEAL EXOSOME BOUND TO MN IONS	3.1.13
2JEM	NATIVE FAMILY 12 XYLOGLUCANASE FROM BACILLUS LICHENIFORMIS	3.2.1.4 3.2.1.151
2JEN	FAMILY 12 XYLOGLUCANASE FROM BACILLUS LICHENIFORMIS IN COMPLEX WITH LIGAND	3.2.1.4 3.2.1.151
2JEP	NATIVE FAMILY 5 XYLOGLUCANASE FROM PAENIBACILLUS PABULI	3.2.1.151 3.2.1.4
2JEQ	FAMILY 5 XYLOGLUCANASE FROM PAENIBACILLUS PABULI IN COMPLEX WITH LIGAND	3.2.1.151 3.2.1.4
2JET	CRYSTAL STRUCTURE OF A TRYPSIN-LIKE MUTANT (S189D , A226G) CHYMOTRYPSIN.	3.4.21.1
2JEW	CRYSTAL STRUCTURE OF ((2S)-5-AMINO-2-((1-N-PROPYL-1H-IMIDAZOL-4-YL) METHYL)PENTANOIC ACID) UK396,082 A TAFIA INHIBITOR, BOUND TO ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASEB	3.4.17.2
2JEY	MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH HLO-7	3.1.1.7 3.1.1.1
2JEZ	MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH TABUN AND HLO-7	3.1.1.7 3.1.1.1
2JF0	MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH TABUN AND ORTHO-7	3.1.1.7 3.1.1.1
2JF4	FAMILY 37 TREHALASE FROM ESCHERICHIA COLI IN COMPLEX WITH VALIDOXYLAMINE	3.2.1.28
2JF6	STRUCTURE OF INACTIVE MUTANT OF STRICTOSIDINE GLUCOSIDASE IN COMPLEX WITH STRICTOSIDINE	3.2.1.105
2JF7	STRUCTURE OF STRICTOSIDINE GLUCOSIDASE	3.2.1.105
2JFE	THE CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC BETA-GLUCOSIDASE	3.2.1.21
2JFK	STRUCTURE OF THE MAT DOMAIN OF HUMAN FAS WITH MALONYL-COA	2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 1.1.1.100 4.2.1.59 1.3.1.39 3.1.2.14
2JG0	FAMILY 37 TREHALASE FROM ESCHERICHIA COLI IN COMPLEX WITH 1- THIATREHAZOLIN	3.2.1.28
2JG4	SUBSTRATE-FREE IDE STRUCTURE IN ITS CLOSED CONFORMATION	3.4.24.56
2JG6	CRYSTAL STRUCTURE OF A 3-METHYLADENINE DNA GLYCOSYLASE I FROM STAPHYLOCOCCUS AUREUS	3.2.2.20
2JGA	CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC 5'-NUCLEOTIDASE III IN COMPLEX WITH PHOSPHATE AND MAGNESIUM	3.1.3.5 3.1.3.91
2JGE	CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE INHIBITED BY NON-AGED METHAMIDOPHOS	3.1.1.7
2JGF	CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE INHIBITED BY NON-AGED FENAMIPHOS	3.1.1.7
2JGI	CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE INHIBITED BY NON-AGED DIISOPROPYL FLUOROPHOSPHATE (DFP)	3.1.1.7
2JGJ	CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE INHIBITED BY AGED METHAMIDOPHOS	3.1.1.7
2JGK	CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE INHIBITED BY AGED FENAMIPHOS	3.1.1.7
2JGL	CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE INHIBITED BY AGED VX AND SARIN	3.1.1.7
2JGM	CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE INHIBITED BY AGED DIISOPROPYL FLUOROPHOSPHATE (DFP)	3.1.1.7
2JGN	DDX3 HELICASE DOMAIN	3.6.1 3.6.4.13
2JH0	HUMAN THROMBIN HIRUGEN INHIBITOR COMPLEX	3.4.21.5
2JH2	X-RAY CRYSTAL STRUCTURE OF A COHESIN-LIKE MODULE FROM CLOSTRIDIUM PERFRINGENS	3.2.1.169
2JH5	HUMAN THROMBIN HIRUGEN INHIBITOR COMPLEX	3.4.21.5
2JH6	HUMAN THROMBIN HIRUGEN INHIBITOR COMPLEX	3.4.21.5
2JHJ	3-METHYLADENINE DNA-GLYCOSYLASE FROM ARCHAEOGLOBUS FULGIDUS	3.2.2.21
2JHN	3-METHYLADENINE DNA-GLYCOSYLASE FROM ARCHAEOGLOBUS FULGIDUS	3.2.2.21
2JHQ	CRYSTAL STRUCTURE OF URACIL DNA-GLYCOSYLASE FROM VIBRIO CHOLERAE	3.2.2.3 3.2.2.27
2JIC	HIGH RESOLUTION STRUCTURE OF XYLANASE-II FROM ONE MICRON BEAM EXPERIMENT	3.2.1.8
2JID	HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH 1-(3,4-DIMETHOXY-PHENYL) -3-M-TOLYL-PIPERIDINE-4-YLAMINE	3.4.14.5
2JIE	BETA-GLUCOSIDASE B FROM BACILLUS POLYMYXA COMPLEXED WITH 2-F-GLUCOSE	3.2.1.21
2JIH	CRYSTAL STRUCTURE OF HUMAN ADAMTS-1 CATALYTIC DOMAIN AND CYSTEINE- RICH DOMAIN (COMPLEX-FORM)	3.4.24
2JIW	BACTEROIDES THETAIOTAOMICRON GH84 O-GLCNACASE IN COMPLEX WITH 2- ACETYLAMINO-2-DEOXY-1-EPIVALIENAMINE	3.2.1.52 3.2.1.169
2JJB	FAMILY 37 TREHALASE FROM ESCHERICHIA COLI IN COMPLEX WITH CASUARINE-6- O-ALPHA-GLUCOPYRANOSE	3.2.1.28
2JJI	ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR.	3.4.23.22
2JJJ	ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR.	3.4.23.22
2JJK	FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE -1- PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEXED WITH A DUAL BINDING AMP SITE INHIBITOR	3.1.3.11
2JJR	V232K, N236D-TRICHOSANTHIN	3.2.2.22
2JKA	NATIVE STRUCTURE OF A FAMILY 97 ALPHA-GLUCOSIDASE FROM BACTEROIDES THETAIOTAOMICRON	3.2.1.20 3.2.1.3
2JKB	CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANB IN COMPLEX WITH 2, 7-ANHYDRO-NEU5AC	4.2.2.15 3.2.1.18
2JKE	STRUCTURE OF A FAMILY 97 ALPHA-GLUCOSIDASE FROM BACTEROIDES THETAIOTAOMICRON IN COMPLEX WITH DEOXYNOJIRIMYCIN	3.2.1.20 3.2.1.3
2JKH	FACTOR XA - CATION INHIBITOR COMPLEX	3.4.21.6
2JKP	STRUCTURE OF A FAMILY 97 ALPHA-GLUCOSIDASE FROM BACTEROIDES THETAIOTAOMICRON IN COMPLEX WITH CASTANOSPERMINE	3.2.1.20 3.2.1.3
2JLQ	DENGUE VIRUS 4 NS3 HELICASE STRUCTURE, APO ENZYME.	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2JLR	DENGUE VIRUS 4 NS3 HELICASE IN COMPLEX WITH AMPPNP	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2JLS	DENGUE VIRUS 4 NS3 HELICASE IN COMPLEX WITH ADP	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2JLU	DENGUE VIRUS 4 NS3 HELICASE IN COMPLEX WITH SSRNA	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2JLV	DENGUE VIRUS 4 NS3 HELICASE IN COMPLEX WITH SSRNA AND AMPPNP	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2JLW	DENGUE VIRUS 4 NS3 HELICASE IN COMPLEX WITH SSRNA2	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2JLX	DENGUE VIRUS 4 NS3 HELICASE IN COMPLEX WITH SSRNA AND ADP-VANADATE	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2JLY	DENGUE VIRUS 4 NS3 HELICASE IN COMPLEX WITH SSRNA AND ADP-PHOSPHATE	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2JLZ	DENGUE VIRUS 4 NS3 HELICASE IN COMPLEX WITH SSRNA AND ADP	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2JM1	STRUCTURES AND CHEMICAL SHIFT ASSIGNMENTS FOR THE ADD DOMAIN OF THE ATRX PROTEIN	3.6.1 3.6.4.12
2JMU	NMR STRUCTURE OF THE MOUSE THIAMINE TRIPHOSPHATASE	3.6.1.28
2JMX	OSCP-NT (1-120) IN COMPLEX WITH N-TERMINAL (1-25) ALPHA SUBUNIT FROM F1-ATPASE	3.6.3.14
2JNK	SOLUTION STRUCTURE OF A DOCKERIN-CONTAINING MODULAR PAIR FROM A FAMILY 84 GLYCOSIDE HYDROLASE	3.2.1.35
2JNP	SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 3 (MMP-3) IN THE PRESENCE OF N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID (NNGH)	3.4.24.17
2JO0	THE SOLUTION STRUCTURE OF THE MONOMERIC SPECIES OF THE C TERMINAL DOMAIN OF THE CA PROTEIN OF HIV-1	3.4.23.16
2JOA	HTRA1 BOUND TO AN OPTIMIZED PEPTIDE: NMR ASSIGNMENT OF PDZ DOMAIN AND LIGAND RESONANCES	3.4.21
2JOG	STRUCTURE OF THE CALCINEURIN-NFAT COMPLEX	3.1.3.16
2JON	SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN OLE E 9	3.2.1.39
2JPN	SOLUTION STRUCTURE OF T4 BACTERIOPHAGE HELICASE UVSW.1	3.6.1 3.6.4.12
2JPR	JOINT REFINEMENT OF THE HIV-1 CA-NTD IN COMPLEX WITH THE ASSEMBLY INHIBITOR CAP-1	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2JQ9	VPS4A MIT-CHMP1A COMPLEX	3.6.4.6
2JQF	FULL LENGTH LEADER PROTEASE OF FOOT AND MOUTH DISEASE VIRUS C51A MUTANT	3.4.22.46 3.6.1.15 3.4.22.28 2.7.7.48
2JQG	LEADER PROTEASE	3.4.22.46 3.6.1.15 3.4.22.28 2.7.7.48
2JQH	VPS4B MIT	3.6.4.6
2JQK	VPS4B MIT-CHMP2B COMPLEX	3.6.4.6
2JQM	YELLOW FEVER ENVELOPE PROTEIN DOMAIN III NMR STRUCTURE (S288-K398)	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2JRC	SOLUTION STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM MYCOBACTERIUM TUBERCULOSIS H37RV.	3.1.1.29
2JRI	SOLUTION STRUCTURE OF THE JOSEPHIN DOMAIN OF ATAXIN-3 IN COMPLEX WITH UBIQUITIN MOLECULE.	3.4.22 3.4.19.12
2JSD	SOLUTION STRUCTURE OF MMP20 COMPLEXED WITH NNGH	3.4.24
2JT2	SOLUTION STRUCTURE OF THE AQUIFEX AEOLICUS LPXC- CHIR-090 COMPLEX	3.5.1 3.5.1.108
2JT5	SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 3 (MMP-3) IN THE PRESENCE OF N-HYDROXY-2-[N-(2-HYDROXYETHYL)BIPHENYL-4-SULFONAMIDE] HYDROXAMIC ACID (MLC88)	3.4.24.17
2JT6	SOLUTION STRUCTURE OF MATRIX METALLOPROTEINASE 3 (MMP-3) IN THE PRESENCE OF 3-4'-CYANOBYPHENYL-4-YLOXY)-N-HDYDROXYPROPIONAMIDE (MMP-3 INHIBITOR VII)	3.4.24.17
2JTC	3D STRUCTURE AND BACKBONE DYNAMICS OF SPE B	3.4.22.10
2JU4	NMR STRUCTURE OF THE GAMMA SUBUNIT OF CGMP PHOSPHODIESTERASE	3.1.4.17 3.1.4.35
2JV6	YF ED3 PROTEIN NMR STRUCTURE	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2JVB	SOLUTION STRUCTURE OF CATALYTIC DOMAIN OF YDCP2	3 3.6.1.62
2JXR	STRUCTURE OF YEAST PROTEINASE A	3.4.23.25
2JXY	SOLUTION STRUCTURE OF THE HEMOPEXIN-LIKE DOMAIN OF MMP12	3.4.24.65
2JYG	SOLUTION STRUCTURE OF THE W184A/M185A MUTANT OF THE CARBOXY-TERMINAL DIMERIZATION DOMAIN OF THE HIV-1 CAPSID PROTEIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2JYL	SOLUTION STRUCTURE OF A DOUBLE MUTANT OF THE CARBOXY-TERMINAL DIMERIZATION DOMAIN OF THE HIV-1 CAPSID PROTEIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2JYS	SOLUTION STRUCTURE OF SIMIAN FOAMY VIRUS (MAC) PROTEASE	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
2JYW	SOLUTION STRUCTURE OF C-TERMINAL DOMAIN OF APOBEC3G	3.5.4
2JZD	NMR STRUCTURE OF THE DOMAIN 527-651 OF THE SARS-COV NONSTRUCTURAL PROTEIN NSP3	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2JZE	NMR STRUCTURE OF THE DOMAIN 527-651 OF THE SARS-COV NONSTRUCTURAL PROTEIN NSP3, SINGLE CONFORMER CLOSEST TO THE MEAN COORDINATES OF AN ENSEMBLE OF TWENTY ENERGY MINIMIZED CONFORMERS	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2JZF	NMR CONFORMER CLOSEST TO THE MEAN COORDINATES OF THE DOMAIN 513-651 OF THE SARS-COV NONSTRUCTURAL PROTEIN NSP3	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2K11	SOLUTION STRUCTURE OF HUMAN PANCREATIC RIBONUCLEASE	3.1.27.5 4.6.1.18
2K1G	SOLUTION NMR STRUCTURE OF LIPOPROTEIN SPR FROM ESCHERICHIA COLI K12. NORTHEAST STRUCTURAL GENOMICS TARGET ER541-37-162	3.4 3.4.17.13
2K1Q	NMR STRUCTURE OF HEPATITIS C VIRUS NS3 SERINE PROTEASE COMPLEXED WITH THE NON-COVALENTLY BOUND PHENETHYLAMIDE INHIBITOR	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
2K1R	THE SOLUTION NMR STRUCTURE OF THE COMPLEX BETWEEN MNK1 AND HAH1 MEDIATED BY CU(I)	3.6.3.4 7.2.2.8
2K2G	SOLUTION STRUCTURE OF THE WILD-TYPE CATALYTIC DOMAIN OF HUMAN MATRIX METALLOPROTEINASE 12 (MMP-12) IN COMPLEX WITH A TIGHT-BINDING INHIBITOR	3.4.24.65
2K2J	NMR SOLUTION STRUCTURE OF THE SPLIT PH DOMAIN FROM PHOSPHOLIPASE C GAMMA 2	3.1.4.11
2K31	SOLUTION STRUCTURE OF CGMP-BINDING GAF DOMAIN OF PHOSPHODIESTERASE 5	3.1.4.35
2K3R	PFU RPP21 STRUCTURE AND ASSIGNMENTS	3.1.26.5
2K3W	NMR STRUCTURE OF VPS4A-MIT-CHMP6	3.6.4.6
2K4E	SOLUTION STRUCTURE OF THE HIV-2 UNMYRISTOYLATED MATRIX PROTEIN	3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2K4H	SOLUTION STRUCTURE OF THE HIV-2 MYRISTOYLATED MATRIX PROTEIN	3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2K4I	SOLUTION STRUCTURE OF HIV-2 MYRMA BOUND TO DI-C4-PI(4,5)P2	3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2K4P	SOLUTION STRUCTURE OF SHIP2-SAM	3.1.3.86
2K4R	NMR SOLUTION STRUCTURE OF THE NEUROTRYPSIN KRINGLE DOMAIN	3.4.21
2K51	NMR SOLUTION STRUCTURE OF THE NEUROTRYPSIN KRINGLE DOMAIN	3.4.21
2K6H	NMR STRUCTURE OF AN UNUSUALLY 28 KDA ACTIVE MUTANT OF MAIZE RIBOSOME-INACTIVATING PROTEIN (MOD)	3.2.2.22
2K72	SOLUTION NMR STRUCTURE OF TOXIN-LIKE POTASSIUM CHANNEL BLOCKING DOMAIN IN MMP23	3.4.24
2K7J	HUMAN ACYLPHOSPHATASE(ACPH) SURFACE CHARGE-OPTIMIZED	3.6.1.7
2K7K	HUMAN ACYLPHOSPHATASE (ACPH) COMMON TYPE	3.6.1.7
2K7X	SOLUTION STRUCTURE OF C-TERMINAL DOMAIN OF SARS-COV MAIN PROTEASE	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2K7Z	SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF PROCASPASE-8	3.4.22.61
2K87	NMR STRUCTURE OF A PUTATIVE RNA BINDING PROTEIN (SARS1) FROM SARS CORONAVIRUS	3.4.19.12 3.4.22 3.4.22.69
2K9C	PARAMAGNETIC SHIFTS IN SOLID-STATE NMR OF PROTEINS TO ELICIT STRUCTURAL INFORMATION	3.4.24.65
2KAF	SOLUTION STRUCTURE OF THE SARS-UNIQUE DOMAIN-C FROM THE NONSTRUCTURAL PROTEIN 3 (NSP3) OF THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS	3.4.22 3.4.19.12 3.4.22.69
2KAI	REFINED 2.5 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF THE COMPLEX FORMED BY PORCINE KALLIKREIN A AND THE BOVINE PANCREATIC TRYPSIN INHIBITOR. CRYSTALLIZATION, PATTERSON SEARCH, STRUCTURE DETERMINATION, REFINEMENT, STRUCTURE AND COMPARISON WITH ITS COMPONENTS AND WITH THE BOVINE TRYPSIN-PANCREATIC TRYPSIN INHIBITOR COMPLEX	3.4.21.8 3.4.21.35
2KAU	THE CRYSTAL STRUCTURE OF UREASE FROM KLEBSIELLA AEROGENES AT 2.2 ANGSTROMS RESOLUTION	3.5.1.5
2KB0	CDC42(T35A)	3.6.5.2
2KB5	SOLUTION NMR STRUCTURE OF EOSINOPHIL CATIONIC PROTEIN/RNASE 3	3.1.27
2KB6	SOLUTION STRUCTURE OF ONCONASE C87A/C104A	3.1.27
2KBE	SOLUTION STRUCTURE OF AMINO-TERMINAL DOMAIN OF DBP5P	3.6.1 3.6.4.13
2KBF	SOLUTION STRUCTURE OF CARBOXYL-TERMINAL DOMAIN OF DBP5P	3.6.1 3.6.4.13
2KBO	STRUCTURE, INTERACTION, AND REAL-TIME MONITORING OF THE ENZYMATIC REACTION OF WILD TYPE APOBEC3G	3.5.4
2KC8	STRUCTURE OF E. COLI TOXIN RELE (R81A/R83A) MUTANT IN COMPLEX WITH ANTITOXIN RELBC (K47-L79) PEPTIDE	3.1
2KC9	STRUCTURE OF E. COLI TOXIN RELE (R81A/R83A) MUTANT IN THE FREE STATE	3.1
2KDT	PC1/3 DCSG SORTING DOMAIN STRUCTURE IN DPC	3.4.21.93
2KDV	SOLUTION STRUCTURE OF RNA PYROPHOSPHOHYDROLASE RPPH FROM ESCHERICHIA COLI	3.6.1
2KDW	SOLUTION STRUCTURE OF RPPH MUTANT E53A FROM ESCHERICHIA COLI	3.6.1
2KE3	PC1/3 DCSG SORTING DOMAIN IN CHAPS	3.4.21.93
2KE5	SOLUTION STRUCTURE AND DYNAMICS OF THE SMALL GTPASE RALB IN ITS ACTIVE CONFORMATION: SIGNIFICANCE FOR EFFECTOR PROTEIN BINDING	3.6.5.2
2KEM	EXTENDED STRUCTURE OF CITIDINE DEAMINASE DOMAIN OF APOBEC3G	3.5.4
2KF3	BARNASE, LOW PRESSURE REFERENCE NMR STRUCTURE	3.1.27
2KF4	BARNASE HIGH PRESSURE STRUCTURE	3.1.27
2KF5	BARNASE BOUND TO D(CGAC), LOW PRESSURE	3.1.27
2KF6	BARNASE BOUND TO D(CGAC) HIGH PRESSURE	3.1.27
2KHS	SOLUTION STRUCTURE OF SNASE121:SNASE(111-143) COMPLEX	3.1.31.1
2KHX	DROSHA DOUBLE-STRANDED RNA BINDING MOTIF	3.1.26.3
2KHZ	SOLUTION STRUCTURE OF RCL	3.2.2
2KI7	THE SOLUTION STRUCTURE OF RPP29-RPP21 COMPLEX FROM PYROCOCCUS FURIOSUS	3.1.26.5
2KIE	A PH DOMAIN WITHIN OCRL BRIDGES CLATHRIN MEDIATED MEMBRANE TRAFFICKING TO PHOSPHOINOSITIDE METABOLIS	3.1.3.36 3.1.3.56 3.1.3.86
2KIG	A PH DOMAIN WITHIN OCRL BRIDGES CLATHRIN MEDIATED MEMBRANE TRAFFICKING TO PHOSPHOINOSITIDE METABOLISM	3.1.3.36
2KIJ	SOLUTION STRUCTURE OF THE ACTUATOR DOMAIN OF THE COPPER-TRANSPORTING ATPASE ATP7A	3.6.3.4 7.2.2.8
2KJK	SOLUTION STRUCTURE OF THE SECOND DOMAIN OF THE LISTERIA PROTEIN LIN2157, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET LKR136B	3.4.21.53
2KKN	SOLUTION NMR STRUCTURE OF THEMOTOGA MARITIMA PROTEIN TM1076: NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET VT57	3.1.4
2KL1	SOLUTION STRUCTURE OF GTR34C FROM GEOBACILLUS THERMODENITRIFICANS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET GTR34C	3.4.21.53
2KLH	NMR STRUCTURE OF RCL IN COMPLEX WITH GMP	3.2.2
2KLQ	THE SOLUTION STRUCTURE OF CBD OF HUMAN MCM6	3.6.4.12
2KLZ	SOLUTION STRUCTURE OF THE TANDEM UIM DOMAIN OF ATAXIN-3 COMPLEXED WITH UBIQUITIN	3.4.22 3.4.19.12
2KMN	SOLUTION STRUCTURE OF PEPTIDE DEFORMYLASE COMPLEXED WITH ACTINONIN	3.5.1.88
2KMU	RECQL4 AMINO-TERMINAL DOMAIN	3.6.1 3.6.4.12
2KMV	SOLUTION STRUCTURE OF THE NUCLEOTIDE BINDING DOMAIN OF THE HUMAN MENKES PROTEIN IN THE ATP-FREE FORM	3.6.3.4 7.2.2.8
2KMX	SOLUTION STRUCTURE OF THE NUCLEOTIDE BINDING DOMAIN OF THE HUMAN MENKES PROTEIN IN THE ATP-BOUND FORM	3.6.3.4 7.2.2.8
2KN7	STRUCTURE OF THE XPF-SINGLE STRAND DNA COMPLEX	3.1
2KN8	NMR STRUCTURE OF THE C-TERMINAL DOMAIN OF PUL89	3.1
2KNF	SOLUTION STRUCTURE AND FUNCTIONAL CHARACTERIZATION OF HUMAN PLASMINOGEN KRINGLE 5	3.4.21.7
2KNO	NMR SOLUTION STRUCTURE OF SH2 DOMAIN OF THE HUMAN TENSIN LIKE C1 DOMAIN CONTAINING PHOSPHATASE (TENC1)	3.1.3 3.1.3.48
2KNU	SOLUTION STRUCTURE OF THE TRANSMEMBRANE PROXIMAL REGION OF THE HEPATIS C VIRUS E1 GLYCOPROTEIN	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2KOD	A HIGH-RESOLUTION NMR STRUCTURE OF THE DIMERIC C-TERMINAL DOMAIN OF HIV-1 CA	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2KOU	DICER LIKE PROTEIN	3.1.26
2KOY	STRUCTURE OF THE E1064A MUTANT OF THE N-DOMAIN OF WILSON DISEASE ASSOCIATED PROTEIN	3.6.3.4 7.2.2.8
2KP7	SOLUTION NMR STRUCTURE OF THE MUS81 N-TERMINAL HHH. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET MMT1A	3.1.22
2KPN	SOLUTION NMR STRUCTURE OF A BACTERIAL IG-LIKE (BIG_3) DOMAIN FROM BACILLUS CEREUS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BCR147A	3.4.24.28
2KQ3	SOLUTION STRUCTURE OF SNASE140	3.1.31.1
2KQ8	SOLUTION NMR STRUCTURE OF A DOMAIN FROM BT9727_4915 FROM BACILLUS THURINGIENSIS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BUR95A	3.5.1.28
2KQB	FIRST PBZ DOMAIN OF HUMAN APLF PROTEIN	4.2.99.18 3.1
2KQC	SECOND PBZ DOMAIN OF HUMAN APLF PROTEIN	4.2.99.18 3.1
2KQD	FIRST PBZ DOMAIN OF HUMAN APLF PROTEIN IN COMPLEX WITH RIBOFURANOSYLADENOSINE	4.2.99.18 3.1
2KQE	SECOND PBZ DOMAIN OF HUMAN APLF PROTEIN IN COMPLEX WITH RIBOFURANOSYLADENOSINE	4.2.99.18 3.1
2KQV	SARS CORONAVIRUS-UNIQUE DOMAIN (SUD): THREE-DOMAIN MOLECULAR ARCHITECTURE IN SOLUTION AND RNA BINDING. I: STRUCTURE OF THE SUD-M DOMAIN OF SUD-MC	3.4.19.12 3.4.22 3.4.22.69
2KQW	SARS CORONAVIRUS-UNIQUE DOMAIN (SUD): THREE-DOMAIN MOLECULAR ARCHITECTURE IN SOLUTION AND RNA BINDING. II: STRUCTURE OF THE SUD-C DOMAIN OF SUD-MC	3.4.19.12 3.4.22 3.4.22.69
2KR6	SOLUTION STRUCTURE OF PRESENILIN-1 CTF SUBUNIT	3.4.23
2KRJ	HIGH-RESOLUTION SOLID-STATE NMR STRUCTURE OF A 17.6 KDA PROTEIN	3.4.24.65
2KSG	SOLUTION STRUCTURE OF DERMCIDIN-1L, A HUMAN ANTIBIOTIC PEPTIDE	3.4
2KSV	THE NMR STRUCTURE OF PROTEIN-GLUTAMINASE FROM CHRYSEOBACTERIUM PROTEOLYTICUM	3.5.1.44
2KU1	DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR	3.4.25.1
2KU2	DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR	3.4.25.1
2KUO	STRUCTURE AND IDENTIFICATION OF ADP-RIBOSE RECOGNITION MOTIFS OF APLF AND ROLE IN THE DNA DAMAGE RESPONSE	3.1
2KV2	SOLUTION STRUCTURE OF THE HUMAN BLM HRDC DOMAIN	3.6.4.12
2KVR	SOLUTION NMR STRUCTURE OF HUMAN UBIQUITIN SPECIFIC PROTEASE USP7 UBL DOMAIN (RESIDUES 537-664). NESG TARGET HR4395C/ SGC-TORONTO	3.1.2.15 3.4.19.12
2KWA	1H, 13C AND 15N BACKBONE AND SIDE CHAIN RESONANCE ASSIGNMENTS OF THE N-TERMINAL DOMAIN OF THE HISTIDINE KINASE INHIBITOR KIPI FROM BACILLUS SUBTILIS	3.5.2.9
2KWI	RALB-RLIP76 (RALBP1) COMPLEX	3.6.5.2
2KWT	SOLUTION STRUCTURE OF NS2 [27-59]	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2KWZ	SOLUTION STRUCTURE OF NS2 [60-99]	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2KX3	THE SOLUTION STRUCTURE OF THE MUTANT OF UBL DOMAIN OF UBLCP1, I5M	3.1.3.16
2KXE	N-TERMINAL DOMAIN OF THE DP1 SUBUNIT OF AN ARCHAEAL D-FAMILY DNA POLYMERASE	2.7.7.7 3.1.11.1
2KYS	NMR STRUCTURE OF THE SARS CORONAVIRUS NONSTRUCTURAL PROTEIN NSP7 IN SOLUTION AT PH 6.5	3.4.19.12 3.4.22 3.4.22.69
2KYT	SOLUTION STRUCTURE OF THE H-REV107 N-TERMINAL DOMAIN	3.1.1.4 2.3.1 3.1.1.32
2KZQ	S34R STRUCTURE	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2KZR	SOLUTION NMR STRUCTURE OF UBIQUITIN THIOESTERASE OTU1 (EC 3.1.2.-) FROM MUS MUSCULUS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET MMT2A	3.1.2 3.4.19.12
2L0R	CONFORMATIONAL DYNAMICS OF THE ANTHRAX LETHAL FACTOR CATALYTIC CENTER	3.4.24.83
2L0S	SOLUTION STRUCTURE OF HUMAN PLASMINOGEN KRINGLE 3	3.4.21.7
2L17	AN ARSENATE REDUCTASE IN THE REDUCED STATE	1.20.4.1 3.1.3.48
2L18	AN ARSENATE REDUCTASE IN THE PHOSPHATE BINDING STATE	1.20.4.1 3.1.3.48
2L19	AN ARSENATE REDUCTASE IN THE INTERMEDIATE STATE	1.20.4.1 3.1.3.48
2L2D	SOLUTION NMR STRUCTURE OF HUMAN UBA-LIKE DOMAIN OF OTUD7A_11_83, NESG TARGET HT6304A/OCSP TARGET OTUD7A_11_83/SGC-TORONTO	3.4.19.12
2L37	3D SOLUTION STRUCTURE OF ARGININE/GLUTAMATE-RICH POLYPEPTIDE LUFFIN P1 FROM THE SEEDS OF SPONGE GOURD (LUFFA CYLINDRICAL)	3.2.2.22
2L3C	SOLUTION STRUCTURE OF ADAR2 DSRBM1 BOUND TO LSL RNA	3.5 3.5.4.37
2L3F	SOLUTION NMR STRUCTURE OF A PUTATIVE URACIL DNA GLYCOSYLASE FROM METHANOSARCINA ACETIVORANS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET MVR76	3.2.2
2L3H	NMR STRUCTURE IN A MEMBRANE ENVIRONMENT REVEALS PUTATIVE AMYLOIDOGENIC REGIONS OF THE SEVI PRECURSOR PEPTIDE PAP248-286	3.1.3.2 3.1.3.5
2L3J	THE SOLUTION STRUCTURE OF THE ADAR2 DSRBM-RNA COMPLEX REVEALS A SEQUENCE-SPECIFIC READ OUT OF THE MINOR GROOVE	3.5 3.5.4.37
2L45	C-TERMINAL ZINC KNUCKLE OF THE HIVNCP7 WITH DNA	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2L46	C-TERMINAL ZINC FINGER OF THE HIVNCP7 WITH PLATINATED DNA	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2L47	SOLUTION STRUCTURE OF THE PLYG CATALYTIC DOMAIN	3.5.1.28
2L4L	STRUCTURAL INSIGHTS INTO THE CTAR DNA RECOGNITION BY THE HIV-1 NUCLEOCAPSID PROTEIN: ROLE OF SUGAR DEOXYRIBOSES IN THE BINDING POLARITY OF NC	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2L4Z	NMR STRUCTURE OF FUSION OF CTIP (641-685) TO LMO4-LIM1 (18-82)	3.1
2L54	SOLUTION STRUCTURE OF THE ZALPHA DOMAIN MUTANT OF ADAR1 (N43A,Y47A)	3.5.4 3.5.4.37
2L5C	SOLUTION STRUCTURES OF HUMAN PIWI-LIKE 1 PAZ DOMAIN	3.1.26
2L5D	SOLUTION STRUCTURES OF HUMAN PIWI-LIKE 1 PAZ DOMAIN WITH SSRNA (5'-PUGACA)	3.1.26
2L5U	STRUCTURE OF THE FIRST PHD FINGER (PHD1) FROM CHD4 (MI2B)	3.6.4.12
2L6E	NMR STRUCTURE OF THE MONOMERIC MUTANT C-TERMINAL DOMAIN OF HIV-1 CAPSID IN COMPLEX WITH STAPLED PEPTIDE INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2L6K	SOLUTION STRUCTURE OF A NONPHOSPHORYLATED PEPTIDE RECOGNIZING DOMAIN	3.1.3.48
2L6M	STRUCTURE OF C-TERMINAL DSRBD OF THE FISSION YEAST DICER (DCR1)	3.1.26 3.6.4
2L75	SOLUTION STRUCTURE OF CHD4-PHD2 IN COMPLEX WITH H3K9ME3	3.6.4.12
2L77	SOLUTION NMR STRUCTURE OF PAP248-286 IN 50% TFE	3.1.3.2 3.1.3.5
2L78	DESIGN AND STRUCTURAL ANALYSIS OF ALTERNATIVE HYDROPHOBIC CORE PACKING ARRANGEMENTS IN BACTERIOPHAGE T4 LYSOZYME	3.2.1.17
2L79	SOLUTION NMR STRUCTURE OF PAP248-286 IN 30% TFE	3.1.3.2 3.1.3.5
2L7Y	SOLUTION STRUCTURE OF A PUTATIVE SURFACE PROTEIN	3.2.1.96
2L80	SOLUTION STRUCTURE OF THE ZINC FINGER DOMAIN OF USP13	3.4.19.12
2L8A	STRUCTURE OF A NOVEL CBM3 LACKING THE CALCIUM-BINDING SITE	3.2.1.4
2L8B	TRAI (381-569)	3.6.4.12 5.6.2.1
2L8K	NMR STRUCTURE OF THE ARTERIVIRUS NONSTRUCTURAL PROTEIN 7 ALPHA (NSP7 ALPHA)	3.4.22 3.4.19.12 3.4.21 2.7.7.48 3.6.4.12 3.6.4.13
2L8L	STRUCTURE OF AN ENGINEERED SPLICING INTEIN MUTANT BASED ON MYCOBACTERIUM TUBERCULOSIS RECA	3.1
2L8R	SOLUTION STRUCTURE OF HUMAN PROTEIN C6ORF130 IN COMPLEX WITH ADP-RIBOSE	3.5.1 3.2.2
2L95	SOLUTION STRUCTURE OF CYTOTOXIC T-LYMPHOCYTE ANTIGENT-2(CTLA PROTEIN), CRAMMER AT PH 6.0	3.4
2LAA	SOLUTION STRUCUTURE OF THE CBM25-1 OF BETA/ALPHA-AMYLASE FROM PAENIBACILLUS POLYMYXA	3.2.1.2 3.2.1.1
2LAB	SOLUTION STRUCUTURE OF THE CBM25-2 OF BETA/ALPHA-AMYLASE FROM PAENIBACILLUS POLYMYXA	3.2.1.2 3.2.1.1
2LBC	SOLUTION STRUCTURE OF TANDEM UBA OF USP13	3.4.19.12
2LBM	SOLUTION STRUCTURE OF THE ADD DOMAIN OF ATRX COMPLEXED WITH HISTONE TAIL H3 1-15 K9ME3	3.6.4.12
2LC9	SOLUTION STRUCTURE OF A MINOR AND TRANSIENTLY FORMED STATE OF A T4 LYSOZYME MUTANT	3.2.1.17
2LCB	SOLUTION STRUCTURE OF A MINOR AND TRANSIENTLY FORMED STATE OF A T4 LYSOZYME MUTANT	3.2.1.17
2LCF	SOLUTION STRUCTURE OF GPPNHP-BOUND H-RAST35S MUTANT PROTEIN	3.6.5.2
2LCJ	SOLUTION NMR STRUCTURE OF PAB POLII INTEIN	2.7.7.7 3.1.11.1
2LCQ	SOLUTION STRUCTURE OF THE ENDONUCLEASE NOB1 FROM P.HORIKOSHII	3.1
2LD1	STRUCTURES AND CHEMICAL SHIFT ASSIGNMENTS FOR THE ADD DOMAIN OF THE ATRX PROTEIN	3.6.4.12
2LDI	NMR SOLUTION STRUCTURE OF ZIAAN SUB MUTANT	3.6.3.5 7.2.2.12
2LE8	THE PROTEIN COMPLEX FOR DNA REPLICATION	3.6.4.12
2LEN	SOLUTION STRUCTURE OF UCHL1 S18Y VARIANT	3.4.19.12
2LEP	SOLUTION STRUCTURE OF N-TERMINAL CYTOSOLIC DOMAIN OF RHOMBOID INTRAMEMBRANE PROTEASE FROM ESCHERICHIA COLI	3.4.21.105
2LF4	STRUCTURE OF A MONOMERIC MUTANT OF THE HIV-1 CAPSID PROTEIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2LFJ	SOLUTION STRUCTURE OF THE MONOMERIC DERIVATIVE OF BS-RNASE	3.1.27.5 4.6.1.18
2LGD	THE HIGH RESOLUTION STRUCTURE OF UBIQUITIN LIKE DOMAIN OF UBLCP1	3.1.3.16
2LGJ	SOLUTION STRUCTURE OF MSPTH	3.1.1.29
2LGR	SOLUTION STRUCTURE OF HUMAN PROTEIN C6ORF130, A PUTATIVE MACRO DOMAIN	3.5.1 3.2.2
2LHI	SOLUTION STRUCTURE OF CA2+/CNA1 PEPTIDE-BOUND YCAM	3.1.3.16
2LHM	CRYSTAL STRUCTURES OF THE APO-AND HOLOMUTANT HUMAN LYSOZYMES WITH AN INTRODUCED CA2+ BINDING SITE	3.2.1.17
2LIP	PSEUDOMONAS LIPASE OPEN CONFORMATION	3.1.1.3
2LIZ	NMR SOLUTION STRUCTURE OF C-TERMINAL DOMAIN OF SARS-COV MAIN PROTEASE IN 2.5M UREA	3.4.22 3.4.19.12 3.4.22.69
2LJH	NMR STRUCTURE OF DOUBLE-STRANDED RNA-SPECIFIC EDITASE ADAR	3.5
2LJP	BACKBONE 1H, 13C, AND 15N CHEMICAL SHIFT ASSIGNMENTS FOR E.COLI RIBONUCLEASE P PROTEIN	3.1.26.5
2LJV	SOLUTION STRUCTURE OF RHODOSTOMIN G50L MUTANT	3.4.24
2LKT	SOLUTION STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN TIG3 IN 2 M UREA	3.1.1 2.3.1 3.1.1.32 3.1.1.4
2LKV	STAPHYLOCOCCAL NUCLEASE PHS VARIANT	3.1.31.1
2LLZ	GHOS (YJDK) MONOMER	3.1
2LNA	SOLUTION NMR STRUCTURE OF THE MITOCHONDRIAL INNER MEMBRANE DOMAIN (RESIDUES 164-251), FTSH_EXT, FROM THE PARAPLEGIN-LIKE PROTEIN AFG3L2 FROM HOMO SAPIENS, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR6741A	3.4.24
2LNC	SOLUTION NMR STRUCTURE OF NORWALK VIRUS PROTEASE	3.4.22.66 3.6.1.15 2.7.7.48
2LOZ	THE NOVEL BINDING MODE OF DLC1 AND TENSIN2 PTB DOMAIN	3.1.3 3.1.3.48
2LPR	STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS	3.4.21.12
2LQB	METAL BINDING REPEAT 2 OF THE WILSON DISEASE PROTEIN (ATP7B)	3.6.3.4 7.2.2.8
2LQJ	SOLUTION STRUCTURE OF THE C-TERMINAL DOMAIN OF THE MGTC PROTEIN FROM MYCOBACTERIUM TUBERCULOSIS	3.6.3.1
2LRO	SOLUTION STRUCTURE, DYNAMICS AND BINDING STUDIES OF CTCBM11	3.2.1.4
2LRP	SOLUTION STRUCTURE, DYNAMICS AND BINDING STUDIES OF CTCBM11	3.2.1.4
2LRR	SOLUTION STRUCTURE OF THE R3H DOMAIN FROM HUMAN SMUBP-2 IN COMPLEX WITH 2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE	3.6.4.12 3.6.4.13
2LRS	THE SECOND DSRBD DOMAIN FROM A. THALIANA DICER-LIKE 1	3.1.26
2LS6	SOLUTION NMR STRUCTURE OF A NON-CANONICAL GALACTOSE-BINDING CBM32 FROM CLOSTRIDIUM PERFRINGENS	3.2.1.35
2LSN	SOLUTION STRUCTURE OF PFV RNASE H DOMAIN	2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1
2LT5	ZYMOGEN-FLG OF THE ONCONASE	3.1.27
2LTJ	CONFORMATIONAL ANALYSIS OF STRH, THE SURFACE-ATTACHED EXO- BETA-D-N-ACETYLGLUCOSAMINIDASE FROM STREPTOCOCCUS PNEUMONIAE	3.2.1.52
2LU1	PFSUB2 SOLUTION NMR STRUCTURE	3.4.21.62
2LUO	NMR SOLUTION STRUCTURE OF APO-MPTPA	3.1.3.48
2LUQ	SOLUTION STRUCTURE OF DOUBLE-STRANDED RNA BINDING DOMAIN OF S.CEREVISIAE RNASE III (RNT1P)	3.1.26.3
2LUW	SOLUTION STRUCTURE OF VEP C-TER 100	3.4.24
2LVA	NMR SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN USP28, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HT8470A	3.4.19.12
2LVG	NMR STRUCTURE OF HCV NON-STRUCTURAL PROTEIN AB, NS4B(1-40)	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2LVX	MRH DOMAIN OF THE GLUCOSIDASE II BETA SUBUNIT FROM S. POMBE	3.2.1.84
2LVZ	SOLUTION STRUCTURE OF A EOSINOPHIL CATIONIC PROTEIN-TRISACCHARIDE HEPARIN MIMETIC COMPLEX	3.1.27
2LW1	THE C-TERMINAL DOMAIN OF THE UUP PROTEIN IS A DNA-BINDING COILED COIL MOTIF	3.6.1
2LWD	SOLUTION STRUCTURE OF SECOND CARD OF HUMAN RIG-I	3.6.4.13
2LWE	SOLUTION STRUCTURE OF MUTANT (T170E) SECOND CARD OF HUMAN RIG-I	3.6.4.13
2LWF	STRUCTURE OF N-TERMINAL DOMAIN OF A PLANT GRX	3.1
2LWI	SOLUTION STRUCTURE OF H-RAST35S MUTANT PROTEIN IN COMPLEX WITH KOBE2601	3.6.5.2
2LXF	SOLUTION NMR STRUCTURE OF A POTENTIAL ACYLPHOSPHATASE FROM GIARDIA LAMBLIA, SEATTLE STRUCTURAL GENOMICS CENTER FOR INFECTIOUS DISEASE TARGET GILAA.01396.A	3.6.1.7
2LYA	STRUCTURE OF HIV-1 MYR(-) MATRIX PROTEIN IN COMPLEX WITH 1,2-DIOCTANOYL-SN-PHOSPHATIDYLCHOLINE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2LYB	STRUCTURE OF HIV-1 MYR(-) MATRIX PROTEIN IN COMPLEX WITH 1,2-DIOCTANOYL-SN-PHOSPHATIDYL-L-SERINE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2LYM	CRYSTAL STRUCTURE OF HEN EGG-WHITE LYSOZYME AT A HYDROSTATIC PRESSURE OF 1000 ATMOSPHERES	3.2.1.17
2LYO	CROSS-LINKED CHICKEN LYSOZYME CRYSTAL IN 90% ACETONITRILE-WATER	3.2.1.17
2LYZ	REAL-SPACE REFINEMENT OF THE STRUCTURE OF HEN EGG-WHITE LYSOZYME	3.2.1.17
2LZ2	THE THREE DIMENSIONAL STRUCTURE OF TURKEY EGG WHITE LYSOZYME AT 2.2 ANGSTROMS RESOLUTION	3.2.1.17
2LZM	STRUCTURE OF BACTERIOPHAGE T4 LYSOZYME REFINED AT 1.7 ANGSTROMS RESOLUTION	3.2.1.17
2LZP	STRUCTURE OF NS2(2-32) GBVB PROTEIN	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2LZQ	STRUCTURE OF NS2(32-57) GBVB PROTEIN	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2LZT	REFINEMENT OF TRICLINIC LYSOZYME. II. THE METHOD OF STEREOCHEMICALLY RESTRAINED LEAST-SQUARES	3.2.1.17
2M00	SOLUTION STRUCTURE OF STAPHYLOCOCCAL NUCLEASE E43S MUTANT IN THE PRESENCE OF SSDNA AND CD2+	3.1.31.1
2M0A	SOLUTION STRUCTURE OF MHV NSP3A	3.4.19.12 3.4.22.69 3.4.22
2M0S	SOLUTION STRUCTURE OF THE TRANS-MEMBRANE DOMAIN OF THE NS2A OF DENGUE VIRUS	3.4.21.91 3.6.1.15 3.6.4.13
2M0Z	CIS FORM OF A PHOTOSWITCHABLE PDZ DOMAIN CROSSLINKED WITH AN AZOBENZENE DERIVATIVE	3.1.3.48
2M10	TRANS FORM OF A PHOTOSWITCHABLE PDZ DOMAIN CROSSLINKED WITH AN AZOBENZENE DERIVATIVE	3.1.3.48
2M17	UBIQUITIN-LIKE DOMAIN-CONTAINING C-TERMINAL DOMAIN PHOSPHATASE (UBLCP1)	3.1.3.16
2M1C	HADDOCK STRUCTURE OF GTYYBT PAS HOMODIMER	3.1.4.59
2M2F	THE MEMBRAN-PROXIMAL DOMAIN OF ADAM17	3.4.24.86
2M3D	NMR STRUCTURE OF THE GUCT DOMAIN FROM HUMAN DEAD BOX POLYPEPTIDE 21	3.6.4.13
2M3Z	NMR SOLUTION STRUCTURE OF HIV-1 NUCLEOCAPSID PROTEIN IN COMPLEX WITH AN INHIBITOR DISPLAYING A 2 INHIBITORS:1 NC STOICHIOMETRY	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2M45	NMR SOLUTION STRUCTURE OF THE C-TERMINUS OF THE MINICHROMOSOME MAINTENANCE PROTEIN MCM FROM SULFOLOBUS SOLFATARICUS	3.6.4.12
2M4G	SOLUTION STRUCTURE OF THE CORE DOMAIN (11-85) OF THE MURINE NOROVIRUS VPG PROTEIN	2.7.7.48 3.4.22.66 3.6.1.15
2M4H	SOLUTION STRUCTURE OF THE CORE DOMAIN (10-76) OF THE FELINE CALICIVIRUS VPG PROTEIN	3.6.1.15 2.7.7.48 3.4.22.66
2M5C	SOLUTION STRUCTURE OF THE BACILLUS CEREUS METALLO-BETA-LACTAMASE BCII	3.5.2.6
2M5D	SOLUTION STRUCTURE OF THE BACILLUS CEREUS METALLO-BETA-LACTAMASE BCII IN COMPLEX WITH R-THIOMANDELIC ACID	3.5.2.6
2M5L	NS5A308	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
2M5T	SOLUTION STRUCTURE OF THE 2A PROTEINASE FROM A COMMON COLD AGENT, HUMAN RHINOVIRUS RV-C02, STRAIN W12	3.4.22.28 3.4.22.29 3.6.1.15
2M65	NMR STRUCTURE OF HUMAN RESTRICTION FACTOR APOBEC3A	3.5.4 3.5.4.38
2M6X	STRUCTURE OF THE P7 CHANNEL OF HEPATITIS C VIRUS, GENOTYPE 5A	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2M73	SOLUTION STRUCTURE OF THE CALMODULIN-BINDING DOMAIN OF PLANT CALCIUM-ATPASE ACA8	3.6.3.8 7.2.2.10
2M75	THE C-TERMINAL REGION OF DISINTEGRIN MODULATE ITS 3D CONFORMATION AND COOPERATE WITH RGD LOOP IN REGULATING RECOGNITIONS OF INTEGRINS	3.4.24
2M7E	SOLUTION STRUCTURE OF THE CALMODULIN-BINDING DOMAIN OF PLANT CALCIUM-ATPASE ACA2	3.6.3.8 7.2.2.10
2M7F	THE C-TERMINAL REGION OF DISINTEGRIN MODULATE ITS 3D CONFORMATION AND COOPERATE WITH RGD LOOP IN REGULATING INTEGRINS RECOGNITIONS	3.4.24
2M7H	THE C-TERMINAL REGION OF DISINTEGRIN MODULATE ITS 3D CONFORMATION AND COOPERATE WITH RGD LOOP IN REGULATING INTEGRIN ALPHA-IIB BETA-3 RECOGNITION	3.4.24
2M7Y	THE MENGOVIRUS LEADER PROTEIN	3.6.4.13 3.4.22.28 2.7.7.48
2M85	PHD DOMAIN FROM HUMAN SHPRH	3.6.4 6.3.2 2.3.2.27
2M8L	HIV CAPSID DIMER STRUCTURE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2M8N	HIV-1 CAPSID MONOMER STRUCTURE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2M8P	THE STRUCTURE OF THE W184AM185A MUTANT OF THE HIV-1 CAPSID PROTEIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2M9P	NMR STRUCTURE OF AN INHIBITOR BOUND DENGUE NS3 PROTEASE	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2M9Q	NMR STRUCTURE OF AN INHIBITOR BOUND DENGUE NS3 PROTEASE	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2M9U	SOLUTION NMR STRUCTURE OF THE C-TERMINAL DOMAIN (CTD) OF MOLONEY MURINE LEUKEMIA VIRUS INTEGRASE, NORTHEAST STRUCTURAL GENOMICS TARGET OR41A	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
2MA1	SOLUTION STRUCTURE OF HRDC1 DOMAIN OF RECQ HELICASE FROM DEINOCOCCUS RADIODURANS	3.6.4.12
2MA3	NMR SOLUTION STRUCTURE OF THE C-TERMINUS OF THE MINICHROMOSOME MAINTENANCE PROTEIN MCM FROM METHANOTHERMOBACTER THERMAUTOTROPHICUS	3.6.4.12
2MAN	MANNOTRIOSE COMPLEX OF THERMOMONOSPORA FUSCA BETA-MANNANASE	3.2.1.78
2MAS	PURINE NUCLEOSIDE HYDROLASE WITH A TRANSITION STATE INHIBITOR	3.2.2.1 3.2.2.2 3.2.2.3
2MAT	E.COLI METHIONINE AMINOPEPTIDASE AT 1.9 ANGSTROM RESOLUTION	3.4.11.18
2MBC	SOLUTION STRUCTURE OF HUMAN HOLO-PRL-3 IN COMPLEX WITH VANADATE	3.1.3.48
2MC3	NMR SOLUTION STRUCTURE OF THE WINGED-HELIX DOMAIN FROM MUS81 STRUCTURE-SPECIFIC ENDONUCLEASE	3.1.22
2MCD	BACKBONE 1H, 13C, AND 15N CHEMICAL SHIFT ASSIGNMENTS FOR MURINE NOROVIRUS NS1/2 D94E MUTANT	2.7.7.48 3.4.22.66 3.6.1.15
2MCH	BACKBONE 1H, 13C, AND 15N CHEMICAL SHIFT ASSIGNMENTS FOR MURINE NOROVIRUS NS1/2 CW3 WT	2.7.7.48 3.4.22.66 3.6.1.15
2MCK	BACKBONE 1H, 13C, AND 15N CHEMICAL SHIFT ASSIGNMENTS FOR MURINE NOROVIRUS CR6 NS1/2 PROTEIN	2.7.7.48 3.4.22.66 3.6.1.15
2MCR	SOLUTION STRUCTURE OF SHK-LIKE IMMUNOMODULATORY PEPTIDE FROM BRUGIA MALAYI (FILARIAL WORM)	3.4.24
2MD1	FRAGMENT BASED APPROACH AND BINDING BEHAVIOR OF LFAMPINB WITH LIPOPOLYSACCHARIDE:BIOPHYSICAL ASPECTS	3.4.21
2MD2	FRAGMENT BASED APPROACH AND BINDING BEHAVIOR OF LFAMPINB WITH LIPOPOLYSACCHARIDE: BIOPHYSICAL ASPECTS	3.4.21
2MDR	SOLUTION STRUCTURE OF THE THIRD DOUBLE-STRANDED RNA-BINDING DOMAIN (DSRBD3) OF HUMAN ADENOSINE-DEAMINASE ADAR1	3.5.4.37
2MEA	CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS	3.2.1.17
2MEB	CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS	3.2.1.17
2MEC	CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS	3.2.1.17
2MED	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME	3.2.1.17
2MEE	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME	3.2.1.17
2MEF	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME	3.2.1.17
2MEG	CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS.	3.2.1.17
2MEH	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME	3.2.1.17
2MEI	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME	3.2.1.17
2MEV	STRUCTURAL REFINEMENT AND ANALYSIS OF MENGO VIRUS	3.6.4.13 3.4.22.28 2.7.7.48
2MF2	STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE MRNA INTERFERASE SAMAZF FROM STAPHYLOCOCCUS AUREUS.	3.1
2MH9	RESONANCE ASSIGNMENT OF RQC DOMAIN OF HUMAN BLOOM SYNDROME PROTEIN	3.6.4.12
2MIP	CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) TYPE 2 PROTEASE IN COMPLEX WITH A REDUCED AMIDE INHIBITOR AND COMPARISON WITH HIV-1 PROTEASE STRUCTURES	3.4.23.47 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2MJA	SOLUTION STRUCTURE OF DOMAIN-SWAPPED GLPG	3.4.21.105
2MJL	SOLUTION STRUCTURE OF PEPTIDYL-TRNA HYROLASE FROM VIBRIO CHOLERAE	3.1.1.29
2MJP	STRUCTURE-BASED IDENTIFICATION OF THE BIOCHEMICAL FUNCTION OF A HYPOTHETICAL PROTEIN FROM METHANOCOCCUS JANNASCHII:MJ0226	3.6.1.66
2MK2	SOLUTION NMR STRUCTURE OF N-TERMINAL DOMAIN (SH2 DOMAIN) OF HUMAN INOSITOL POLYPHOSPHATE PHOSPHATASE-LIKE PROTEIN 1 (INPPL1) (FRAGMENT 20-117), NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR9134A	3.1.3.86
2MKB	STRUCTURE OF NS2(113-137) GBVB PROTEIN	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2MKX	SOLUTION STRUCTURE OF LYSM THE PEPTIDOGLYCAN BINDING DOMAIN OF AUTOLYSIN ATLA FROM ENTEROCOCCUS FAECALIS	3.2.1
2MLL	MISTLETOE LECTIN I FROM VISCUM ALBUM	3.2.2.22
2MLR	MEMBRANE BILAYER COMPLEX WITH MATRIX METALLOPROTEINASE-12 AT ITS ALPHA-FACE	3.4.24.65
2MLS	MEMBRANE BILAYER COMPLEX WITH MATRIX METALLOPROTEINASE-12 AT ITS BETA-FACE	3.4.24.65
2MM8	STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF JABURETOX	3.5.1.5
2MMH	UNPHOSPHORYLATED MENGOVIRUS LEADER PROTEIN: NMR STUDIES OF THE PHOSPHORYLATION OF THE MENGOVIRUS LEADER PROTEIN REVEAL STABILIZATION OF INTERMOLECULAR DOMAIN INTERACTIONS	3.6.4.13 3.4.22.28 2.7.7.48
2MMI	MENGOVIRUS LEADER: STRUCTURAL CHARACTERIZATION OF THE MENGOVIRUS LEADER PROTEIN BOUND TO RAN GTPASE BY NUCLEAR MAGNETIC RESONANCE	3.6.4.13 3.4.22.28 2.7.7.48
2MMK	Y41 AND T47 PHOSPHORYLATION OF THE MENGOVIRUS LEADER PROTEIN: NMR STUDIES OF THE PHOSPHORYLATION OF THE MENGOVIRUS LEADER PROTEIN REVEAL STABILIZATION OF INTERMOLECULAR DOMAIN INTERACTIONS	3.6.4.13 3.4.22.28 2.7.7.48
2MML	T47 PHOSPHORYLATION OF THE MENGOVIRUS LEADER PROTEIN: NMR STUDIES OF THE PHOSPHORYLATION OF THE MENGOVIRUS LEADER PROTEIN REVEAL STABILIZATION OF INTERMOLECULAR DOMAIN INTERACTIONS	3.6.4.13 3.4.22.28 2.7.7.48
2MOE	SOLUTION STRUCTURE OF MBD4 METHYL-CYTOSINE BINDING DOMAIN BOUND TO METHYLATED DNA	3.2.2
2MQK	SOLUTION STRUCTURE OF N TERMINAL DOMAIN OF THE MUB AAA+ ATPASE	3.6.1.3 3.6.1
2MQS	TRANSIENT COLLAGEN TRIPLE HELIX BINDING TO A KEY METALLOPROTEINASE IN INVASION AND DEVELOPMENT: SPIN LABELS TO STRUCTURE	3.4.24.80
2MQV	SOLUTION NMR STRUCTURE OF THE U5-PRIMER BINDING SITE (U5-PBS) DOMAIN OF MURINE LEUKEMIA VIRUS RNA GENOME BOUND TO THE RETROVIRAL NUCLEOCAPSID PROTEIN	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
2MR9	NMR STRUCTURE OF UBA DOMAIN OF DNA-DAMAGE-INDUCIBLE 1 PROTEIN (DDI1)	3.4.23
2MRP	NMR SOLUTION STRUCTURE OF THE UBIQUITIN LIKE DOMAIN (UBL) OF DNA-DAMAGE-INDUCIBLE 1 PROTEIN (DDI1)	3.4.23
2MS0	SOLUTION NMR STRUCTURE PF TRNAPRO:MLV-NUCLEOCAPSID (1:2) COMPLEX	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
2MS1	SOLUTION NMR STRUCTURE OF TRNAPRO:MLV NUCLEOCAPSID PROTEIN (1:1) COMPLEX	3.4.23 2.7.7.49 2.7.7.7 3.1.26.4 2.7.7 3.1
2MSN	NMR STRUCTURE OF A PUTATIVE PHOSPHOGLYCOLATE PHOSPHATASE (NP_346487.1) FROM STREPTOCOCCUS PNEUMONIAE TIGR4	3.1.3.18
2MTE	SOLUTION STRUCTURE OF DOC48S	3.2.1.176
2MTS	THREE-DIMENSIONAL STRUCTURE AND INTERACTION STUDIES OF HEPATITIS C VIRUS P7 IN 1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOCHOLINE BY SOLUTION NUCLEAR MAGNETIC RESONANCE	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2MUG	PROTECTIVE CELLULAR IMMUNITY AGAINST P. FALCIPARUM MALARIA MEROZOITE IS ASSOCIATED WITH A DIFFERENT P7 AND P8 RESIDUE ORIENTATION IN THE MHC-PEPTIDE-TCR COMPLEX	3.4.22
2MV3	THE N-DOMAIN OF THE AAA METALLOPROTEINASE YME1 FROM SACCHAROMYCES CEREVISIAE	3.4.24
2MWJ	SOLUTION STRUCTURE OF FAMILY 1 CARBOHYDRATE-BINDING MODULE FROM TRICHODERMA REESEI CEL7A WITH O-MANNOSE RESIDUES AT THR1 AND SER3	3.2.1.91
2MWK	FAMILY 1 CARBOHYDRATE-BINDING MODULE FROM TRICHODERMA REESEI CEL7A WITH O-MANNOSE RESIDUES AT THR1, SER3, AND SER14	3.2.1.91
2MXD	SOLUTION STRUCTURE OF VPG OF PORCINE SAPOVIRUS	3.6.1.15 2.7.7.48 3.4.22.66
2MXZ	BACTERIOPHAGE T5 L-ALANOYL-D-GLUTAMATE PEPTIDASE COMLPEX WITH ZN2+ (ENDO T5-ZN2+)	3.4.24
2MY9	SOLUTION STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN TIG3	3.1.1 2.3.1 3.1.1.32 3.1.1.4
2MYN	AN ARSENATE REDUCTASE IN REDUCED STATE	1.20.4.1 3.1.3.48
2MYP	AN ARSENATE REDUCTASE IN THE PHOSPHATE BINDING STATE	1.20.4.1 3.1.3.48
2MYT	AN ARSENATE REDUCTASE IN THE INTERMEDIATE STATE	1.20.4.1 3.1.3.48
2MYU	AN ARSENATE REDUCTASE IN OXIDIZED STATE	1.20.4.1 3.1.3.48
2MZE	NMR SOLUTION STRUCTURE OF THE PRO FORM OF HUMAN MATRILYSIN (PROMMP-7)	3.4.24.23
2MZH	NMR SOLUTION STRUCTURE OF THE PRO FORM OF HUMAN MATRILYSIN (PROMMP-7) IN COMPLEX WITH ZWITTERIONIC MEMBRANE	3.4.24.23
2MZI	NMR SOLUTION STRUCTURE OF THE PRO FORM OF HUMAN MATRILYSIN (PROMMP-7) IN COMPLEX WITH ANIONIC MEMBRANE	3.4.24.23
2MZN	NMR STRUCTURE OF THE HLTF HIRAN DOMAIN IN ITS DNA-BOUND CONFORMATION	2.3.2.27 3.6.4
2N16	SOLUTION STRUCTURE OF G-QUADRUPLEX RECOGNITION DOMAIN OF RHAU	3.6.4.12 3.6.4.13
2N21	SOLUTION STRUCTURE OF COMPLEX BETWEEN DNA G-QUADRUPLEX AND G-QUADRUPLEX RECOGNITION DOMAIN OF RHAU	3.6.4.12 3.6.4.13
2N42	EC-NMR STRUCTURE OF HUMAN H-RAST35S MUTANT PROTEIN DETERMINED BY COMBINING EVOLUTIONARY COUPLINGS (EC) AND SPARSE NMR DATA	3.6.5.2
2N46	EC-NMR STRUCTURE OF HUMAN H-RAST35S MUTANT PROTEIN DETERMINED BY COMBINING EVOLUTIONARY COUPLINGS (EC) AND SPARSE NMR DATA	3.6.5.2
2N5N	STRUCTURE OF AN N-TERMINAL DOMAIN OF CHD4	3.6.4.12
2N5Z	MYCOBACTERIUM TUBERCULOSIS: A DYNAMIC VIEW OF THE RESUSCITATION PROMOTING FACTOR RPFC CATALYTIC DOMAIN	3
2N6J	SOLUTION STRUCTURE OF ZMP1, A ZINC-DEPENDENT METALLOPROTEASE SECRETED BY CLOSTRIDIUM DIFFICILE	3.4.24 3.4.24.89
2N8R	PRODUCTIVE COMPLEX BETWEEN MMP-12 AND SYNTHETIC TRIPLE-HELICAL COLLAGEN, REVEALED THROUGH PARAMAGNETIC NMR	3.4.24.65
2NA2	DROSHA QUAD MUTANT DOUBLE-STRANDED RNA BINDING COMPETENT	3.1.26.3
2NAF	SOLUTION STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM MYCOBACTERIUM SMEGMATIS	3.1.1.29
2NDK	20 LOWEST ENERGY ENSEMBLE OF DERMCIDIN (DCD1L) NMR STRUCTURE	3.4
2NGR	TRANSITION STATE COMPLEX FOR GTP HYDROLYSIS BY CDC42: COMPARISONS OF THE HIGH RESOLUTION STRUCTURES FOR CDC42 BOUND TO THE ACTIVE AND CATALYTICALLY COMPROMISED FORMS OF THE CDC42-GAP.	3.6.5.2
2NLK	CRYSTAL STRUCTURE OF D1 AND D2 CATALYTIC DOMAINS OF HUMAN PROTEIN TYROSINE PHOSPHATASE GAMMA (D1+D2 PTPRG)	3.1.3.48
2NLR	STREPTOMYCES LIVIDANS ENDOGLUCANASE (EC: 3.2.1.4) COMPLEX WITH MODIFIED GLUCOSE TRIMER	3.2.1.4
2NM1	STRUCTURE OF BONT/B IN COMPLEX WITH ITS PROTEIN RECEPTOR	3.4.24.69
2NMM	CRYSTAL STRUCTURE OF HUMAN PHOSPHOHISTIDINE PHOSPHATASE. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR1409	3.1.3 3.9.1.3
2NMV	DAMAGE DETECTION BY THE UVRABC PATHWAY: CRYSTAL STRUCTURE OF UVRB BOUND TO FLUORESCEIN-ADDUCTED DNA	3.1
2NMY	CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A INHIBITOR SAQUINAVIR	3.4.23.16
2NMZ	CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT V82A WITH A INHIBITOR SAQUINAVIR	3.4.23.16
2NN3	STRUCTURE OF PRO-SF-CASPASE-1	3.4.22.36 3.4.22
2NNK	CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A INHIBITOR SAQUINAVIR	3.4.23.16
2NNP	CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE MUTANT I84V WITH A INHIBITOR SAQUINAVIR	3.4.23.16
2NO4	CRYSTAL STRUCTURE ANALYSIS OF A DEHALOGENASE	3.8.1.2
2NO5	CRYSTAL STRUCTURE ANALYSIS OF A DEHALOGENASE WITH INTERMEDIATE COMPLEX	3.8.1.2
2NOB	STRUCTURE OF CATALYTICALLY INACTIVE H270A HUMAN 8-OXOGUANINE GLYCOSYLASE CROSSLINKED TO 8-OXOGUANINE DNA	3.2.2 4.2.99.18
2NOE	STRUCTURE OF CATALYTICALLY INACTIVE G42A HUMAN 8-OXOGUANINE GLYCOSYLASE COMPLEXED TO 8-OXOGUANINE DNA	3.2.2 4.2.99.18
2NOF	STRUCTURE OF Q315F HUMAN 8-OXOGUANINE GLYCOSYLASE PROXIMAL CROSSLINK TO 8-OXOGUANINE DNA	3.2.2 4.2.99.18
2NOH	STRUCTURE OF CATALYTICALLY INACTIVE Q315A HUMAN 8-OXOGUANINE GLYCOSYLASE COMPLEXED TO 8-OXOGUANINE DNA	3.2.2 4.2.99.18
2NOI	STRUCTURE OF G42A HUMAN 8-OXOGUANINE GLYCOSYLASE CROSSLINKED TO UNDAMAGED G-CONTAINING DNA	3.2.2 4.2.99.18
2NOL	STRUCTURE OF CATALYTICALLY INACTIVE HUMAN 8-OXOGUANINE GLYCOSYLASE DISTAL CROSSLINK TO OXOG DNA	3.2.2 4.2.99.18
2NOO	CRYSTAL STRUCTURE OF MUTANT NIKA	3.6.3.24
2NOT	NOTECHIS II-5, NEUROTOXIC PHOSPHOLIPASE A2 FROM NOTECHIS SCUTATUS SCUTATUS	3.1.1.4
2NOZ	STRUCTURE OF Q315F HUMAN 8-OXOGUANINE GLYCOSYLASE DISTAL CROSSLINK TO 8-OXOGUANINE DNA	3.2.2 4.2.99.18
2NP0	CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN TYPE B COMPLEXED WITH SYNAPTOTAGAMIN-II ECTODOMAIN	3.4.24.69
2NPH	CRYSTAL STRUCTURE OF HIV1 PROTEASE IN SITU PRODUCT COMPLEX	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2NQ6	CRYSTAL STRUCTURE OF HUMAN METHIONINE AMINOPEPTIDASE TYPE 1 IN COMPLEX WITH 3-TERT-BUTOXYCARBONYLAMINOPYRIDINE-2-CARBOXYLIC ACID THIAZOLE-2-YLAMIDE	3.4.11.18
2NQ7	CRYSTAL STRUCTURE OF TYPE 1 HUMAN METHIONINE AMINOPEPTIDASE IN COMPLEX WITH 3-(2,2-DIMETHYLPROPIONYLAMINO)PYRIDINE-2-CARBOXYLIC ACID THIAZOLE-2-YLAMIDE	3.4.11.18
2NQ9	HIGH RESOLUTION CRYSTAL STRUCTURE OF ESCHERICHIA COLI ENDONUCLEASE IV (ENDO IV) Y72A MUTANT BOUND TO DAMAGED DNA	3.1.21.2
2NQA	CATALYTIC DOMAIN OF HUMAN CALPAIN 8	3.4.22.53
2NQG	CALPAIN 1 PROTEOLYTIC CORE INACTIVATED BY WR18(S,S), AN EPOXYSUCCINYL-TYPE INHIBITOR.	3.4.22.52
2NQH	HIGH RESOLUTION CRYSTAL STRUCTURE OF ESCHERICHIA COLI ENDONUCLEASE IV (ENDO IV) E261Q MUTANT	3.1.21.2
2NQI	CALPAIN 1 PROTEOLYTIC CORE INACTIVATED BY WR13(R,R), AN EPOXYSUCCINYL-TYPE INHIBITOR.	3.4.22.52
2NQJ	CRYSTAL STRUCTURE OF ESCHERICHIA COLI ENDONUCLEASE IV (ENDO IV) E261Q MUTANT BOUND TO DAMAGED DNA	3.1.21.2
2NQY	CRYSTAL STRUCTURE OF ALKALINE THERMOPHLIC XYLANASE FROM BACILLUS SP. (NCL 86-6-10) WITH COMPLEX XYLOTRIOSE: XYLOTRIOSE CLEAVED TO XYLOBIOSE AND XYLOSE	3.2.1.8
2NR9	CRYSTAL STRUCTURE OF GLPG, RHOMBOID PEPTIDASE FROM HAEMOPHILUS INFLUENZAE	3.4.21.105
2NRF	CRYSTAL STRUCTURE OF GLPG, A RHOMBOID FAMILY INTRAMEMBRANE PROTEASE	3.4.21.105
2NS6	CRYSTAL STRUCTURE OF THE MINIMAL RELAXASE DOMAIN OF MOBA FROM PLASMID R1162	3.6.1
2NSM	CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE N (KININASE I) CATALYTIC DOMAIN	3.4.17.3
2NSP	CRYSTAL STRUCTURE OF PECTIN METHYLESTERASE D178A MUTANT IN COMPLEX WITH HEXASACCHARIDE I	3.1.1.11
2NST	CRYSTAL STRUCTURE OF PECTIN METHYLESTERASE D178A MUTANT IN COMPLEX WITH HEXASACCHARIDE II	3.1.1.11
2NSX	STRUCTURE OF ACID-BETA-GLUCOSIDASE WITH PHARMACOLOGICAL CHAPERONE PROVIDES INSIGHT INTO GAUCHER DISEASE	3.2.1.45 2.4.1 3.2.1
2NT0	ACID-BETA-GLUCOSIDASE LOW PH, GLYCEROL BOUND	3.2.1.45 2.4.1 3.2.1
2NT1	STRUCTURE OF ACID-BETA-GLUCOSIDASE AT NEUTRAL PH	3.2.1.45 2.4.1 3.2.1
2NT2	CRYSTAL STRUCTURE OF SLINGSHOT PHOSPHATASE 2	3.1.3.48 3.1.3.16
2NT6	CRYSTAL STRUCTURE OF PECTIN METHYLESTERASE D178A MUTANT IN COMPLEX WITH HEXASACCHARIDE III	3.1.1.11
2NT7	CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX	3.1.3.48
2NT9	CRYSTAL STRUCTURE OF PECTIN METHYLESTERASE D178A MUTANT IN COMPLEX WITH HEXASACCHARIDE IV	3.1.1.11
2NTA	CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX	3.1.3.48
2NTB	CRYSTAL STRUCTURE OF PECTIN METHYLESTERASE IN COMPLEX WITH HEXASACCHARIDE V	3.1.1.11
2NTG	STRUCTURE OF SPIN-LABELED T4 LYSOZYME MUTANT T115R7	3.2.1.17
2NTH	STRUCTURE OF SPIN-LABELED T4 LYSOZYME MUTANT L118R1	3.2.1.17
2NTK	CRYSTAL STRUCTURE OF PURO/IMP FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS	3.5.4.10
2NTL	CRYSTAL STRUCTURE OF PURO/AICAR FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS	3.5.4.10
2NTM	CRYSTAL STRUCTURE OF PURO FROM METHANOTHERMOBACTER THERMOAUTOTROPHICUS	3.5.4.10
2NTP	CRYSTAL STRUCTURE OF PECTIN METHYLESTERASE IN COMPLEX WITH HEXASACCHARIDE VI	3.1.1.11
2NTQ	CRYSTAL STRUCTURE OF PECTIN METHYLESTERASE IN COMPLEX WITH HEXASACCHARIDE VII	3.1.1.11
2NTR	CRYSTAL STRUCTURE OF HUMAN BACE-1 BOUND TO INHIBITOR	3.4.23.46
2NU0	MOLECULAR STRUCTURES OF THE COMPLEXES OF SGPB WITH OMTKY3 AROMATIC P1 VARIANTS TRP18I, HIS18I, PHE18I, AND TYR18I	3.4.21.81
2NU1	MOLECULAR STRUCTURES OF THE COMPLEXES OF SGPB WITH OMTKY3 AROMATIC P1 VARIANTS TRP18I, HIS18I, PHE18I AND TYR18I	3.4.21.81
2NU2	ACCOMMODATION OF POSITIVELY-CHARGED RESIDUES IN A HYDROPHOBIC SPECIFICITY POCKET: CRYSTAL STRUCTURES OF SGPB IN COMPLEX WITH OMTKY3 VARIANTS LYS18I AND ARG18I	3.4.21.81
2NU3	ACCOMMODATION OF POSITIVELY-CHARGED RESIDUES IN A HYDROPHOBIC SPECIFICITY POCKET: CRYSTAL STRUCTURES OF SGPB IN COMPLEX WITH OMTKY3 VARIANTS LYS18I AND ARG18I	3.4.21.81
2NU4	ACCOMMODATION OF POSITIVELY-CHARGED RESIDUES IN A HYDROPHOBIC SPECIFICITY POCKET: CRYSTAL STRUCTURES OF SGPB IN COMPLEX WITH OMTKY3 VARIANTS LYS18I AND ARG18I	3.4.21.81
2NUC	STAPHLOCOCCAL NUCLEASE, ETHANE THIOL DISULFIDE TO V23C VARIANT	3.1.31.1
2NUE	CRYSTAL STRUCTURE OF RNASE III FROM AQUIFEX AEOLICUS COMPLEXED WITH DS-RNA AT 2.9-ANGSTROM RESOLUTION	3.1.26.3
2NUF	CRYSTAL STRUCTURE OF RNASE III FROM AQUIFEX AEOLICUS COMPLEXED WITH DS-RNA AT 2.5-ANGSTROM RESOLUTION	3.1.26.3
2NUG	CRYSTAL STRUCTURE OF RNASE III FROM AQUIFEX AEOLICUS COMPLEXED WITH DS-RNA AT 1.7-ANGSTROM RESOLUTION	3.1.26.3
2NUI	X-RAY STRUCTURE OF SYNTHETIC [D83A]RNASE A	3.1.27.5
2NUV	CRYSTAL STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH ATENOLOL AT 2.25 A RESOLUTION	3.4.21
2NV0	STRUCTURE OF THE GLUTAMINASE SUBUNIT PDX2 (YAAE) OF PLP SYNTHASE FROM BACILLUS SUBTILIS	2.6 4.3.3.6 3.5.1.2
2NV5	CRYSTAL STRUCTURE OF A C-TERMINAL PHOSPHATASE DOMAIN OF RATTUS NORVEGICUS ORTHOLOG OF HUMAN PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE, D (PTPRD)	3.1.3.48
2NVJ	NMR STRUCTURES OF TRANSMEMBRANE SEGMENT FROM SUBUNIT A FROM THE YEAST PROTON V-ATPASE	3.6.3.14
2NW0	CRYSTAL STRUCTURE OF A LYSIN	3.2.1.17
2NW6	BURKHOLDERIA CEPACIA LIPASE COMPLEXED WITH S-INHIBITOR	3.1.1.3
2NWD	STRUCTURE OF CHEMICALLY SYNTHESIZED HUMAN LYSOZYME AT 1 ANGSTROM RESOLUTION	3.2.1.17
2NWJ	STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH DISACCHARIDE AT 1.75 A RESOLUTION	3.4.21
2NWN	NEW PHARMACOPHORE FOR SERINE PROTEASE INHIBITION REVEALED BY CRYSTAL STRUCTURE OF HUMAN UROKINASE-TYPE PLASMINOGEN ACTIVATOR COMPLEXED WITH A CYCLIC PEPTIDYL INHIBITOR, UPAIN-1	3.4.21.73
2NX8	THE CRYSTAL STRUCTURE OF THE TRNA-SPECIFIC ADENOSINE DEAMINASE FROM STREPTOCOCCUS PYOGENES	3.5.4 3.5.4.33
2NXA	STRUCTURE OF ZN-DEPENDENT METALLO-BETA-LACTAMASE FROM BACILLUS CEREUS R121H, C221D DOUBLE MUTANT	3.5.2.6
2NXD	STRUCTURE OF HIV-1 PROTEASE D25N COMPLEXED WITH RT-RH ANALOGUE PEPTIDE GLY-ALA-ASP-ILE-PHE*TYR-LEU-ASP-GLY-ALA	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2NXF	CRYSTAL STRUCTURE OF A DIMETAL PHOSPHATASE FROM DANIO RERIO LOC 393393	3.6.1.13 3.6.1.16 3.6.1.53
2NXL	STRUCTURE OF HIV-1 PROTEASE D25N COMPLEXED WITH THE RT-RH ANALOGUE PEPTIDE GLY-ALA-GLU-VAL-PHE*TYR-VAL-ASP-GLY-ALA	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2NXM	STRUCTURE OF HIV-1 PROTEASE D25N COMPLEXED WITH THE RT-RH ANALOGUE PEPTIDE GLY-ALA-GLN-THR-PHE*TYR-VAL-ASP-GLY-ALA	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2NYP	STRUCTURE OF BETA-LACTAMASE II FROM BACILLUS CEREUS. R121H, C221D DOBLE MUTANT WITH TWO ZINC IONS.	3.5.2.6
2NYQ	STRUCTURE OF VIBRIO PROTEOLYTICUS AMINOPEPTIDASE WITH A BOUND TRP FRAGMENT OF DLWCF	3.4.11.10
2NYR	CRYSTAL STRUCTURE OF HUMAN SIRTUIN HOMOLOG 5 IN COMPLEX WITH SURAMIN	3.5.1 2.3.1
2NYT	THE APOBEC2 CRYSTAL STRUCTURE AND FUNCTIONAL IMPLICATIONS FOR AID	3.5.4 3.5.4.36
2NYV	X-RAY CRYSTAL STRUCTURE OF A PHOSPHOGLYCOLATE PHOSPHATASE FROM AQUIFEX AEOLICUS	3.1.3.18
2NYY	CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1	3.4.24.69
2NZ6	CRYSTAL STRUCTURE OF THE PTPRJ INACTIVATING MUTANT C1239S	3.1.3.48
2NZ8	N-TERMINAL DHPH CASSETTE OF TRIO IN COMPLEX WITH NUCLEOTIDE-FREE RAC1	3.6.5.2
2NZ9	CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2	3.4.24.69
2NZE	STRUCTURE OF BETA-LACTAMASE II FROM BACILLUS CEREUS. R121H, C221S DOUBLE MUTANT. SPACE GROUP P3121.	3.5.2.6
2NZF	STRUCTURE OF BETA-LACTAMASE II FROM BACILLUS CEREUS. R121H, C221S DOUBLE MUTANT. SPACE GROUP C2.	3.5.2.6
2O0H	T4 GP17 ATPASE DOMAIN MUTANT COMPLEXED WITH ATP	3.6.4 3.1.21
2O0J	T4 GP17 ATPASE DOMAIN MUTANT COMPLEXED WITH ADP	3.6.4 3.1.21
2O0K	T4 GP17 ATPASE DOMAIN MUTANT	3.6.4 3.1.21
2O14	X-RAY CRYSTAL STRUCTURE OF PROTEIN YXIM_BACSU FROM BACILLUS SUBTILIS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET SR595	3.1
2O1C	STRUCTURE OF THE E. COLI DIHYDRONEOPTERIN TRIPHOSPHATE PYROPHOSPHOHYDROLASE	3.6.1 3.6.1.67
2O1L	STRUCTURE OF A COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH DISACCHARIDE AT 1.97 A RESOLUTION	3.4.21
2O1N	CRYSTAL STRUCTURE OF A COMPLEX OF PHOSPHOLIPASE A2 WITH A PEPTIDE ALA-ILE-ALA-SER AT 2.8 A RESOLUTION	3.1.1.4
2O2H	CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE RV2579 FROM MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH 1,2-DICHLOROETHANE	3.8.1.5
2O2I	CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE RV2579 FROM MYCOBACTERIUM TUBERCULOSIS COMPLEXED WITH 1,3-PROPANDIOL	3.8.1.5
2O2X	CRYSTAL STRUCTURE OF A PUTATIVE HAD-LIKE PHOSPHATASE (MLL2559) FROM MESORHIZOBIUM LOTI AT 1.50 A RESOLUTION	3.1.3.82
2O36	CRYSTAL STRUCTURE OF ENGINEERED THIMET OLIGOPEPTIDASE WITH NEUROLYSIN SPECIFICITY IN NEUROTENSIN CLEAVAGE SITE	3.4.24.15
2O3B	CRYSTAL STRUCTURE COMPLEX OF NUCLEASE A (NUCA) WITH INTRA-CELLULAR INHIBITOR NUIA	3.1.30
2O3C	CRYSTAL STRUCTURE OF ZEBRAFISH APE	3.1
2O3E	CRYSTAL STRUCTURE OF ENGINEERED NEUROLYSIN WITH THIMET OLIGOPEPTIDASE SPECIFICITY FOR NEUROTENSIN CLEAVAGE SITE.	3.4.24.16
2O3H	CRYSTAL STRUCTURE OF THE HUMAN C65A APE	4.2.99.18 3.1
2O3K	YEAST CYTOSINE DEAMINASE D92E TRIPLE MUTANT BOUND TO TRANSITION STATE ANALOGUE HPY	3.5.4.1
2O3Q	STRUCTURAL BASIS FOR FORMATION AND HYDROLYSIS OF CALCIUM MESSENGER CYCLIC ADP-RIBOSE BY HUMAN CD38	3.2.2.5 3.2.2.6 2.4.99.20
2O3R	STRUCTURAL BASIS FOR FORMATION AND HYDROLYSIS OF CALCIUM MESSENGER CYCLIC ADP-RIBOSE BY HUMAN CD38	3.2.2.5 3.2.2.6 2.4.99.20
2O3S	STRUCTURAL BASIS FOR FORMATION AND HYDROLYSIS OF CALCIUM MESSENGER CYCLIC ADP-RIBOSE BY HUMAN CD38	3.2.2.5 3.2.2.6 2.4.99.20
2O3T	STRUCTURAL BASIS FOR FORMATION AND HYDROLYSIS OF CALCIUM MESSENGER CYCLIC ADP-RIBOSE BY HUMAN CD38	3.2.2.5 3.2.2.6 2.4.99.20
2O3U	STRUCTURAL BASIS FOR FORMATION AND HYDROLYSIS OF CALCIUM MESSENGER CYCLIC ADP-RIBOSE BY HUMAN CD38	3.2.2.5 3.2.2.6 2.4.99.20
2O3Z	X-RAY CRYSTAL STRUCTURE OF LPXC COMPLEXED WITH 3-HEPTYLOXYBENZOATE	3.5.1 3.5.1.108
2O40	CRYSTAL STRUCTURE OF A CHEMICALLY SYNTHESIZED 203 AMINO ACID 'COVALENT DIMER' HIV-1 PROTEASE MOLECULE	3.4.23.16
2O4E	THE SOLUTION STRUCTURE OF A PROTEIN-PROTEIN INTERACTION MODULE FROM A FAMILY 84 GLYCOSIDE HYDROLASE OF CLOSTRIDIUM PERFRINGENS	3.2.1.52 3.2.1.169
2O4G	STRUCTURE OF TREX1 IN COMPLEX WITH A NUCLEOTIDE	3.1.11.2
2O4H	HUMAN BRAIN ASPARTOACYLASE COMPLEX WITH INTERMEDIATE ANALOG (N-PHOSPHONOMETHYL-L-ASPARTATE)	3.5.1.15
2O4I	STRUCTURE OF TREX1 IN COMPLEX WITH DNA	3.1.11.2
2O4K	CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K) IN COMPLEX WITH ATAZANAVIR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2O4L	CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K, I50V) IN COMPLEX WITH TIPRANAVIR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2O4M	STRUCTURE OF PHOSPHOTRIESTERASE MUTANT I106G/F132G/H257Y	3.1.8.1
2O4N	CRYSTAL STRUCTURE OF HIV-1 PROTEASE (TRM MUTANT) IN COMPLEX WITH TIPRANAVIR	2.7.7.49 3.1.26.13 3.4.23.16 2.7.7.7 3.1.13.2 2.7.7 3.1
2O4Q	STRUCTURE OF PHOSPHOTRIESTERASE MUTANT G60A	3.1.8.1
2O4S	CRYSTAL STRUCTURE OF HIV-1 PROTEASE (Q7K) IN COMPLEX WITH LOPINAVIR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2O4W	T4 LYSOZYME CIRCULAR PERMUTANT	3.2.1.17
2O4X	CRYSTAL STRUCTURE OF HUMAN P100 TUDOR DOMAIN	3.1.31.1
2O51	CRYSTAL STRUCTURE OF BOVINE C-LOBE WITH FRUCTOSE AT 3.0 A RESOLUTION	3.4.21
2O53	CRYSTAL STRUCTURE OF APO-ASPARTOACYLASE FROM HUMAN BRAIN	3.5.1.15
2O5D	THIAZOLONE-ACYLSULFONAMIDES AS NOVEL HCV NS5B POLYMERASE ALLOSTERIC INHIBITORS: CONVERGENCE OF STRUCTURE-BASED DRUG DESIGN AND X-RAY CRYSTALLOGRAPHIC STUDY	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2O5F	CRYSTAL STRUCTURE OF DR0079 FROM DEINOCOCCUS RADIODURANS AT 1.9 ANGSTROM RESOLUTION	3.6 3.6.1
2O5W	STRUCTURE OF THE E. COLI DIHYDRONEOPTERIN TRIPHOSPHATE PYROPHOSPHOHYDROLASE IN COMPLEX WITH SM+3 AND PYROPHOSPHATE	3.6.1 3.6.1.67
2O6M	H98Q MUTANT OF THE HOMING ENDONUCLEASE I-PPOI COMPLEXED WITH DNA	3.1
2O6X	CRYSTAL STRUCTURE OF PROCATHEPSIN L1 FROM FASCIOLA HEPATICA	3.4.22.15 3.4.22
2O79	T4 LYSOZYME WITH C-TERMINAL EXTENSION	3.2.1.17
2O7A	T4 LYSOZYME C-TERMINAL FRAGMENT	3.2.1.17
2O7L	THE OPEN-CAP CONFORMATION OF GLPG	3.4.21.105
2O7M	THE C-TERMINAL LOOP OF THE HOMING ENDONUCLEASE I-CREI IS ESSENTIAL FOR DNA BINDING AND CLEAVAGE. IDENTIFICATION OF A NOVEL SITE FOR SPECIFICITY ENGINEERING IN THE I-CREI SCAFFOLD	3.1
2O7R	PLANT CARBOXYLESTERASE AECXE1 FROM ACTINIDIA ERIANTHA WITH ACYL ADDUCT	3.1.1.1
2O7V	CARBOXYLESTERASE AECXE1 FROM ACTINIDIA ERIANTHA COVALENTLY INHIBITED BY PARAOXON	3.1.1.1
2O8A	RAT PP1CGAMMA COMPLEXED WITH MOUSE INHIBITOR-2	3.1.3.16
2O8G	RAT PP1C GAMMA COMPLEXED WITH MOUSE INHIBITOR-2	3.1.3.16
2O8H	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF RAT PHOSPHODIESTERASE 10A	3.1.4.17 3.1.4.35
2O8L	STRUCTURE OF V8 PROTEASE FROM STAPHYLOCOCCUS AUREUS	3.4.21.19
2O8M	CRYSTAL STRUCTURE OF THE S139A MUTANT OF HEPATITIS C VIRUS NS3/4A PROTEASE	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2O8O	CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLG COLLAGENASE COLLAGEN-BINDING DOMAIN 3B AT 1.35 ANGSTROM RESOLUTION IN PRESENCE OF CALCIUM	3.4.24.3
2O8T	CRYSTAL STRUCTURE AND BINDING EPITOPES OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (C122A/N145Q) IN COMPLEX WITH INHIBITORS	3.4.21.73
2O8U	CRYSTAL STRUCTURE AND BINDING EPITOPES OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (C122A/N145Q/S195A) IN COMPLEX WITH INHIBITORS	3.4.21.73
2O8W	CRYSTAL STRUCTURE AND BINDING EPITOPES OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (C122A/N145Q/S195A) IN COMPLEX WITH INHIBITORS	3.4.21.73
2O94	THE 97H/F MUTANT STRUCTURE OF A GLUTAMINE-RICH DOMAIN FROM HISTONE DEACETYLASE 4	3.5.1.98
2O9J	CRYSTAL STRUCTURE OF CALCIUM ATPASE WITH BOUND MAGNESIUM FLUORIDE AND CYCLOPIAZONIC ACID	3.6.3.8 7.2.2.10
2O9P	BETA-GLUCOSIDASE B FROM PAENIBACILLUS POLYMYXA	3.2.1.21
2O9Q	THE CRYSTAL STRUCTURE OF BOVINE TRYPSIN COMPLEXED WITH A SMALL INHIBITION PEPTIDE ORB2K	3.4.21.4
2O9R	BETA-GLUCOSIDASE B COMPLEXED WITH THIOCELLOBIOSE	3.2.1.21
2O9T	BETA-GLUCOSIDASE B FROM BACILLUS POLYMYXA COMPLEXED WITH GLUCOSE	3.2.1.21
2OA0	CRYSTAL STRUCTURE OF CALCIUM ATPASE WITH BOUND ADP AND CYCLOPIAZONIC ACID	3.6.3.8 7.2.2.10
2OA8	CRYSTAL STRUCTURE OF MTREX1 WITH SSDNA	3.1.11.2
2OAG	CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) WITH PYRROLIDINE-CONSTRAINED PHENETHYLAMINE 29G	3.4.14.5
2OAH	CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR	3.4.23.46
2OAZ	HUMAN METHIONINE AMINOPEPTIDASE-2 COMPLEXED WITH SB-587094	3.4.11.18
2OB3	STRUCTURE OF PHOSPHOTRIESTERASE MUTANT H257Y/L303T	3.1.8.1
2OBC	THE CRYSTAL STRUCTURE OF RIBD FROM ESCHERICHIA COLI IN COMPLEX WITH A SUBSTRATE ANALOGUE, RIBOSE 5-PHOSPHATE (BETA FORM), BOUND TO THE ACTIVE SITE OF THE REDUCTASE DOMAIN	3.5.4.26 1.1.1.193
2OBQ	DISCOVERY OF THE HCV NS3/4A PROTEASE INHIBITOR SCH503034. KEY STEPS IN STRUCTURE-BASED OPTIMIZATION	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2OC0	STRUCTURE OF NS3 COMPLEXED WITH A KETOAMIDE INHIBITOR SCH491762	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2OC1	STRUCTURE OF THE HCV NS3/4A PROTEASE INHIBITOR CVS4819	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2OC2	STRUCTURE OF TESTIS ACE WITH RXPA380	3.4.15.1 3.2.1
2OC3	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PROTEIN TYROSINE PHOSPHATASE NON-RECEPTOR TYPE 18	3.1.3.48
2OC7	STRUCTURE OF HEPATITIS C VIRAL NS3 PROTEASE DOMAIN COMPLEXED WITH NS4A PEPTIDE AND KETOAMIDE SCH571696	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2OC8	STRUCTURE OF HEPATITIS C VIRAL NS3 PROTEASE DOMAIN COMPLEXED WITH NS4A PEPTIDE AND KETOAMIDE SCH503034	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2OCA	THE CRYSTAL STRUCTURE OF T4 UVSW	3.6.1.8 3.6.4.12
2OCD	CRYSTAL STRUCTURE OF L-ASPARAGINASE I FROM VIBRIO CHOLERAE O1 BIOVAR ELTOR STR. N16961	3.5.1.1
2OCI	CRYSTAL STRUCTURE OF VALACYCLOVIR HYDROLASE COMPLEXED WITH A PRODUCT ANALOGUE	3.1
2OCK	CRYSTAL STRUCTURE OF VALACYCLOVIR HYDROLASE D123N MUTANT	3.1
2OCL	CRYSTAL STRUCTURE OF VALACYCLOVIR HYDROLASE S122A MUTANT	3.1
2OCU	STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH N-(4-HYDROXYPHENYL) ACETAMIDE AT 2.38 A RESOLUTION	3.4.21
2OCV	STRUCTURAL BASIS OF NA+ ACTIVATION MIMICRY IN MURINE THROMBIN	3.4.21.5
2OD2	CRYSTAL STRUCTURE OF YHST2 I117F MUTANT BOUND TO CARBA-NAD+ AND AN ACETYLATED H4 PEPTIDE	3.5.1 2.3.1.286
2OD3	HUMAN THROMBIN CHIMERA WITH HUMAN RESIDUES 184A, 186, 186A, 186B, 186C AND 222 REPLACED BY MURINE THROMBIN EQUIVALENTS.	3.4.21.5
2OD7	CRYSTAL STRUCTURE OF YHST2 BOUND TO THE INTERMEDIATE ANALOGUE ADP-HPD, AND AND ACEYLATED H4 PEPTIDE	3.5.1 2.3.1.286
2OD9	STRUCTURAL BASIS FOR NICOTINAMIDE INHIBITION AND BASE EXCHANGE IN SIR2 ENZYMES	3.5.1 2.3.1.286
2ODB	THE CRYSTAL STRUCTURE OF HUMAN CDC42 IN COMPLEX WITH THE CRIB DOMAIN OF HUMAN P21-ACTIVATED KINASE 6 (PAK6)	3.6.5.2
2ODJ	CRYSTAL STRUCTURE OF THE OUTER MEMBRANE PROTEIN OPRD FROM PSEUDOMONAS AERUGINOSA	3.4.21
2ODN	MSRECA-DATP COMPLEX	3.4.99.37
2ODP	COMPLEMENT COMPONENT C2A, THE CATALYTIC FRAGMENT OF C3- AND C5-CONVERTASE OF HUMAN COMPLEMENT	3.4.21.43
2ODQ	COMPLEMENT COMPONENT C2A, THE CATALYTIC FRAGMENT OF C3- AND C5-CONVERTASE OF HUMAN COMPLEMENT	3.4.21.43
2ODW	MSRECA-ATP-GAMA-S COMPLEX	3.4.99.37
2ODY	THROMBIN-BOUND BOOPHILIN DISPLAYS A FUNCTIONAL AND ACCESSIBLE REACTIVE-SITE LOOP	3.4.21.5
2OE2	MSRECA-NATIVE-LOW HUMIDITY 95%	3.4.99.37
2OE4	HIGH PRESSURE PSUEDO WILD TYPE T4 LYSOZYME	3.2.1.17
2OE7	HIGH-PRESSURE T4 LYSOZYME	3.2.1.17
2OE9	HIGH-PRESSURE STRUCTURE OF PSEUDO-WT T4 LYSOZYME	3.2.1.17
2OEA	HIGH-PRESSURE STRUCTURE OF PSEUDO-WT T4 LYSOZYME	3.2.1.17
2OEO	CRYOGENIC CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT TRUNCATED DELTA+PHS I92D	3.1.31.1
2OEP	MSRECA-ADP-COMPLEX	3.4.99.37
2OES	MSRECA-NATIVE-SSB	3.4.99.37
2OF0	X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 5	3.4.23.46
2OF1	CRYOGENIC CRYSTAL STRUCTURE OF THE STAPHYLOCOCCAL NUCLEASE VARIANT TRUNCATED DELTA+PHS I92W	3.1.31.1
2OFG	SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF THE ZINC(II) ATPASE ZIAA IN ITS APO FORM	3.6.3.5 7.2.2.12
2OFH	SOLUTION STRUCTURE OF THE N-TERMINAL DOMAIN OF THE ZINC(II) ATPASE ZIAA IN ITS APO FORM	3.6.3.5 7.2.2.12
2OFI	CRYSTAL STRUCTURE OF 3-METHYLADENINE DNA GLYCOSYLASE I (TAG) BOUND TO DNA/3MA	3.2.2.20
2OFK	CRYSTAL STRUCTURE OF 3-METHYLADENINE DNA GLYCOSYLASE I (TAG)	3.2.2.20
2OFO	MSRECA-NATIVE	3.4.99.37
2OG1	CRYSTAL STRUCTURE OF BPHD, A C-C HYDROLASE FROM BURKHOLDERIA XENOVORANS LB400	3.7.1.8
2OGJ	CRYSTAL STRUCTURE OF A DIHYDROOROTASE	3.1.1
2OGS	CRYSTAL STRUCTURE OF THE GEOBACILLUS STEAROTHERMOPHILUS CARBOXYLESTERASE EST55 AT PH 6.2	3.1.1.1 3.1.1
2OGT	CRYSTAL STRUCTURE OF THE GEOBACILLUS STEAROTHERMOPHILUS CARBOXYLESTERASE EST55 AT PH 6.8	3.1.1.1 3.1.1
2OGZ	CRYSTAL STRUCTURE OF DPP-IV COMPLEXED WITH LILLY ARYL KETONE INHIBITOR	3.4.14.5
2OHE	STRUCTURAL AND MUTATIONAL ANALYSIS OF TRNA-INTRON SPLICING ENDONUCLEASE FROM THERMOPLASMA ACIDOPHILUM DSM 1728	3.1.27.9 4.6.1.16
2OHK	X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH 1-AMINO-ISOQUINOLINE	3.4.23.46
2OHL	X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH 2-AMINOQUINOLINE	3.4.23.46
2OHM	X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH N~3~-BENZYLPYRIDINE-2,3-DIAMINE	3.4.23.46
2OHN	X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH 4-(4-FLUOROBENZYL)PIPERIDINE	3.4.23.46
2OHP	X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 3	3.4.23.46
2OHQ	X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 4	3.4.23.46
2OHR	X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 6A	3.4.23.46
2OHS	X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 6B	3.4.23.46
2OHT	X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 7	3.4.23.46
2OHU	X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 8B	3.4.23.46
2OI0	CRYSTAL STRUCTURE ANALYSIS 0F THE TNF-A COVERTING ENZYME (TACE) IN COMPLEXED WITH ARYL-SULFONAMIDE	3.4.24.86
2OIE	CRYSTAL STRUCTURE OF RS21-C6 CORE SEGMENT RSCUT	3.6.1.12
2OIG	CRYSTAL STRUCTURE OF RS21-C6 CORE SEGMENT AND DM5CTP COMPLEX	3.6.1.12
2OIN	CRYSTAL STRUCTURE OF HCV NS3-4A R155K MUNTANT	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2OIW	THE STRUCTURE OF A PREDICTED THIOESTERASE FROM BACILLUS STEAROTHERMOPHILUS	3.1.2
2OK5	HUMAN COMPLEMENT FACTOR B	3.4.21.47
2OK9	PRTX-I-BPB	3.1.1.4
2OKB	HIGH RESOLUTION CRYSTAL STRUCTURES OF VACCINIA VIRUS DUTPASE	3.6.1.23
2OKD	HIGH RESOLUTION CRYSTAL STRUCTURES OF VACCINIA VIRUS DUTPASE	3.6.1.23
2OKE	HIGH RESOLUTION CRYSTAL STRUCTURES OF VACCINIA VIRUS DUTPASE	3.6.1.23
2OKN	CRYSTAL STRCTURE OF HUMAN PROLIDASE	3.4.13.9
2OKV	C-MYC DNA UNWINDING ELEMENT BINDING PROTEIN	3.1 3.1.1.96
2OKX	CRYSTAL STRUCTURE OF GH78 FAMILY RHAMNOSIDASE OF BACILLUS SP. GL1 AT 1.9 A	3.2.1.40
2OL0	HIGH RESOLUTION CRYSTAL STRUCTURES OF VACCINIA VIRUS DUTPASE	3.6.1.23
2OL1	HIGH RESOLUTION CRYSTAL STRUCTURES OF VACCINIA VIRUS DUTPASE	3.6.1.23
2OLE	CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (DPPIV) COMPLEX WITH CYCLIC HYDRAZINE DERIVATIVES	3.4.14.5
2OLG	CRYSTAL STRUCTURE OF THE SERINE PROTEASE DOMAIN OF PROPHENOLOXIDASE ACTIVATING FACTOR-I IN A ZYMOGEN FORM	3.4.21
2OLI	CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN A GROUP II PHOSPHOLIPASE A2 AND AN INDOLE DERIVATIVE AT 2.2 A RESOLUTION	3.1.1.4
2OLJ	ABC PROTEIN ARTP IN COMPLEX WITH ADP/MG2+	3.6.3.21
2OLK	ABC PROTEIN ARTP IN COMPLEX WITH ADP-BETA-S	3.6.3.21
2OLU	STRUCTURAL INSIGHT INTO THE TRANSGLYCOSYLATION STEP OF BACTERIAL CELL WALL BIOSYNTHESIS : APOENZYME	2.3.2 2.4.1.129 3.4.16.4
2OLV	STRUCTURAL INSIGHT INTO THE TRANSGLYCOSYLATION STEP OF BACTERIAL CELL WALL BIOSYNTHESIS : DONOR LIGAND COMPLEX	2.3.2 2.4.1.129 3.4.16.4
2OM6	HYPOTHETICAL PROTEIN (PROBABLE PHOSPHOSERINE PHOSPH (PH0253) FROM PYROCOCCUS HORIKOSHII OT3	3.1.3.3
2ONJ	STRUCTURE OF THE MULTIDRUG ABC TRANSPORTER SAV1866 FROM S. AUREUS IN COMPLEX WITH AMP-PNP	3.6.3 7.6.2
2OOD	CRYSTAL STRUCTURE OF GUANINE DEAMINASE FROM BRADYRHIZOBIUM JAPONICUM	3.5.4.3
2OOF	THE CRYSTAL STRUCTURE OF 4-IMIDAZOLONE-5-PROPANOATE AMIDOHYDROLASE FROM ENVIRONMENTAL SAMPLE	3.5.2.7
2OOG	CRYSTAL STRUCTURE OF GLYCEROPHOSPHORYL DIESTER PHOSPHODIESTERASE FROM STAPHYLOCOCCUS AUREUS	3.1.4.46
2OOQ	CRYSTAL STRUCTURE OF THE HUMAN RECEPTOR PHOSPHATASE PTPRT	3.1.3.48
2OOT	A HIGH RESOLUTION STRUCTURE OF LIGAND-FREE HUMAN GLUTAMATE CARBOXYPEPTIDASE II	3.4.17.21
2OP2	CRYSTAL STRUCTURE OF RNASE DOUBLE-MUTANT V43C R85C WITH EXTRA DISULPHIDE BOND	3.1.27.5 4.6.1.18
2OP3	THE STRUCTURE OF CATHEPSIN S WITH A NOVEL 2-ARYLPHENOXYACETALDEHYDE INHIBITOR DERIVED BY THE SUBSTRATE ACTIVITY SCREENING (SAS) METHOD	3.4.22.27
2OP6	PEPTIDE-BINDING DOMAIN OF HEAT SHOCK 70 KDA PROTEIN D PRECURSOR FROM C.ELEGANS	3.6.4.10
2OP9	SUBSTRATE SPECIFICITY PROFILING AND IDENTIFICATION OF A NEW CLASS OF INHIBITOR FOR THE MAJOR PROTEASE OF THE SARS CORONAVIRUS	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2OPF	CRYSTAL STRUCTURE OF THE DNA REPAIR ENZYME ENDONUCLEASE-VIII (NEI) FROM E. COLI (R252A) IN COMPLEX WITH AP-SITE CONTAINING DNA SUBSTRATE	3.2.2 4.2.99.18
2OPH	HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH AN ALPHA AMINO ACID INHIBITOR	3.4.14.5
2OPP	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2OPQ	CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2OPR	CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2OPS	CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2OQ5	CRYSTAL STRUCTURE OF DESC1, A NEW MEMBER OF THE TYPE II TRANSMEMBRANE SERINE PROTEINASES FAMILY	3.4.21
2OQA	X-RAY SEQUENCE AND CRYSTAL STRUCTURE OF LUFFACULIN 1, A NOVEL TYPE 1 RIBOSOME-INACTIVATING PROTEIN	3.2.2.22
2OQC	CRYSTAL STRUCTURE OF PENICILLIN V ACYLASE FROM BACILLUS SUBTILIS	3.5.1.11
2OQD	CRYSTAL STRUCTURE OF BTHTX-II	3.1.1.4
2OQF	STRUCTURE OF A SYNTHETIC, NON-NATURAL ANALOGUE OF RNASE A: [N71K(ADE), D83A]RNASE A	3.1.27.5
2OQL	STRUCTURE OF PHOSPHOTRIESTERASE MUTANT H254Q/H257F	3.1.8.1
2OQO	CRYSTAL STRUCTURE OF A PEPTIDOGLYCAN GLYCOSYLTRANSFERASE FROM A CLASS A PBP: INSIGHT INTO BACTERIAL CELL WALL SYNTHESIS	2.4.2 2.4.1.129 3.4.16.4
2OQU	HIGH PRESSURE CRYOCOOLING OF CAPILLARY SAMPLE CRYOPROTECTION AND DIFFRACTION PHASING AT LONG WAVELENGTHS	3.4.21.36
2OQV	HUMAN DIPEPTIDYL PEPTIDASE IV (DPP4) WITH PIPERIDINE-CONSTRAINED PHENETHYLAMINE	3.4.14.5
2OQW	THE CRYSTAL STRUCTURE OF SORTASE B FROM B.ANTHRACIS IN COMPLEX WITH AAEK1	3.4.22.71
2OQZ	THE CRYSTAL STRUCTURE OF SORTASE B FROM B.ANTHRACIS IN COMPLEX WITH AAEK2	3.4.22.51 3.4.22.71
2OR3	PRE-OXIDATION COMPLEX OF HUMAN DJ-1	3.1.2 3.5.1 3.5.1.124
2OR4	A HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II IN COMPLEX WITH QUISQUALIC ACID	3.4.17.21
2ORY	CRYSTAL STRUCTURE OF M37 LIPASE	3.1.1.3
2OS0	STRUCTURES OF ACTINONIN BOUND PEPTIDE DEFORMYLASES FROM E. FAECALIS AND S. PYOGENES	3.5.1.88
2OS1	STRUCTURES OF ACTINONIN BOUND PEPTIDE DEFORMYLASES FROM E. FAECALIS AND S. PYOGENES	3.5.1.88
2OSH	CRYSTAL STRUCTURE OF NATRATOXIN, A SNAKE SPLA2 THAT BLOCKS A-TYPE K+ CHANNEL	3.1.1.4
2OSN	AN ALTERNATE DESCRIPTION OF A CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 FROM BUNGARUS CAERULEUS	3.1.1.4
2OSU	PROBABLE GLUTAMINASE FROM BACILLUS SUBTILIS COMPLEXED WITH 6-DIAZO-5-OXO-L-NORLEUCINE	3.5.1.2
2OSW	ENDO-GLYCOCERAMIDASE II FROM RHODOCOCCUS SP.	3.2.1.123
2OSX	ENDO-GLYCOCERAMIDASE II FROM RHODOCOCCUS SP.: GANGLIOSIDE GM3 COMPLEX	3.2.1.123
2OSY	ENDO-GLYCOCERAMIDASE II FROM RHODOCOCCUS SP.: LACTOSYL-ENZYME INTERMEDIATE	3.2.1.123
2OTD	THE CRYSTAL STRUCTURE OF THE GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE FROM SHIGELLA FLEXNERI 2A	3.1.4.1
2OTF	CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND ATENOLOL AT 1.95 A RESOLUTION	3.1.1.4
2OTH	CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF PHOSPHOLIPASE A2 WITH INDOMETHACIN AND NIMESULIDE AT 2.9 A RESOLUTION	3.1.1.4
2OTV	CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN BOVINE TRYPSIN AND NICOTINAMIDE AT 1.56 A RESOLUTION	3.4.21.4
2OTY	1,2-DICHLOROBENZENE IN COMPLEX WITH T4 LYSOZYME L99A	3.2.1.17
2OTZ	N-METHYLANILINE IN COMPLEX WITH T4 LYSOZYME L99A	3.2.1.17
2OU0	1-METHYLPYRROLE IN COMPLEX WITH T4 LYSOZYME L99A	3.2.1.17
2OU8	STRUCTURE OF SPIN-LABELED T4 LYSOZYME MUTANT T115R1 AT ROOM TEMPERATURE	3.2.1.17
2OU9	STRUCTURE OF SPIN-LABELED T4 LYSOZYME MUTANT T115R1/R119A	3.2.1.17
2OUB	CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND ATENOLOL AT 2.75 A RESOLUTION	3.1.1.4
2OUC	CRYSTAL STRUCTURE OF THE MAP KINASE BINDING DOMAIN OF MKP5	3.1.3.48 3.1.3.16
2OUD	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MKP5	3.1.3.48 3.1.3.16
2OUK	ABC PROTEIN ARTP IN COMPLEX WITH SULPHATE	3.6.3.21
2OUN	CRYSTAL STRUCTURE OF PDE10A2 IN COMPLEX WITH AMP	3.1.4.17 3.1.4.35
2OUP	CRYSTAL STRUCTURE OF PDE10A	3.1.4.17 3.1.4.35
2OUQ	CRYSTAL STRUCTURE OF PDE10A2 IN COMPLEX WITH GMP	3.1.4.17 3.1.4.35
2OUR	CRYSTAL STRUCTURE OF PDE10A2 MUTANT D674A IN COMPLEX WITH CAMP	3.1.4.17 3.1.4.35
2OUS	CRYSTAL STRUCTURE OF PDE10A2 MUTANT D674A	3.1.4.17 3.1.4.35
2OUU	CRYSTAL STRUCTURE OF PDE10A2 MUTANT D674A IN COMPLEX WITH CGMP	3.1.4.17 3.1.4.35
2OUV	CRYSTAL STRUCTURE OF PDE10A2 MUTANT OF D564N	3.1.4.17 3.1.4.35
2OUY	CRYSTAL STRUCTURE OF PDE10A2 MUTANT D564A IN COMPLEX WITH CAMP.	3.1.4.17 3.1.4.35
2OV2	THE CRYSTAL STRUCTURE OF THE HUMAN RAC3 IN COMPLEX WITH THE CRIB DOMAIN OF HUMAN P21-ACTIVATED KINASE 4 (PAK4)	3.6.5.2
2OV5	CRYSTAL STRUCTURE OF THE KPC-2 CARBAPENEMASE	3.5.2.6
2OV6	THE NMR STRUCTURE OF SUBUNIT F OF THE METHANOGENIC A1AO ATP SYNTHASE AND ITS INTERACTION WITH THE NUCLEOTIDE-BINDING SUBUNIT B	3.6.3.14
2OVV	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF RAT PHOSPHODIESTERASE 10A	3.1.4.17 3.1.4.35
2OVW	ENDOGLUCANASE I COMPLEXED WITH CELLOBIOSE	3.2.1.4
2OVX	MMP-9 ACTIVE SITE MUTANT WITH BARBITURATE INHIBITOR	3.4.24.35
2OVY	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF RAT PHOSPHODIESTERASE 10A	3.1.4.17 3.1.4.35
2OVZ	MMP-9 ACTIVE SITE MUTANT WITH PHOSPHINATE INHIBITOR	3.4.24.35
2OW0	MMP-9 ACTIVE SITE MUTANT WITH IODINE-LABELED CARBOXYLATE INHIBITOR	3.4.24.35
2OW1	MMP-9 ACTIVE SITE MUTANT WITH TRIFLUOROMETHYL HYDROXAMATE INHIBITOR	3.4.24.35
2OW2	MMP-9 ACTIVE SITE MUTANT WITH DIFLUORO BUTANOIC ACID INHIBITOR	3.4.24.35
2OW6	GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH (1R,5S,6S,7R,8S)-1-THIONIABICYCLO[4.3.0]NONAN-5,7,8-TRIOL CHLORIDE	3.2.1.114
2OW7	GOLGI ALPHA-MANNOSIDASE II COMPLEX WITH (1R,6S,7R,8S)-1-THIONIABICYCLO[4.3.0]NONAN-7,8-DIOL CHLORIDE	3.2.1.114
2OW9	CRYSTAL STRUCTURE ANALYSIS OF THE MMP13 CATALYTIC DOMAIN IN COMPLEX WITH SPECIFIC INHIBITOR	3.4.24
2OWD	CRYSTAL STRUCTURE OF TTHB049 FROM THERMUS THERMOPHILUS HB8	3.1.3
2OWE	CRYSTAL STRUCTURE OF TTHB049 FROM THERMUS THERMOPHILUS HB8	3.1.3.73
2OWM	MOTOR DOMAIN OF NEUROSPORA CRASSA KINESIN-3 (NCKIN3)	3.6.4.4
2OWN	CRYSTAL STRUCTURE OF OLEOYL THIOESTERASE (PUTATIVE) (NP_784467.1) FROM LACTOBACILLUS PLANTARUM AT 2.00 A RESOLUTION	3.1.2.14
2OWQ	CRYSTAL STRUCTURE OF VACCINIA VIRUS URACIL-DNA GLYCOSYLASE	3.2.2 3.2.2.27
2OWZ	R-STATE, CITRATE AND FRU-6-P-BOUND ESCHERICHIA COLI FRUCTOSE-1,6-BISPHOSPHATASE	3.1.3.11
2OX3	R-STATE, PEP AND FRU-6-P-BOUND, ESCHERICHIA COLI FRUCTOSE-1,6-BISPHOSPHATASE	3.1.3.11
2OXC	HUMAN DEAD-BOX RNA HELICASE DDX20, DEAD DOMAIN IN COMPLEX WITH ADP	3.6.1 3.6.4.13
2OXE	STRUCTURE OF THE HUMAN PANCREATIC LIPASE-RELATED PROTEIN 2	3.1.1.3 3.1.1.26
2OXM	CRYSTAL STRUCTURE OF A UNG2/MODIFIED DNA COMPLEX THAT REPRESENT A STABILIZED SHORT-LIVED EXTRAHELICAL STATE IN EZYMATIC DNA BASE FLIPPING	3.2.2.27
2OXN	VIBRIO CHOLERAE FAMILY 3 GLYCOSIDE HYDROLASE (NAGZ) IN COMPLEX WITH PUGNAC	3.2.1.52
2OXO	CRYSTALLIZATION AND STRUCTURE DETERMINATION OF THE CORE-BINDING DOMAIN OF BACTERIOPHAGE LAMBDA INTEGRASE	2.7.7 3.1
2OXP	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE MUTANT V66D/P117G/H124L/S128A	3.1.31.1
2OXR	PAB0955 CRYSTAL STRUCTURE : A GTPASE IN GDP AND MG BOUND FORM FROM PYROCOCCUS ABYSSI (AFTER GTP HYDROLYSIS)	3.6.5
2OXS	CRYSTAL STRUCTURE OF THE TRYPSIN COMPLEX WITH BENZAMIDINE AT HIGH TEMPERATURE (35 C)	3.4.21.4
2OXT	CRYSTAL STRUCTURE OF MEABAN VIRUS NUCLEOSIDE-2'-O-METHYLTRANSFERASE	3.4.21.91 3.6.1.15 3.6.4.13
2OXU	UNINHIBITED FORM OF HUMAN MMP-12	3.4.24.65
2OXV	STRUCTURE OF THE A138T PROMISCUOUS MUTANT OF THE ECORI RESTRICTION ENDONUCLEASE BOUND TO ITS COGNATE RECOGNITION SITE.	3.1.21.4
2OXW	HUMAN MMP-12 COMPLEXED WITH THE PEPTIDE IAG	3.4.24.65
2OXZ	HUMAN MMP-12 IN COMPLEX WITH TWO PEPTIDES PQG AND IAG	3.4.24.65
2OY0	CRYSTAL STRUCTURE OF THE WEST NILE VIRUS METHYLTRANSFERASE	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2OY2	HUMAN MMP-8 IN COMPLEX WITH PEPTIDE IAG	3.4.24.34
2OY4	UNINHIBITED HUMAN MMP-8	3.4.24.34
2OYC	CRYSTAL STRUCTURE OF HUMAN PYRIDOXAL PHOSPHATE PHOSPHATASE	3.1.3.74 3.1.3.3
2OYF	CRYSTAL STRUCTURE OF THE COMPLEX OF PHOSPHOLIPASE A2 WITH INDOLE ACETIC ACID AT 1.2 A RESOLUTION	3.1.1.4
2OYK	ENDO-GLYCOCERAMIDASE II FROM RHODOCOCCUS SP.: CELLOBIOSE-LIKE ISOFAGOMINE COMPLEX	3.2.1.123
2OYL	ENDO-GLYCOCERAMIDASE II FROM RHODOCOCCUS SP.: CELLOBIOSE-LIKE IMIDAZOLE COMPLEX	3.2.1.123
2OYM	ENDO-GLYCOCERAMIDASE II FROM RHODOCOCCUS SP.: FIVE-MEMBERED IMINOCYCLITOL COMPLEX	3.2.1.123
2OYT	CRYSTAL STRUCTURE OF UNG2/DNA(TM)	3.2.2 3.2.2.27
2OZ2	CRYSTAL STRUCTURE ANALYSIS OF CRUZAIN BOUND TO VINYL SULFONE DERIVED INHIBITOR (K11777)	3.4.22.51
2OZK	STRUCTURE OF AN N-TERMINAL TRUNCATED FORM OF NENDOU (NSP15) FROM SARS-CORONAVIRUS	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2OZM	CRYSTAL STRUCTURE OF RB69 GP43 IN COMPLEX WITH DNA WITH 5-NITP OPPOSITE AN ABASIC SITE ANALOG	2.7.7.7 3.1.11
2OZN	THE COHESIN-DOCKERIN COMPLEX OF NAGJ AND NAGH FROM CLOSTRIDIUM PERFRINGENS	3.2.1.169
2OZR	MMP13 CATALYTIC DOMAIN COMPLEXED WITH 4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID	3.4.24
2OZS	CRYSTAL STRUCTURE OF RB69 GP43 IN COMPLEX WITH DNA WITH DATP OPPOSITE DTMP	2.7.7.7 3.1.11
2OZW	SOLUTION STRUCTURE OF HUMAN PHOSPHOHISTIDINE PHOSPHATASE 1 WITH PHOSPHATE LIGAND	3.1.3 3.9.1.3
2OZX	SOLUTION STRUCTURE OF HUMAN PHOSPHOHISTIDINE PHOSPHATASE 1 IN PHOSPHATE FREE FORM	3.1.3 3.9.1.3
2P0R	STRUCTURE OF HUMAN CALPAIN 9 IN COMPLEX WITH LEUPEPTIN	3.4.22.52 3.4.22
2P14	CRYSTAL STRUCTURE OF SMALL SUBUNIT (R.BSPD6I2) OF THE HETERODIMERIC RESTRICTION ENDONUCLEASE R.BSPD6I	3.1.21.4
2P16	FACTOR XA IN COMPLEX WITH THE INHIBITOR APIXABAN (BMS-562247) AKA 1-(4-METHOXYPHENYL)-7-OXO-6-(4-(2-OXO-1-PIPERIDINYL)PHENYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3, 4-C]PYRIDINE-3-CARBOXAMIDE	3.4.21.6
2P18	CRYSTAL STRUCTURE OF THE LEISHMANIA INFANTUM GLYOXALASE II	3.1.2.6
2P1D	CRYSTAL STRUCTURE OF DENGUE METHYLTRANSFERASE IN COMPLEX WITH GTP AND S-ADENOSYL-L-HOMOCYSTEINE	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57
2P1E	CRYSTAL STRUCTURE OF THE LEISHMANIA INFANTUM GLYOXALASE II WITH D-LACTATE AT THE ACTIVE SITE	3.1.2.6
2P1S	CRYSTAL STRUCTURE OF THE C-TERMINAL LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH O-ALPHA-D-GLUCOPYRANOSYL-(1 3)-ALPHA-D-FRUCTOFURANOSYL- (2 1)- ALPHA-D-GLUCOPYRANOSIDE AT 1.93 A RESOLUTION	3.4.21
2P27	CRYSTAL STRUCTURE OF HUMAN PYRIDOXAL PHOSPHATE PHOSPHATASE WITH MG2+ AT 1.9 A RESOLUTION	3.1.3.74 3.1.3.3
2P2D	CRYSTAL STRUCTURE AND ALLOSTERIC REGULATION OF THE CYTOPLASMIC ESCHERICHIA COLI L-ASPARAGINASE I	3.5.1.1
2P2L	RAC1-GDP-ZINC COMPLEX	3.6.5.2
2P2N	CRYSTAL STRUCTURE AND ALLOSTERIC REGULATION OF THE CYTOPLASMIC ESCHERICHIA COLI L-ASPARAGINASE I	3.5.1.1
2P2Y	CRYSTAL STRUCTURE OF TTHB049 FROM THERMUS THERMOPHILUS HB8	3.1.3.73
2P2Z	CRYSTAL STRUCTURE OF TTHB049 FROM THERMUS THERMOPHILUS HB8	3.1.3.73
2P30	CRYSTAL STRUCTURE OF TTHB049 FROM THERMUS THERMOPHILUS HB8	3.1.3.73
2P3A	CRYSTAL STRUCTURE OF THE MULTI-DRUG RESISTANT MUTANT SUBTYPE B HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR	3.4.23.16
2P3B	CRYSTAL STRUCTURE OF THE SUBTYPE B WILD TYPE HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR	3.4.23.16
2P3C	CRYSTAL STRUCTURE OF THE SUBTYPE F WILD TYPE HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR	3.4.23.16
2P3D	CRYSTAL STRUCTURE OF THE MULTI-DRUG RESISTANT MUTANT SUBTYPE F HIV PROTEASE COMPLEXED WITH TL-3 INHIBITOR	3.4.23.16
2P3F	CRYSTAL STRUCTURE OF THE FACTOR XA/NAP5 COMPLEX	3.4.21.6
2P3L	CRYSTAL STRUCTURE OF DENGUE METHYLTRANSFERASE IN COMPLEX WITH GPPPA AND S-ADENOSYL-L-HOMOCYSTEINE	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13
2P3N	THERMOTOGA MARITIMA IMPASE TM1415	3.1.3.25 3.1.3.11
2P3O	CRYSTAL STRUCTURE OF DENGUE METHYLTRANSFERASE IN COMPLEX WITH 7MEGPPPA AND S-ADENOSYL-L-HOMOCYSTEINE	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13
2P3Q	CRYSTAL STRUCTURE OF DENGUE METHYLTRANSFERASE IN COMPLEX WITH GPPPG AND S-ADENOSYL-L-HOMOCYSTEINE	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13
2P3T	CRYSTAL STRUCTURE OF HUMAN FACTOR XA COMPLEXED WITH 3-CHLORO-4-(2-METHYLAMINO-IMIDAZOL-1-YLMETHYL)-THIOPHENE-2-CARBOXYLIC ACID [4-CHLORO-2-(5-CHLORO-PYRIDIN-2-YLCARBAMOYL)-6-METHOXY-PHENYL]-AMIDE	3.4.21.6
2P3U	CRYSTAL STRUCTURE OF HUMAN FACTOR XA COMPLEXED WITH 3-CHLORO-N-(4-CHLORO-2-{[(5-CHLOROPYRIDIN-2-YL)AMINO]CARBONYL}-6-METHOXYPHENYL)-4-[(1-METHYL-1H-IMIDAZOL-2-YL)METHYL]THIOPHENE-2-CARBOXAMIDE {PFIZER 320663}	3.4.21.6
2P3V	THERMOTOGA MARITIMA IMPASE TM1415	3.1.3.25 3.1.3.11
2P3W	CRYSTAL STRUCTURE OF THE HTRA3 PDZ DOMAIN BOUND TO A PHAGE-DERIVED LIGAND (FGRWV)	3.4.21
2P40	CRYSTAL STRUCTURE OF DENGUE METHYLTRANSFERASE IN COMPLEX WITH 7MEGPPPG	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13
2P41	CRYSTAL STRUCTURE OF DENGUE METHYLTRANSFERASE IN COMPLEX WITH 7MEGPPPG2'OME AND S-ADENOSYL-L-HOMOCYSTEINE	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13
2P42	COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 1.8A RESOLUTION: SE3-MONO-2 CRYSTAL FORM WITH THREE SE-MET SITES (M34, M51, M83) IN VHH SCAFFOLD	3.1.27.5 4.6.1.18
2P43	COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 1.65A RESOLUTION: SE3-MONO-1 CRYSTAL FORM WITH THREE SE-MET SITES (M34, M51, M83) IN VHH SCAFFOLD	3.1.27.5 4.6.1.18
2P44	COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 1.8A RESOLUTION: SE5A-MONO-1 CRYSTAL FORM WITH FIVE SE-MET SITES (M34, M51, F68M, M83, L86M) IN VHH SCAFFOLD	3.1.27.5 4.6.1.18
2P45	COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 1.1A RESOLUTION: SE5B-ORTHO-1 CRYSTAL FORM WITH FIVE SE-MET SITES (L4M, M34, M51, F68M, M83) IN VHH SCAFFOLD.	3.1.27.5 4.6.1.18
2P46	COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 2.5A RESOLUTION: SE5B-ORTHO-2 CRYSTAL FORM WITH FIVE SE-MET SITES (L4M, M34, M51, F68M, M83) IN VHH SCAFFOLD.	3.1.27.5 4.6.1.18
2P47	COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 2.5A RESOLUTION: SE5B-TRI CRYSTAL FORM WITH FIVE SE-MET SITES (L4M, M34, M51, F68M, M83) IN VHH SCAFFOLD.	3.1.27.5 4.6.1.18
2P48	COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 2.3A RESOLUTION: SE5B-TETRA CRYSTAL FORM WITH FIVE SE-MET SITES (L4M, M34, M51, F68M, M83) IN VHH SCAFFOLD.	3.1.27.5 4.6.1.18
2P49	COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 1.4A RESOLUTION: NATIVE MONO_1 CRYSTAL FORM	3.1.27.5 4.6.1.18
2P4A	X-RAY STRUCTURE OF A CAMELID AFFINITY MATURED SINGLE-DOMAIN VHH ANTIBODY FRAGMENT IN COMPLEX WITH RNASE A	3.1.27.5 4.6.1.18
2P4D	STRUCTURE-ASSISTED DISCOVERY OF VARIOLA MAJOR H1 PHOSPHATASE INHIBITORS	3.1.3.48 3.1.3.16 3.1.3
2P4E	CRYSTAL STRUCTURE OF PCSK9	3.4.21
2P4J	CRYSTAL STRUCTURE OF BETA-SECRETASE BOND TO AN INHIBITOR WITH ISOPHTHALAMIDE DERIVATIVES AT P2-P3	3.4.23.46
2P4U	CRYSTAL STRUCTURE OF ACID PHOSPHATASE 1 (ACP1) FROM MUS MUSCULUS	3.1.3.2 3.1.3.48
2P50	CRYSTAL STRUCTURE OF N-ACETYL-D-GLUCOSAMINE-6-PHOSPHATE DEACETYLASE LIGANDED WITH ZN	3.5.1.25
2P51	CRYSTAL STRUCTURE OF THE S. POMBE POP2P DEADENYLATION SUBUNIT	3.1.13.4
2P53	CRYSTAL STRUCTURE OF N-ACETYL-D-GLUCOSAMINE-6-PHOSPHATE DEACETYLASE D273N MUTANT COMPLEXED WITH N-ACETYL PHOSPHONAMIDATE-D-GLUCOSAMINE-6-PHOSPHATE	3.5.1.25
2P5P	CRYSTAL STRUCTURE ANALYSIS OF THE WEST NILE VIRUS ENVELOPE (E) PROTEIN DOMAIN III	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2P5X	CRYSTAL STRUCTURE OF MAF DOMAIN OF HUMAN N-ACETYLSEROTONIN O-METHYLTRANSFERASE-LIKE PROTEIN	3.6.1.9 2.1.1
2P67	CRYSTAL STRUCTURE OF LAO/AO TRANSPORT SYSTEM KINASE	2.7 3.6.5
2P69	CRYSTAL STRUCTURE OF HUMAN PYRIDOXAL PHOSPHATE PHOSPHATASE WITH PLP	3.1.3.74 3.1.3.3
2P6B	CRYSTAL STRUCTURE OF HUMAN CALCINEURIN IN COMPLEX WITH PVIVIT PEPTIDE	3.1.3.16
2P6M	CRYSTAL STRUCTURE OF TTHB049 FROM THERMUS THERMOPHILUS HB8	3.1.3.73
2P6N	HUMAN DEAD-BOX RNA HELICASE DDX41, HELICASE DOMAIN	3.6.1 3.6.4.13
2P6O	CRYSTAL STRUCTURE OF TTHB049 FROM THERMUS THERMOPHILUS HB8	3.1.3.73
2P6X	CRYSTAL STRUCTURE OF HUMAN TYROSINE PHOSPHATASE PTPN22	3.1.3.48
2P6Z	ENZYMATIC AND STRUCTURAL CHARACTERISATION OF AMPHINASE, A NOVEL CYTOTOXIC RIBONUCLEASE FROM RANA PIPIENS OOCYTES	3.1.27
2P74	CTX-M-9 CLASS A BETA-LACTAMASE APO CRYSTAL STRUCTURE AT 0.88 ANGSTROM RESOLUTION	3.5.2.6
2P75	CRYSTAL STRUCTURE OF TTHB049 FROM THERMUS THERMOPHILUS HB8	3.1.3.73
2P77	CRYSTAL STRUCTURE OF TTHB049 FROM THERMUS THERMOPHILUS HB8	3.1.3.73
2P78	CRYSTAL STRUCTURE OF TTHB049 FROM THERMUS THERMOPHILUS HB8	3.1.3.73
2P79	CRYSTAL STRUCTURE OF TTHB049 FROM THERMUS THERMOPHILUS HB8	3.1.3.73
2P7S	ENZYMATIC AND STRUCTURAL CHARACTERISATION OF AMPHINASE, A NOVEL CYTOTOXIC RIBONUCLEASE FROM RANA PIPIENS OOCYTES	3.1.27
2P82	CYSTEINE PROTEASE ATG4A	3.4.22
2P83	POTENT AND SELECTIVE ISOPHTHALAMIDE S2 HYDROXYETHYLAMINE INHIBITOR OF BACE1	3.4.23.46
2P86	THE HIGH RESOLUTION CRYSTAL STRUCTURE OF RHODESAIN, THE MAJOR CATHEPSIN L PROTEASE FROM T. BRUCEI RHODESIENSE, BOUND TO INHIBITOR K11002	3.4.22.15
2P8E	CRYSTAL STRUCTURE OF THE SERINE/THREONINE PHOSPHATASE DOMAIN OF HUMAN PPM1B	3.1.3.16
2P8H	CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR	3.4.23.46
2P8N	RICIN A-CHAIN (RECOMBINANT) COMPLEX WITH ADENINE	3.2.2.22
2P8O	CRYSTAL STRUCTURE OF A BENZOHYDROXAMIC ACID/VANADATE COMPLEX BOUND TO CHYMOTRYPSIN A	3.4.21.1
2P8S	HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH A CYCLOHEXALAMINE INHIBITOR	3.4.14.5
2P93	FACTOR XA IN COMPLEX WITH THE INHIBITOR 5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE	3.4.21.6
2P94	FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)CYCLOHEXYL)-1H-INDOLE-6-CARBOXAMIDE	3.4.21.6
2P95	FACTOR XA IN COMPLEX WITH THE INHIBITOR 5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE	3.4.21.6
2P98	E. COLI METHIONINE AMINOPEPTIDASE MONOMETALATED WITH INHIBITOR YE7	3.4.11.18
2P99	E. COLI METHIONINE AMINOPEPTIDASE MONOMETALATED WITH INHIBITOR YE6	3.4.11.18
2P9A	E. COLI METHIONINE AMINOPEPTIDASE DIMETALATED WITH INHIBITOR YE6	3.4.11.18
2P9V	STRUCTURE OF AMPC BETA-LACTAMASE WITH CROSS-LINKED ACTIVE SITE AFTER EXPOSURE TO SMALL MOLECULE INHIBITOR	3.5.2.6
2P9Y	CRYSTAL STRUCTURE OF TTHB049 FROM THERMUS THERMOPHILUS HB8	3.1.3.73
2P9Z	CRYSTAL STRUCTURE OF TTHB049 FROM THERMUS THERMOPHILUS HB8	3.1.3.73
2PA0	CRYSTAL STRUCTURE OF TTHB049 FROM THERMUS THERMOPHILUS HB8	3.1.3.73
2PA5	CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN9	3.1.3.48
2PAD	BINDING OF CHLOROMETHYL KETONE SUBSTRATE ANALOGUES TO CRYSTALLINE PAPAIN	3.4.22.2
2PAQ	CRYSTAL STRUCTURE OF THE 5'-DEOXYNUCLEOTIDASE YFBR	3.1.3.5 3.1.3.89
2PAR	CRYSTAL STRUCTURE OF THE 5'-DEOXYNUCLEOTIDASE YFBR MUTANT E72A COMPLEXED WITH CO(2+) AND TMP	3.1.3.5 3.1.3.89
2PAU	CRYSTAL STRUCTURE OF THE 5'-DEOXYNUCLEOTIDASE YFBR MUTANT E72A COMPLEXED WITH CO(2+) AND DAMP	3.1.3.5 3.1.3.89
2PB1	EXO-B-(1,3)-GLUCANASE FROM CANDIDA ALBICANS IN COMPLEX WITH UNHYDROLYSED AND COVALENTLY LINKED 2,4-DINITROPHENYL-2-DEOXY-2-FLUORO-B-D-GLUCOPYRANOSIDE AT 1.9 A	3.2.1.58 2.4.1
2PB8	CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND PEPTIDE ALA-VAL-TYR-SER AT 2.0 A RESOLUTION	3.1.1.4
2PBG	6-PHOSPHO-BETA-D-GALACTOSIDASE FORM-B	3.2.1.85
2PBH	CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN B AT 3.3 ANGSTROM RESOLUTION	3.4.22.1
2PBN	CRYSTAL STRUCTURE OF THE HUMAN TYROSINE RECEPTOR PHOSPHATE GAMMA	3.1.3.48
2PBO	E27Q MUTANT OF EXO-B-(1,3)-GLUCANASE FROM CANDIDA ALBICANS AT 1.85 A	3.2.1.58 2.4.1
2PBY	PROBABLE GLUTAMINASE FROM GEOBACILLUS KAUSTOPHILUS HTA426	3.5.1.2
2PC0	APO WILD-TYPE HIV PROTEASE IN THE OPEN CONFORMATION	3.4.23.16
2PC2	LYSOZYME COCRYSTALLIZED WITH TRIS-DIPICOLINATE EU COMPLEX	3.2.1.17
2PC5	NATIVE CRYSTAL STRUCTURE ANALYSIS ON ARABIDOPSIS DUTPASE	3.6.1.23
2PC8	E292Q MUTANT OF EXO-B-(1,3)-GLUCANASE FROM CANDIDA ALBICANS IN COMPLEX WITH TWO SEPARATELY BOUND GLUCOPYRANOSIDE UNITS AT 1.8 A	3.2.1.58 2.4.1
2PCJ	CRYSTAL STRUCTURE OF ABC TRANSPORTER (AQ_297) FROM AQUIFEX AEOLICUS VF5	3.6.3 7.6.2
2PCL	CRYSTAL STRUCTURE OF ABC TRANSPORTER WITH COMPLEX (AQ_297) FROM AQUIFEX AEOLICUS VF5	3.6.3 7.6.2
2PCR	CRYSTAL STRUCTURE OF MYO-INOSITOL-1(OR 4)-MONOPHOSPHATASE (AQ_1983) FROM AQUIFEX AEOLICUS VF5	3.1.3.25 3.1.3.11
2PCU	HUMAN CARBOXYPEPTIDASE A4 IN COMPLEX WITH A CLEAVED HEXAPEPTIDE.	3.4.17
2PE4	STRUCTURE OF HUMAN HYALURONIDASE 1, A HYALURONAN HYDROLYZING ENZYME INVOLVED IN TUMOR GROWTH AND ANGIOGENESIS	3.2.1.35
2PF0	F258I MUTANT OF EXO-B-(1,3)-GLUCANASE FROM CANDIDA ALBICANS AT 1.9 A	3.2.1.58 2.4.1
2PF1	STRUCTURE OF BOVINE PROTHROMBIN FRAGMENT 1 REFINED AT 2.25 ANGSTROMS RESOLUTION	3.4.21.5
2PF2	THE CA+2 ION AND MEMBRANE BINDING STRUCTURE OF THE GLA DOMAIN OF CA-PROTHROMBIN FRAGMENT 1	3.4.21.5
2PFC	STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS RV0098	3.1.2 3.1.2.2
2PFJ	CRYSTAL STRUCTURE OF T7 ENDO I RESOLVASE IN COMPLEX WITH A HOLLIDAY JUNCTION	3.1.21.2
2PG3	CRYSTAL STRUCTURE OF A QUEUOSINE BIOSYNTHESIS PROTEIN QUEC (ECA1155) FROM ERWINIA CAROTOVORA SUBSP. ATROSEPTICA SCRI1043 AT 2.40 A RESOLUTION	3.5 6.3.4.20
2PGB	INHIBITOR-FREE HUMAN THROMBIN MUTANT C191A-C220A	3.4.21.5
2PGF	CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE FROM PLASMODIUM VIVAX IN COMPLEX WITH ADENOSINE	3.5.4.4
2PGJ	CATALYSIS ASSOCIATED CONFORMATIONAL CHANGES REVEALED BY HUMAN CD38 COMPLEXED WITH A NON-HYDROLYZABLE SUBSTRATE ANALOG	3.2.2.5 3.2.2.6 2.4.99.20
2PGL	CATALYSIS ASSOCIATED CONFORMATIONAL CHANGES REVEALED BY HUMAN CD38 COMPLEXED WITH A NON-HYDROLYZABLE SUBSTRATE ANALOG	3.2.2.5 3.2.2.6 2.4.99.20
2PGQ	HUMAN THROMBIN MUTANT C191A-C220A IN COMPLEX WITH THE INHIBITOR PPACK	3.4.21.5
2PGR	CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE FROM PLASMODIUM VIVAX IN COMPLEX WITH PENTOSTATIN	3.5.4.4
2PH6	CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR	3.4.23.46
2PH8	CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR	3.4.23.46
2PHA	CRYSTAL STRUCTURE OF NATIVE, UNLIGANDED HUMAN ARGINASE AT 1.90 RESOLUTION	3.5.3.1
2PHB	AN ORALLY EFFICACIOUS FACTOR XA INHIBITOR	3.4.21.6
2PHI	A LARGE CONFORMATIONAL CHANGE IS FOUND IN THE CRYSTAL STRUCTURE OF THE PORCINE PANCREATIC PHOSPHOLIPASE A2 POINT MUTANT F63V	3.1.1.4
2PHO	CRYSTAL STRUCTURE OF HUMAN ARGINASE I COMPLEXED WITH THIOSEMICARBAZIDE AT 1.95 RESOLUTION	3.5.3.1
2PI7	STRUCTURE OF THE CATALYTIC DOMAIN OF THE CHICK RETINAL NEURITE INHIBITOR-RECEPTOR PROTEIN TYROSINE PHOSPHATASE CRYP-2/CPTPRO	3.1.3.48
2PI8	CRYSTAL STRUCTURE OF E. COLI MLTA WITH BOUND CHITOHEXAOSE	3.2.1 4.2.2
2PIC	E. COLI LYTIC TRANSGLYCOSYLASE MLTA-D308A IN APO-2 FORM	3.2.1 4.2.2
2PIY	CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B (S)-2-(3-AMINOMETHYL-PHENYL)-3-{HYDROXY-[(R)-2-METHYL-1-(3-PHENYL-PROPANE-1-SULFONYLAMINO)-PROPYL]-PHOSPHINOYL}-PROPIONIC ACID {ZK 528} COMPLEX	3.4.17.2
2PIZ	CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B 2-(3-GUANIDINO-PHENYL)-3-[HYDROXY-(3-PHENYL-PROPYL)-PHOSPHINOYL]-PROPIONIC ACID COMPLEX	3.4.17.2
2PJ0	CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B [((R)-1-BENZYLOXYCARBONYLAMINO-2-METHYL-PROPYL)-HYDROXY-PHOSPHINOYLOXY]-(3-GUANIDINO-PHENYL)-ACETIC ACID COMPLEX	3.4.17.2
2PJ1	CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B (3-AMINOMETHYL-PHENYL)-[((R)-1-BENZYLOXYCARBONYLAMINO-2-METHYL-PROPYL)-HYDROXY-PHOSPHINOYLOXY]-ACETIC ACID COMPLEX	3.4.17.2
2PJ2	CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B 2-(3-AMINOMETHYL-PHENYL)-3-[((R)-1-BENZYLOXYCARBONYLAMINO-2-METHYL-PROPYL)-HYDROXY-PHOSPHINOYL]-PROPIONIC ACID COMPLEX	3.4.17.2
2PJ3	CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B (3-GUANIDINO-PHENYL)-{HYDROXY-[(R)-2-METHYL-1-(3-PHENYL-PROPIONYLAMINO)-PROPYL]-PHOSPHINOYLOXY}-ACETIC ACID COMPLEX	3.4.17.2
2PJ4	CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B [((R)-BENZYLOXYCARBONYLAMINO-CYCLOHEXYL-METHYL)-HYDROXY-PHOSPHINOYLOXY]-(3-GUANIDINO-PHENYL)-ACETIC ACID COMPLEX	3.4.17.2
2PJ5	CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B [((R)-1-BENZYLOXYCARBONYLAMINO-HEXYL)-HYDROXY-PHOSPHINOYLOXY]-(3-GUANIDINO-PHENYL)-ACETIC ACID COMPLEX	3.4.17.2
2PJ6	CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B 2-(3-AMINOMETHYL-PHENYL)-3-{HYDROXY-[(R)-2-METHYL-1-(2-PHENYL-ETHANESULFONYLAMINO)-PROPYL]-PHOSPHINOYL}-PROPIONIC ACID COMPLEX	3.4.17.2
2PJ7	CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B 2-(3-AMINOMETHYL-PHENYL)-3-[((R)-1-BENZENESULFONYLAMINO-2-METHYL-PROPYL)-HYDROXY-PHOSPHINOYL]-PROPIONIC ACID COMPLEX	3.4.17.2
2PJ8	CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B 2-(3-AMINOMETHYL-PHENYL)-3-{[(R)-1-(BIPHENYL-4-SULFONYLAMINO)-2-METHYL-PROPYL]-HYDROXY-PHOSPHINOYL}-PROPIONIC ACID COMPLEX	3.4.17.2
2PJ9	CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B 2-(3-AMINOMETHYL-PHENYL)-3-{[(R)-1-(BENZO[1,2,5]THIADIAZOLE-4-SULFONYLAMINO)-2-METHYL-PROPYL]-HYDROXY-PHOSPHINOYL}-PROPIONIC ACID COMPLEX	3.4.17.2
2PJA	CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B 3-{[(R)-1-((S)-2-BENZYLOXYCARBONYLAMINO-3-PHENYL-PROPIONYLAMINO)-2-METHYL-PROPYL]-HYDROXY-PHOSPHINOYL}-2-(3-GUANIDINO-PHENYL)-PROPIONIC ACID COMPLEX	3.4.17.2
2PJB	CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B 2-(3-AMINOMETHYL-PHENYL)-3-{[1-((S)-2-BENZYLOXYCARBONYLAMINO-3-PHENYL-PROPANE-1-SULFONYLAMINO)-2-METHYL-PROPYL]-HYDROXY-PHOSPHINOYL}-PROPIONIC ACID COMPLEX	3.4.17.2
2PJC	CRYSTAL STRUCTURE OF ACTIVATED PORCINE PANCREATIC CARBOXYPEPTIDASE B ({(R)-1-[(S)-2-BENZYLOXYCARBONYLAMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]-2-METHYL-PROPYL}-HYDROXY-PHOSPHINOYLOXY)-(3-GUANIDINO-PHENYL)-ACETIC ACID COMPLEX	3.4.17.2
2PJF	SOLUTION STRUCTURE OF RHODOSTOMIN	3.4.24
2PJG	SOLUTION STRUCTURE OF RHODOSTOMIN D51E MUTANT	3.4.24
2PJI	SOLUTION STRUCTURE OF RHODOSTOMIN P48A MUTANT	3.4.24
2PJJ	E. COLI LYTIC TRANSGLYCOSYLASE MLTA-D308A IN APO-1 FORM	3.2.1 4.2.2
2PJO	RICIN A-CHAIN (RECOMBINANT) COMPLEX WITH N-METHYLUREA	3.2.2.22
2PJR	HELICASE PRODUCT COMPLEX	3.6.1 3.6.4.12
2PJT	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MMP-13 COMPLEXED WITH WAY-344	3.4.24
2PK0	STRUCTURE OF THE S. AGALACTIAE SERINE/THREONINE PHOSPHATASE AT 2.65 RESOLUTION	3.1.3.16
2PK4	THE REFINED STRUCTURE OF THE EPSILON-AMINOCAPROIC ACID COMPLEX OF HUMAN PLASMINOGEN KRINGLE	3.4.21.7
2PKA	REFINED 2 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF PORCINE PANCREATIC KALLIKREIN A, A SPECIFIC TRYPSIN-LIKE SERINE PROTEINASE. CRYSTALLIZATION, STRUCTURE DETERMINATION, CRYSTALLOGRAPHIC REFINEMENT, STRUCTURE AND ITS COMPARISON WITH BOVINE TRYPSIN	3.4.21.35
2PKC	CRYSTAL STRUCTURE OF CALCIUM-FREE PROTEINASE K AT 1.5 ANGSTROMS RESOLUTION	3.4.21.64
2PKS	THROMBIN IN COMPLEX WITH INHIBITOR	3.4.21.5
2PKY	THE EFFECT OF DEUTERATION ON PROTEIN STRUCTURE A HIGH RESOLUTION COMPARISON OF HYDROGENOUS AND PERDEUTERATED HALOALKANE DEHALOGENASE	3.8.1.5
2PL3	HUMAN DEAD-BOX RNA HELICASE DDX10, DEAD DOMAIN IN COMPLEX WITH ADP	3.6.1 3.6.4.13
2PLC	PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C FROM LISTERIA MONOCYTOGENES	3.1.4.10 4.6.1.13
2PLD	NUCLEAR MAGNETIC RESONANCE STRUCTURE OF AN SH2 DOMAIN OF PHOSPHOLIPASE C-GAMMA1 COMPLEXED WITH A HIGH AFFINITY BINDING PEPTIDE	3.1.4.11
2PLE	NUCLEAR MAGNETIC RESONANCE STRUCTURE OF AN SH2 DOMAIN OF PHOSPHOLIPASE C-GAMMA1 COMPLEXED WITH A HIGH AFFINITY BINDING PEPTIDE	3.1.4.11
2PLF	THE STRUCTURE OF AIF2GAMMA SUBUNIT FROM THE ARCHAEON SULFOLOBUS SOLFATARICUS IN THE NUCLEOTIDE-FREE FORM.	3.6.5.3
2PLL	CRYSTAL STRUCTURE OF PERDEUTERATED HUMAN ARGINASE I	3.5.3.1
2PLM	CRYSTAL STRUCTURE OF THE PROTEIN TM0936 FROM THERMOTOGA MARITIMA COMPLEXED WITH ZN AND S-INOSYLHOMOCYSTEINE	3.5.4.28 3.5.4.31
2PLQ	CRYSTAL STRUCTURE OF THE AMIDASE FROM GEOBACILLUS PALLIDUS RAPC8	3.5.1.4
2PLV	STRUCTURAL FACTORS THAT CONTROL CONFORMATIONAL TRANSITIONS AND SEROTYPE SPECIFICITY IN TYPE 3 POLIOVIRUS	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
2PLX	TRYPSIN COMPLEXED TO A SYNTHETIC PEPTIDE FROM VERONICA HEDERIFOLIA	3.4.21.4
2PM8	CRYSTAL STRUCTURE OF RECOMBINANT FULL LENGTH HUMAN BUTYRYLCHOLINESTERASE	3.1.1.8
2PMD	THE STRUCTURES OF AIF2GAMMA SUBUNIT FROM THE ARCHAEON SULFOLOBUS SOLFATARICUS IN THE GDP-BOUND FORM.	3.6.5.3
2PMJ	CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND 1, 2 BENZOPYRONE AT 2.4 A RESOLUTION	3.1.1.4
2PMS	CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN LACTOFERRIN N-LOBE AND LACTOFERRIN-BINDING DOMAIN OF PNEUMOCOCCAL SURFACE PROTEIN A	3.4.21
2PMW	THE CRYSTAL STRUCTURE OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)	3.4.21
2PNG	TYPE I RAT FATTY ACID SYNTHASE ACYL CARRIER PROTEIN (ACP) DOMAIN	2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 1.1.1.100 4.2.1.59 1.3.1.39 3.1.2.14
2PNM	CRYSTAL STRUCTURE OF VP4 PROTEASE FROM INFECTIOUS PANCREATIC NECROSIS VIRUS (IPNV) IN SPACE GROUP P6122	3.4.21
2PNQ	CRYSTAL STRUCTURE OF PYRUVATE DEHYDROGENASE PHOSPHATASE 1 (PDP1)	3.1.3.43
2PNS	1.9 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF A PLANT CYSTEINE PROTEASE ERVATAMIN-C REFINEMENT WITH CDNA DERIVED AMINO ACID SEQUENCE	3.4.22
2PNZ	CRYSTAL STRUCTURE OF THE P. ABYSSI EXOSOME RNASE PH RING COMPLEXED WITH UDP AND GMP	3.1.13
2PO0	CRYSTAL STRUCTURE OF THE P. ABYSSI EXOSOME RNASE PH RING COMPLEXED WITH ADP IN DOUBLE CONFORMATION	3.1.13
2PO1	CRYSTAL STRUCTURE OF THE P. ABYSSI EXOSOME RNASE PH RING COMPLEXED WITH A SINGLE STRANDED 10-MER POLY(A) RNA	3.1.13
2PO2	CRYSTAL STRUCTURE OF THE P. ABYSSI EXOSOME RNASE PH RING COMPLEXED WITH CDP	3.1.13
2POF	CRYSTAL STRUCTURE OF CDP-DIACYLGLYCEROL PYROPHOSPHATASE	3.6.1.26
2POJ	NMR SOLUTION STRUCTURE OF THE INHIBITOR-FREE STATE OF MACROPHAGE METALLOELASTASE (MMP-12)	3.4.24.65
2POO	THERMOSTABLE PHYTASE IN FULLY CALCIUM LOADED STATE	3.1.3.8
2PPL	HUMAN PANCREATIC LIPASE-RELATED PROTEIN 1	3.1.1.3
2PQ2	STRUCTURE OF SERINE PROTEINASE K COMPLEX WITH A HIGHLY FLEXIBLE HYDROPHOBIC PEPTIDE AT 1.8A RESOLUTION	3.4.21.64
2PQ5	CRYSTAL STRUCTURE OF DUAL SPECIFICITY PROTEIN PHOSPHATASE 13 (DUSP13)	3.1.3.48 3.1.3.16
2PQE	SOLUTION STRUCTURE OF PROLINE-FREE MUTANT OF STAPHYLOCOCCAL NUCLEASE	3.1.31.1
2PQG	CRYSTAL STRUCTURE OF INACTIVE RIBOSOME INACTIVATING PROTEIN FROM MAIZE (B-32)	3.2.2.22
2PQI	CRYSTAL STRUCTURE OF ACTIVE RIBOSOME INACTIVATING PROTEIN FROM MAIZE (B-32)	3.2.2.22
2PQJ	CRYSTAL STRUCTURE OF ACTIVE RIBOSOME INACTIVATING PROTEIN FROM MAIZE (B-32), COMPLEX WITH ADENINE	3.2.2.22
2PQX	E. COLI RNASE 1 (IN VIVO FOLDED)	3.1.27.6 4.6.1.21
2PQY	E. COLI RNASE 1 (IN VITRO REFOLDED WITH DSBA ONLY)	3.1.27.6 4.6.1.21
2PQZ	HIV-1 PROTEASE IN COMPLEX WITH A PYRROLIDINE-BASED INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2PR3	FACTOR XA INHIBITOR	3.4.21.6
2PRD	CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATASE FROM THERMUS THERMOPHILUS	3.6.1.1
2PRE	CRYSTAL STRUCTURE OF PLANT CYSTEINE PROTEASE ERVATAMIN-C COMPLEXED WITH IRREVERSIBLE INHIBITOR E-64 AT 2.7 A RESOLUTION	3.4.22
2PRK	SYNCHROTRON X-RAY DATA COLLECTION AND RESTRAINED LEAST-SQUARES REFINEMENT OF THE CRYSTAL STRUCTURE OF PROTEINASE K AT 1.5 ANGSTROMS RESOLUTION	3.4.21.14 3.4.21.64
2PRO	PRO REGION OF ALPHA-LYTIC PROTEASE	3.4.21.12
2PRQ	X-RAY CRYSTALLOGRAPHIC CHARACTERIZATION OF THE CO(II)-SUBSTITUTED TRIS-BOUND FORM OF THE AMINOPEPTIDASE FROM AEROMONAS PROTEOLYTICA	3.4.11.10
2PSG	REFINED STRUCTURE OF PORCINE PEPSINOGEN AT 1.8 ANGSTROMS RESOLUTION	3.4.23.1
2PSX	CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 5 IN COMPLEX WITH LEUPEPTIN	3.4.21
2PSY	CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 5 IN COMPLEX WITH LEUPEPTIN AND ZINC	3.4.21
2PTC	THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS	3.4.21.4
2PTD	PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C MUTANT D198E	3.1.4.10 4.6.1.13
2PTH	PEPTIDYL-TRNA HYDROLASE FROM ESCHERICHIA COLI	3.1.1.29
2PTN	ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY	3.4.21.4
2PU2	AMPC BETA-LACTAMASE WITH BOUND PHTHALAMIDE INHIBITOR	3.5.2.6
2PU3	STRUCTURAL ADAPTATION OF ENDONUCLEASE I FROM THE COLD-ADAPTED AND HALOPHILIC BACTERIUM VIBRIO SALMONICIDA	3.1.21.1
2PU4	AMPC BETA-LACAMASE WITH BOUND COVALENT OXADIAZOLE INHIBITOR	3.5.2.6
2PU5	CRYSTAL STRUCTURE OF A C-C BOND HYDROLASE, BPHD, FROM BURKHOLDERIA XENOVORANS LB400	3.7.1 3.7.1.8
2PU7	CRYSTAL STRUCTURE OF S112A/H265A DOUBLE MUTANT OF A C-C HYDROLASE, BPHD, FROM BURKHOLDERIA XENOVORANS LB400	3.7.1 3.7.1.8
2PUH	CRYSTAL STRUCTURE OF THE S112A MUTANT OF A C-C HYDROLASE, BPHD FROM BURKHOLDERIA XENOVORANS LB400, IN COMPLEX WITH ITS SUBSTRATE HOPDA	3.7.1 3.7.1.8
2PUJ	CRYSTAL STRUCTURE OF THE S112A/H265A DOUBLE MUTANT OF A C-C HYDROLASE, BPHD FROM BURKHOLDERIA XENOVORANS LB400, IN COMPLEX WITH ITS SUBSTRATE HOPDA	3.7.1 3.7.1.8
2PUQ	CRYSTAL STRUCTURE OF ACTIVE SITE INHIBITED COAGULATION FACTOR VIIA IN COMPLEX WITH SOLUBLE TISSUE FACTOR	3.4.21.21
2PUX	CRYSTAL STRUCTURE OF MURINE THROMBIN IN COMPLEX WITH THE EXTRACELLULAR FRAGMENT OF MURINE PAR3	3.4.21.5
2PUZ	CRYSTAL STRUCTURE OF IMIDAZOLONEPROPIONASE FROM AGROBACTERIUM TUMEFACIENS WITH BOUND PRODUCT N-FORMIMINO-L-GLUTAMATE	3.5.2.7
2PV9	CRYSTAL STRUCTURE OF MURINE THROMBIN IN COMPLEX WITH THE EXTRACELLULAR FRAGMENT OF MURINE PAR4	3.4.21.5
2PVA	OXIDIZED PENICILLIN V ACYLASE FROM B. SPHAERICUS	3.5.1.11
2PVI	PVUII ENDONUCLEASE COMPLEXED TO AN IODINATED COGNATE DNA	3.1.21.4
2PVS	STRUCTURE OF HUMAN PANCREATIC LIPASE RELATED PROTEIN 2 MUTANT N336Q	3.1.1.3 3.1.1.26
2PVT	CRYSTAL STRUCTURE OF A NEW ISOFORM OF PHOSPHOLIPASE A2 FROM RUSSELLS VIPER AT 2.1 A RESOLUTION	3.1.1.4
2PVV	STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH L-SERINE-O-SULFATE	3.4.17.21
2PVW	A HIGH RESOLUTION STRUCTURE OF HUMAN GLUTAMATE CARBOXYPEPTIDASE II (GCPII) IN COMPLEX WITH 2-(PHOSPHONOMETHYL)PENTANEDIOIC ACID (2-PMPA)	3.4.17.21
2PW3	STRUCTURE OF THE PDE4D-CAMP COMPLEX	3.1.4.17 3.1.4.53
2PW5	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT V66Y/P117G/H124L/S128A AT ROOM TEMPERATURE	3.1.31.1
2PW7	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT V66Y/P117G/H124L/S128A AT 100K	3.1.31.1
2PW8	CRYSTAL STRUCTURE OF SULFO-HIRUDIN COMPLEXED TO THROMBIN	3.4.21.5
2PWA	CRYSTAL STRUCTURE OF THE COMPLEX OF PROTEINASE K WITH ALANINE BORONIC ACID AT 0.83A RESOLUTION	3.4.21.64
2PWB	CRYSTAL STRUCTURE OF THE COMPLEX OF PROTEINASE K WITH COUMARIN AT 1.9 A RESOLUTION	3.4.21.64
2PWC	HIV-1 PROTEASE IN COMPLEX WITH A AMINO DECORATED PYRROLIDINE-BASED INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2PWM	CRYSTAL STRUCTURE OF HIV-1 CA146 A92E REAL CELL	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2PWR	HIV-1 PROTEASE IN COMPLEX WITH A CARBAMOYL DECORATED PYRROLIDINE-BASED INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2PWS	CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PHOSPHOLIPASE A2 AND 2-(4-ISOBUTYL-PHENYL)-PROPIONIC ACID AT 2.2 A RESOLUTION	3.1.1.4
2PWX	CRYSTAL STRUCTURE OF G11A MUTANT OF SARS-COV 3C-LIKE PROTEASE	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2PX1	CRYSTAL STRUCTURE OF THE COMPLEX OF BOVINE LACTOFERRIN C-LOBE WITH RIBOSE AT 2.5 A RESOLUTION	3.4.21
2PX2	CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH (MONOCLINIC FORM 1)	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57
2PX4	CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH (MONOCLINIC FORM 2)	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57
2PX5	CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH (ORTHORHOMBIC CRYSTAL FORM)	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57
2PX6	CRYSTAL STRUCTURE OF THE THIOESTERASE DOMAIN OF HUMAN FATTY ACID SYNTHASE INHIBITED BY ORLISTAT	2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 1.1.1.100 4.2.1.59 1.3.1.39 3.1.2.14
2PX8	CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH AND 7M-GTP	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57
2PXA	CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAH AND GTPG	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57
2PXC	CRYSTAL STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS NS5 2'-O METHYLTRANSFERASE DOMAIN IN COMPLEX WITH SAM AND GTPA	2.7.7.48 3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57
2PY4	FULL LENGTH STRUCTURE OF THE MYCOBACTERIUM TUBERCULOSIS DUTPASE COMPLEXED WITH MAGNESIUM AND ALPHA,BETA-IMIDO-DUTP.	3.6.1.23
2PY5	PHI29 DNA POLYMERASE COMPLEXED WITH SINGLE-STRANDED DNA	2.7.7.7 3.1.11
2PYC	CRYSTAL STRUCTURE OF A MONOMERIC PHOSPHOLIPASE A2 FROM RUSSELL'S VIPER AT 1.5A RESOLUTION	3.1.1.4
2PYJ	PHI29 DNA POLYMERASE COMPLEXED WITH PRIMER-TEMPLATE DNA AND INCOMING NUCLEOTIDE SUBSTRATES (TERNARY COMPLEX)	2.7.7.7 3.1.11
2PYK	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT V66Q/P117G/H124L/S128A AT ROOM TEMPERATURE	3.1.31.1
2PYL	PHI29 DNA POLYMERASE COMPLEXED WITH PRIMER-TEMPLATE DNA AND INCOMING NUCLEOTIDE SUBSTRATES (TERNARY COMPLEX)	2.7.7.7 3.1.11
2PYM	HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2PYN	HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2PYU	STRUCTURE OF THE E. COLI INOSINE TRIPHOSPHATE PYROPHOSPHATASE RGDB IN COMPLEX WITH IMP	3.6.1.19 3.6.1.66
2PYZ	CRYSTAL STRUCTURE OF THE COMPLEX OF PROTEINASE K WITH AURAMINE AT 1.8A RESOLUTION	3.4.21.64
2PZD	CRYSTAL STRUCTURE OF THE HTRA2/OMI PDZ DOMAIN BOUND TO A PHAGE-DERIVED LIGAND (WTMFWV)	3.4.21.108
2PZF	MINIMAL HUMAN CFTR FIRST NUCLEOTIDE BINDING DOMAIN AS A HEAD-TO-TAIL DIMER WITH DELTA F508	3.6.3.49 5.6.1.6
2PZH	YBGC THIOESTERASE (HP0496) FROM HELICOBACTER PYLORI	3.1.2
2PZT	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT V66Q/P117G/H124L/S128A AT 100 K	3.1.31.1
2PZU	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT V66N/P117G/H124L/S128A AT CRYOGENIC TEMPERATURE	3.1.31.1
2PZW	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT V66N/P117G/H124L/S128A AT ROOM TEMPERATURE	3.1.31.1
2Q05	CRYSTAL STRUCTURE OF TYR/SER PROTEIN PHOSPHATASE FROM VACCINIA VIRUS WR	3.1.3.48 3.1.3.16 3.1.3
2Q09	CRYSTAL STRUCTURE OF IMIDAZOLONEPROPIONASE FROM ENVIRONMENTAL SAMPLE WITH BOUND INHIBITOR 3-(2,5-DIOXO-IMIDAZOLIDIN-4-YL)-PROPIONIC ACID	3.5.2.7
2Q0H	ABC PROTEIN ARTP IN COMPLEX WITH ADP/MG2+, ATP-GAMMA-S HYDROLYZED	3.6.3.21
2Q0I	STRUCTURE OF PSEUDOMONAS QUINOLONE SIGNAL RESPONSE PROTEIN PQSE	3.1.2.32
2Q0J	STRUCTURE OF PSEUDOMONAS QUINOLONE SIGNAL RESPONSE PROTEIN PQSE	3.1.2.32
2Q0M	TRICARBONYLMANGANESE(I)-LYSOZYME COMPLEX : A STRUCTURALLY CHARACTERIZED ORGANOMETALLIC PROTEIN	3.2.1.17
2Q0S	STRUCTURE OF THE INHIBITOR BOUND FORM OF M. SMEGMATIS ARYL ESTERASE	3.1.1.2
2Q0Z	CRYSTAL STRUCTURE OF Q9P172/SEC63 FROM HOMO SAPIENS. NORTHEAST STRUCTURAL GENOMICS TARGET HR1979.	3.6.4.13
2Q11	STRUCTURE OF BACE COMPLEXED TO COMPOUND 1	3.4.23.46
2Q15	STRUCTURE OF BACE COMPLEXED TO COMPOUND 3A	3.4.23.46
2Q16	STRUCTURE OF THE E. COLI INOSINE TRIPHOSPHATE PYROPHOSPHATASE RGDB IN COMPLEX WITH ITP	3.6.1.19 3.6.1.66
2Q1J	THE DISCOVERY OF GLYCINE AND RELATED AMINO ACID-BASED FACTOR XA INHIBITORS	3.4.21.6
2Q1P	CRYSTAL STRUCTURE OF PHOSPHOLIPASE A2 COMPLEX WITH PROPANOL AT 1.5 A RESOLUTION	3.1.1.4
2Q21	CRYSTAL STRUCTURES AT 2.2 ANGSTROMS RESOLUTION OF THE CATALYTIC DOMAINS OF NORMAL RAS PROTEIN AND AN ONCOGENIC MUTANT COMPLEXED WITH GSP	3.6.5.2
2Q2B	CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF MOUSE ACYL-COA THIOESTERASE 7	3.1.2.2
2Q37	CRYSTAL STRUCTURE OF OHCU DECARBOXYLASE IN THE PRESENCE OF (S)-ALLANTOIN	4.1.1.97 3.5.2.17
2Q3F	X-RAY CRYSTAL STRUCTURE OF PUTATIVE HUMAN RAS-RELATED GTP BINDING D IN COMPLEX WITH GMPPNP	3.6.5
2Q3K	CRYSTAL STRUCTURE OF LYSINE SULFONAMIDE INHIBITOR REVEALS THE DISPLACEMENT OF THE CONSERVED FLAP WATER MOLECULE IN HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2Q3N	AGGLUTININ FROM ABRUS PRECATORIUS (APA-I)	3.2.2.22
2Q3S	ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT5G06450	3.1.13.1
2Q3U	ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT5G08170, AGMATINE IMINOHYDROLASE	3.5.3.12
2Q40	ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT2G17340	3.1.3
2Q42	ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF GLYOXALASE II FROM ARABIDOPSIS THALIANA GENE AT2G31350	3.1.2.6
2Q43	ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF IAA-AMINOACID HYDROLASE FROM ARABIDOPSIS THALIANA GENE AT5G56660	3.5.1
2Q47	ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF A PUTATIVE PHOSPHOPROTEIN PHOSPHATASE FROM ARABIDOPSIS THALIANA GENE AT1G05000	3.1.3.48
2Q4D	ENSEMBLE REFINEMENT OF THE CRYSTAL STRUCTURE OF A LYSINE DECARBOXYLASE-LIKE PROTEIN FROM ARABIDOPSIS THALIANA GENE AT5G11950	3.2.2
2Q4O	ENSEMBLE REFINEMENT OF THE CRYSTAL STRUCTURE OF A LYSINE DECARBOXYLASE-LIKE PROTEIN FROM ARABIDOPSIS THALIANA GENE AT2G37210	3.2.2
2Q4P	ENSEMBLE REFINEMENT OF THE CRYSTAL STRUCTURE OF PROTEIN FROM MUS MUSCULUS MM.29898	3.6.1.12
2Q4T	ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF A CYTOSOLIC 5'-NUCLEOTIDASE III FROM MUS MUSCULUS MM.158936	3.1.3.5 3.1.3.91
2Q4X	ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF GENE PRODUCT FROM ARABIDOPSIS THALIANA AT3G16990	3.5.1 3.5.99.2
2Q4Z	ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF AN ASPARTOACYLASE FROM RATTUS NORVEGICUS	3.5.1.15
2Q51	ENSEMBLE REFINEMENT OF THE PROTEIN CRYSTAL STRUCTURE OF AN ASPARTOACYLASE FROM HOMO SAPIENS	3.5.1.15
2Q5E	CRYSTAL STRUCTURE OF HUMAN CARBOXY-TERMINAL DOMAIN RNA POLYMERASE II POLYPEPTIDE A SMALL PHOSPHATASE 2	3.1.3.16
2Q5X	CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF HNUP98	3.4.21
2Q5Y	CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF HNUP98	3.4.21
2Q5Z	CRYSTAL STRUCTURE OF IMAZG FROM VIBRIO DAT 722: NTAG-IMAZG (P43212)	3.6.1.19
2Q63	HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2Q64	HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2Q6D	CRYSTAL STRUCTURE OF INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE	3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1 2.1.1
2Q6F	CRYSTAL STRUCTURE OF INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE IN COMPLEX WITH A MICHAEL ACCEPTOR INHIBITOR N3	3.4.22
2Q6G	CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE H41A MUTANT IN COMPLEX WITH AN N-TERMINAL SUBSTRATE	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2Q6T	CRYSTAL STRUCTURE OF THE THERMUS AQUATICUS DNAB MONOMER	3.6.1 3.6.4.12
2Q73	CRYSTAL STRUCTURE OF IMAZG FROM VIBRIO DAT 722: CTAG-IMAZG (P41212)	3.6.1.19
2Q74	MYCOBACTERIUM TUBERCULOSIS SUHB	3.1.3.25
2Q7T	CRYSTAL STRUCTURE OF THE F PLASMID TRAI RELAXASE DOMAIN WITH THE SCISSILE THYMIDINE BASE	3.6.1 5.6.2.1 3.6.4.12
2Q7U	CRYSTAL STRUCTURE OF THE F PLASMID TRAI RELAXASE DOMAIN WITH THE SCISSILE THYMIDINE BASE AND IMIDODIPHOSPHATE	3.6.1 5.6.2.1 3.6.4.12
2Q8J	CRYSTAL STRUCTURE OF THE COMPLEX OF C-LOBE OF BOVINE LACTOFERRIN WITH MANNITOL AND MANNOSE AT 2.7 A RESOLUTION	3.4.21
2Q8M	T-LIKE FRUCTOSE-1,6-BISPHOSPHATASE FROM ESCHERICHIA COLI WITH AMP, GLUCOSE 6-PHOSPHATE, AND FRUCTOSE 1,6-BISPHOSPHATE BOUND	3.1.3.11
2Q8W	CRYSTAL STRUCTURE OF PAP-S1ACI, A POKEWEED ANTIVIRAL PROTEIN FROM SEEDS OF PHYTOLACCA ACINOSA	3.2.2.22
2Q92	E. COLI METHIONINE AMINOPEPTIDASE MN-FORM WITH INHIBITOR B23	3.4.11.18
2Q93	E. COLI METHIONINE AMINOPEPTIDASE MN-FORM WITH INHIBITOR B21	3.4.11.18
2Q94	E. COLI METHIONINE AMINOPEPTIDASE MN-FORM WITH INHIBITOR A04	3.4.11.18
2Q95	E. COLI METHIONINE AMINOPEPTIDASE MN-FORM WITH INHIBITOR A05	3.4.11.18
2Q96	E. COLI METHIONINE AMINOPEPTIDASE MN-FORM WITH INHIBITOR A18	3.4.11.18
2Q9D	STRUCTURE OF SPIN-LABELED T4 LYSOZYME MUTANT A41R1	3.2.1.17
2Q9E	STRUCTURE OF SPIN-LABELED T4 LYSOZYME MUTANT S44R1	3.2.1.17
2Q9L	CRYSTAL STRUCTURE OF IMAZG FROM VIBRIO DAT 722: CTAG-IMAZG (P43212)	3.6.1.19
2Q9M	4-SUBSTITUTED TRINEMS AS BROAD SPECTRUM-LACTAMASE INHIBITORS: STRUCTURE-BASED DESIGN, SYNTHESIS AND BIOLOGICAL ACTIVITY	3.5.2.6
2Q9N	4-SUBSTITUTED TRINEMS AS BROAD SPECTRUM-LACTAMASE INHIBITORS: STRUCTURE-BASED DESIGN, SYNTHESIS AND BIOLOGICAL ACTIVITY	3.5.2.6
2Q9P	HUMAN DIPHOSPHOINOSITOL POLYPHOSPHATE PHOSPHOHYDROLASE 1, MG-F COMPLEX	3.6.1.52 3.6.1
2QA9	CRYSTAL STRUCTURE OF THE SECOND TETRAHEDRAL INTERMEDIATES OF SGPB AT PH 4.2	3.4.21.81
2QAA	CRYSTAL STRUCTURE OF THE SECOND TETRAHEDRAL INTERMEDIATES OF SGPB AT PH 7.3	3.4.21.81
2QAI	CRYSTAL STRUCTURE OF THE V-TYPE ATP SYNTHASE SUBUNIT F FROM PYROCOCCUS FURIOSUS. NESG TARGET PFR7.	3.6.3.14
2QAK	HIV-1 PR MUTANT IN COMPLEX WITH NELFINAVIR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QB6	SACCHAROMYCES CEREVISIAE CYTOSOLIC EXOPOLYPHOSPHATASE, SULFATE COMPLEX	3.6.1.11
2QB7	SACCHAROMYCES CEREVISIAE CYTOSOLIC EXOPOLYPHOSPHATASE, PHOSPHATE COMPLEX	3.6.1.11
2QB8	SACCHAROMYCES CEREVISIAE CYTOSOLIC EXOPOLYPHOSPHATASE, ATP COMPLEX	3.6.1.11
2QBP	CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX	3.1.3.48
2QBQ	CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX	3.1.3.48
2QBR	CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX	3.1.3.48
2QBS	CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX	3.1.3.48
2QC2	CRYSTAL STRUCTURE OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) 3C-LIKE PROTEASE ASN214ALA MUTANT	3.4.22
2QCA	A NEW CRYSTAL FORM OF BOVINE PANCREATIC RNASE A IN COMPLEX WITH 2'-DEOXYGUANOSINE-5'-MONOPHOSPHATE	3.1.27.5 4.6.1.18
2QCI	HIV-1 PROTEASE MUTANT D30N WITH POTENT ANTIVIRAL INHIBITOR GRL-98065	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QCJ	NATIVE STRUCTURE OF LYP	3.1.3.48
2QCX	CRYSTAL STRUCTURE OF BACILLUS SUBTILIS TENA Y112F MUTANT COMPLEXED WITH FORMYL AMINOMETHYL PYRIMIDINE	3.5.99.2
2QCY	CRYSTAL STRUCTURE OF A MONOMERIC FORM OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) 3C-LIKE PROTEASE MUTANT	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2QD6	HIV-1 PROTEASE MUTANT I50V WITH POTENT ANTIVIRAL INHIBITOR GRL-98065	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QD7	HIV-1 PROTEASE MUTANT V82A WITH POTENT ANTIVIRAL INHIBITOR GRL-98065	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QD8	HIV-1 PROTEASE MUTANT I84V WITH POTENT ANTIVIRAL INHIBITOR GRL-98065	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QDB	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT E75Q/D21N/T33V/T41I/S59A/P117G/S128A AT 100 K	3.1.31.1
2QDC	CRYSTAL STRUCTURE OF THE HEPTP CATALYTIC DOMAIN D236A MUTANT	3.1.3.48
2QDM	CRYSTAL STRUCTURE OF THE HEPTP CATALYTIC DOMAIN C270S/D236A/Q314A MUTANT	3.1.3.48
2QDP	CRYSTAL STRUCTURE OF THE HEPTP CATALYTIC DOMAIN C270S MUTANT CRYSTALLIZED IN AMMONIUM ACETATE	3.1.3.48
2QDS	CRYSTAL STRUCTURE OF THE ZINC CARBAPENEMASE CPHA IN COMPLEX WITH THE INHIBITOR D-CAPTOPRIL	3.5.2.6
2QDT	STRUCTURAL BASIS FOR THE BROAD-SPECTRUM INHIBITION OF METALLO-{BETA}-LACTAMASES: L1- IS38 COMPLEX	3.5.2.6
2QE2	STRUCTURE OF HCV NS5B BOUND TO AN ANTHRANILIC ACID INHIBITOR	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
2QE5	STRUCTURE OF HCV NS5B BOUND TO AN ANTHRANILIC ACID INHIBITOR	2.7.7.48 3.4.21.98 3.6.1.15 3.6.4.13
2QED	CRYSTAL STRUCTURE OF SALMONELLA THYPHIMURIUM LT2 GLYOXALASE II	3.1.2.6
2QEP	CRYSTAL STRUCTURE OF THE D1 DOMAIN OF PTPRN2 (IA2BETA)	3.1.3.48 3.1.3
2QEQ	CRYSTAL STRUCTURE OF KUNJIN VIRUS NS3 HELICASE	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2QES	CRYSTAL STRUCTURE OF THE RIBOSOME INACTIVATING PROTEIN PDL4 FROM P. DIOICA LEAVES IN COMPLEX WITH ADENINE	3.2.2.22
2QET	STRUCTURE OF THE MUTANT S211A OF THE RIBOSOME INACTIVATING PROTEIN PDL4 FROM P. DIOICA IN COMPLEX WITH ADENINE	3.2.2.22
2QF0	STRUCTURE OF THE DELTA PDZ TRUNCATION OF THE DEGS PROTEASE	3.4.21 3.4.21.107
2QF3	STRUCTURE OF THE DELTA PDZ TRUNCATION OF THE DEGS PROTEASE	3.4.21 3.4.21.107
2QFB	CRYSTAL STRUCTURE OF THE REGULATORY DOMAIN OF HUMAN RIG-I WITH BOUND ZN	3.6.1 3.6.4.13
2QFD	CRYSTAL STRUCTURE OF THE REGULATORY DOMAIN OF HUMAN RIG-I WITH BOUND HG	3.6.1 3.6.4.13
2QFE	DISTAL C2-LIKE DOMAIN OF HUMAN CALPAIN-7	3.4.22
2QFL	STRUCTURE OF SUHB: INOSITOL MONOPHOSPHATASE AND EXTRAGENIC SUPPRESSOR FROM E. COLI	3.1.3.25
2QFP	CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH FLUORIDE	3.1.3.2
2QGR	STRUCTURE OF THE R178A MUTANT OF DELTA PDZ DEGS PROTEASE	3.4.21 3.4.21.107
2QHA	FROM STRUCTURE TO FUNCTION: INSIGHTS INTO THE CATALYTIC SUBSTRATE SPECIFICITY AND THERMOSTABILITY DISPLAYED BY BACILLUS SUBTILIS MANNANASE BCMAN	3.2.1.78
2QHC	THE INFLUENCE OF I47A MUTATION ON REDUCED SUSCEPTIBILITY TO THE PROTEASE INHIBITOR LOPINAVIR	3.4.23.16
2QHD	CRYSTAL STRUCTURE OF ECARPHOLIN S (SER49-PLA2) COMPLEXED WITH FATTY ACID	3.1.1.4
2QHE	CRYSTAL STRUCTURE OF SER49-PLA2 (ECARPHOLIN S) FROM ECHIS CARINATUS SOCHUREKI SNAKE VENOM	3.1.1.4
2QHW	CRYSTAL STRUCTURE OF A COMPLEX OF PHOSPHOLIPASE A2 WITH A GRAMINE DERIVATIVE AT 2.2 RESOLUTION	3.1.1.4
2QHY	CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-1-AC86 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QHZ	CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-1-AC87 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QI0	CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-1-KK80 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QI1	CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-1-KK81 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QI2	CRYSTAL STRUCTURE OF THE THERMOPLASMA ACIDOPHILUM PELOTA PROTEIN	3.1
2QI3	CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-AD94 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QI4	CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-AD93 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QI5	CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-KC08 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QI6	CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-KB98 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QI7	CRYSTAL STRUCTURE OF PROTEASE INHIBITOR, MIT-2-AD86 IN COMPLEX WITH WILD TYPE HIV-1 PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QIM	CRYSTAL STRUCTURE OF PATHOGENESIS-RELATED PROTEIN LLPR-10.2B FROM YELLOW LUPINE IN COMPLEX WITH CYTOKININ	3.1.27
2QIN	STENOTROPHOMONAS MALTOPHILIA L1 METALLO-BETA-LACTAMASE ASP-120 CYS MUTANT	3.5.2.6
2QIQ	STRUCTURE-BASED DESIGN AND SYNTHESIS AND BIOLOGICAL EVALUATION OF PEPTIDOMIMETIC SARS-3CLPRO INHIBITORS	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2QJC	CRYSTAL STRUCTURE OF A PUTATIVE DIADENOSINE TETRAPHOSPHATASE	3.6.1.41
2QJE	CRYSTAL STRUCTURE OF THE COMPLEX OF BOVINE C-LOBE WITH AMYGDALIN AT 2.3A RESOLUTION	3.4.21
2QJO	CRYSTAL STRUCTURE OF A BIFUNCTIONAL NMN ADENYLYLTRANSFERASE/ADP RIBOSE PYROPHOSPHATASE (NADM) COMPLEXED WITH ADPRP AND NAD FROM SYNECHOCYSTIS SP.	2.7.7.1 3.6.1
2QJR	DIPEPDYL PEPTIDASE IV IN COMPLEX WITH INHIBITOR PZF	3.4.14.5
2QJS	STENOTROPHOMONAS MALTOPHILIA L1 METALLO-BETA-LACTAMASE ASP-120 ASN MUTANT	3.5.2.6
2QJT	CRYSTAL STRUCTURE OF A BIFUNCTIONAL NMN ADENYLYLTRANSFERASE/ADP RIBOSE PYROPHOSPHATASE COMPLEXED WITH AMP AND MN ION FROM FRANCISELLA TULARENSIS	2.7.7.1 3.6.1
2QK5	STRUCTURE OF BACE1 BOUND TO SCH626485	3.4.23.46
2QK9	HUMAN RNASE H CATALYTIC DOMAIN MUTANT D210N IN COMPLEX WITH 18-MER RNA/DNA HYBRID	3.1.26.4
2QKB	HUMAN RNASE H CATALYTIC DOMAIN MUTANT D210N IN COMPLEX WITH 20-MER RNA/DNA HYBRID	3.1.26.4
2QKK	HUMAN RNASE H CATALYTIC DOMAIN MUTANT D210N IN COMPLEX WITH 14-MER RNA/DNA HYBRID	3.1.26.4
2QKM	THE CRYSTAL STRUCTURE OF FISSION YEAST MRNA DECAPPING ENZYME DCP1-DCP2 COMPLEX	3.6.1.30
2QKY	COMPLEX STRUCTURE OF DIPEPTIDYL PEPTIDASE IV AND A OXADIAZOLYL KETONE	3.4.14.5
2QL5	CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DMQD-CHO	3.4.22.60
2QL7	CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-IEPD-CHO	3.4.22.60
2QL9	CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DQMD-CHO	3.4.22.60
2QLB	CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-ESMD-CHO	3.4.22.60
2QLF	CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DNLD-CHO	3.4.22.60
2QLJ	CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-WEHD-CHO	3.4.22.60
2QLP	BIFUNCTIONAL DCTP DEAMINASE:DUTPASE FROM MYCOBACTERIUM TUBERCULOSIS, APO FORM	3.5.4.13 3.5.4.30
2QLT	CRYSTAL STRUCTURE OF AN ISOFORM OF DL-GLYCEROL-3-PHOSPHATASE, RHR2P, FROM SACCHAROMYCES CEREVISIAE	3.1.3 3.1.3.21
2QLY	CRYSTRAL STRUCTURE OF THE N-TERMINAL SUBUNIT OF HUMAN MALTASE-GLUCOAMYLASE	3.2.1 3.2.1.20 3.2.1.3
2QMD	STRUCTURE OF BACE BOUND TO SCH722924	3.4.23.46
2QME	CRYSTAL STRUCTURE OF HUMAN RAC3 IN COMPLEX WITH CRIB DOMAIN OF HUMAN P21-ACTIVATED KINASE 1 (PAK1)	3.6.5.2
2QMF	STRUCTURE OF BACE BOUND TO SCH735310	3.4.23.46
2QMG	STRUCTURE OF BACE BOUND TO SCH745966	3.4.23.46
2QMJ	CRYSTRAL STRUCTURE OF THE N-TERMINAL SUBUNIT OF HUMAN MALTASE-GLUCOAMYLASE IN COMPLEX WITH ACARBOSE	3.2.1 3.2.1.20 3.2.1.3
2QMK	HUMAN PANCREATIC ALPHA-AMYLASE COMPLEXED WITH NITRITE	3.2.1.1
2QMP	CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH PL-100	3.4.23.16
2QMU	STRUCTURE OF AN ARCHAEAL HETEROTRIMERIC INITIATION FACTOR 2 REVEALS A NUCLEOTIDE STATE BETWEEN THE GTP AND THE GDP STATES	3.6.5.3
2QN0	STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE C1 LIGHT CHAIN PROTEASE	3.4.24.69
2QN6	STRUCTURE OF AN ARCHAEAL HETEROTRIMERIC INITIATION FACTOR 2 REVEALS A NUCLEOTIDE STATE BETWEEN THE GTP AND THE GDP STATES	3.6.5.3
2QNC	CRYSTAL STRUCTURE OF T4 ENDONUCLEASE VII N62D MUTANT IN COMPLEX WITH A DNA HOLLIDAY JUNCTION	3.1.22.4 3.1
2QNF	CRYSTAL STRUCTURE OF T4 ENDONUCLEASE VII H43N MUTANT IN COMPLEX WITH HETERODUPLEX DNA CONTAINING BASE MISMATCHES	3.1.22.4 3.1
2QNN	HIV-1 PROTEASE IN COMPLEX WITH A MULTIPLE DECORATED PYRROLIDINE-BASED INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QNO	CRYSTAL STRUCTURE OF THE MUTANT E55Q OF THE CELLULASE CEL48F IN COMPLEX WITH A THIO-OLIGOSACCHARIDE	3.2.1.4
2QNP	HIV-1 PROTEASE IN COMPLEX WITH A IODO DECORATED PYRROLIDINE-BASED INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QNQ	HIV-1 PROTEASE IN COMPLEX WITH A CHLORO DECORATED PYRROLIDINE-BASED INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2QOE	HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A TRIAZOLOPIPERAZINE-BASED BETA AMINO ACID INHIBITOR	3.4.14.5
2QOG	CROTOXIN B, THE BASIC PLA2 FROM CROTALUS DURISSUS TERRIFICUS.	3.1.1.4
2QOM	THE CRYSTAL STRUCTURE OF THE E.COLI ESPP AUTOTRANSPORTER BETA-DOMAIN.	3.4.21
2QP8	STRUCTURE OF BACE BOUND TO SCH734723	3.4.23.46
2QPJ	HUMAN NEP COMPLEXED WITH A BIFUNCTIONAL NEP/DPP IV INHIBITOR	3.4.24.11
2QPN	GES-1 BETA-LACTAMASE	3.5.2.6
2QPS	SUGAR TONGS" MUTANT Y380A IN COMPLEX WITH ACARBOSE"	3.2.1.1
2QPU	SUGAR TONGS MUTANT S378P IN COMPLEX WITH ACARBOSE	3.2.1.1
2QQ2	CRYSTAL STRUCTURE OF C-TERMINAL DOMAIN OF HUMAN ACYL-COA THIOESTERASE 7	3.1.2.2
2QQF	HST2 BOUND TO ADP-HPD AND ACETYLATED HISTONE H4	3.5.1 2.3.1.286
2QQG	HST2 BOUND TO ADP-HPD, ACETYLLATED HISTONE H4 AND NICOTINAMIDE	3.5.1 2.3.1.286
2QQU	CRYSTAL STRUCTURE OF A CELL-WALL INVERTASE (D239A) FROM ARABIDOPSIS THALIANA IN COMPLEX WITH SUCROSE	3.2.1.26
2QQV	CRYSTAL STRUCTURE OF A CELL-WALL INVERTASE (E203A) FROM ARABIDOPSIS THALIANA IN COMPLEX WITH SUCROSE	3.2.1.26
2QQW	CRYSTAL STRUCTURE OF A CELL-WALL INVERTASE (D23A) FROM ARABIDOPSIS THALIANA IN COMPLEX WITH SUCROSE	3.2.1.26
2QR5	AEROPYRUM PERNIX ACYLAMINOACYL PEPTIDASE, H367A MUTANT	3.4.19.1
2QRR	CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF THE ABC TRANSPORTER, ATP-BINDING PROTEIN FROM VIBRIO PARAHAEMOLYTICUS	3.6.3 7.4.2.11
2QRZ	CDC42 BOUND TO GMP-PCP: INDUCED FIT BY EFFECTOR IS REQUIRED	3.6.5.2
2QS9	CRYSTAL STRUCTURE OF THE HUMAN RETINOBLASTOMA-BINDING PROTEIN 9 (RBBP-9). NESG TARGET HR2978	3
2QSR	CRYSTAL STRUCTURE OF C-TERMINAL DOMAIN OF TRANSCRIPTION-REPAIR COUPLING FACTOR	3.6.4
2QSU	STRUCTURE OF ARABIDOPSIS THALIANA 5'-METHYLTHIOADENOSINE NUCLEOSIDASE IN APO FORM	3.2.2.16
2QSW	CRYSTAL STRUCTURE OF C-TERMINAL DOMAIN OF ABC TRANSPORTER / ATP-BINDING PROTEIN FROM ENTEROCOCCUS FAECALIS	3.6.3 7.4.2.11
2QT3	CRYSTAL STRUCTURE OF N-ISOPROPYLAMMELIDE ISOPROPYLAMINOHYDROLASE ATZC FROM PSEUDOMONAS SP. STRAIN ADP COMPLEXED WITH ZN	3.5.99.4 3.5.4.42
2QT7	CRYSTALLOGRAPHIC STRUCTURE OF THE MATURE ECTODOMAIN OF THE HUMAN RECEPTOR-TYPE PROTEIN-TYROSINE PHOSPHATASE IA-2 AT 1.30 ANGSTROMS	3.1.3.48
2QT9	HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH A 4-ARYL CYCLOHEXYLALANINE INHIBITOR	3.4.14.5
2QTB	HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 IN COMPLEX WITH A 4-ARYL CYCLOHEXYLALANINE INHIBITOR	3.4.14.5
2QTG	CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA 5'-METHYLTHIOADENOSINE NUCLEOSIDASE IN COMPLEX WITH 5'-METHYLTHIOTUBERCIDIN	3.2.2.16
2QTT	CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA 5'-METHYLTHIOADENOSINE NUCLEOSIDASE IN COMPLEX WITH FORMYCIN A	3.2.2.16
2QTW	THE CRYSTAL STRUCTURE OF PCSK9 AT 1.9 ANGSTROMS RESOLUTION REVEALS STRUCTURAL HOMOLOGY TO RESISTIN WITHIN THE C-TERMINAL DOMAIN	3.4.21
2QTY	CRYSTAL STRUCTURE OF MOUSE ADP-RIBOSYLHYDROLASE 3 (MARH3)	3.2.1.143 3.5.1 3.2.2
2QU2	BACE1 WITH COMPOUND 1	3.4.23.46
2QU3	BACE1 WITH COMPOUND 2	3.4.23.46
2QU9	CRYSTAL STRUCTURE OF THE COMPLEX OF GROUP II PHOSPHOLIPASE A2 WITH EUGENOL	3.1.1.4
2QUA	CRYSTAL STRUCTURE OF LIPA FROM SERRATIA MARCESCENS	3.1.1.3
2QUE	SATURATION OF SUBSTRATE-BINDING SITE USING TWO NATURAL LIGANDS: CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF PHOSPHOLIPASE A2 WITH ANISIC ACID AND AJMALINE AT 2.25 A RESOLUTION	3.1.1.4
2QUY	TRUNCATED MUTANT ASN175ALA OF PENICILLIN V ACYLASE FROM BACILLUS SPHAERICUS	3.5.1.11
2QUZ	CRYSTAL STRUCTURE OF THE ACTIVATING H-RASK117R MUTANT IN COSTELLO SYNDROME, BOUND TO MG-GDP	3.6.5.2
2QV2	A ROLE OF THE LOWE SYNDROME PROTEIN OCRL IN EARLY STEPS OF THE ENDOCYTIC PATHWAY	3.1.3.36 3.1.3.56 3.1.3.86
2QV4	HUMAN PANCREATIC ALPHA-AMYLASE COMPLEXED WITH NITRITE AND ACARBOSE	3.2.1.1
2QV6	GTP CYCLOHYDROLASE III FROM M. JANNASCHII (MJ0145) COMPLEXED WITH GTP AND METAL IONS	3.5.4.29
2QVB	CRYSTAL STRUCTURE OF HALOALKANE DEHALOGENASE RV2579 FROM MYCOBACTERIUM TUBERCULOSIS	3.8.1.5
2QVD	IDENTIFICATION OF A POTENT ANTI-INFLAMMATORY AGENT FROM THE NATURAL EXTRACT OF PLANT CARDIOSPERMUN HELICACABUM: CRYSTAL STRUCTURE OF THE COMPLEX OF PHOSPHOLIPASE A2 WITH BENZO(G)-1,3-BENZODIOXOLO(5,6-A)QUINOLIZINIUM, 5,6-DIHYDRO-9,10-DIMETHOXY AT 1.93 A RESOLUTION	3.1.1.4
2QVN	CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE FROM PLASMODIUM VIVAX IN COMPLEX WITH GUANOSINE	3.5.4.4
2QVR	E. COLI FRUCTOSE-1,6-BISPHOSPHATASE: CITRATE, FRU-2,6-P2, AND MG2+ BOUND	3.1.3.11
2QVU	PORCINE LIVER FRUCTOSE-1,6-BISPHOSPHATASE COCRYSTALLIZED WITH FRU-2,6-P2 AND MG2+, I(T)-STATE	3.1.3.11
2QVV	PORCINE LIVER FRUCTOSE-1,6-BISPHOSPHATASE COCRYSTALLIZED WITH FRU-2,6-P2 AND ZN2+, I(T)-STATE	3.1.3.11
2QWA	THE X-RAY STRUCTURE OF A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
2QWB	THE X-RAY STRUCTURE OF A COMPLEX OF SIALIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
2QWC	THE X-RAY STRUCTURE OF A COMPLEX OF NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
2QWD	THE X-RAY STRUCTURE OF A COMPLEX OF 4-AMINO-NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
2QWE	THE X-RAY STRUCTURE OF A COMPLEX OF 4-GUANIDINO-NEU5AC2EN AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
2QWF	THE X-RAY STRUCTURE OF A COMPLEX OF N-ACETYL-4-GUANIDINO-6-METHYL(PROPYL)CARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
2QWG	THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-4-AMINO-6-DIETHYLCARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
2QWH	THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-5-AMINO-3-(1-ETHYLPROPOXY)-1-CYCLOHEXENE-1-CARBOXYLIC ACID (GS4071) AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
2QWI	THE X-RAY STRUCTURE OF A COMPLEX OF N-ACETYL-4-GUANIDINO-6-METHYL(PROPYL)CARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND WILDTYPE TERN N9 INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
2QWJ	THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-4-AMINO-6-DIETHYLCARBOXAMIDE-4,5-DIHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND A DRUG RESISTANT VARIANT R292K OF TERN N9 INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
2QWK	THE X-RAY STRUCTURE OF A COMPLEX OF 5-N-ACETYL-5-AMINO-3-(1-ETHYLPROPOXY)-1-CYCLOHEXENE-1-CARBOXYLIC ACID (GS4071) AND WILDTYPE TERN N9 INFLUENZA VIRUS NEURAMINIDASE	3.2.1.18
2QXF	PRODUCT BOUND STRUCTURE OF EXONUCLEASE I AT 1.5 ANGSTROM RESOLUTION	3.1.11.1
2QXG	CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 7 IN COMPLEX WITH ALA-ALA-PHE-CHLOROMETHYLKETONE	3.4.21.117
2QXH	CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 7 IN COMPLEX WITH SUC-ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE	3.4.21.117
2QXI	HIGH RESOLUTION STRUCTURE OF HUMAN KALLIKREIN 7 IN COMPLEX WITH SUC-ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE	3.4.21.117
2QXJ	CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 7 IN COMPLEX WITH SUC-ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE AND COPPER	3.4.21.117
2QXT	CRYSTAL STRUCTURE ANALYSIS OF THE BACILLUS SUBTILIS LIPASE CRYSTALLIZED AT PH 4.5	3.1.1.3
2QXU	CRYSTAL STRUCTURE ANALYSIS OF THE BACILLUS SUBTILIS LIPASE CRYSTALLIZED AT PH 5.0	3.1.1.3
2QXX	BIFUNCTIONAL DCTP DEAMINASE: DUTPASE FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH DTTP	3.5.4.13 3.5.4.30
2QY0	ACTIVE DIMERIC STRUCTURE OF THE CATALYTIC DOMAIN OF C1R REVEALS ENZYME-PRODUCT LIKE CONTACTS	3.4.21.41
2QY2	CHARACTERIZATION OF A TRIFUNCTIONAL MIMIVIRUS MRNA CAPPING ENZYME AND CRYSTAL STRUCTURE OF THE RNA TRIPHOSPHATASE DOMAINM.	3.1.3.33 2.7.7.50 2.1.1.56
2QYI	CRYSTAL STRUCTURE OF A BINARY COMPLEX BETWEEN AN ENGINEERED TRYPSIN INHIBITOR AND BOVINE TRYPSIN	3.4.21.4
2QYK	CRYSTAL STRUCTURE OF PDE4A10 IN COMPLEX WITH INHIBITOR NPV	3.1.4.53
2QYL	CRYSTAL STRUCTURE OF PDE4B2B IN COMPLEX WITH INHIBITOR NPV	3.1.4.53
2QYM	CRYSTAL STRUCTURE OF UNLIGANDED PDE4C2	3.1.4.53
2QYN	CRYSTAL STRUCTURE OF PDE4D2 IN COMPLEX WITH INHIBITOR NPV	3.1.4.17 3.1.4.53
2QYV	CRYSTAL STRUCTURE OF PUTATIVE XAA-HIS DIPEPTIDASE (YP_718209.1) FROM HAEMOPHILUS SOMNUS 129PT AT 2.11 A RESOLUTION	3.4.13.20
2QZ2	CRYSTAL STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 11 XYLANASE FROM ASPERGILLUS NIGER IN COMPLEX WITH XYLOPENTAOSE	3.2.1.8
2QZ3	CRYSTAL STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 11 XYLANASE FROM BACILLUS SUBTILIS IN COMPLEX WITH XYLOTETRAOSE	3.2.1.8
2QZ4	HUMAN PARAPLEGIN, AAA DOMAIN IN COMPLEX WITH ADP	3.4.24
2QZ6	FIRST CRYSTAL STRUCTURE OF A PSYCHROPHILE CLASS C BETA-LACTAMASE	3.5.2.6
2QZE	MONOCLINIC MIMIVIRUS CAPPING ENZYME TRIPHOSPHATASE.	3.1.3.33 2.7.7.50 2.1.1.56
2QZK	CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH I21	3.4.23.46
2QZL	CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH IXS	3.4.23.46
2QZP	CRYSTAL STRUCTURE OF MUTATION OF AN ACYLPTIDE HYDROLASE/ESTERASE FROM AEROPYRUM PERNIX K1	3.4.19.1
2QZW	SECRETED ASPARTIC PROTEINASE (SAP) 1 FROM CANDIDA ALBICANS	3.4.23.24
2QZX	SECRETED ASPARTIC PROTEINASE (SAP) 5 FROM CANDIDA ALBICANS	3.4.23.24
2R04	STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
2R06	STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
2R07	STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
2R0K	PROTEASE DOMAIN OF HGFA WITH INHIBITOR FAB58	3.4.21
2R0L	SHORT FORM HGFA WITH INHIBITORY FAB75	3.4.21
2R11	CRYSTAL STRUCTURE OF PUTATIVE HYDROLASE (2632844) FROM BACILLUS SUBTILIS AT 1.96 A RESOLUTION	3.1.1.1
2R18	STRUCTURAL INSIGHTS INTO THE MULTIFUNCTIONAL PROTEIN VP3 OF BIRNAVIRUSES	3.4.21
2R1K	OPDA FROM AGROBACTERIUM RADIOBACTER WITH BOUND DIETHYL PHOSPHATE FROM CRYSTAL SOAKING WITH THE COMPOUND- 1.9 A	3.1.8.1
2R1L	OPDA FROM AGROBACTERIUM RADIOBACTER WITH BOUND DIETHYL THIOPHOSPHATE FROM CRYSTAL SOAKING WITH THE COMPOUND- 1.95 A	3.1.8.1
2R1M	OPDA FROM AGROBACTERIUM RADIOBACTER WITH BOUND PRODUCT DIETHYL PHOSPHATE FROM CRYSTAL SOAKING WITH DIETHYL 4-METHOXYPHENYL PHOSPHATE (450H)- 2.5 A	3.1.8.1
2R1N	OPDA FROM AGROBACTERIUM RADIOBACTER WITH BOUND SLOW SUBSTRATE DIETHYL 4-METHOXYPHENYL PHOSPHATE (20H)- 1.7 A	3.1.8.1
2R1P	OPDA FROM AGROBACTERIUM RADIOBACTER WITH BOUND PRODUCT DIETHYL THIOPHOSPHATE FROM CO-CRYSTALLISATION WITH TETRAETHYL DITHIOPYROPHOSPHATE- 1.8 A	3.1.8.1
2R1T	DOPAMINE QUINONE CONJUGATION TO DJ-1	3.1.2 3.5.1 3.5.1.124
2R1U	DJ-1 ACTIVATION BY CATECHOL QUINONE MODIFICATION	3.1.2 3.5.1 3.5.1.124
2R1V	NOREPINEPHRINE QUINONE CONJUGATION TO DJ-1	3.1.2 3.5.1 3.5.1.124
2R29	NEUTRALIZATION OF DENGUE VIRUS BY A SEROTYPE CROSS-REACTIVE ANTIBODY ELUCIDATED BY CRYOELECTRON MICROSCOPY AND X-RAY CRYSTALLOGRAPHY	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2R2D	STRUCTURE OF A QUORUM-QUENCHING LACTONASE (AIIB) FROM AGROBACTERIUM TUMEFACIENS	3.1.1.81
2R2M	2-(2-CHLORO-6-FLUOROPHENYL)ACETAMIDES AS POTENT THROMBIN INHIBITORS	3.4.21.5
2R2R	D(ATTAGTTATAACTAAT) COMPLEXED WITH MMLV RT CATALYTIC FRAGMENT	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
2R2S	CO(III)BLEOMYCINB2 BOUND TO D(ATTAGTTATAACTAAT) COMPLEXED WITH MMLV RT CATALYTIC FRAGMENT	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
2R2T	D(ATTTAGTTAACTAAAT) COMPLEXED WITH MMLV RT CATALYTIC FRAGMENT	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
2R2U	CO(III)BLEOMYCINB2 BITHIAZOLE/C-TERMINAL TAIL DOMAIN BOUND TO D(ATTTAGTTAACTAAAT) COMPLEXED WITH MMLV RT CATALYTIC FRAGMENT	2.7.7.49 3.4.23 2.7.7.7 3.1.26.4 2.7.7 3.1
2R2W	UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-GPPE COMPLEX	3.4.21.73
2R2X	RICIN A-CHAIN (RECOMBINANT) COMPLEX WITH UREA	3.2.2.22
2R38	I84V HIV-1 PROTEASE MUTANT IN COMPLEX WITH A CARBAMOYL DECORATED PYRROLIDINE-BASED INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2R3D	RICIN A-CHAIN (RECOMBINANT) COMPLEX WITH ACETAMIDE	3.2.2.22
2R3T	I50V HIV-1 PROTEASE MUTANT IN COMPLEX WITH A CARBAMOYL DECORATED PYRROLIDINE-BASED INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2R3U	CRYSTAL STRUCTURE OF THE PDZ DELETION MUTANT OF DEGS	3.4.21 3.4.21.107
2R3W	I84V HIV-1 PROTEASE IN COMPLEX WITH A AMINO DECORATED PYRROLIDINE-BASED INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2R3Y	CRYSTAL STRUCTURE OF THE DEGS PROTEASE IN COMPLEX WITH THE YWF ACTIVATING PEPTIDE	3.4.21 3.4.21.107
2R43	I50V HIV-1 PROTEASE IN COMPLEX WITH AN AMINO DECORATED PYRROLIDINE-BASED INHIBITOR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2R49	MUTATIONAL AND STRUCTURAL STUDIES OF E85I REVEAL THE FLEXIBLE LOOPS OF FIBROBACTER SUCCINOGENES 1,3-1,4-BETA-D-GLUCANASEGLUCANASE	3.2.1.73
2R59	LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH INHIBITOR RB3041	3.3.2.6 3.4.11.4
2R5O	CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF WZT	3.6.3.40
2R5P	CRYSTAL STRUCTURE ANALYSIS OF HIV-1 SUBTYPE C PROTEASE COMPLEXED WITH INDINAVIR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2R5Q	CRYSTAL STRUCTURE ANALYSIS OF HIV-1 SUBTYPE C PROTEASE COMPLEXED WITH NELFINAVIR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2R5R	THE CRYSTAL STRUCTURE OF DUF198 FROM NITROSOMONAS EUROPAEA ATCC 19718	3.5.4.16
2R5U	CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF DNAB HELICASE FROM MYCOBACTERIUM TUBERCULOSIS	3.6.1 3.6.4.12 3.1
2R5W	CRYSTAL STRUCTURE OF A BIFUNCTIONAL NMN ADENYLYLTRANSFERASE/ADP RIBOSE PYROPHOSPHATASE FROM FRANCISELLA TULARENSIS	2.7.7.1 3.6.1
2R62	CRYSTAL STRUCTURE OF HELICOBACTER PYLORI ATP DEPENDENT PROTEASE, FTSH	3.4.24
2R65	CRYSTAL STRUCTURE OF HELICOBACTER PYLORI ATP DEPENDENT PROTEASE, FTSH ADP COMPLEX	3.4.24
2R69	CRYSTAL STRUCTURE OF FAB 1A1D-2 COMPLEXED WITH E-DIII OF DENGUE VIRUS AT 3.8 ANGSTROM RESOLUTION	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2R6A	CRYSTAL FORM BH1	3.6.4.12
2R6E	CRYSTAL FORM B2	3.6.4.12
2R6G	THE CRYSTAL STRUCTURE OF THE E. COLI MALTOSE TRANSPORTER	3.6.3.19 7.5.2.1
2R6N	CRYSTAL STRUCTURE OF A PYRROLOPYRIMIDINE INHIBITOR IN COMPLEX WITH HUMAN CATHEPSIN K	3.4.22.38
2R71	CRYSTAL STRUCTURE OF THE COMPLEX OF BOVINE C-LOBE WITH INOSITOL AT 2.1A RESOLUTION	3.4.21
2R7C	CRYSTALLOGRAPHIC AND BIOCHEMICAL ANALYSIS OF ROTAVIRUS NSP2 WITH NUCLEOTIDES REVEALS AN NDP KINASE LIKE ACTIVITY	3.6.4
2R7J	CRYSTAL STRUCTURE OF ROTAVIRUS NON STRUCTURAL PROTEIN NSP2 WITH H225A MUTATION	3.6.4
2R7P	CRYSTAL STRUCTURE OF H225A NSP2 AND AMPPNP COMPLEX	3.6.4
2R7Y	SELENIUM DERIVATIZED RNA/DNA HYBRID IN COMPLEX WITH RNASE H CATALYTIC DOMAIN MUTANT D132N	3.1.26.4
2R8E	CRYSTAL STRUCTURE OF YRBI FROM ESCHERICHIA COLI IN COMPLEX WITH MG	3.1.3.45
2R8F	CRYSTAL STRUCTURE OF H225A NSP2 AND ATP-GS COMPLEX	3.6.4
2R8N	STRUCTURAL ANALYSIS OF THE UNBOUND FORM OF HIV-1 SUBTYPE C PROTEASE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2R8Q	STRUCTURE OF LMJPDEB1 IN COMPLEX WITH IBMX	3.1.4.17 3.1.4
2R8T	CRYSTAL STRUCTURE OF THE FRUCTOSE 1,6-BISPHOSPHATASE GLPX FROM E.COLI IN THE COMPLEX WITH FRUCTOSE 1,6-BISPHOSPHATE	3.1.3.11
2R8X	CRYSTAL STRUCTURE OF YRBI PHOSPHATASE FROM ESCHERICHIA COLI	3.1.3.45
2R9B	STRUCTURAL ANALYSIS OF PLASMEPSIN 2 FROM PLASMODIUM FALCIPARUM COMPLEXED WITH A PEPTIDE-BASED INHIBITOR	3.4.23.39
2R9C	CALPAIN 1 PROTEOLYTIC CORE INACTIVATED BY ZLAK-3001, AN ALPHA-KETOAMIDE	3.4.22.52
2R9F	CALPAIN 1 PROTEOLYTIC CORE INACTIVATED BY ZLAK-3002, AN ALPHA-KETOAMIDE	3.4.22.52
2R9J	LIGAND RECOGNITION IN C-LOBE: THE CRYSTAL STRUCTURE OF THE COMPLEX OF LACTOFERRIN C-LOBE WITH NICOTINAMIDE AT 2.5 A RESOLUTION	3.4.21
2R9K	CRYSTAL STRUCTURE OF MISTELTOE LECTIN I IN COMPLEX WITH PHLORETAMIDE	3.2.2.22
2R9M	CATHEPSIN S COMPLEXED WITH COMPOUND 15	3.4.22.27
2R9N	CATHEPSIN S COMPLEXED WITH COMPOUND 26	3.4.22.27
2R9O	CATHEPSIN S COMPLEXED WITH COMPOUND 8	3.4.22.27
2R9P	HUMAN MESOTRYPSIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR(BPTI)	3.4.21.4
2R9V	CRYSTAL STRUCTURE OF ATP SYNTHASE SUBUNIT ALPHA (TM1612) FROM THERMOTOGA MARITIMA AT 2.10 A RESOLUTION	3.6.3.14 7.1.2.2
2R9W	AMPC BETA-LACTAMASE WITH BOUND PHTHALAMIDE INHIBITOR	3.5.2.6
2R9X	AMPC BETA-LACTAMASE WITH BOUND PHTHALAMIDE INHIBITOR	3.5.2.6
2RA0	X-RAY STRUCTURE OF FXA IN COMPLEX WITH 7-FLUOROINDAZOLE	3.4.21.6
2RA3	HUMAN CATIONIC TRYPSIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI)	3.4.21.4
2RAP	THE SMALL G PROTEIN RAP2A IN COMPLEX WITH GTP	3.6.5.2
2RAT	EFFECTS OF TEMPERATURE ON PROTEIN STRUCTURE AND DYNAMICS: X-RAY CRYSTALLOGRAPHIC STUDIES OF THE PROTEIN RIBONUCLEASE-A AT NINE DIFFERENT TEMPERATURES FROM 98 TO 320 K	3.1.27.5 4.6.1.18
2RAY	BETA-CHLOROPHENETOLE IN COMPLEX WITH T4 LYSOZYME L99A	3.2.1.17
2RAZ	4-(METHYLTHIO)NITROBENZENE IN COMPLEX WITH T4 LYSOZYME L99A	3.2.1.17
2RB0	2,6-DIFLUOROBENZYLBROMIDE COMPLEX WITH T4 LYSOZYME L99A	3.2.1.17
2RB1	2-ETHOXYPHENOL IN COMPLEX WITH T4 LYSOZYME L99A	3.2.1.17
2RB2	3-METHYLBENZYLAZIDE IN COMPLEX WITH T4 LYSOZYME L99A	3.2.1.17
2RB4	CRYSTAL STRUCTURE OF THE HELICASE DOMAIN OF HUMAN DDX25 RNA HELICASE	3.6.1 3.6.4.13
2RBA	STRUCTURE OF HUMAN THYMINE DNA GLYCOSYLASE BOUND TO ABASIC AND UNDAMAGED DNA	3.2.2 3.2.2.29
2RBI	STRUCTURE OF BINASE MUTANT HIS 101 ASN	3.1.27
2RBM	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT DELTA+PHS I72K AT CRYOGENIC TEMPERATURE	3.1.31.1
2RBN	N-PHENYLGLYCINONITRILE IN COMPLEX WITH T4 LYSOZYME L99A/M102Q	3.2.1.17
2RBO	2-NITROTHIOPHENE IN COMPLEX WITH T4 LYSOZYME L99A/M102Q	3.2.1.17
2RBP	2-(N-PROPYLTHIO)ETHANOL IN COMPLEX WITH T4 LYSOZYME L99A/M102Q	3.2.1.17
2RBQ	3-METHYLBENZYLAZIDE IN COMPLEX WITH T4 L99A/M102Q	3.2.1.17
2RBR	2-PHENOXYETHANOL IN COMPLEX WITH T4 LYSOZYME L99A/M102Q	3.2.1.17
2RBS	(R)(+)-3-CHLORO-1-PHENYL-1-PROPANOL IN COMPLEX WITH T4 LYSOZYME L99A/M102Q	3.2.1.17
2RCE	DFP MODIFIED DEGS DELTA PDZ	3.4.21 3.4.21.107
2RCN	CRYSTAL STRUCTURE OF THE RIBOSOMAL INTERACTING GTPASE YJEQ FROM THE ENTEROBACTERIAL SPECIES SALMONELLA TYPHIMURIUM.	3.6.1
2RCX	AMPC BETA-LACTAMASE IN COMPLEX WITH (1R)-1-(2-THIOPHEN-2-YL-ACETYLAMINO)-1-(3-(2-CARBOXYVINYL)-PHENYL) METHYLBORONIC ACID	3.5.2.6
2RD3	CRYSTAL STRUCTURE OF TENA HOMOLOGUE (HP1287) FROM HELICOBACTER PYLORI	3.5.99.2
2RD4	DESIGN OF SPECIFIC INHIBITORS OF PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX OF PHOSPHOLIPASE A2 WITH PENTAPEPTIDE LEU-VAL-PHE-PHE-ALA AT 2.9 A RESOLUTION	3.1.1.4
2RDF	CRYSTAL STRUCTURE OF STAPHYLOCCOCAL NUCLEASE VIAGAN/E75A VARIANT AT CRYOGENIC TEMPERATURE	3.1.31.1
2REN	STRUCTURE OF RECOMBINANT HUMAN RENIN, A TARGET FOR CARDIOVASCULAR-ACTIVE DRUGS, AT 2.5 ANGSTROMS RESOLUTION	3.4.23.15
2REU	CRYSTAL STRUCTURE OF THE C-TERMINAL OF SAU3AI FRAGMENT	3.1.21.4
2RF2	HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7E (NNRTI)	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2RF6	CRYSTAL STRUCTURE OF THE VACCINIA VIRUS DUAL-SPECIFICITY PHOSPHATASE VH1	3.1.3.48 3.1.3.16 3.1.3
2RF8	CRYSTAL STRUCTURE OF THE MUTANT C2A CONJUGATED BILE ACID HYDROLASE FROM CLOSTRIDIUM PERFRINGENS	3.5.1.24 3.5.1
2RFH	CRYSTAL STRUCTURE ANALYSIS OF CPA-2-BENZYL-3-NITROPROPANOIC ACID COMPLEX	3.4.17.1
2RFL	CRYSTAL STRUCTURE OF THE PUTATIVE PHOSPHOHISTIDINE PHOSPHATASE SIXA FROM AGROBACTERIUM TUMEFACIENS	5.4.2.1 3.1.3.13 5.4.2.4
2RFW	CRYSTAL STRUCTURE OF CELLOBIOHYDROLASE FROM MELANOCARPUS ALBOMYCES	3.2.1.91 3.2.1
2RFY	CRYSTAL STRUCTURE OF CELLOBIOHYDROLASE FROM MELANOCARPUS ALBOMYCES COMPLEXED WITH CELLOBIOSE	3.2.1.91 3.2.1
2RFZ	CRYSTAL STRUCTURE OF CELLOBIOHYDROLASE FROM MELANOCARPUS ALBOMYCES COMPLEXED WITH CELLOTRIOSE	3.2.1.91 3.2.1
2RG0	CRYSTAL STRUCTURE OF CELLOBIOHYDROLASE FROM MELANOCARPUS ALBOMYCES COMPLEXED WITH CELLOTETRAOSE	3.2.1.91 3.2.1
2RG2	CRYSTAL STRUCTURE OF VARIANT R18L OF CONJUGATED BILE ACID HYDROLASE FROM CLOSTRIDIUM PERFRINGENS	3.5.1.24 3.5.1
2RG3	COVALENT COMPLEX STRUCTURE OF ELASTASE	3.4.21.37
2RG9	CRYSTAL STRUCTURE OF VISCUM ALBUM MISTLETOE LECTIN I IN NATIVE STATE AT 1.95 A RESOLUTION, COMPARISON OF STRUCTURE ACTIVE SITE CONFORMATION IN RICIN AND IN VISCUMIN	3.2.2.22
2RGA	CRYSTAL STRUCTURE OF H-RASQ61I-GPPNHP	3.6.5.2
2RGB	CRYSTAL STRUCTURE OF H-RASQ61K-GPPNHP	3.6.5.2
2RGC	CRYSTAL STRUCTURE OF H-RASQ61V-GPPNHP	3.6.5.2
2RGD	CRYSTAL STRUCTURE OF H-RASQ61L-GPPNHP	3.6.5.2
2RGE	CRYSTAL STRUCTURE OF H-RAS-GPPNHP	3.6.5.2
2RGG	CRYSTAL STRUCTURE OF H-RASQ61I-GPPNHP, TRIGONAL CRYSTAL FORM	3.6.5.2
2RGL	RICE BGLU1 BETA-GLUCOSIDASE, A PLANT EXOGLUCANASE/BETA-GLUCOSIDASE	3.2.1.21
2RGM	RICE BGLU1 BETA-GLUCOSIDASE, A PLANT EXOGLUCANASE/BETA-GLUCOSIDASE	3.2.1.21
2RGU	CRYSTAL STRUCTURE OF COMPLEX OF HUMAN DPP4 AND INHIBITOR	3.4.14.5
2RH1	HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN B2-ADRENERGIC G PROTEIN-COUPLED RECEPTOR.	3.2.1.17
2RH6	STRUCTURE OF XAC NPP FOR EVALUATION OF REFINEMENT METHODOLOGY	3.6.1.9
2RHB	CRYSTAL STRUCTURE OF NSP15-H234A MUTANT- HEXAMER IN ASYMMETRIC UNIT	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2RHF	D. RADIODURANS RECQ HRDC DOMAIN 3	3.6.4.12
2RHT	CRYSTAL STRUCTURE OF THE S112A MUTANT OF A C-C HYDROLASE, BPHD FROM BURKHOLDERIA XENOVORANS LB400, IN COMPLEX WITH 3-CL HOPDA	3.7.1 3.7.1.8
2RHW	CRYSTAL STRUCTURE OF THE S112A MUTANT OF A C-C HYDROLASE, BPHD FROM BURKHOLDERIA XENOVORANS LB400, IN COMPLEX WITH 3,10-DI-FLUORO HOPDA	3.7.1 3.7.1.8
2RI0	CRYSTAL STRUCTURE OF GLUCOSAMINE 6-PHOSPHATE DEAMINASE (NAGB) FROM S. MUTANS	3.5.99.6
2RI1	CRYSTAL STRUCTURE OF GLUCOSAMINE 6-PHOSPHATE DEAMINASE (NAGB) WITH GLCN6P FROM S. MUTANS	3.5.99.6
2RI6	CRYSTAL STRUCTURE OF S112A MUTANT OF A C-C HYDROLASE, BPHD FROM BURKHOLDERIA XENOVORANS LB400	3.7.1 3.7.1.8
2RI8	PENICILLIUM CITRINUM ALPHA-1,2-MANNOSIDASE COMPLEX WITH GLYCEROL	3.2.1.113
2RI9	PENICILLIUM CITRINUM ALPHA-1,2-MANNOSIDASE IN COMPLEX WITH A SUBSTRATE ANALOG	3.2.1.113
2RIO	STRUCTURE OF THE DUAL ENZYME IRE1 REVEALS THE BASIS FOR CATALYSIS AND REGULATION OF NON-CONVENTIONAL SPLICING	2.7.11.1 3.1.26
2RIP	STRUCTURE OF DPPIV IN COMPLEX WITH AN INHIBITOR	3.4.14.5
2RJP	CRYSTAL STRUCTURE OF ADAMTS4 WITH INHIBITOR BOUND	3.4.24.82
2RJQ	CRYSTAL STRUCTURE OF ADAMTS5 WITH INHIBITOR BOUND	3.4.24
2RK3	STRUCTURE OF A104T DJ-1	3.1.2 3.5.1 3.5.1.124
2RK4	STRUCTURE OF M26I DJ-1	3.1.2 3.5.1 3.5.1.124
2RK6	STRUCTURE OF E163K DJ-1	3.1.2 3.5.1 3.5.1.124
2RKF	HIV-1 PR RESISTANT MUTANT + LPV	3.4.23.16 2.7.7.49 3.1.26.13
2RKG	HIV-1 PR RESISTANT MUTANT + LPV	3.4.23.16 2.7.7.49 3.1.26.13
2RKI	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A TRIAZOLE DERIVED NNRTI	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2RKS	CRYSTAL STRUCTURE OF STAPHYLOCOCCAL NUCLEASE VARIANT PHS L38K AT CRYOGENIC TEMPERATURE	3.1.31.1
2RKW	INTERMEDIATE POSITION OF ATP ON ITS TRAIL TO THE BINDING POCKET INSIDE THE SUBUNIT B MUTANT R416W OF THE ENERGY CONVERTER A1AO ATP SYNTHASE	3.6.3.14
2RL3	CRYSTAL STRUCTURE OF THE OXA-10 W154H MUTANT AT PH 7	3.5.2.6
2RLA	ALTERING THE BINUCLEAR MANGANESE CLUSTER OF ARGINASE DIMINISHES THERMOSTABILITY AND CATALYTIC FUNCTION	3.5.3.1
2RLC	CRYSTAL STRUCTURE OF THE CONJUGATED BILE ACID HYDROLASE FROM CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH REACTION PRODUCTS GLYCINE AND CHOLATE	3.5.1.24 3.5.1
2RLN	THERMODYNAMIC AND STRUCTURAL CONSEQUENCES OF CHANGING A SULPHUR ATOM TO A METHYLENE GROUP IN THE M13NLE MUTATION IN RIBONUCLEASE S	3.1.27.5 4.6.1.18
2RLT	PHOSPHORYLATED CPI-17 (22-120)	3.1
2RM2	STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
2RMJ	SOLUTION STRUCTURE OF RIG-I C-TERMINAL DOMAIN	3.6.1 3.6.4.13
2RMK	RAC1/PRK1 COMPLEX	3.6.5.2
2RML	SOLUTION STRUCTURE OF THE N-TERMINAL SOLUBLE DOMAINS OF BACILLUS SUBTILIS COPA	3.6.3 7.2.2.8
2RMP	RMP-PEPSTATIN A COMPLEX	3.4.23.23
2RMU	THREE-DIMENSIONAL STRUCTURES OF DRUG-RESISTANT MUTANTS OF HUMAN RHINOVIRUS 14	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
2RMX	SOLUTION STRUCTURE OF THE SHP-1 C-TERMINAL SH2 DOMAIN COMPLEXED WITH A TYROSINE-PHOSPHORYLATED PEPTIDE FROM NKG2A	3.1.3.48
2RN2	STRUCTURAL DETAILS OF RIBONUCLEASE H FROM ESCHERICHIA COLI AS REFINED TO AN ATOMIC RESOLUTION	3.1.26.4
2RNF	X-RAY CRYSTAL STRUCTURE OF HUMAN RIBONUCLEASE 4 IN COMPLEX WITH D(UP)	3.1.27
2RNK	NMR STRUCTURE OF THE DOMAIN 513-651 OF THE SARS-COV NONSTRUCTURAL PROTEIN NSP3	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2RNS	REFINEMENT OF THE CRYSTAL STRUCTURE OF RIBONUCLEASE S. COMPARISON WITH AND BETWEEN THE VARIOUS RIBONUCLEASE A STRUCTURES	3.1.27.5 4.6.1.18
2RNT	THREE-DIMENSIONAL STRUCTURE OF RIBONUCLEASE T1 COMPLEXED WITH GUANYLYL-2(PRIME),5(PRIME)-GUANOSINE AT 1.8 ANGSTROMS RESOLUTION	3.1.27.3 4.6.1.24
2ROK	SOLUTION STRUCTURE OF THE CAP-BINDING DOMAIN OF PARN COMPLEXED WITH THE CAP ANALOG	3.1.13.4
2RON	THE EXTERNAL THIOESTERASE OF THE SURFACTIN-SYNTHETASE	3.1.2
2ROP	SOLUTION STRUCTURE OF DOMAINS 3 AND 4 OF HUMAN ATP7B	3.6.3.4 7.2.2.8
2RPA	THE SOLUTION STRUCTURE OF N-TERMINAL DOMAIN OF MICROTUBULE SEVERING ENZYME	3.6.4.3 5.6.1.1
2RPI	THE NMR STRUCTURE OF THE SUBMILLISECOND FOLDING INTERMEDIATE OF THE THERMUS THERMOPHILUS RIBONUCLEASE H	3.1.26.4
2RPZ	SOLUTION STRUCTURE OF THE MONOMERIC FORM OF MOUSE APOBEC2	3.5.4 3.5.4.36
2RQ6	SOLUTION STRUCTURE OF THE EPSILON SUBUNIT OF THE F1-ATPASE FROM THERMOSYNECHOCOCCUS ELONGATUS BP-1	3.6.3.14
2RQA	SOLUTION STRUCTURE OF LGP2 CTD	3.6.1 3.6.4.13
2RQB	SOLUTION STRUCTURE OF MDA5 CTD	3.6.1 3.6.4.13
2RR1	STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
2RRD	STRUCTURE OF HRDC DOMAIN FROM HUMAN BLOOM SYNDROME PROTEIN, BLM	3.6.4.12
2RRK	SOLUTION STRUCTURE OF THE E. COLI ORF135 PROTEIN	3.6.1 3.6.1.65
2RS1	STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
2RS3	STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
2RS5	STRUCTURAL ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES	3.4.22.29 3.6.1.15 3.4.22.28 2.7.7.48
2RS6	SOLUTION STRUCTURE OF THE N-TERMINAL DSRBD FROM RNA HELICASE A	3.6.4.13
2RS7	SOLUTION STRUCTURE OF THE SECOND DSRBD FROM RNA HELICASE A	3.6.4.13
2RSC	SOLUTION STRUCTURE OF THE BOMBYX MORI LYSOZYME	3.2.1.17
2RSP	STRUCTURE OF THE ASPARTIC PROTEASE FROM ROUS SARCOMA RETROVIRUS REFINED AT 2 ANGSTROMS RESOLUTION	3.4.23
2RSW	NMR STRUCTURE, LOCALIZATION AND VESICLE FUSION OF CHIKUNGUNYA VIRUS FUSION PEPTIDE	3.4.21.90
2RTX	SOLUTION STRUCTURE OF THE GGQ DOMAIN OF YAEJ PROTEIN FROM ESCHERICHIA COLI	3.1.1.29
2RVE	THE CRYSTAL STRUCTURE OF ECORV ENDONUCLEASE AND OF ITS COMPLEXES WITH COGNATE AND NON-COGNATE DNA SEGMENTS	3.1.21.4
2SAM	STRUCTURE OF THE PROTEASE FROM SIMIAN IMMUNODEFICIENCY VIRUS: COMPLEX WITH AN IRREVERSIBLE NON-PEPTIDE INHIBITOR	2.7.7.49 3.1.13.2 3.1.26.13
2SBT	A COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF SUBTILISIN BPN AND SUBTILISIN NOVO	3.4.21.14 3.4.21.62
2SEC	STRUCTURAL COMPARISON OF TWO SERINE PROTEINASE-PROTEIN INHIBITOR COMPLEXES. EGLIN-C-SUBTILISIN CARLSBERG AND CI-2-SUBTILISIN NOVO	3.4.21.62
2SFA	SERINE PROTEINASE FROM STREPTOMYCES FRADIAE ATCC 14544	3.4.21
2SGA	ELECTRON DENSITY CALCULATIONS AS AN EXTENSION OF PROTEIN STRUCTURE REFINEMENT. STREPTOMYCES GRISEUS PROTEASE AT 1.5 ANGSTROMS RESOLUTION	3.4.21.80
2SGD	ASP 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 10.7	3.4.21.81
2SGE	GLU 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 10.7	3.4.21.81
2SGF	PHE 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B	3.4.21.81
2SGP	PRO 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5	3.4.21.81
2SGQ	GLN 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5	3.4.21.81
2SHP	TYROSINE PHOSPHATASE SHP-2	3.1.3.48
2SIC	REFINED CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' AND STREPTOMYCES SUBTILISIN INHIBITOR AT 1.8 ANGSTROMS RESOLUTION	3.4.21.14 3.4.21.62
2SIL	THE STRUCTURES OF SALMONELLA TYPHIMURIUM LT2 NEURAMINIDASE AND ITS COMPLEX WITH A TRANSITION STATE ANALOGUE AT 1.6 ANGSTROMS RESOLUTION	3.2.1.18
2SIM	THE STRUCTURES OF SALMONELLA TYPHIMURIUM LT2 NEURAMINIDASE AND ITS COMPLEX WITH A TRANSITION STATE ANALOGUE AT 1.6 ANGSTROMS RESOLUTION	3.2.1.18
2SLI	LEECH INTRAMOLECULAR TRANS-SIALIDASE COMPLEXED WITH 2,7-ANHYDRO-NEU5AC, THE REACTION PRODUCT	3.2.1.18 4.2.2.15
2SNI	STRUCTURAL COMPARISON OF TWO SERINE PROTEINASE-PROTEIN INHIBITOR COMPLEXES. EGLIN-C-SUBTILISIN CARLSBERG AND CI-2-SUBTILISIN NOVO	3.4.21.14 3.4.21.62
2SNM	IN A STAPHYLOCOCCAL NUCLEASE MUTANT THE SIDE-CHAIN OF A LYSINE REPLACING VALINE 66 IS FULLY BURIED IN THE HYDROPHOBIC CORE	3.1.31.1
2SNS	STAPHYLOCOCCAL NUCLEASE. PROPOSED MECHANISM OF ACTION BASED ON STRUCTURE OF ENZYME-THYMIDINE 3(PRIME),5(PRIME)-BIPHOSPHATE-CALCIUM ION COMPLEX AT 1.5-ANGSTROMS RESOLUTION	3.1.31.1
2SNV	THE REFINED STRUCTURE OF SINDBIS VIRUS CORE PROTEIN IN COMPARISON WITH OTHER CHYMOTRYPSIN-LIKE SERINE PROTEINASE STRUCTURES	3.4.21.90
2SNW	SINDBIS VIRUS CAPSID PROTEIN, TYPE3 CRYSTAL FORM	3.4.21 3.4.21.90
2SOB	SN-OB, OB-FOLD SUB-DOMAIN OF STAPHYLOCOCCAL NUCLEASE, NMR, 10 STRUCTURES	3.1.31.1
2SPT	DIFFERENCES IN THE METAL ION STRUCTURE BETWEEN SR-AND CA-PROTHROMBIN FRAGMENT 1	3.4.21.5
2SRT	CATALYTIC DOMAIN OF HUMAN STROMELYSIN-1 AT PH 5.5 AND 40OC COMPLEXED WITH INHIBITOR	3.4.24.17
2ST1	THE THREE-DIMENSIONAL STRUCTURE OF BACILLUS AMYLOLIQUEFACIENS SUBTILISIN AT 1.8 ANGSTROMS AND AN ANALYSIS OF THE STRUCTURAL CONSEQUENCES OF PEROXIDE INACTIVATION	3.4.21.14 3.4.21.62
2STA	ANIONIC SALMON TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA MAXIMA TRYPSIN INHIBITOR I)	3.4.21.4
2STB	ANIONIC SALMON TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA PEPO TRYPSIN INHIBITOR II)	3.4.21.4
2TAA	STRUCTURE AND POSSIBLE CATALYTIC RESIDUES OF TAKA-AMYLASE A	3.2.1.1
2TBS	COLD-ADAPTION OF ENZYMES: STRUCTURAL COMPARISON BETWEEN SALMON AND BOVINE TRYPSINS	3.4.21.4
2TCL	STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR	3.4.24.7
2TEC	MOLECULAR DYNAMICS REFINEMENT OF A THERMITASE-EGLIN-C COMPLEX AT 1.98 ANGSTROMS RESOLUTION AND COMPARISON OF TWO CRYSTAL FORMS THAT DIFFER IN CALCIUM CONTENT	3.4.21.66
2TGA	ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY	3.4.21.4
2TGD	LACK OF THE TRANSITION STATE STABILIZATION SITE IS A FACTOR IN THE INACTIVITY OF TRYPSINOGEN, A SERINE PROTEASE ZYMOGEN. STRUCTURE OF DFP INHIBITED BOVINE TRYPSINOGEN AT 2.1 ANGSTROMS RESOLUTION	3.4.21.4
2TGT	ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY	3.4.21.4
2THF	STRUCTURE OF HUMAN ALPHA-THROMBIN Y225F MUTANT BOUND TO D-PHE-PRO-ARG-CHLOROMETHYLKETONE	3.4.21.5
2TIO	LOW PACKING DENSITY FORM OF BOVINE BETA-TRYPSIN IN CYCLOHEXANE	3.4.21.4
2TLD	CRYSTAL STRUCTURE OF AN ENGINEERED SUBTILISIN INHIBITOR COMPLEXED WITH BOVINE TRYPSIN	3.4.21.4
2TLI	THERMOLYSIN (5% ISOPROPANOL SOAKED CRYSTALS)	3.4.24.27
2TLX	THERMOLYSIN (NATIVE)	3.4.24.27
2TMN	CRYSTALLOGRAPHIC STRUCTURAL ANALYSIS OF PHOSPHORAMIDATES AS INHIBITORS AND TRANSITION-STATE ANALOGS OF THERMOLYSIN	3.4.24.27
2TRM	THE THREE-DIMENSIONAL STRUCTURE OF ASN102 MUTANT OF TRYPSIN. ROLE OF ASP102 IN SERINE PROTEASE CATALYSIS	3.4.21.4
2UBP	STRUCTURE OF NATIVE UREASE FROM BACILLUS PASTEURII	3.5.1.5
2ULL	MULTIPLE CONFORMATION STRUCTURE OF ALPHA-LYTIC PROTEASE AT 120 K	3.4.21.12
2UPJ	HIV-1 PROTEASE COMPLEX WITH U100313 ([3-[[3-[CYCLOPROPYL [4-HYDROXY-2OXO-6-[1-(PHENYLMETHYL)PROPYL]-2H-PYRAN-3-YL] METHYL]PHENYL]AMINO]-3-OXO-PROPYL]CARBAMIC ACID TERT-BUTYL ESTER)	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2USH	5'-NUCLEOTIDASE FROM E. COLI	3.1.3.5 3.6.1.45
2USN	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST STROMELYSIN-1 INHIBITED WITH THIADIAZOLE INHIBITOR PNU-141803	3.4.24.17
2UUF	THROMBIN-HIRUGEN BINARY COMPLEX AT 1.26A RESOLUTION	3.4.21.5
2UUG	ESCHERICHIA COLI URACIL-DNA GLYCOSYLASE:INHIBITOR COMPLEX WITH H187D MUTANT UDG AND WILD-TYPE UGI	3.2.2.3 3.2.2.27
2UUJ	THROMBIN-HIRUGEN-GW473178 TERNARY COMPLEX AT 1.32A RESOLUTION	3.4.21.5
2UUK	THROMBIN-HIRUGEN-GW420128 TERNARY COMPLEX AT 1.39A RESOLUTION	3.4.21.5
2UUT	THE 2.4 ANGSTROM RESOLUTION STRUCTURE OF THE D346G MUTANT OF THE SAPPORO VIRUS RDRP POLYMERASE	2.7.7.48 3.6.1.15 3.4.22.66
2UUW	2.75 ANGSTROM STRUCTURE OF THE D347G D348G MUTANT STRUCTURE OF SAPPORO VIRUS RDRP POLYMERASE	2.7.7.48 3.6.1.15 3.4.22.66
2UUY	STRUCTURE OF A TICK TRYPTASE INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN	3.4.21.4
2UWA	CRYSTAL STRUCTURE OF THE NASTURTIUM SEEDLING XYLOGLUCANASE ISOFORM NXG1	3.2.1.151 3.2.1.4 2.4.1.207
2UWB	CRYSTAL STRUCTURE OF THE NASTURTIUM SEEDLING MUTANT XYLOGLUCANASE ISOFORM NXG1-DELTA-YNIIG	3.2.1.151 3.2.1.4 2.4.1.207
2UWC	CRYSTAL STRUCTURE OF NASTURTIUM XYLOGLUCAN HYDROLASE ISOFORM NXG2	3.2.1.151 3.2.1.4 2.4.1.207
2UWF	CRYSTAL STRUCTURE OF FAMILY 10 XYLANASE FROM BACILLUS HALODURANS	3.2.1.8
2UWL	SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA	3.4.21.6
2UWO	SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA	3.4.21.6
2UWP	FACTOR XA INHIBITOR COMPLEX	3.4.21.6
2UWX	ACTIVE SITE RESTRUCTURING REGULATES LIGAND RECOGNITION IN CLASS A PENICILLIN-BINDING PROTEINS	2.4.1.129 2.3.2 3.4.16.4
2UXS	2.7A CRYSTAL STRUCTURE OF INORGANIC PYROPHOSPHATASE (RV3628) FROM MYCOBACTERIUM TUBERCULOSIS AT PH 7.5	3.6.1.1
2UXY	ALIPHATIC AMIDASE	3.5.1.4
2UXZ	TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY- ALCOHOL-CONTAINING TRANSITION-STATE MIMIC	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2UY0	TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY- ALCOHOL-CONTAINING TRANSITION-STATE MIMIC	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2UY2	SCCTS1_APO CRYSTAL STRUCTURE	3.2.1.14
2UY3	SCCTS1_8-CHLOROTHEOPHYLLINE CRYSTAL STRUCTURE	3.2.1.14
2UY4	SCCTS1_ACETAZOLAMIDE CRYSTAL STRUCTURE	3.2.1.14
2UY5	SCCTS1_KINETIN CRYSTAL STRUCTURE	3.2.1.14
2UYJ	CRYSTAL STRUCTURE OF E. COLI TDCF WITH BOUND ETHYLENE GLYCOL	3.5.4
2UYK	CRYSTAL STRUCTURE OF E. COLI TDCF WITH BOUND SERINE	3.5.4
2UYN	CRYSTAL STRUCTURE OF E. COLI TDCF WITH BOUND 2-KETOBUTYRATE	3.5.4
2UYP	CRYSTAL STRUCTURE OF E. COLI TDCF WITH BOUND PROPIONATE	3.5.4
2UYR	CRYSTAL STRUCTURE OF BACILLUS CEREUS SPHINGOMYELINASE MUTANT :N57A	3.1.4.12
2UYX	METALLO-BETA-LACTAMASE (1BC2) SINGLE POINT MUTANT D120S	3.5.2.6
2UZ9	HUMAN GUANINE DEAMINASE (GUAD) IN COMPLEX WITH ZINC AND ITS PRODUCT XANTHINE.	3.5.4.3
2UZG	ZF-UBP DOMAIN OF VDU1	3.4.19.12
2UZJ	CRYSTAL STRUCTURE OF THE MATURE STREPTOCOCCAL CYSTEINE PROTEASE, MSPEB	3.4.22.10
2UZQ	PROTEIN PHOSPHATASE, NEW CRYSTAL FORM	3.1.3.48
2V00	X-RAY CRYSTAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH COMPOUND 1	3.4.23.22
2V06	CRYSTAL STRUCTURE OF THE PPM SER-THR PHOSPHATASE MSPP FROM MYCOBACTERIUM SMEGMATIS AT PH 5.5	3.1.3
2V0B	SAD STRUCTURE SOLUTION PORCINE PANCREATIC ELASTASE FROM A SELENATE DERIVATIVE	3.4.21.36
2V0E	BRK DOMAIN FROM HUMAN CHD7	3.6.1 3.6.4.12
2V0F	BRK DOMAIN FROM HUMAN CHD7	3.6.1 3.6.4.12
2V0R	CRYSTAL STRUCTURE OF A HAIRPIN EXCHANGE VARIANT (LTX) OF THE TARGETING LINE-1 RETROTRANSPOSON ENDONUCLEASE	2.7.7.49 3.1.21
2V0S	CRYSTAL STRUCTURE OF A HAIRPIN EXCHANGE VARIANT (LR1) OF THE TARGETING LINE-1 RETROTRANSPOSON ENDONUCLEASE	2.7.7.49 3.1.21
2V0Z	CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 10 (ALISKIREN)	3.4.23.15
2V10	CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 9	3.4.23.15
2V11	CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 6	3.4.23.15
2V12	CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 8	3.4.23.15
2V13	CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 7	3.4.23.15
2V16	CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 3	3.4.23.15
2V1O	CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF ACYL-COA THIOESTERASE 7	3.1.2.2
2V1X	CRYSTAL STRUCTURE OF HUMAN RECQ-LIKE DNA HELICASE	3.6.1 3.6.4.12
2V1Z	STRUCTURE OF A TEM-1 BETA-LACTAMASE INSERTANT ALLOSTERICALLY REGULATED BY KANAMYCIN AND ANIONS.	3.5.2.6
2V20	STRUCTURE OF A TEM-1 BETA-LACTAMASE INSERTANT ALLOSTERICALLY REGULATED BY KANAMYCIN AND ANIONS. COMPLEX WITH SULFATE.	3.5.2.6
2V2F	CRYSTAL STRUCTURE OF PBP1A FROM DRUG-RESISTANT STRAIN 5204 FROM STREPTOCOCCUS PNEUMONIAE	2.4.1.129 3.4.16.4
2V33	HIGH RESOLUTION CRYSTAL STRUCTURE OF DOMAIN III OF E1 FUSION GLYCOPROTEIN OF SEMLIKI FOREST VIRUS	3.4.21.90
2V35	PORCINE PANCREATIC ELASTASE IN COMPLEX WITH INHIBITOR JM54	3.4.21.36
2V36	CRYSTAL STRUCTURE OF GAMMA-GLUTAMYL TRANSFERASE FROM BACILLUS SUBTILIS	2.3.2.2 3.4.19.13
2V38	FAMILY 5 ENDOGLUCANASE CEL5A FROM BACILLUS AGARADHAERENS IN COMPLEX WITH CELLOBIO-DERIVED NOEUROMYCIN	3.2.1.4
2V3D	ACID-BETA-GLUCOSIDASE WITH N-BUTYL-DEOXYNOJIRIMYCIN	3.2.1.45 2.4.1 3.2.1
2V3E	ACID-BETA-GLUCOSIDASE WITH N-NONYL-DEOXYNOJIRIMYCIN	3.2.1.45 2.4.1 3.2.1
2V3F	ACID-BETA-GLUCOSIDASE PRODUCED IN CARROT	3.2.1.45 2.4.1 3.2.1
2V3G	STRUCTURE OF A FAMILY 26 LICHENASE IN COMPLEX WITH NOEUROMYCIN	3.2.1.4
2V3H	THROMBIN WITH 3-CYCLE NO F	3.4.21.5
2V3I	HYPOCREA JECORINA CEL7A IN COMPLEX WITH (R)-DIHYDROXY-PHENANTHRENOLOL	3.2.1.91
2V3O	THROMBIN WITH 3-CYCLE WITH F	3.4.21.5
2V3R	HYPOCREA JECORINA CEL7A IN COMPLEX WITH (S)-DIHYDROXY-PHENANTHRENOLOL	3.2.1.91
2V3X	HIS243ALA ESCHERICHIA COLI AMINOPEPTIDASE P IN COMPLEX WITH SUBSTRATE	3.4.11.9
2V3Y	HIS361ALA ESCHERICHIA COLI AMINOPEPTIDASE P IN COMPLEX WITH PRODUCT	3.4.11.9
2V3Z	GLU383ALA ESCHERICHIA COLI AMINOPEPTIDASE P IN COMPLEX WITH SUBSTRATE	3.4.11.9
2V4B	CRYSTAL STRUCTURE OF HUMAN ADAMTS-1 CATALYTIC DOMAIN AND CYSTEINE- RICH DOMAIN (APO-FORM)	3.4.24
2V4N	CRYSTAL STRUCTURE OF SALMONELLA TYPHIMURIUM SURE AT 1.7 ANGSTROM RESOLUTION IN ORTHORHOMBIC FORM	3.1.3.5 3.1.3.6 3.6.1.11
2V4O	CRYSTAL STRUCTURE OF SALMONELLA TYPHIMURIUM SURE AT 2.75 ANGSTROM RESOLUTION IN MONOCLINIC FORM	3.1.3.5 3.1.3.6 3.1.3.11 3.6.1.11
2V4V	CRYSTAL STRUCTURE OF A FAMILY 6 CARBOHYDRATE-BINDING MODULE FROM CLOSTRIDIUM CELLULOLYTICUM IN COMPLEX WITH XYLOSE	3.2.1.4
2V5C	FAMILY 84 GLYCOSIDE HYDROLASE FROM CLOSTRIDIUM PERFRINGENS, 2.1 ANGSTROM STRUCTURE	3.2.1.52 3.2.1.169
2V5D	STRUCTURE OF A FAMILY 84 GLYCOSIDE HYDROLASE AND A FAMILY 32 CARBOHYDRATE-BINDING MODULE IN TANDEM FROM CLOSTRIDIUM PERFRINGENS.	3.2.1.52 3.2.1.169
2V5W	CRYSTAL STRUCTURE OF HDAC8-SUBSTRATE COMPLEX	3.5.1.98
2V5X	CRYSTAL STRUCTURE OF HDAC8-INHIBITOR COMPLEX	3.5.1.98
2V5Y	CRYSTAL STRUCTURE OF THE RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU ECTODOMAIN	3.1.3.48
2V6I	KOKOBERA VIRUS HELICASE	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2V6J	KOKOBERA VIRUS HELICASE: MUTANT MET47THR	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2V6N	CRYSTAL STRUCTURES OF THE SARS-CORONAVIRUS MAIN PROTEINASE INACTIVATED BY BENZOTRIAZOLE COMPOUNDS	3.4.24 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2V6X	STRACTURAL INSIGHT INTO THE INTERACTION BETWEEN ESCRT-III AND VPS4	3.6.4.6
2V6Y	STRUCTURE OF THE MIT DOMAIN FROM A S. SOLFATARICUS VPS4-LIKE ATPASE	3.6.4.6
2V77	CRYSTAL STRUCTURE OF HUMAN CARBOXYPEPTIDASE A1	3.4.17.1
2V8B	SAD STRUCTURE SOLUTION OF PROTEINASE K GROWN IN SELENATE SOLUTION	3.4.21.64
2V8D	CRYSTAL STRUCTURE OF MUTANT E159A OF BETA-ALANINE SYNTHASE FROM SACCHAROMYCES KLUYVERI	3.5.1.6
2V8G	CRYSTAL STRUCTURE OF BETA-ALANINE SYNTHASE FROM SACCHAROMYCES KLUYVERI IN COMPLEX WITH THE PRODUCT BETA-ALANINE	3.5.1.6
2V8H	CRYSTAL STRUCTURE OF MUTANT E159A OF BETA-ALANINE SYNTHASE FROM SACCHAROMYCES KLUYVERI IN COMPLEX WITH ITS SUBSTRATE N-CARBAMYL-BETA- ALANINE	3.5.1.6
2V8L	CARBOHYDRATE-BINDING OF THE STARCH BINDING DOMAIN OF RHIZOPUS ORYZAE GLUCOAMYLASE IN COMPLEX WITH BETA-CYCLODEXTRIN AND MALTOHEPTAOSE	3.2.1.3
2V8M	CARBOHYDRATE-BINDING OF THE STARCH BINDING DOMAIN OF RHIZOPUS ORYZAE GLUCOAMYLASE IN COMPLEX WITH BETA-CYCLODEXTRIN AND MALTOHEPTAOSE	3.2.1.3
2V8O	STRUCTURE OF THE MURRAY VALLEY ENCEPHALITIS VIRUS RNA HELICASE TO 1. 9A RESOLUTION	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2V8V	CRYSTAL STRUCTURE OF MUTANT R322A OF BETA-ALANINE SYNTHASE FROM SACCHAROMYCES KLUYVERI	3.5.1.6
2V96	STRUCTURE OF THE UNPHOTOLYSED COMPLEX OF TCACHE WITH 1-(2- NITROPHENYL)-2,2,2-TRIFLUOROETHYL-ARSENOCHOLINE AT 100K	3.1.1.7
2V9X	E138D VARIANT OF ESCHERICHIA COLI DCTP DEAMINASE IN COMPLEX WITH DUTP	3.5.4.13
2V9Z	STRUCTURE OF THE RHODOCOCCUS HALOALKANE DEHALOGENASE MUTANT WITH ENHANCED ENANTIOSELECTIVITY	3.8.1.5
2VA5	X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 8C	3.4.23.46
2VA6	X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 24	3.4.23.46
2VA7	X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 27	3.4.23.46
2VA9	STRUCTURE OF NATIVE TCACHE AFTER A 9 SECONDS ANNEALING TO ROOM TEMPERATURE DURING THE FIRST 5 SECONDS OF WHICH LASER IRRADIATION AT 266NM TOOK PLACE	3.1.1.7
2VB0	CRYSTAL STRUCTURE OF COXSACKIEVIRUS B3 PROTEINASE 3C	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
2VB1	HEWL AT 0.65 ANGSTROM RESOLUTION	3.2.1.17
2VBC	CRYSTAL STRUCTURE OF THE NS3 PROTEASE-HELICASE FROM DENGUE VIRUS	3.4.21.91 3.6.1.15 3.6.4.13
2VBE	TAILSPIKE PROTEIN OF BACTERIOPHAGE SF6	3.2.1
2VBJ	MOLECULAR BASIS OF HUMAN XPC GENE RECOGNITION AND CLEAVAGE BY ENGINEERED HOMING ENDONUCLEASE HETERODIMERS	3.1
2VBK	NATIVE TAILSPIKE PROTEIN OF BACTERIOPHAGE SF6	3.2.1
2VBL	MOLECULAR BASIS OF HUMAN XPC GENE RECOGNITION AND CLEAVAGE BY ENGINEERED HOMING ENDONUCLEASE HETERODIMERS	3.1
2VBM	TAILSPIKE PROTEIN OF BACTERIOPHAGE SF6 COMPLEXED WITH TETRASACCHARIDE	3.2.1
2VBN	MOLECULAR BASIS OF HUMAN XPC GENE RECOGNITION AND CLEAVAGE BY ENGINEERED HOMING ENDONUCLEASE HETERODIMERS	3.1
2VBO	MOLECULAR BASIS OF HUMAN XPC GENE RECOGNITION AND CLEAVAGE BY ENGINEERED HOMING ENDONUCLEASE HETERODIMERS	3.1
2VC3	RICIN A-CHAIN (RECOMBINANT) E177D MUTANT WITH A BOUND ACETATE	3.2.2.22
2VC4	RICIN A-CHAIN (RECOMBINANT) E177D MUTANT	3.2.2.22
2VC5	STRUCTURAL BASIS FOR NATURAL LACTONASE AND PROMISCUOUS PHOSPHOTRIESTERASE ACTIVITIES	3.1.8.1
2VC9	FAMILY 89 GLYCOSIDE HYDROLASE FROM CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH 2-ACETAMIDO-1,2-DIDEOXYNOJIRMYCIN	3.2.1.50
2VCA	FAMILY 89 GLYCOSIDE HYDROLASE FROM CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH BETA-N-ACETYL-D-GLUCOSAMINE	3.2.1.50
2VCB	FAMILY 89 GLYCOSIDE HYDROLASE FROM CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH PUGNAC	3.2.1.50
2VCC	FAMILY 89 GLYCOSIDE HYDROLASE FROM CLOSTRIDIUM PERFRINGENS	3.2.1.50
2VCG	CRYSTAL STRUCTURE OF A HDAC-LIKE PROTEIN HDAH FROM BORDETELLA SP. WITH THE BOUND INHIBITOR ST-17	3.5.1
2VEO	X-RAY STRUCTURE OF CANDIDA ANTARCTICA LIPASE A IN ITS CLOSED STATE.	3.1.1.3
2VES	CRYSTAL STRUCTURE OF LPXC FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH THE POTENT BB-78485 INHIBITOR	3.5.1.108
2VEU	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR	3.1.3.48
2VEV	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR	3.1.3.48
2VEW	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR	3.1.3.48
2VEX	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR	3.1.3.48
2VEY	CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR	3.1.3.48
2VF2	X-RAY CRYSTAL STRUCTURE OF HSAD FROM MYCOBACTERIUM TUBERCULOSIS	3.7.1.8 3.7.1.17
2VFJ	STRUCTURE OF THE A20 OVARIAN TUMOUR (OTU) DOMAIN	3.4.19.12 2.3.2
2VFM	LOW TEMPERATURE STRUCTURE OF P22 TAILSPIKE PROTEIN FRAGMENT (109-666)	3.2.1
2VFN	LOW TEMPERATURE STRUCTURE OF P22 TAILSPIKE PROTEIN FRAGMENT (109-666), MUTANT V125A	3.2.1
2VFO	LOW TEMPERATURE STRUCTURE OF P22 TAILSPIKE PROTEIN FRAGMENT (109-666), MUTANT V125L	3.2.1
2VFP	LOW TEMPERATURE STRUCTURE OF P22 TAILSPIKE PROTEIN FRAGMENT (109-666), MUTANT V349L	3.2.1
2VFQ	LOW TEMPERATURE STRUCTURE OF P22 TAILSPIKE PROTEIN FRAGMENT (109-666), MUTANT V450A	3.2.1
2VG5	CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS	2.7.7.49 2.7.7.7 3.1.26.4 3.4.23.16 3.1.26.13 3.1.13.2 2.7.7 3.1
2VG6	CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS	2.7.7.49 2.7.7.7 3.1.26.4 3.4.23.16 3.1.26.13 3.1.13.2 2.7.7 3.1
2VG7	CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS	2.7.7.49 2.7.7.7 3.1.26.4 3.4.23.16 3.1.26.13 3.1.13.2 2.7.7 3.1
2VG9	CRYSTAL STRUCTURE OF LOOP SWAP MUTANT OF NECALLIMASTIX PATRICIARUM XYN11A	3.2.1.8
2VGC	GAMMA-CHYMOTRYPSIN D-PARA-CHLORO-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX	3.4.21.1
2VGD	CRYSTAL STRUCTURE OF ENVIRONMENTAL ISOLATED GH11 IN COMPLEX WITH XYLOBIOSE AND FERULOYL-ARABINO-XYLOTRIOSE	3.2.1.8
2VGJ	CRYSTAL STRUCTURE OF ACTINOMADURA R39 DD-PEPTIDASE COMPLEXED WITH A PEPTIDOGLYCAN-MIMETIC CEPHALOSPORIN	3.4.16.4
2VGK	CRYSTAL STRUCTURE OF ACTINOMADURA R39 DD-PEPTIDASE COMPLEXED WITH A PEPTIDOGLYCAN-MIMETIC CEPHALOSPORIN	3.4.16.4
2VGM	STRUCTURE OF YEAST DOM34 : A PROTEIN RELATED TO TRANSLATION TERMINATION FACTOR ERF1 AND INVOLVED IN NO-GO DECAY.	3.1
2VGN	STRUCTURE OF YEAST DOM34 : A PROTEIN RELATED TO TRANSLATION TERMINATION FACTOR ERF1 AND INVOLVED IN NO-GO DECAY.	3.1
2VH0	STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS:BIARYL PYRROLIDIN-2-ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS	3.4.21.6
2VH6	STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS	3.4.21.6
2VH7	CRYSTAL STRUCTURE OF HUMAN COMMON-TYPE ACYLPHOSPHATASE	3.6.1.7
2VH9	CRYSTAL STRUCTURE OF NXG1-DELTAYNIIG IN COMPLEX WITH XLLG, A XYLOGLUCAN DERIVED OLIGOSACCHARIDE	3.2.1.151 3.2.1.4 2.4.1.207
2VHF	STRUCTURE OF THE CYLD USP DOMAIN	3.1.2.15 3.4.19.12
2VHH	CRYSTAL STRUCTURE OF A PYRIMIDINE DEGRADING ENZYME FROM DROSOPHILA MELANOGASTER	3.5.1.6 3.5.1
2VHL	THE THREE-DIMENSIONAL STRUCTURE OF THE N-ACETYLGLUCOSAMINE-6- PHOSPHATE DEACETYLASE FROM BACILLUS SUBTILIS	3.5.1.25
2VHS	CATHSILICATEIN, A CHIMERA	3.4.22.15
2VI0	LICHENASE CTLIC26 IN COMPLEX WITH A THIO-OLIGOSACCHARIDE	3.2.1.4
2VID	SERINE PROTEASE SPLB FROM STAPHYLOCOCCUS AUREUS AT 1.8A RESOLUTION	3.4.21
2VIE	HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-1-BENZYL-2-HYDROXY-3-((1,1,5- TRIMETHYLHEXYL)AMINO)PROPYL)-3-(ETHYLAMINO)-5-(2-OXOPYRROLIDIN-1-YL) BENZAMIDE	3.4.23.46
2VIJ	HUMAN BACE-1 IN COMPLEX WITH 3-(1,1-DIOXIDOTETRAHYDRO-2H-1,2-THIAZIN- 2-YL)-5-(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-1-(PHENYLMETHYL)-3-(1,2,3,4- TETRAHYDRO-1-NAPHTHALENYLAMINO)PROPYL)BENZAMIDE	3.4.23.46
2VIN	FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR	3.4.21.73
2VIO	FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR	3.4.21.73
2VIP	FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR	3.4.21.73
2VIQ	FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR	3.4.21.73
2VIV	FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR	3.4.21.73
2VIW	FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR	3.4.21.73
2VIY	HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-(CYCLOHEXYLAMINO)- 1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-3-(PENTYLSULFONYL)BENZAMIDE	3.4.23.46
2VIZ	HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-(CYCLOHEXYLAMINO)- 1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-3-(2-OXO- 1-PYRROLIDINYL)-5-(PROPYLOXY)BENZAMIDE	3.4.23.46
2VJ1	A STRUCTURAL VIEW OF THE INACTIVATION OF THE SARS-CORONAVIRUS MAIN PROTEINASE BY BENZOTRIAZOLE ESTERS	3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2VJ6	HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-(CYCLOHEXYLAMINO)- 1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-3-(ETHYLAMINO)-5-(2-OXO-1-PYRROLIDINYL)BENZAMIDE	3.4.23.46
2VJ7	HUMAN BACE-1 IN COMPLEX WITH 3-(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-1-(PHENYLMETHYL)-3-(((3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO)PROPYL)-5-(2-OXO-1-PYRROLIDINYL)BENZAMIDE	3.4.23.46
2VJ8	COMPLEX OF HUMAN LEUKOTRIENE A4 HYDROLASE WITH A HYDROXAMIC ACID INHIBITOR	3.3.2.6 3.4.11.4
2VJ9	HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(CYCLOHEXYLAMINO)-2-HYDROXY- 1-(PHENYLMETHYL)PROPYL)-3-(ETHYLAMINO)-5-(2-OXO-1-PYRROLIDINYL) BENZAMIDE	3.4.23.46
2VJA	TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A NON HYDROLYSABLE SUBSTRATE ANALOGUE, 4-OXO-N,N,N- TRIMETHYLPENTANAMINIUM - ORTHORHOMBIC SPACE GROUP - DATASET A AT 100K	3.1.1.7
2VJB	TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A NON HYDROLYSABLE SUBSTRATE ANALOGUE, 4-OXO-N,N,N- TRIMETHYLPENTANAMINIUM - ORTHORHOMBIC SPACE GROUP - DATASET D AT 100K	3.1.1.7
2VJC	TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A NON HYDROLYSABLE SUBSTRATE ANALOGUE, 4-OXO-N,N,N- TRIMETHYLPENTANAMINIUM - ORTHORHOMBIC SPACE GROUP - DATASET A AT 150K	3.1.1.7
2VJD	TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A NON HYDROLYSABLE SUBSTRATE ANALOGUE, 4-OXO-N,N,N- TRIMETHYLPENTANAMINIUM - ORTHORHOMBIC SPACE GROUP - DATASET C AT 150K	3.1.1.7
2VJX	STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES	3.2.1.25
2VK5	THE STRUCTURE OF CLOSTRIDIUM PERFRINGENS NANI SIALIDASE AND ITS CATALYTIC INTERMEDIATES	3.2.1.18
2VK6	THE STRUCTURE OF CLOSTRIDIUM PERFRINGENS NANI SIALIDASE AND ITS CATALYTIC INTERMEDIATES	3.2.1.18
2VK7	THE STRUCTURE OF CLOSTRIDIUM PERFRINGENS NANI SIALIDASE AND ITS CATALYTIC INTERMEDIATES	3.2.1.18
2VK9	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF ALPHA-TOXIN FROM CLOSTRIDIUM NOVYI	3.4.22 2.4.1
2VKC	SOLUTION STRUCTURE OF THE B3BP SMR DOMAIN	3
2VKD	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF LETHAL TOXIN FROM CLOSTRIDIUM SORDELLII IN COMPLEX WITH UDP-GLC AND MANGANESE ION	3.4.22 2.4.1
2VKH	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF LETHAL TOXIN FROM CLOSTRIDIUM SORDELLII IN COMPLEX WITH UDP-GLC AND CALCIUM ION	3.4.22 2.4.1
2VKM	CRYSTAL STRUCTURE OF GRL-8234 BOUND TO BACE (BETA-SECRETASE)	3.4.23.46
2VKQ	CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC 5'-NUCLEOTIDASE III (CN-III, NT5C3) IN COMPLEX WITH BERYLLIUM TRIFLUORIDE	3.1.3.5 3.1.3.91
2VKY	HEADBINDING DOMAIN OF PHAGE P22 TAILSPIKE C-TERMINALLY FUSED TO ISOLEUCINE ZIPPER PIIGCN4 (CHIMERA I)	3.2.1
2VL1	CRYSTAL STRUCTURE OF BETA-ALANINE SYNTHASE FROM SACCHAROMYCES KLUYVERI IN COMPLEX WITH A GLY-GLY PEPTIDE	3.5.1.6
2VL4	STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES	3.2.1.25
2VL6	STRUCTURAL ANALYSIS OF THE SULFOLOBUS SOLFATARICUS MCM PROTEIN N- TERMINAL DOMAIN	3.6.4.12
2VL7	STRUCTURE OF S. TOKODAII XPD4	3.6.4.12
2VL8	CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF LETHAL TOXIN FROM CLOSTRIDIUM SORDELLII IN COMPLEX WITH UDP, CASTANOSPERMINE AND CALCIUM ION	3.4.22 2.4.1
2VLA	CRYSTAL STRUCTURE OF RESTRICTION ENDONUCLEASE BPUJI RECOGNITION DOMAIN IN COMPLEX WITH COGNATE DNA	3.1.21.4
2VLC	CRYSTAL STRUCTURE OF NATURAL CINNAMOMIN (ISOFORM III)	3.2.2.22
2VLD	CRYSTAL STRUCTURE OF A REPAIR ENDONUCLEASE FROM PYROCOCCUS ABYSSI	3.1
2VMF	STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES	3.2.1.25
2VMK	CRYSTAL STRUCTURE OF E. COLI RNASE E APOPROTEIN - CATALYTIC DOMAIN	3.1.4 3.1.26.12
2VN4	GLYCOSIDE HYDROLASE FAMILY 15 GLUCOAMYLASE FROM HYPOCREA JECORINA	3.2.1.3
2VN7	GLYCOSIDE HYDROLASE FAMILY 15 GLUCOAMYLASE FROM HYPOCREA JECORINA	3.2.1.3
2VND	THE N69Q MUTANT OF VIBRIO CHOLERAE ENDONUCLEASE I	3.1.21
2VNG	FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH BLOOD GROUP A-TRISACCHARIDE LIGAND.	3.2.1
2VNL	MUTANT Y108WDEL OF THE HEADBINDING DOMAIN OF PHAGE P22 TAILSPIKE C- TERMINALLY FUSED TO ISOLEUCINE ZIPPER PIIGCN4 (CHIMERA II)	3.2.1
2VNM	HUMAN BACE-1 IN COMPLEX WITH 3-(1,1-DIOXIDOTETRAHYDRO-2H-1,2-THIAZIN- 2-YL)-5-(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-1-(PHENYLMETHYL)-3-(((3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO)PROPYL)BENZAMIDE	3.4.23.46
2VNN	HUMAN BACE-1 IN COMPLEX WITH 7-ETHYL-N-((1S,2R)-2-HYDROXY-1-(PHENYLMETHYL)-3-(((3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO)PROPYL)-1- METHYL-3,4-DIHYDRO-1H-(1,2,5)THIADIAZEPINO(3,4,5-HI)INDOLE-9- CARBOXAMIDE 2,2-DIOXIDE	3.4.23.46
2VNO	FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS IN COMPLEX WITH BLOOD GROUP B-TRISACCHARIDE LIGAND.	3.2.1
2VNR	FAMILY 51 CARBOHYDRATE BINDING MODULE FROM A FAMILY 98 GLYCOSIDE HYDROLASE PRODUCED BY CLOSTRIDIUM PERFRINGENS.	3.2.1
2VNT	UROKINASE-TYPE PLASMINOGEN ACTIVATOR INHIBITOR COMPLEX WITH A 1-(7- SULPHOAMIDOISOQUINOLINYL)GUANIDINE	3.4.21.73
2VO5	STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES	3.2.1.25
2VO8	COHESIN MODULE FROM CLOSTRIDIUM PERFRINGENS ATCC13124 FAMILY 33 GLYCOSIDE HYDROLASE.	3.2.1
2VO9	CRYSTAL STRUCTURE OF THE ENZYMATICALLY ACTIVE DOMAIN OF THE LISTERIA MONOCYTOGENES BACTERIOPHAGE 500 ENDOLYSIN PLY500	3.4.24
2VOT	STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES	3.2.1.25
2VOY	CRYOEM MODEL OF COPA, THE COPPER TRANSPORTING ATPASE FROM ARCHAEOGLOBUS FULGIDUS	3.6.3.4 7.2.2.8
2VPH	CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE, NON- RECEPTOR TYPE 4, PDZ DOMAIN	3.1.3.48
2VPT	CLOSTRIDIUM THERMOCELLUM FAMILY 3 CARBOHYDRATE ESTERASE	3.1.1.72
2VQ4	CARBOHYDRATE-BINDING OF THE STARCH BINDING DOMAIN OF RHIZOPUS ORYZAE GLUCOAMYLASE IN COMPLEX WITH BETA-CYCLODEXTRIN AND MALTOHEPTAOSE	3.2.1.3
2VQ6	TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED WITH 2-PAM	3.1.1.7
2VQ9	RNASE ZF-3E	3.1.27
2VQJ	STRUCTURE OF HDAC4 CATALYTIC DOMAIN BOUND TO A TRIFLUOROMETHYLKETONE INHBITOR	3.5.1.98
2VQM	STRUCTURE OF HDAC4 CATALYTIC DOMAIN BOUND TO A HYDROXAMIC ACID INHBITOR	3.5.1.98
2VQO	STRUCTURE OF HDAC4 CATALYTIC DOMAIN WITH A GAIN-OF-FUNCTION MUATION BOUND TO A TRIFLUOROMETHYLKETONE INHBITOR	3.5.1.98
2VQQ	STRUCTURE OF HDAC4 CATALYTIC DOMAIN (A DOUBLE CYSTEINE-TO-ALANINE MUTANT) BOUND TO A TRIFLUOROMETHYLKETONE INHBITOR	3.5.1.98
2VQR	CRYSTAL STRUCTURE OF A PHOSPHONATE MONOESTER HYDROLASE FROM RHIZOBIUM LEGUMINOSARUM: A NEW MEMBER OF THE ALKALINE PHOSPHATASE SUPERFAMILY	3.1.4 3.1.3
2VQT	STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES	3.2.1.25
2VQU	STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES	3.2.1.25
2VQV	STRUCTURE OF HDAC4 CATALYTIC DOMAIN WITH A GAIN-OF-FUNCTION MUTATION BOUND TO A HYDROXAMIC ACID INHIBITOR	3.5.1.98
2VQW	STRUCTURE OF INHIBITOR-FREE HDAC4 CATALYTIC DOMAIN (WITH GAIN-OF- FUNCTION MUTATION HIS332TYR)	3.5.1.98
2VQX	PRECURSOR OF PROTEALYSIN, METALLOPROTEINASE FROM SERRATIA PROTEAMACULANS.	3.4.24
2VR2	HUMAN DIHYDROPYRIMIDINASE	3.5.2.2
2VR4	TRANSITION-STATE MIMICRY IN MANNOSIDE HYDROLYSIS: CHARACTERISATION OF TWENTY SIX INHIBITORS AND INSIGHT INTO BINDING FROM LINEAR FREE ENERGY RELATIONSHIPS AND 3-D STRUCTURE	3.2.1.25
2VR5	CRYSTAL STRUCTURE OF TREX FROM SULFOLOBUS SOLFATARICUS IN COMPLEX WITH ACARBOSE INTERMEDIATE AND GLUCOSE	3.2.1
2VRI	STRUCTURE OF THE NSP3 X-DOMAIN OF HUMAN CORONAVIRUS NL63	3.4.19.12 3.4.22
2VRJ	BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH N-OCTYL-5- DEOXY-6-OXA-N-(THIO)CARBAMOYLCALYSTEGINE	3.2.1.21
2VRT	CRYSTAL STRUCTURE OF E. COLI RNASE E POSSESSING M1 RNA FRAGMENTS - CATALYTIC DOMAIN	3.1.4 3.1.26.12
2VRW	CRITICAL STRUCTURAL ROLE FOR THE PH AND C1 DOMAINS OF THE VAV1 EXCHANGE FACTOR	3.6.5.2
2VS2	NEUTRON DIFFRACTION STRUCTURE OF ENDOTHIAPEPSIN IN COMPLEX WITH A GEM- DIOL INHIBITOR.	3.4.23.22
2VS6	K173A, R174A, K177A-TRICHOSANTHIN	3.2.2.22
2VS7	THE CRYSTAL STRUCTURE OF I-DMOI IN COMPLEX WITH DNA AND CA	3.1
2VS8	THE CRYSTAL STRUCTURE OF I-DMOI IN COMPLEX WITH DNA AND MN	3.1
2VSF	STRUCTURE OF XPD FROM THERMOPLASMA ACIDOPHILUM	3.6.4.12
2VSM	NIPAH VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2	3.2.1.18
2VSO	CRYSTAL STRUCTURE OF A TRANSLATION INITIATION COMPLEX	3.6.1 3.6.4.13
2VSW	THE STRUCTURE OF THE RHODANESE DOMAIN OF THE HUMAN DUAL SPECIFICITY PHOSPHATASE 16	3.1.3.16 3.1.3.48
2VSX	CRYSTAL STRUCTURE OF A TRANSLATION INITIATION COMPLEX	3.6.1 3.6.4.13
2VT0	X-RAY STRUCTURE OF A CONJUGATE WITH CONDURITOL-BETA-EPOXIDE OF ACID-BETA-GLUCOSIDASE OVEREXPRESSED IN CULTURED PLANT CELLS	3.2.1.45 2.4.1 3.2.1
2VT6	NATIVE TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COLLECTED WITH A CUMULATED DOSE OF 9400000 GY	3.1.1.7
2VT7	NATIVE TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COLLECTED WITH A CUMULATED DOSE OF 800000 GY	3.1.1.7
2VTC	THE STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 61 MEMBER, CEL61B FROM THE HYPOCREA JECORINA.	3.2.1.4
2VTF	X-RAY CRYSTAL STRUCTURE OF THE ENDO-BETA-N-ACETYLGLUCOSAMINIDASE FROM ARTHROBACTER PROTOPHORMIAE E173Q MUTANT REVEALS A TIM BARREL CATALYTIC DOMAIN AND TWO ANCILLARY DOMAINS	3.2.1.96
2VU8	CRYSTAL STRUCTURE OF AN INSECT INHIBITOR WITH A FUNGAL TRYPSIN	3.4.21.4
2VU9	CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN IN COMPLEX WITH GT1B	3.4.24.69
2VUA	CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN	3.4.24.69
2VUJ	ENVIRONMENTALLY ISOLATED GH11 XYLANASE	3.2.1.8
2VUL	THERMOSTABLE MUTANT OF ENVIRONMENTALLY ISOLATED GH11 XYLANASE	3.2.1.8
2VUN	THE CRYSTAL STRUCTURE OF ENAMIDASE AT 1.9 A RESOLUTION - A NEW MEMBER OF THE AMIDOHYDROLASE SUPERFAMILY	3.5.2.18
2VUR	CHEMICAL DISSECTION OF THE LINK BETWEEN STREPTOZOTOCIN, O-GLCNAC AND PANCREATIC CELL DEATH	3.2.1.35 3.2.1.169
2VUY	CRYSTAL STRUCTURE OF GLYCOGEN DEBRANCHING EXZYME TREX FROM SULFOLOBUS SOLFATARIUS	3.2.1
2VVC	AMINOPYRROLIDINE FACTOR XA INHIBITOR	3.4.21.6
2VVN	BTGH84 IN COMPLEX WITH NH-BUTYLTHIAZOLINE	3.2.1.52 3.2.1.169
2VVS	BTGH84 STRUCTURE IN COMPLEX WITH PUGNAC	3.2.1.52 3.2.1.169
2VVU	AMINOPYRROLIDINE FACTOR XA INHIBITOR	3.4.21.6
2VVV	AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR	3.4.21.6
2VVZ	STRUCTURE OF THE CATALYTIC DOMAIN OF STREPTOCOCCUS PNEUMONIAE SIALIDASE NANA	3.2.1.18
2VW0	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE	3.2.1.18
2VW1	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE	3.2.1.18
2VW2	CRYSTAL STRUCTURE OF THE NANB SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE	3.2.1.18
2VW8	CRYSTAL STRUCTURE OF QUINOLONE SIGNAL RESPONSE PROTEIN PQSE FROM PSEUDOMONAS AERUGINOSA	3.1.2.32
2VWB	STRUCTURE OF THE ARCHAEAL KAE1-BUD32 FUSION PROTEIN MJ1130: A MODEL FOR THE EUKARYOTIC EKC-KEOPS SUBCOMPLEX INVOLVED IN TRANSCRIPTION AND TELOMERE HOMEOSTASIS.	3.4.24.57 2.3.1.234 2.7.11.1
2VWL	AMINOPYRROLIDINE FACTOR XA INHIBITOR	3.4.21.6
2VWM	AMINOPYRROLIDINE FACTOR XA INHIBITOR	3.4.21.6
2VWN	AMINOPYRROLIDINE FACTOR XA INHIBITOR	3.4.21.6
2VWO	AMINOPYRROLIDINE FACTOR XA INHIBITOR	3.4.21.6
2VX4	CELLVIBRIO JAPONICUS MANNANASE CJMAN26C NATIVE FORM	3.2.1
2VX5	CELLVIBRIO JAPONICUS MANNANASE CJMAN26C MANNOSE-BOUND FORM	3.2.1
2VX6	CELLVIBRIO JAPONICUS MANNANASE CJMAN26C GAL1MAN4-BOUND FORM	3.2.1
2VX7	CELLVIBRIO JAPONICUS MANNANASE CJMAN26C MANNOBIOSE-BOUND FORM	3.2.1
2VXR	CRYSTAL STRUCTURE OF THE BOTULINUM NEUROTOXIN SEROTYPE G BINDING DOMAIN	3.4.24.69
2VY0	THE X-RAY STRUCTURE OF ENDO-BETA-1,3-GLUCANASE FROM PYROCOCCUS FURIOSUS	3.2.1.39
2VYA	CRYSTAL STRUCTURE OF FATTY ACID AMIDE HYDROLASE CONJUGATED WITH THE DRUG-LIKE INHIBITOR PF-750	3.5.1.4 3.5.1.99 3.1.1
2VYE	CRYSTAL STRUCTURE OF THE DNAC-SSDNA COMPLEX	3.6.1 3.6.4.12
2VYF	CRYSTAL STRUCTURE OF THE DNAC	3.6.1 3.6.4.12
2VYO	CHITIN DEACETYLASE FAMILY MEMBER FROM ENCEPHALITOZOON CUNICULI	3.5.1.41
2VZ8	CRYSTAL STRUCTURE OF MAMMALIAN FATTY ACID SYNTHASE	2.3.1.85 1.1.1.100 1.3.1.39 2.3.1.38 2.3.1.39 2.3.1.41 3.1.2.14 4.2.1.59
2VZO	CRYSTAL STRUCTURE OF AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA	3.2.1.165
2VZP	ATOMIC RESOLUTION STRUCTURE OF THE C-TERMINAL CBM35 FROM AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA	3.2.1.165
2VZQ	C-TERMINAL CBM35 FROM AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA IN COMPLEX WITH DIGALACTURONIC ACID	3.2.1.165
2VZR	C-TERMINAL CBM35 FROM AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA IN COMPLEX WITH GLUCURONIC ACID	3.2.1.165
2VZS	CHITOSAN PRODUCT COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA	3.2.1.165
2VZT	COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA E541A WITH PNP-BETA-D-GLUCOSAMINE	3.2.1.165
2VZU	COMPLEX OF AMYCOLATOPSIS ORIENTALIS EXO-CHITOSANASE CSXA D469A WITH PNP-BETA-D-GLUCOSAMINE	3.2.1.165
2W00	CRYSTAL STRUCTURE OF THE HSDR SUBUNIT OF THE ECOR124I RESTRICTION ENZYME IN COMPLEX WITH ATP	3.1.21.3
2W0D	DOES A FAST NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY- AND X-RAY CRYSTALLOGRAPHY HYBRID APPROACH PROVIDE RELIABLE STRUCTURAL INFORMATION OF LIGAND-PROTEIN COMPLEXES? A CASE STUDY OF METALLOPROTEINASES.	3.4.24.65
2W11	STRUCTURE OF THE L-2-HALOACID DEHALOGENASE FROM SULFOLOBUS TOKODAII	3.8.1.2
2W12	HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE P-I SNAKE VENOM METALLOPROTEINASE BAP1 IN COMPLEX WITH A PEPTIDOMIMETIC: INSIGHTS INTO INHIBITOR BINDING	3.4.24
2W13	HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE P-I SNAKE VENOM METALLOPROTEINASE BAP1 IN COMPLEX WITH A PEPTIDOMIMETIC: INSIGHTS INTO INHIBITOR BINDING	3.4.24
2W14	HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE P-I SNAKE VENOM METALLOPROTEINASE BAP1 IN COMPLEX WITH A PEPTIDOMIMETIC: INSIGHTS INTO INHIBITOR BINDING	3.4.24
2W15	HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE P-I SNAKE VENOM METALLOPROTEINASE BAP1 IN COMPLEX WITH A PEPTIDOMIMETIC: INSIGHTS INTO INHIBITOR BINDING	3.4.24
2W1L	THE INTERDEPENDENCE OF WAVELENGTH, REDUNDANCY AND DOSE IN SULFUR SAD EXPERIMENTS: 0.979 A WAVELENGTH 991 IMAGES DATA	3.2.1.17
2W1M	THE INTERDEPENDENCE OF WAVELENGTH, REDUNDANCY AND DOSE IN SULFUR SAD EXPERIMENTS: 2.070 A WAVELENGTH WITH 2THETA 30 DEGREES DATA	3.2.1.17
2W1N	COHESIN AND FIBRONECTIN TYPE-III DOUBLE MODULE CONSTRUCT FROM THE CLOSTRIDIUM PERFRINGENS GLYCOSIDE HYDROLASE GH84C	3.2.1.52 3.2.1.169
2W1Q	UNIQUE LIGAND BINDING SPECIFICITY FOR A FAMILY 32 CARBOHYDRATE- BINDING MODULE FROM THE MU TOXIN PRODUCED BY CLOSTRIDIUM PERFRINGENS	3.2.1.35
2W1S	UNIQUE LIGAND BINDING SPECIFICITY OF A FAMILY 32 CARBOHYDRATE-BINDING MODULE FROM THE MU TOXIN PRODUCED BY CLOSTRIDIUM PERFRINGENS	3.2.1.35
2W1U	A FAMILY 32 CARBOHYDRATE-BINDING MODULE, FROM THE MU TOXIN PRODUCED BY CLOSTRIDIUM PERFRINGENS, IN COMPLEX WITH BETA-D-GLCNAC-BETA(1,3) GALNAC	3.2.1.35
2W1V	CRYSTAL STRUCTURE OF MOUSE NITRILASE-2 AT 1.4A RESOLUTION	3.5 3.5.1.3
2W1X	THE INTERDEPENDENCE OF WAVELENGTH, REDUNDANCY AND DOSE IN SULFUR SAD EXPERIMENTS: 1.284 A WAVELENGTH 360 IMAGES DATA	3.2.1.17
2W1Y	THE INTERDEPENDENCE OF WAVELENGTH, REDUNDANCY AND DOSE IN SULFUR SAD EXPERIMENTS: 1.540 A WAVELENGTH 180 IMAGES DATA	3.2.1.17
2W20	STRUCTURE OF THE CATALYTIC DOMAIN OF THE NATIVE NANA SIALIDASE FROM STREPTOCOCCUS PNEUMONIAE	3.2.1.18
2W22	ACTIVATION MECHANISM OF BACTERIAL THERMOALKALOPHILIC LIPASES	3.1.1.3
2W26	FACTOR XA IN COMPLEX WITH BAY59-7939	3.4.21.6
2W2D	CRYSTAL STRUCTURE OF A CATALYTICALLY ACTIVE, NON-TOXIC ENDOPEPTIDASE DERIVATIVE OF CLOSTRIDIUM BOTULINUM TOXIN A	3.4.24.69
2W2G	HUMAN SARS CORONAVIRUS UNIQUE DOMAIN	3.4.22 3.4.19.12 3.4.22.69
2W2M	WT PCSK9-DELTAC BOUND TO WT EGF-A OF LDLR	3.4.21
2W2N	WT PCSK9-DELTAC BOUND TO EGF-A H306Y MUTANT OF LDLR	3.4.21
2W2O	PCSK9-DELTAC D374Y MUTANT BOUND TO WT EGF-A OF LDLR	3.4.21
2W2P	PCSK9-DELTAC D374A MUTANT BOUND TO WT EGF-A OF LDLR	3.4.21
2W2Q	PCSK9-DELTAC D374H MUTANT BOUND TO WT EGF-A OF LDLR	3.4.21
2W2W	PLCG2 SPLIT PLECKSTRIN HOMOLOGY (PH) DOMAIN	3.1.4.11
2W35	STRUCTURES OF ENDONUCLEASE V WITH DNA REVEAL INITIATION OF DEAMINATED ADENINE REPAIR	3.1.21.7
2W36	STRUCTURES OF ENDONUCLEASE V WITH DNA REVEAL INITIATION OF DEAMINATED ADENINE REPAIR	3.1.21.7
2W39	GLC(BETA-1-3)GLC DISACCHARIDE IN -1 AND -2 SITES OF LAMINARINASE 16A FROM PHANEROCHAETE CHRYSOSPORIUM	3.2.1.6
2W3I	CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4-DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 2	3.4.21.6
2W3K	CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4-DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 1	3.4.21.6
2W3O	CRYSTAL STRUCTURE OF THE HUMAN PNKP FHA DOMAIN IN COMPLEX WITH AN XRCC1-DERIVED PHOSPHOPEPTIDE	3.1.3.32 2.7.1.78
2W3T	CHLORO COMPLEX OF THE NI-FORM OF E.COLI DEFORMYLASE	3.5.1.31 3.5.1.88
2W3U	FORMATE COMPLEX OF THE NI-FORM OF E.COLI DEFORMYLASE	3.5.1.31 3.5.1.88
2W3Z	STRUCTURE OF A STREPTOCOCCUS MUTANS CE4 ESTERASE	3.5.1.41
2W43	STRUCTURE OF L-HALOACID DEHALOGENASE FROM S. TOKODAII	3.1.8.2 3.8.1.2
2W45	EPSTEIN-BARR VIRUS ALKALINE NUCLEASE	3.1.11 3.1
2W46	CBM35 FROM CELLVIBRIO JAPONICUS ABF62	3.2.1.55
2W4B	EPSTEIN-BARR VIRUS ALKALINE NUCLEASE D203S MUTANT	3.1.11 3.1
2W4C	HUMAN COMMON-TYPE ACYLPHOSPHATASE VARIANT, A99	3.6.1.7
2W4D	ACYLPHOSPHATASE VARIANT G91A FROM PYROCOCCUS HORIKOSHII	3.6.1.7
2W4E	STRUCTURE OF AN N-TERMINALLY TRUNCATED NUDIX HYDROLASE DR2204 FROM DEINOCOCCUS RADIODURANS	3.6.1.13
2W4L	HUMAN DCMP DEAMINASE	3.5.4.12
2W4M	THE CRYSTAL STRUCTURE OF HUMAN N-ACETYLNEURAMINIC ACID PHOSPHATASE, NANP	3.1.3.29
2W4P	HUMAN COMMON-TYPE ACYLPHOSPHATASE VARIANT, A99G	3.6.1.7
2W4R	CRYSTAL STRUCTURE OF THE REGULATORY DOMAIN OF HUMAN LGP2	3.6.1 3.6.4.13
2W4X	BTGH84 IN COMPLEX WITH STZ	3.2.1.52 3.2.1.169
2W52	2 BETA-GLUCANS (6-O-GLUCOSYL-LAMINARITRIOSE) IN BOTH DONOR AND ACCEPTOR SITES OF GH16 LAMINARINASE 16A FROM PHANEROCHAETE CHRYSOSPORIUM.	3.2.1.6
2W5F	HIGH RESOLUTION CRYSTALLOGRAPHIC STRUCTURE OF THE CLOSTRIDIUM THERMOCELLUM N-TERMINAL ENDO-1,4-BETA-D-XYLANASE 10B (XYN10B) CBM22-1- GH10 MODULES COMPLEXED WITH XYLOHEXAOSE	3.2.1.8
2W5G	RNASE A-5'-ATP COMPLEX	3.1.27.5 4.6.1.18
2W5I	RNASE A-AP3A COMPLEX	3.1.27.5 4.6.1.18
2W5J	STRUCTURE OF THE C14-ROTOR RING OF THE PROTON TRANSLOCATING CHLOROPLAST ATP SYNTHASE	3.6.3.14
2W5K	RNASE A-NADPH COMPLEX	3.1.27.5 4.6.1.18
2W5L	RNASE A-NADP COMPLEX	3.1.27.5 4.6.1.18
2W5M	RNASE A-PYROPHOSPHATE ION COMPLEX	3.1.27.5 4.6.1.18
2W5N	NATIVE STRUCTURE OF THE GH93 ALPHA-L-ARABINOFURANOSIDASE OF FUSARIUM GRAMINEARUM	3.2.1.55
2W5O	COMPLEX STRUCTURE OF THE GH93 ALPHA-L-ARABINOFURANOSIDASE OF FUSARIUM GRAMINEARUM WITH ARABINOBIOSE	3.2.1.55
2W5V	STRUCTURE OF TAB5 ALKALINE PHOSPHATASE MUTANT HIS 135 ASP WITH MG BOUND IN THE M3 SITE.	3.1.3.1
2W5W	STRUCTURE OF TAB5 ALKALINE PHOSPHATASE MUTANT HIS 135 ASP WITH ZN BOUND IN THE M3 SITE.	3.1.3.1
2W5X	STRUCTURE OF TAB5 ALKALINE PHOSPHATASE MUTANT HIS 135 GLU WITH MG BOUND IN THE M3 SITE.	3.1.3.1
2W66	BTGH84 IN COMPLEX WITH HQ602	3.2.1.52 3.2.1.169
2W67	BTGH84 IN COMPLEX WITH FMA34	3.2.1.52 3.2.1.169
2W68	ENHANCING THE RECEPTOR AFFINITY OF THE SIALIC ACID-BINDING DOMAIN OF VIBRIO CHOLERAE SIALIDASE THROUGH MULTIVALENCY	3.2.1.18
2W69	INFLUENZA POLYMERASE FRAGMENT	3.1
2W6C	ACHE IN COMPLEX WITH A BIS-(-)-NOR-MEPTAZINOL DERIVATIVE	3.1.1.7
2W6D	BACTERIAL DYNAMIN-LIKE PROTEIN LIPID TUBE BOUND	3.6.5.5
2W6F	LOW RESOLUTION STRUCTURES OF BOVINE MITOCHONDRIAL F1-ATPASE DURING CONTROLLED DEHYDRATION: HYDRATION STATE 2.	3.6.3.14
2W7S	SPLA SERINE PROTEASE OF STAPHYLOCOCCUS AUREUS (1.8A)	3.4.21.19 3.4.21
2W7U	SPLA SERINE PROTEASE OF STAPHYLOCOCCUS AUREUS (2.4A)	3.4.21.19 3.4.21
2W87	XYL-CBM35 IN COMPLEX WITH GLUCURONIC ACID CONTAINING DISACCHARIDE.	3.2.1
2W8S	CRYSTAL STRUCTURE OF A CATALYTICALLY PROMISCUOUS PHOSPHONATE MONOESTER HYDROLASE FROM BURKHOLDERIA CARYOPHYLLI	3.1.4 3.1 3.1.3 3.1.6
2W91	STRUCTURE OF A STREPTOCOCCUS PNEUMONIAE FAMILY 85 GLYCOSIDE HYDROLASE, ENDO-D.	3.2.1.96
2W92	STRUCTURE OF A STREPTOCOCCUS PNEUMONIAE FAMILY 85 GLYCOSIDE HYDROLASE, ENDO-D, IN COMPLEX WITH NAG-THIAZOLINE.	3.2.1.96
2W9X	THE ACTIVE SITE OF A CARBOHYDRATE ESTERASE DISPLAYS DIVERGENT CATALYTIC AND NON-CATALYTIC BINDING FUNCTIONS	3.1.1 3.1.1.72
2WA1	STRUCTURE OF THE METHYLTRANSFERASE DOMAIN FROM MODOC VIRUS, A FLAVIVIRUS WITH NO KNOWN VECTOR (NKV)	3.4.21.91 3.6.1.15 3.6.4.13
2WA2	STRUCTURE OF THE METHYLTRANSFERASE DOMAIN FROM MODOC VIRUS, A FLAVIVIRUS WITH NO KNOWN VECTOR (NKV)	3.4.21.91 3.6.1.15 3.6.4.13
2WAA	STRUCTURE OF A FAMILY TWO CARBOHYDRATE ESTERASE FROM CELLVIBRIO JAPONICUS	3.1.1.72 3.1.1
2WAB	STRUCTURE OF AN ACTIVE SITE MUTANT OF A FAMILY TWO CARBOHYDRATE ESTERASE FROM CLOSTRIDIUM THERMOCELLUM IN COMPLEX WITH CELLUOHEXASE	3.2.1.4 3.1.1 3.1.1.72
2WAC	EXTENDED TUDOR DOMAIN OF DROSOPHILA MELANOGASTER TUDOR-SN (P100)	3.1.31.1
2WAE	PENICILLIN-BINDING PROTEIN 2B (PBP-2B) FROM STREPTOCOCCUS PNEUMONIAE (STRAIN 5204)	3.4
2WAF	PENICILLIN-BINDING PROTEIN 2B (PBP-2B) FROM STREPTOCOCCUS PNEUMONIAE (STRAIN R6)	3.4
2WAG	THE STRUCTURE OF A FAMILY 25 GLYCOSYL HYDROLASE FROM BACILLUS ANTHRACIS.	3.2.1.17
2WAN	PULLULANASE FROM BACILLUS ACIDOPULLULYTICUS	3.2.1.41
2WAO	STRUCTURE OF A FAMILY TWO CARBOHYDRATE ESTERASE FROM CLOSTRIDIUM THERMOCELLUM IN COMPLEX WITH CELLOHEXAOSE	3.2.1.4 3.1.1 3.1.1.72
2WAP	3D-CRYSTAL STRUCTURE OF HUMANIZED-RAT FATTY ACID AMIDE HYDROLASE (FAAH) CONJUGATED WITH THE DRUG-LIKE UREA INHIBITOR PF-3845	3.5.1.4 3.5.1.99 3.1.1
2WAR	HEN EGG WHITE LYSOZYME E35Q CHITOPENTAOSE COMPLEX	3.2.1.17
2WAX	STRUCTURE OF THE HUMAN DDX6 C-TERMINAL DOMAIN IN COMPLEX WITH AN EDC3- FDF PEPTIDE	3.6.1 3.6.4.13
2WAY	STRUCTURE OF THE HUMAN DDX6 C-TERMINAL DOMAIN IN COMPLEX WITH AN EDC3- FDF PEPTIDE	3.6.1 3.6.4.13
2WB5	GLCNACSTATINS ARE NANOMOLAR INHIBITORS OF HUMAN O-GLCNACASE INDUCING CELLULAR HYPER-O-GLCNACYLATION	3.2.1.35 3.2.1.52 3.2.1.169
2WBB	FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE-1- PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEXED WITH AN AMP SITE INHIBITOR	3.1.3.11
2WBD	FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE-1- PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEXED WITH AN AMP SITE INHIBITOR	3.1.3.11
2WBF	CRYSTAL STRUCTURE ANALYSIS OF SERA5E FROM PLASMODIUM FALCIPARUM WITH LOOP 690-700 ORDERED	3.4.22
2WBG	STRUCTURE OF FAMILY 1 BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH 3-IMINO-2-OXA-(+)-CASTANOSPERMINE	3.2.1.21
2WBK	STRUCTURE OF THE MICHAELIS COMPLEX OF BETA-MANNOSIDASE, MAN2A, PROVIDES INSIGHT INTO THE CONFORMATIONAL ITINERARY OF MANNOSIDE HYDROLYSIS	3.2.1.25
2WBN	CRYSTAL STRUCTURE OF THE G2P (LARGE TERMINASE) NUCLEASE DOMAIN FROM THE BACTERIOPHAGE SPP1	3.1 3.6.4
2WBY	CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH INSULIN	3.4.24.56
2WC0	CRYSTAL STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH IODINATED INSULIN	3.4.24.56
2WC3	STRUCTURE OF FAMILY 1 BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH 3-IMINO-2-OXA-(+)-8-EPI-CASTANOSPERMINE	3.2.1.21
2WC4	STRUCTURE OF FAMILY 1 BETA-GLUCOSIDASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH 3-IMINO-2-THIA-(+)-CASTANOSPERMINE	3.2.1.21
2WC7	CRYSTAL STRUCTURE OF NOSTOC PUNCTIFORME DEBRANCHING ENZYME(NPDE)(ACARBOSE SOAKED)	3.2.1.54
2WC9	CRYSTAL STRUCTURE OF THE G2P (LARGE TERMINASE) NUCLEASE DOMAIN FROM THE BACTERIOPHAGE SPP1 WITH BOUND MN	3.1 3.6.4
2WCA	BTGH84 IN COMPLEX WITH N-BUTYL PUGNAC	3.2.1.52 3.2.1.169
2WCG	X-RAY STRUCTURE OF ACID-BETA-GLUCOSIDASE WITH N-OCTYL(CYCLIC GUANIDINE)-NOJIRIMYCIN IN THE ACTIVE SITE	3.2.1.45 2.4.1 3.2.1
2WCS	CRYSTAL STRUCTURE OF DEBRANCHING ENZYME FROM NOSTOC PUNCTIFORME (NPDE)	3.2.1.54
2WCT	HUMAN SARS CORONAVIRUS UNIQUE DOMAIN (TRICLINIC FORM)	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2WCW	1.6A RESOLUTION STRUCTURE OF ARCHAEOGLOBUS FULGIDUS HJC, A HOLLIDAY JUNCTION RESOLVASE FROM AN ARCHAEAL HYPERTHERMOPHILE	3.1.22.4
2WCX	CRYSTAL STRUCTURE OF HEPATITIS C VIRUS NS5B POLYMERASE IN COMPLEX WITH THIENOPYRROLE-BASED FINGER-LOOP INHIBITORS	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2WCZ	1.6A RESOLUTION STRUCTURE OF ARCHAEOGLOBUS FULGIDUS HJC, A HOLLIDAY JUNCTION RESOLVASE FROM AN ARCHAEAL HYPERTHERMOPHILE	3.1.22.4
2WDB	A FAMILY 32 CARBOHYDRATE-BINDING MODULE, FROM THE MU TOXIN PRODUCED BY CLOSTRIDIUM PERFRINGENS, IN COMPLEX WITH BETA-D-GLCNAC-BETA(1,2) MANNOSE	3.2.1.35
2WDP	CRYSTAL STRUCTURE OF LIGAND FREE HUMAN CASPASE-6	3.4.22.59
2WDT	CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM UCHL3 IN COMPLEX WITH THE SUICIDE INHIBITOR UBVME	3.4.19.12
2WE0	EBV DUTPASE MUTANT CYS4SER	3.6.1.23
2WE1	EBV DUTPASE MUTANT ASP131ASN WITH BOUND DUMP	3.6.1.23
2WE2	EBV DUTPASE DOUBLE MUTANT GLY78ASP-ASP131SER WITH DUMP	3.6.1.23
2WE3	EBV DUTPASE INACTIVE MUTANT DELETED OF MOTIF V	3.6.1.23
2WE6	CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM UBIQUITIN CARBOXYL- TERMINAL HYDROLASE 3 (UCHL3)	3.4.19.12
2WEA	ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL[CYCLO-7[(2R)-((N-VALYL) AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY) PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT	3.4.23.20
2WEB	ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-FORMYL)-L-VALYL)AMINO-2-(2-NAPHTHYL)ETHYL)HYDROXYPHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT	3.4.23.20
2WEC	ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE INHIBITOR: METHYL(2S)-[1-(((N-(1-NAPHTHALENEACETYL))-L-VALYL)AMINOMETHYL)HYDROXY PHOSPHINYLOXY]-3-PHENYLPROPANOATE, SODIUM SALT	3.4.23.20
2WED	ACID PROTEINASE (PENICILLOPEPSIN) (E.C.3.4.23.20) COMPLEX WITH PHOSPHONATE MACROCYCLIC INHIBITOR:METHYL[CYCLO-7[(2R)-((N-VALYL)AMINO)-2-(HYDROXYL-(1S)-1-METHYOXYCARBONYL-2-PHENYLETHOXY)PHOSPHINYLOXY-ETHYL]-1-NAPHTHALENEACETAMIDE], SODIUM SALT	3.4.23.20
2WEF	HUMAN 3'(2'), 5'-BISPHOSPHATE NUCLEOTIDASE 1 (BPNT1) IN COMPLEX WITH AMP, PO4 AND MAGNESIUM	3.1.3.7
2WEY	HUMAN PDE-PAPAVERINE COMPLEX OBTAINED BY LIGAND SOAKING OF CROSS- LINKED PROTEIN CRYSTALS	3.1.4.17 3.1.4.35
2WEZ	HUMAN BACE-1 IN COMPLEX WITH 1-ETHYL-N-((1S,2R)-2-HYDROXY-3-(((3-(METHYLOXY)PHENYL)METHYL)AMINO)-1-(PHENYLMETHYL)PROPYL)-4-(2-OXO-1- PYRROLIDINYL)-1H-INDOLE-6-CARBOXAMIDE	3.4.23.46
2WF0	HUMAN BACE-1 IN COMPLEX WITH 4-ETHYL-N-((1S,2R)-2-HYDROXY-1-(PHENYLMETHYL)-3-(((3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO)PROPYL)-8-(2-OXO-1-PYRROLIDINYL)-6-QUINOLINECARBOXAMIDE	3.4.23.46
2WF1	HUMAN BACE-1 IN COMPLEX WITH 7-ETHYL-N-((1S,2R)-2-HYDROXY-3-(((3-(METHYLOXY)PHENYL(METHYL)AMINO)-1-(PHENYLMETHYL)PROPYL)-1-METHYL-3,4- DIHYDRO-1H-(1,2,5)THIADIAZEPINO(3,4,5-HI)INDOLE-9-CARBOXAMIDE 2,2- DIOXIDE	3.4.23.46
2WF2	HUMAN BACE-1 IN COMPLEX WITH 8-ETHYL-N-((1S,2R)-2-HYDROXY-3-(((3-(METHYLOXY)PHENYL)METHYL)AMINO)-1-(PHENYLMETHYL)PROPYL)-1-METHYL-3,4,7, 8-TETRAHYDRO-1H,6H-(1,2,5)THIADIAZEPINO(5,4,3-DE)QUINOXALINE-10- CARBOXAMIDE 2,2-DIOXIDE	3.4.23.46
2WF3	HUMAN BACE-1 IN COMPLEX WITH 6-(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-3-(((3-(METHYLOXY)PHENYL)METHYL)AMINO)-1-(PHENYLMETHYL)PROPYL)-1-METHYL-1, 3,4,5-TETRAHYDRO-2,1-BENZOTHIAZEPINE-8-CARBOXAMIDE 2,2-DIOXIDE	3.4.23.46
2WF4	HUMAN BACE-1 IN COMPLEX WITH 6-ETHYL-1-METHYL-N-((1S)-2-OXO-1-(PHENYLMETHYL)-3-(TETRAHYDRO-2H-PYRAN-4-YLAMINO)PROPYL)-1,3,4,6- TETRAHYDRO(1,2)THIAZEPINO(5,4,3-CD)INDOLE-8-CARBOXAMIDE 2,2-DIOXIDE	3.4.23.46
2WFM	CRYSTAL STRUCTURE OF POLYNEURIDINE ALDEHYDE ESTERASE MUTANT (H244A)	3.1.1.78
2WFZ	NON-AGED CONJUGATE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE WITH SOMAN	3.1.1.7
2WG0	AGED CONJUGATE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE WITH SOMAN (OBTAINED BY IN CRYSTALLO AGING)	3.1.1.7
2WG1	TERNARY COMPLEX OF THE AGED CONJUGATE OF TORPEDO CALIFORNICA ACEYLCHOLINESTERASE WITH SOMAN AND 2-PAM	3.1.1.7
2WG2	NON-AGED CONJUGATE OF TORPEDO CALIFORNICA ACETYLCHOLINESTERASE WITH SOMAN (ALTERNATIVE REFINEMENT)	3.1.1.7
2WG5	PROTEASOME-ACTIVATING NUCLEOTIDASE (PAN) N-DOMAIN (57-134) FROM ARCHAEOGLOBUS FULGIDUS FUSED TO GCN4	3.6.4.8
2WG6	PROTEASOME-ACTIVATING NUCLEOTIDASE (PAN) N-DOMAIN (57-134) FROM ARCHAEOGLOBUS FULGIDUS FUSED TO GCN4, P61A MUTANT	3.6.4.8
2WG7	STRUCTURE OF ORYZA SATIVA (RICE) PLA2	3.1.1.4
2WG8	STRUCTURE OF ORYZA SATIVA (RICE) PLA2, ORTHORHOMBIC CRYSTAL FORM	3.1.1.4
2WG9	STRUCTURE OF ORYZA SATIVA (RICE) PLA2, COMPLEX WITH OCTANOIC ACID	3.1.1.4
2WGI	CRYSTAL STRUCTURE OF THE ACYL-ENZYME OXA-10 W154A-BENZYLPENICILLIN AT PH 6	3.5.2.6
2WGP	CRYSTAL STRUCTURE OF HUMAN DUAL SPECIFICITY PHOSPHATASE 14	3.1.3.48 3.1.3.16
2WGV	CRYSTAL STRUCTURE OF THE OXA-10 V117T MUTANT AT PH 6.5 INHIBITED BY A CHLORIDE ION	3.5.2.6
2WGW	CRYSTAL STRUCTURE OF THE OXA-10 V117T MUTANT AT PH 8.0	3.5.2.6
2WH7	THE PARTIAL STRUCTURE OF A GROUP A STREPTPCOCCAL PHAGE-ENCODED TAIL FIBRE HYALURONATE LYASE HYLP2	3.2.1.35
2WHG	CRYSTAL STRUCTURE OF THE DI-ZINC METALLO-BETA-LACTAMASE VIM-4 FROM PSEUDOMONAS AERUGINOSA	3.5.2.6
2WHH	HIV-1 PROTEASE TETHERED DIMER Q-PRODUCT COMPLEX ALONG WITH NUCLEOPHILIC WATER MOLECULE	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2WHJ	UNDERSTANDING HOW DIVERSE MANNANASES RECOGNISE HETEROGENEOUS SUBSTRATES	3.2.1.78
2WHK	STRUCTURE OF BACILLUS SUBTILIS MANNANASE MAN26	3.2.1.78
2WHL	UNDERSTANDING HOW DIVERSE MANNANASES RECOGNISE HETEROGENEOUS SUBSTRATES	3.2.1.78
2WHM	CELLVIBRIO JAPONICUS MAN26A E121A AND E320G DOUBLE MUTANT IN COMPLEX WITH MANNOBIOSE	3.2.1.78
2WHO	CRYSTAL STRUCTURE OF HEPATITIS C VIRUS NS5B POLYMERASE FROM 1B GENOTYPE IN COMPLEX WITH A NON-NUCLEOSIDE INHIBITOR	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2WHP	CRYSTAL STRUCTURE OF ACETYLCHOLINESTERASE, PHOSPHONYLATED BY SARIN AND IN COMPLEX WITH HI-6	3.1.1.7
2WHQ	CRYSTAL STRUCTURE OF ACETYLCHOLINESTERASE, PHOSPHONYLATED BY SARIN (AGED) IN COMPLEX WITH HI-6	3.1.1.7
2WHR	CRYSTAL STRUCTURE OF ACETYLCHOLINESTERASE IN COMPLEX WITH K027	3.1.1.7
2WHX	A SECOND CONFORMATION OF THE NS3 PROTEASE-HELICASE FROM DENGUE VIRUS	3.4.21.91 3.6.1.15 3.6.1 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2WHZ	DIPEPTIDE INHIBITORS OF THERMOLYSIN	3.4.24.27
2WI0	DIPEPTIDE INHIBITORS OF THERMOLYSIN	3.4.24.27
2WID	NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1	3.1.1.8
2WIE	HIGH-RESOLUTION STRUCTURE OF THE ROTOR RING FROM A PROTON DEPENDENT ATP SYNTHASE	3.6.3.14
2WIF	AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1	3.1.1.8
2WIG	NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA4	3.1.1.8
2WIJ	NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5	3.1.1.8
2WIK	NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA6	3.1.1.8
2WIL	AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5	3.1.1.8
2WIW	CRYSTAL STRUCTURES OF HOLLIDAY JUNCTION RESOLVASES FROM ARCHAEOGLOBUS FULGIDUS BOUND TO DNA SUBSTRATE	3.1.22.4
2WIZ	CRYSTAL STRUCTURES OF HOLLIDAY JUNCTION RESOLVASES FROM ARCHAEOGLOBUS FULGIDUS BOUND TO DNA SUBSTRATE	3.1.22.4
2WJ0	CRYSTAL STRUCTURES OF HOLLIDAY JUNCTION RESOLVASES FROM ARCHAEOGLOBUS FULGIDUS BOUND TO DNA SUBSTRATE	3.1.22.4
2WJ1	3D-CRYSTAL STRUCTURE OF HUMANIZED-RAT FATTY ACID AMIDE HYDROLASE (FAAH) CONJUGATED WITH 7-PHENYL-1-(4-(PYRIDIN-2-YL)OXAZOL-2-YL)HEPTAN- 1-ONE, AN ALPHA-KETOOXAZOLE	3.5.1.4 3.5.1.99 3.1.1
2WJ2	3D-CRYSTAL STRUCTURE OF HUMANIZED-RAT FATTY ACID AMIDE HYDROLASE (FAAH) CONJUGATED WITH 7-PHENYL-1-(5-(PYRIDIN-2-YL)OXAZOL-2-YL)HEPTAN- 1-ONE, AN ALPHA-KETOOXAZOLE	3.5.1.4 3.5.1.99 3.1.1
2WJA	CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE WZB FROM ESCHERICHIA COLI K30 IN COMPLEX WITH PHOSPHATE.	3.1.3.48
2WJD	CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE CPS4B FROM STEPTOCOCCUS PNEUMONIAE TIGR4.	3.1.3.48
2WJE	CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE CPS4B FROM STEPTOCOCCUS PNEUMONIAE TIGR4.	3.1.3.48
2WJF	CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE CPS4B FROM STEPTOCOCCUS PNEUMONIAE TIGR4 IN COMPLEX WITH PHOSPHATE.	3.1.3.48
2WJO	HUMAN BACE (BETA SECRETASE) IN COMPLEX WITH CYCLOHEXANECARBOXYLIC ACID (2-(2-AM INO-6-PHENOXY-4H-QUINAZOLIN-3-YL)-2 -CYCLOHEXYL-ETHYL)- AMIDE	3.4.23.46
2WJV	CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN NONSENSE MEDIATED DECAY FACTORS UPF1 AND UPF2	3.6.1 3.6.4
2WJY	CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN NONSENSE MEDIATED DECAY FACTORS UPF1 AND UPF2 ORTHORHOMBIC FORM	3.6.1 3.6.4
2WK0	CRYSTAL STRUCTURE OF THE CLASS A BETA-LACTAMASE BS3 INHIBITED BY 6- BETA-IODOPENICILLANATE.	3.5.2.6
2WK2	CHITINASE A FROM SERRATIA MARCESCENS ATCC990 IN COMPLEX WITH CHITOTRIO-THIAZOLINE DITHIOAMIDE.	3.2.1.14
2WK3	CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH AMYLOID-BETA (1-42)	3.4.24.56
2WK4	DIMERIC STRUCTURE OF D347G D348G MUTANT OF THE SAPPOROVIRUS RNA DEPENDENT RNA POLYMERASE	3.4.22.66 3.6.1.15 2.7.7.48
2WKE	CRYSTAL STRUCTURE OF THE ACTINOMADURA R39 DD-PEPTIDASE INHIBITED BY 6- BETA-IODOPENICILLANATE.	3.4.16.4
2WKG	NOSTOC PUNCTIFORME DEBRANCHING ENZYME (NPDE)(NATIVE FORM)	3.2.1.54
2WKH	CRYSTAL STRUCTURE OF THE ACYL-ENZYME OXA-10 K70C-AMPICILLIN AT PH 7	3.5.2.6
2WKI	CRYSTAL STRUCTURE OF THE OXA-10 K70C MUTANT AT PH 7.0	3.5.2.6
2WKL	VELAGLUCERASE ALFA	3.2.1.45 2.4.1 3.2.1
2WKP	STRUCTURE OF A PHOTOACTIVATABLE RAC1 CONTAINING LOV2 WILDTYPE	3.6.5.2
2WKQ	STRUCTURE OF A PHOTOACTIVATABLE RAC1 CONTAINING THE LOV2 C450A MUTANT	3.6.5.2
2WKR	STRUCTURE OF A PHOTOACTIVATABLE RAC1 CONTAINING THE LOV2 C450M MUTANT	3.6.5.2
2WKX	CRYSTAL STRUCTURE OF THE NATIVE E. COLI ZINC AMIDASE AMID	3.5.1.28
2WKZ	HIV-1 PROTEASE INHIBITORS CONTAINING A TERTIARY ALCOHOL IN THE TRANSITION-STATE MIMIC WITH IMPROVED CELL-BASED ANTIVIRAL ACTIVITY	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2WL0	HIV-1 PROTEASE INHIBITORS CONTAINING A TERTIARY ALCOHOL IN THE TRANSITION-STATE MIMIC WITH IMPROVED CELL-BASED ANTIVIRAL ACTIVITY	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2WLQ	NUCLEOPHILE-DISABLED LAM16A MUTANT HOLDS LAMINARIHEPTAOSE (L7) IN A CYCLICAL CONFORMATION	3.2.1.6
2WLS	CRYSTAL STRUCTURE OF MUS MUSCULUS ACETYLCHOLINESTERASE IN COMPLEX WITH AMTS13	3.1.1.7
2WLT	THE CRYSTAL STRUCTURE OF HELICOBACTER PYLORI L-ASPARAGINASE AT 1.4 A RESOLUTION	3.5.1.1
2WLY	CHITINASE A FROM SERRATIA MARCESCENS ATCC990 IN COMPLEX WITH CHITOTRIO-THIAZOLINE.	3.2.1.14
2WLZ	CHITINASE A FROM SERRATIA MARCESCENS ATCC990 IN COMPLEX WITH CHITOBIO- THIAZOLINE.	3.2.1.14
2WM0	CHITINASE A FROM SERRATIA MARCESCENS ATCC990 IN COMPLEX WITH CHITOBIO- THIAZOLINE THIOAMIDE.	3.2.1.14
2WM8	CRYSTAL STRUCTURE OF HUMAN MAGNESIUM-DEPENDENT PHOSPHATASE 1 OF THE HALOACID DEHALOGENASE SUPERFAMILY (MGC5987)	3.8.1 3.1.3 3.1.3.48
2WMY	CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE WZB FROM ESCHERICHIA COLI K30 IN COMPLEX WITH SULPHATE.	3.1.3.48
2WNE	MUTANT LAMINARINASE 16A CYCLIZES LAMINARIHEPTAOSE	3.2.1.6
2WNH	CRYSTAL STRUCTURE ANALYSIS OF KLEBSIELLA SP ASR1 PHYTASE	3.1.3.8
2WNI	CRYSTAL STRUCTURE ANALYSIS OF KLEBSIELLA SP ASR1 PHYTASE	3.1.3.8
2WNR	THE STRUCTURE OF METHANOTHERMOBACTER THERMAUTOTROPHICUS EXOSOME CORE ASSEMBLY	3.1.13
2WNW	THE CRYSTAL STRUCTURE OF SRFJ FROM SALMONELLA TYPHIMURIUM	3.2.1.75
2WO8	MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID	3.4.24.65
2WO9	MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID	3.4.24.65
2WOA	MMP12 COMPLEX WITH A BETA HYDROXY CARBOXYLIC ACID	3.4.24.65
2WOC	CRYSTAL STRUCTURE OF THE DINITROGENASE REDUCTASE-ACTIVATING GLYCOHYDROLASE (DRAG) FROM RHODOSPIRILLUM RUBRUM	3.2.2.24
2WOD	CRYSTAL STRUCTURE OF THE DINITROGENASE REDUCTASE-ACTIVATING GLYCOHYDROLASE (DRAG) FROM RHODOSPIRILLUM RUBRUM IN COMPLEX WITH ADP- RIBSOYLLYSINE	3.2.2.24
2WOE	CRYSTAL STRUCTURE OF THE D97N VARIANT OF DINITROGENASE REDUCTASE- ACTIVATING GLYCOHYDROLASE (DRAG) FROM RHODOSPIRILLUM RUBRUM IN COMPLEX WITH ADP-RIBOSE	3.2.2.24
2WOJ	ADP-ALF4 COMPLEX OF S. CEREVISIAE GET3	3.6.3.16 3.6
2WOM	CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (K103N).	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2WON	CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (WILD-TYPE).	2.7.7.49 3.4.23.16 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2WOO	NUCLEOTIDE-FREE FORM OF S. POMBE GET3	3.6.3.16 3.6
2WP7	CRYSTAL STRUCTURE OF DESUMOYLASE(DUF862)	3.4.22 3.4
2WP8	YEAST RRP44 NUCLEASE	3.1.13
2WPH	FACTOR IXA SUPERACTIVE TRIPLE MUTANT	3.4.21.22
2WPI	FACTOR IXA SUPERACTIVE DOUBLE MUTANT	3.4.21.22
2WPJ	FACTOR IXA SUPERACTIVE TRIPLE MUTANT, NACL-SOAKED	3.4.21.22
2WPK	FACTOR IXA SUPERACTIVE TRIPLE MUTANT, ETHYLENE GLYCOL-SOAKED	3.4.21.22
2WPL	FACTOR IXA SUPERACTIVE TRIPLE MUTANT, EDTA-SOAKED	3.4.21.22
2WPM	FACTOR IXA SUPERACTIVE MUTANT, EGR-CMK INHIBITED	3.4.21.22
2WPO	HCMV PROTEASE INHIBITOR COMPLEX	3.4.21 3.4.21.97
2WQ5	NON-ANTIBIOTIC PROPERTIES OF TETRACYCLINES: STRUCTURAL BASIS FOR INHIBITION OF SECRETORY PHOSPHOLIPASE A2.	3.1.1.4
2WQK	CRYSTAL STRUCTURE OF SURE PROTEIN FROM AQUIFEX AEOLICUS	3.1.3.5
2WR0	STRUCTURES OF INFLUENZA H2 HEMAGGLUTININS	3.1.1.53
2WR1	STRUCTURE OF INFLUENZA H2 HEMAGGLUTININ WITH HUMAN RECEPTOR	3.1.1.53
2WR2	STRUCTURE OF INFLUENZA H2 AVIAN HEMAGGLUTININ WITH AVIAN RECEPTOR	3.1.1.53
2WR3	STRUCTURE OF INFLUENZA H2 DUCK ONTARIO HEMAGGLUTININ WITH AVIAN RECEPTOR	3.1.1.53
2WR4	STRUCTURE OF INFLUENZA H2 DUCK ONTARIO HEMAGGLUTININ WITH HUMAN RECEPTOR	3.1.1.53
2WR5	STRUCTURE OF INFLUENZA H2 DUCK ONTARIO HEMAGGLUTININ	3.1.1.53
2WRM	IDENTIFICATION OF NOVEL ALLOSTERIC INHIBITORS OF HEPATITIS C VIRUS NS5B POLYMERASE THUMB DOMAIN (SITE II) BY STRUCTURE-BASED DESIGN	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2WRS	CRYSTAL STRUCTURE OF THE MONO-ZINC METALLO-BETA-LACTAMASE VIM-4 FROM PSEUDOMONAS AERUGINOSA	3.5.2.6
2WSH	STRUCTURE OF BACTERIOPHAGE T4 ENDOII E118A MUTANT	3.1.21 3.1.21.8
2WSK	CRYSTAL STRUCTURE OF GLYCOGEN DEBRANCHING ENZYME GLGX FROM ESCHERICHIA COLI K-12	3.2.1.196
2WSL	AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA4	3.1.1.8
2WSP	THERMOTOGA MARITIMA ALPHA-L-FUCOSYNTHASE, TMD224G, IN COMPLEX WITH ALPHA-L-FUC-(1-2)-BETA-L-FUC-N3	3.2.1.51
2WT4	ROOM TEMPERATURE CRYSTAL STRUCTURE OF HELICOBACTER PYLORI L- ASPARAGINASE AT 1.8 A RESOLUTION	3.5.1.1
2WT9	ACINETOBACTER BAUMANII NICOTINAMIDASE PYRAZINAMIDEASE	3.5.1.19 3.5.1
2WTA	ACINETOBACTER BAUMANII NICOTINAMIDASE PYRAZINAMIDEASE	3.5.1.19 3.5.1
2WU0	CRYSTAL STRUCTURE ANALYSIS OF KLEBSIELLA SP ASR1 PHYTASE	3.1.3.8
2WU1	GLUCOSAMINE-6-PHOSPHATE DEAMINASE COMPLEXED WITH THE ALLOSTERIC ACTIVATOR N-ACETYL-GLUCOAMINE-6-PHOSPHATE BOTH IN THE ACTIVE AND ALLOSTERIC SITES.	3.5.99.6
2WU3	CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE IN COMPLEX WITH FENAMIPHOS AND HI-6	3.1.1.7
2WU4	CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE IN COMPLEX WITH FENAMIPHOS AND ORTHO-7	3.1.1.7
2WUB	CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON- INHIBITORY ANTIBODY FAB40.DELTATRP	3.4.21
2WUD	CRYSTAL STRUCTURE OF S114A MUTANT OF HSAD FROM MYCOBACTERIUM TUBERCULOSIS	3.7.1.8 3.7.1.17
2WUE	CRYSTAL STRUCTURE OF S114A MUTANT OF HSAD FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH HOPODA	3.7.1.8 3.7.1.17
2WUF	CRYSTAL STRUCTURE OF S114A MUTANT OF HSAD FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH 4,9DSHA	3.7.1.8 3.7.1.17
2WUG	CRYSTAL STRUCTURE OF S114A MUTANT OF HSAD FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH HOPDA	3.7.1.8 3.7.1.17
2WUV	CRYSTALLOGRAPHIC ANALYSIS OF COUNTER-ION EFFECTS ON SUBTILISIN ENZYMATIC ACTION IN ACETONITRILE	3.4.21.62
2WUW	CRYSTALLOGRAPHIC ANALYSIS OF COUNTER-ION EFFECTS ON SUBTILISIN ENZYMATIC ACTION IN ACETONITRILE (NATIVE DATA)	3.4.21.62
2WV4	CRYSTAL STRUCTURE OF FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE IN COMPLEX WITH A DECAMERIC PEPTIDE CORRESPONDING TO THE VP1-2A CLEAVAGE JUNCTION	3.4.22.28 3.4.22.46 3.6.1.15 2.7.7.48
2WV5	CRYSTAL STRUCTURE OF FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE IN COMPLEX WITH A DECAMERIC PEPTIDE CORRESPONDING TO THE VP1-2A CLEAVAGE JUNCTION WITH A GLN TO GLU SUBSTITUTION AT P1	3.4.22.28 3.4.22.46 3.6.1.15 2.7.7.48
2WV7	INTRACELLULAR SUBTILISIN PRECURSOR FROM B. CLAUSII	3.4.21.62
2WV9	CRYSTAL STRUCTURE OF THE NS3 PROTEASE-HELICASE FROM MURRAY VALLEY ENCEPHALITIS VIRUS	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2WW5	3D-STRUCTURE OF THE MODULAR AUTOLYSIN LYTC FROM STREPTOCOCCUS PNEUMONIAE AT 1.6 A RESOLUTION	3.2.1.17
2WWC	3D-STRUCTURE OF THE MODULAR AUTOLYSIN LYTC FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH SYNTHETIC PEPTIDOGLYCAN LIGAND	3.2.1.17
2WWD	3D-STRUCTURE OF THE MODULAR AUTOLYSIN LYTC FROM STREPTOCOCCUS PNEUMONIAE IN COMPLEX WITH PNEUMMOCOCCAL PEPTIDOGLYCAN FRAGMENT	3.2.1.17
2WWT	INTRACELLULAR SUBTILISIN PRECURSOR FROM B. CLAUSII	3.4.21.62
2WWW	CRYSTAL STRUCTURE OF METHYLMALONIC ACIDEMIA TYPE A PROTEIN	3.6
2WWY	STRUCTURE OF HUMAN RECQ-LIKE HELICASE IN COMPLEX WITH A DNA SUBSTRATE	3.6.1 3.6.4.12
2WX3	ASYMMETRIC TRIMER OF THE HUMAN DCP1A C-TERMINAL DOMAIN	3
2WXD	A MICROMOLAR O-SULFATED THIOHYDROXIMATE INHIBITOR BOUND TO PLANT MYROSINASE	3.2.3.1 3.2.1.147
2WXT	CLOSTRIDIUM PERFRINGENS ALPHA-TOXIN STRAIN NCTC8237	3.1.4.3
2WXU	CLOSTRIDIUM PERFRINGENS ALPHA-TOXIN STRAIN NCTC8237 MUTANT T74I	3.1.4.3
2WY6	CLOSTRIDIUM PERFRINGENS ALPHA-TOXIN STRAIN NCTC8237 MUTANT T74I	3.1.4.3
2WYB	THE QUORUM QUENCHING N-ACYL HOMOSERINE LACTONE ACYLASE PVDQ WITH A COVALENTLY BOUND DODECANOIC ACID	3.5.1.97
2WYC	THE QUORUM QUENCHING N-ACYL HOMOSERINE LACTONE ACYLASE PVDQ IN COMPLEX WITH 3-OXO-LAURIC ACID	3.5.1.97
2WYD	THE QUORUM QUENCHING N-ACYL HOMOSERINE LACTONE ACYLASE PVDQ IN COMPLEX WITH DODECANOIC ACID	3.5.1.97
2WYE	THE QUORUM QUENCHING N-ACYL HOMOSERINE LACTONE ACYLASE PVDQ IS AN NTN- HYDROLASE WITH AN UNUSUAL SUBSTRATE-BINDING POCKET	3.5.1.97
2WYG	STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS	3.4.21.6
2WYH	STRUCTURE OF THE STREPTOCOCCUS PYOGENES FAMILY GH38 ALPHA-MANNOSIDASE	3.2.1.24
2WYI	STRUCTURE OF THE STREPTOCOCCUS PYOGENES FAMILY GH38 ALPHA-MANNOSIDASE COMPLEXED WITH SWAINSONINE	3.2.1.24
2WYJ	STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS	3.4.21.6
2WYL	APO STRUCTURE OF A METALLO-B-LACTAMASE	3.1.1
2WYM	STRUCTURE OF A METALLO-B-LACTAMASE	3.1.1
2WYN	STRUCTURE OF FAMILY 37 TREHALASE FROM ESCHERICHIA COLI IN COMPLEX WITH A CASUARINE-6-O-A-D-GLUCOSIDE ANALOGUE	3.2.1.28
2WYR	3-D STRUCTURE OF PHTET1-12S, DODECAMER IN THE ASYMMETRIC UNIT	3.4.11
2WYS	HIGH RESOLUTION CRYSTALLOGRAPHIC STRUCTURE OF THE CLOSTRIDIUM THERMOCELLUM N-TERMINAL ENDO-1,4-BETA-D-XYLANASE 10B (XYN10B) CBM22-1- GH10 MODULES COMPLEXED WITH XYLOHEXAOSE	3.2.1.8
2WYX	NEUTRON STRUCTURE OF A CLASS A BETA-LACTAMASE TOHO-1 E166A R274N R276N TRIPLE MUTANT	3.5.2.6
2WZE	HIGH RESOLUTION CRYSTALLOGRAPHIC STRUCTURE OF THE CLOSTRIDIUM THERMOCELLUM N-TERMINAL ENDO-1,4-BETA-D-XYLANASE 10B (XYN10B) CBM22-1- GH10 MODULES COMPLEXED WITH XYLOHEXAOSE	3.2.1.8
2WZH	BTGH84 D242N IN COMPLEX WITH MEUMB-DERIVED OXAZOLINE	3.2.1.52 3.2.1.169
2WZI	BTGH84 D243N IN COMPLEX WITH 5F-OXAZOLINE	3.2.1.52 3.2.1.169
2WZQ	INSERTION MUTANT E173GP174 OF THE NS3 PROTEASE-HELICASE FROM DENGUE VIRUS	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2WZR	THE STRUCTURE OF FOOT AND MOUTH DISEASE VIRUS SEROTYPE SAT1	2.7.7.48 3.4.22.28 3.4.22.46 3.6.1.15
2WZX	AMP-C BETA-LACTAMASE (PSEUDOMONAS AERUGINOSA)IN COMPLEX WITH COMPOUND M-02	3.5.2.6
2WZZ	AMP-C BETA-LACTAMASE (PSEUDOMONAS AERUGINOSA)IN COMPLEX WITH COMPOUND M-03	3.5.2.6
2X01	CRYSTAL STRUCTURE OF THE OXA-10 S67A MUTANT AT PH 7	3.5.2.6
2X02	CRYSTAL STRUCTURE OF THE CLASS D BETA-LACTAMASE OXA-10 AT 1.35 A RESOLUTION	3.5.2.6
2X05	INHIBITION OF THE EXO-BETA-D-GLUCOSAMINIDASE CSXA BY A GLUCOSAMINE- CONFIGURED CASTANOSPERMINE AND AN AMINO-AUSTRALINE ANALOGUE	3.2.1.165
2X09	INHIBITION OF THE EXO-BETA-D-GLUCOSAMINIDASE CSXA BY A GLUCOSAMINE- CONFIGURED CASTANOSPERMINE AND AN AMINO-AUSTRALINE ANALOGUE	3.2.1.165
2X0A	MPD-LYSOZYME STRUCTURE AT 55.5 KEV USING A TRIXXEL CSI-ASI BASED DIGITAL IMAGER AND THE NEW ESRF U22 UNDULATOR SOURCE AT ID15	3.2.1.17
2X0H	BTGH84 MICHAELIS COMPLEX	3.2.1.52 3.2.1.169
2X0Y	SCREENING-BASED DISCOVERY OF DRUG-LIKE O-GLCNACASE INHIBITOR SCAFFOLDS	3.2.1.52 3.2.1.169
2X1V	CRYSTAL STRUCTURE OF THE ACTIVATING H-RAS I163F MUTANT IN COSTELLO SYNDROME, BOUND TO MG-GDP	3.6.5.2
2X2E	DYNAMIN GTPASE DIMER, LONG AXIS FORM	3.6.5.5
2X2F	DYNAMIN 1 GTPASE DIMER, SHORT AXIS FORM	3.6.5.5
2X2Y	CELLULOMONAS FIMI ENDO-BETA-1,4-MANNANASE DOUBLE MUTANT	3.2.1.78
2X36	STRUCTURE OF THE PROTEOLYTIC DOMAIN OF THE HUMAN MITOCHONDRIAL LON PROTEASE	3.4.21 3.4.21.53
2X3A	ASAP1 INACTIVE MUTANT E294Q, AN EXTRACELLULAR TOXIC ZINC METALLOENDOPEPTIDASE	3.4.24.39
2X3B	ASAP1 INACTIVE MUTANT E294A, AN EXTRACELLULAR TOXIC ZINC METALLOENDOPEPTIDASE	3.4.24.39
2X3C	ASAP1 INACTIVE MUTANT E294Q, AN EXTRACELLULAR TOXIC ZINC METALLOENDOPEPTIDASE	3.4.24.39
2X40	STRUCTURE OF BETA-GLUCOSIDASE 3B FROM THERMOTOGA NEAPOLITANA IN COMPLEX WITH GLYCEROL	3.2.1.21
2X41	STRUCTURE OF BETA-GLUCOSIDASE 3B FROM THERMOTOGA NEAPOLITANA IN COMPLEX WITH GLUCOSE	3.2.1.21
2X42	STRUCTURE OF BETA-GLUCOSIDASE 3B FROM THERMOTOGA NEAPOLITANA IN COMPLEX WITH ALPHA-D-GLUCOSE	3.2.1.21
2X47	CRYSTAL STRUCTURE OF HUMAN MACROD1	3.1.1.106 3.2.2
2X4D	CRYSTAL STRUCTURE OF HUMAN PHOSPHOLYSINE PHOSPHOHISTIDINE INORGANIC PYROPHOSPHATE PHOSPHATASE LHPP	3.6.1.1 3.1.3
2X4M	YERSINIA PESTIS PLASMINOGEN ACTIVATOR PLA	3.4.23.48
2X55	YERSINIA PESTIS PLASMINOGEN ACTIVATOR PLA (NATIVE)	3.4.23.48
2X56	YERSINIA PESTIS PLASMINOGEN ACTIVATOR PLA (NATIVE)	3.4.23.48
2X6N	HUMAN FOAMY VIRUS INTEGRASE - CATALYTIC CORE. MANGANESE-BOUND STRUCTURE.	2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1
2X6S	HUMAN FOAMY VIRUS INTEGRASE - CATALYTIC CORE. MAGNESIUM-BOUND STRUCTURE.	2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1
2X71	STRUCTURAL BASIS FOR THE INTERACTION OF LACTIVICINS WITH SERINE BETA- LACTAMASES	3.5.2.6
2X74	HUMAN FOAMY VIRUS INTEGRASE - CATALYTIC CORE.	2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1
2X78	HUMAN FOAMY VIRUS INTEGRASE - CATALYTIC CORE.	2.7.7.49 2.7.7.7 3.1.26.4 3.4.23 2.7.7 3.1
2X7M	CRYSTAL STRUCTURE OF ARCHAEMETZINCIN (AMZA) FROM METHANOPYRUS KANDLERI AT 1.5 A RESOLUTION	3 3.4
2X7V	CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA ENDONUCLEASE IV IN THE PRESENCE OF ZINC	3.1.21.2
2X7W	CRYSTAL STRUCTURE OF THERMOTOGA MARITIMA ENDONUCLEASE IV IN THE PRESENCE OF CADMIUM AND ZINC	3.1.21.2
2X8F	NATIVE STRUCTURE OF ENDO-1,5-ALPHA-L-ARABINANASES FROM BACILLUS SUBTILIS	3.2.1.99
2X8J	INTRACELLULAR SUBTILISIN PRECURSOR FROM B. CLAUSII	3.4.21.62
2X8R	THE STRUCTURE OF A FAMILY GH25 LYSOZYME FROM ASPERGILLUS FUMIGATUS	3.2.1.17
2X8S	CRYSTAL STRUCTURE OF THE ABN2 D171A MUTANT IN COMPLEX WITH ARABINOTRIOSE	3.2.1.99
2X8T	CRYSTAL STRUCTURE OF THE ABN2 H318A MUTANT	3.2.1.99
2X8Y	CRYSTAL STRUCTURE OF ANCE	3.4.15.1
2X8Z	CRYSTAL STRUCTURE OF ANCE-CAPTOPRIL COMPLEX	3.4.15.1
2X90	CRYSTAL STRUCTURE OF ANCE-ENALAPRILAT COMPLEX	3.4.15.1
2X91	CRYSTAL STRUCTURE OF ANCE-LISINOPRIL COMPLEX	3.4.15.1
2X92	CRYSTAL STRUCTURE OF ANCE-RAMIPRILAT COMPLEX	3.4.15.1
2X93	CRYSTAL STRUCTURE OF ANCE-TRANDOLAPRILAT COMPLEX	3.4.15.1
2X94	CRYSTAL STRUCTURE OF ANCE-PERINDOPRILAT COMPLEX	3.4.15.1
2X95	CRYSTAL STRUCTURE OF ANCE-LISINOPRIL-TRYPTOPHAN ANALOGUE, LISW-S COMPLEX	3.4.15.1
2X96	CRYSTAL STRUCTURE OF ANCE-RXPA380 COMPLEX	3.4.15.1
2X97	CRYSTAL STRUCTURE OF ANCE-RXP407 COMPLEX	3.4.15.1
2X98	H.SALINARUM ALKALINE PHOSPHATASE	3.1.3.1
2X9H	CRYSTAL STRUCTURE OF MYOSIN-2 MOTOR DOMAIN IN COMPLEX WITH ADP- METAVANADATE AND PENTACHLOROCARBAZOLE	3.6.4.1
2XAU	CRYSTAL STRUCTURE OF THE PRP43P DEAH-BOX RNA HELICASE IN COMPLEX WITH ADP	3.6.1 3.6.4.13
2XB0	DNA-BINDING DOMAIN FROM SACCHAROMYCES CEREVISIAE CHROMATIN- REMODELLING PROTEIN CHD1	3.6.1 3.6.4
2XB2	CRYSTAL STRUCTURE OF THE CORE MAGO-Y14-EIF4AIII-BARENTSZ-UPF3B ASSEMBLY SHOWS HOW THE EJC IS BRIDGED TO THE NMD MACHINERY	3.6.1 3.6.4.13
2XBD	INTERNAL XYLAN BINDING DOMAIN FROM CELLULOMONAS FIMI XYLANASE D, NMR, MINIMIZED AVERAGE STRUCTURE	3.2.1.8 3.5.1
2XBM	CRYSTAL STRUCTURE OF THE DENGUE VIRUS METHYLTRANSFERASE BOUND TO A 5'- CAPPED OCTAMERIC RNA	3.4.21.91 3.6.1.15 3.6.4.13
2XBR	RAMAN CRYSTALLOGRAPHY OF HEN WHITE EGG LYSOZYME - LOW X-RAY DOSE (0.2 MGY)	3.2.1.17
2XBS	RAMAN CRYSTALLOGRAPHY OF HEN WHITE EGG LYSOZYME - HIGH X-RAY DOSE (16 MGY)	3.2.1.17
2XBV	FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR	3.4.21.6
2XBW	FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR	3.4.21.6
2XBX	FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR	3.4.21.6
2XBY	FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR	3.4.21.6
2XC0	FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR	3.4.21.6
2XC4	FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR	3.4.21.6
2XC5	FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR	3.4.21.6
2XCD	STRUCTURE OF YNCF,THE GENOMIC DUTPASE FROM BACILLUS SUBTILIS	3.6.1.23
2XCE	STRUCTURE OF YNCF IN COMPLEX WITH DUPNHPP	3.6.1.23
2XCV	CRYSTAL STRUCTURE OF THE D52N VARIANT OF CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH INOSINE MONOPHOSPHATE AND 2,3-BISPHOSPHOGLYCERATE	3.1.3.5
2XCW	CRYSTAL STRUCTURE OF THE D52N VARIANT OF CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH INOSINE MONOPHOSPHATE AND ATP	3.1.3.5
2XCX	CRYSTAL STRUCTURE OF THE APOFORM OF THE D52N VARIANT OF CYTOSOLIC 5'- NUCLEOTIDASE II	3.1.3.5
2XCY	CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS SIALIDASE	3.2.1.18
2XD0	A PROCESSED NON-CODING RNA REGULATES A BACTERIAL ANTIVIRAL SYSTEM	3.1.27.3 3.1
2XD1	ACTIVE SITE RESTRUCTURING REGULATES LIGAND RECOGNITION IN CLASS A PENICILLIN-BINDING PROTEINS	2.4.1.129 2.3.2 3.4.16.4
2XD5	STRUCTURAL INSIGHTS INTO THE CATALYTIC MECHANISM AND THE ROLE OF STREPTOCOCCUS PNEUMONIAE PBP1B	2.3.2 2.4.1.129 3.4.16.4
2XDB	A PROCESSED NON-CODING RNA REGULATES A BACTERIAL ANTIVIRAL SYSTEM	3.1.27.3 3.1
2XDD	A PROCESSED NON-CODING RNA REGULATES A BACTERIAL ANTIVIRAL SYSTEM	3.1.27.3 3.1
2XDE	CRYSTAL STRUCTURE OF THE COMPLEX OF PF-3450074 WITH AN ENGINEERED HIV CAPSID N TERMINAL DOMAIN	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2XDM	CRYSTAL STRUCTURE OF A COMPLEX BETWEEN ACTINOMADURA R39 DD PEPTIDASE AND A PEPTIDOGLYCAN MIMETIC BORONATE INHIBITOR	3.4.16.4
2XDW	INHIBITION OF PROLYL OLIGOPEPTIDASE WITH A SYNTHETIC UNNATURAL DIPEPTIDE	3.4.21.26
2XE4	STRUCTURE OF OLIGOPEPTIDASE B FROM LEISHMANIA MAJOR	3.4.21.83 3.4.21.26
2XEF	HUMAN GLUTAMATE CARBOXYPEPTIDASE II IN COMPLEX WITH ANTIBODY- RECRUITING MOLECULE ARM-P8	3.4.17.21
2XEG	HUMAN GLUTAMATE CARBOXYPEPTIDASE II IN COMPLEX WITH ANTIBODY- RECRUITING MOLECULE ARM-P4	3.4.17.21
2XEI	HUMAN GLUTAMATE CARBOXYPEPTIDASE II IN COMPLEX WITH ANTIBODY- RECRUITING MOLECULE ARM-P2	3.4.17.21
2XEJ	HUMAN GLUTAMATE CARBOXYPEPTIDASE II IN COMPLEX WITH ARM-M4, UREA- BASED INHIBITOR	3.4.17.21
2XFB	CHIKUNGUNYA E1 E2 ENVELOPE GLYCOPROTEINS FITTED IN SINDBIS VIRUS CRYO- EM MAP	3.4.21.90
2XFF	CRYSTAL STRUCTURE OF BARLEY BETA-AMYLASE COMPLEXED WITH ACARBOSE	3.2.1.2
2XFG	REASSEMBLY AND CO-CRYSTALLIZATION OF A FAMILY 9 PROCESSIVE ENDOGLUCANASE FROM SEPARATELY EXPRESSED GH9 AND CBM3C MODULES	3.2.1.4
2XFI	HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-(CYCLOHEXYLAMINO)- 1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-3-((METHYLSULFONYL)(PHENYL)AMINO)BENZAMIDE	3.4.23.46
2XFJ	HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-(CYCLOHEXYLAMINO)- 1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-3-(ETHYLAMINO)-5-(2-OXO-1-PYRROLIDINYL)BENZAMIDE	3.4.23.46
2XFK	HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-(CYCLOHEXYLAMINO)- 1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-3-(ETHYLAMINO)-5-((METHYLSULFONYL)(PHENYL)AMINO)BENZAMIDE	3.4.23.46
2XFM	COMPLEX STRUCTURE OF THE MIWI PAZ DOMAIN BOUND TO METHYLATED SINGLE STRANDED RNA	3.1.26
2XFR	CRYSTAL STRUCTURE OF BARLEY BETA-AMYLASE AT ATOMIC RESOLUTION	3.2.1.2
2XFY	CRYSTAL STRUCTURE OF BARLEY BETA-AMYLASE COMPLEXED WITH ALPHA- CYCLODEXTRIN	3.2.1.2
2XG9	CRYSTAL STRUCTURE OF BARLEY BETA-AMYLASE COMPLEXED WITH 4-O-ALPHA-D- GLUCOPYRANOSYLMORANOLINE	3.2.1.2
2XGB	CRYSTAL STRUCTURE OF BARLEY BETA-AMYLASE COMPLEXED WITH 2,3- EPOXYPROPYL-ALPHA-D-GLUCOPYRANOSIDE	3.2.1.2
2XGG	STRUCTURE OF TOXOPLASMA GONDII MICRONEMAL PROTEIN 2 A_I DOMAIN	3.1.1.2 3.4.24.14
2XGI	CRYSTAL STRUCTURE OF BARLEY BETA-AMYLASE COMPLEXED WITH 3,4- EPOXYBUTYL ALPHA-D-GLUCOPYRANOSIDE	3.2.1.2
2XGJ	STRUCTURE OF MTR4, A DEXH HELICASE INVOLVED IN NUCLEAR RNA PROCESSING AND SURVEILLANCE	3.6.4.13 3.6.1
2XGR	EXTRACELLULAR ENDONUCLEASE	3.1.21.1
2XH3	EXTRACELLULAR NUCLEASE	3.1.21.1
2XHI	SEPARATION-OF-FUNCTION MUTANTS UNRAVEL THE DUAL REACTION MODE OF HUMAN 8-OXOGUANINE DNA GLYCOSYLASE	3.2.2 4.2.99.18
2XHL	STRUCTURE OF A FUNCTIONAL DERIVATIVE OF CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE B	3.4.24.69
2XHM	CRYSTAL STRUCTURE OF ANCE-K26 COMPLEX	3.4.15.1
2XHU	HCV-J4 NS5B POLYMERASE ORTHORHOMBIC CRYSTAL FORM	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2XHV	HCV-J4 NS5B POLYMERASE POINT MUTANT ORTHORHOMBIC CRYSTAL FORM	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2XHW	HCV-J4 NS5B POLYMERASE TRIGONAL CRYSTAL FORM	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2XHY	CRYSTAL STRUCTURE OF E.COLI BGLA	3.2.1.86
2XI2	HCV-H77 NS5B APO POLYMERASE	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2XI3	HCV-H77 NS5B POLYMERASE COMPLEXED WITH GTP	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2XI4	TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH AFLATOXIN B1 (ORTHORHOMBIC SPACE GROUP)	3.1.1.7
2XI5	N-TERMINAL ENDONUCLEASE DOMAIN OF LA CROSSE VIRUS L-PROTEIN	2.7.7.48 3.1
2XI7	N-TERMINAL ENDONUCLEASE DOMAIN OF LA CROSSE VIRUS L-PROTEIN	2.7.7.48 3.1
2XII	CRYSTAL STRUCTURE OF AN ALPHA-L-FUCOSIDASE GH29 FROM BACTEROIDES THETAIOTAOMICRON IN COMPLEX WITH AN EXTENDED 9-FLUORENONE IMINOSUGAR INHIBITOR	3.2.1.51
2XIO	STRUCTURE OF PUTATIVE DEOXYRIBONUCLEASE TATDN1 ISOFORM A	3.1.21
2XIV	STRUCTURE OF RV1477, HYPOTHETICAL INVASION PROTEIN OF MYCOBACTERIUM TUBERCULOSIS	3.4
2XJ7	BTGH84 IN COMPLEX WITH 6-ACETAMIDO-6-DEOXY-CASTANOSPERMINE	3.2.1.52 3.2.1.169
2XJB	CRYSTAL STRUCTURE OF THE D52N VARIANT OF CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH DEOXYGUANOSINE MONOPHOSPHATE AND DEOXYADENOSINE TRIPHOSPHATE	3.1.3.5
2XJC	CRYSTAL STRUCTURE OF THE D52N VARIANT OF CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH GUANOSINE MONOPHOSPHATE AND DIADENOSINE TETRAPHOSPHATE	3.1.3.5
2XJD	CRYSTAL STRUCTURE OF THE D52N VARIANT OF CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH INORGANIC PHOSPHATE AND DEOXYADENOSINE TRIPHOSPHATE	3.1.3.5
2XJE	CRYSTAL STRUCTURE OF THE D52N VARIANT OF CYTOSOLIC 5'-NUCLEOTIDASE II IN COMPLEX WITH URIDINE 5'-MONOPHOSPHATE AND ADENOSINE TRIPHOSPHATE	3.1.3.5
2XJF	CRYSTAL STRUCTURE OF THE D52N VARIANT OF CYTOSOLIC 5'-NUCLEOTIDASE II WITH A COVALENTLY MODIFIED ASN52	3.1.3.5
2XJW	LYSOZYME-CO RELEASING MOLECULE ADDUCT	3.2.1.17
2XK1	CRYSTAL STRUCTURE OF A COMPLEX BETWEEN ACTINOMADURA R39 DD-PEPTIDASE AND A BORONATE INHIBITOR	3.4.16.4
2XKV	ATOMIC MODEL OF THE SRP-FTSY EARLY CONFORMATION	3.6.5.4
2XLB	ACETYL XYLAN ESTERASE FROM BACILLUS PUMILUS WITHOUT LIGANDS	3.1.1.72 3.1.1.6
2XLC	ACETYL XYLAN ESTERASE FROM BACILLUS PUMILUS CECT5072 BOUND TO PARAOXON	3.1.1.72 3.1.1.6
2XLI	CRYSTAL STRUCTURE OF THE CSY4-CRRNA COMPLEX, MONOCLINIC FORM	3.1
2XLJ	CRYSTAL STRUCTURE OF THE CSY4-CRRNA COMPLEX, HEXAGONAL FORM	3.1
2XLK	CRYSTAL STRUCTURE OF THE CSY4-CRRNA COMPLEX, ORTHORHOMBIC FORM	3.1
2XLN	CRYSTAL STRUCTURE OF A COMPLEX BETWEEN ACTINOMADURA R39 DD-PEPTIDASE AND A BORONATE INHIBITOR	3.4.16.4
2XM1	BTGH84 IN COMPLEX WITH N-ACETYL GLUCONOLACTAM	3.2.1.52 3.2.1.169
2XM2	BTGH84 IN COMPLEX WITH LOGNAC	3.2.1.52 3.2.1.169
2XMB	G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH SULFATE	3.1.1.8
2XMC	G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH FLUORIDE ANION	3.1.1.8
2XMD	G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ECHOTHIOPHATE	3.1.1.8
2XMG	G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH VX	3.1.1.8
2XMI	CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, COMPLEXED WITH CITRATE	3.1.4.37
2XN0	STRUCTURE OF ALPHA-GALACTOSIDASE FROM LACTOBACILLUS ACIDOPHILUS NCFM, PTCL4 DERIVATIVE	3.2.1.22
2XN2	STRUCTURE OF ALPHA-GALACTOSIDASE FROM LACTOBACILLUS ACIDOPHILUS NCFM WITH GALACTOSE	3.2.1.22
2XNI	PROTEIN-LIGAND COMPLEX OF A NOVEL MACROCYCLIC HCV NS3 PROTEASE INHIBITOR DERIVED FROM AMINO CYCLIC BORONATES	3.4.22 3.4.21.98 3.6.1.15 3.6.4.13 2.7.7.48
2XNS	CRYSTAL STRUCTURE OF HUMAN G ALPHA I1 BOUND TO A DESIGNED HELICAL PEPTIDE DERIVED FROM THE GOLOCO MOTIF OF RGS14	3.6.5.1
2XOG	FUNCTIONAL AND STRUCTURAL ANALYSES OF N-ACYLSULFONAMIDE-LINKED DINUCLEOSIDE INHIBITORS OF RIBONUCLEASE A	3.1.27.5 4.6.1.18
2XOI	FUNCTIONAL AND STRUCTURAL ANALYSES OF N-ACYLSULFONAMIDE-LINKED DINUCLEOSIDE INHIBITORS OF RIBONUCLEASE A	3.1.27.5 4.6.1.18
2XOM	ATOMIC RESOLUTION STRUCTURE OF TMCBM61 IN COMPLEX WITH BETA-1,4- GALACTOTRIOSE	3.2.1.89
2XON	STRUCTURE OF TMCBM61 IN COMPLEX WITH BETA-1,4-GALACTOTRIOSE AT 1.4 A RESOLUTION	3.2.1.89
2XOV	CRYSTAL STRUCTURE OF E.COLI RHOMBOID PROTEASE GLPG, NATIVE ENZYME	3.4.21.105
2XOW	STRUCTURE OF GLPG IN COMPLEX WITH A MECHANISM-BASED ISOCOUMARIN INHIBITOR	3.4.21.105
2XPH	CRYSTAL STRUCTURE OF HUMAN SENP1 WITH THE BOUND COBALT	3.4.22
2XPK	CELL-PENETRANT, NANOMOLAR O-GLCNACASE INHIBITORS SELECTIVE AGAINST LYSOSOMAL HEXOSAMINIDASES	3.2.1.52 3.2.1.169
2XPY	STRUCTURE OF NATIVE LEUKOTRIENE A4 HYDROLASE FROM SACCHAROMYCES CEREVISIAE	3.3.2.6 3.4.11 3.3.2.10
2XPZ	STRUCTURE OF NATIVE YEAST LTA4 HYDROLASE	3.3.2.6 3.4.11 3.3.2.10
2XQ0	STRUCTURE OF YEAST LTA4 HYDROLASE IN COMPLEX WITH BESTATIN	3.3.2.6 3.4.11 3.3.2.10
2XQF	X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC VX	3.1.1.8
2XQG	X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC VR	3.1.1.8
2XQI	X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC CVX	3.1.1.8
2XQJ	X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY PURE ENANTIOMER VX-(R)	3.1.1.8
2XQK	X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY PURE ENANTIOMER VX-(S)	3.1.1.8
2XQX	STRUCTURE OF THE FAMILY 32 CARBOHYDRATE-BINDING MODULE FROM STREPTOCOCCUS PNEUMONIAE ENDOD	3.2.1.96
2XQZ	NEUTRON STRUCTURE OF THE PERDEUTERATED TOHO-1 R274N R276N DOUBLE MUTANT BETA-LACTAMASE	3.5.2.6
2XR0	ROOM TEMPERATURE X-RAY STRUCTURE OF THE PERDEUTERATED TOHO-1 R274N R276N DOUBLE MUTANT BETA-LACTAMASE	3.5.2.6
2XR9	CRYSTAL STRUCTURE OF AUTOTAXIN (ENPP2)	3.1.4.39
2XRC	HUMAN COMPLEMENT FACTOR I	3.4.21.45
2XRE	DETECTION OF COBALT IN PREVIOUSLY UNASSIGNED HUMAN SENP1 STRUCTURE	3.4.22
2XRG	CRYSTAL STRUCTURE OF AUTOTAXIN (ENPP2) IN COMPLEX WITH THE HA155 BORONIC ACID INHIBITOR	3.1.4.39
2XRI	CRYSTAL STRUCTURE OF HUMAN ERI1 EXORIBONUCLEASE 3	3.1
2XRM	PROCESSED INTRACELLULAR SUBTILISIN FROM B. CLAUSII	3.4.21.62
2XS3	STRUCTURE OF KARILYSIN CATALYTIC MMP DOMAIN	3.4.24
2XS4	STRUCTURE OF KARILYSIN CATALYTIC MMP DOMAIN IN COMPLEX WITH MAGNESIUM	3.4.24
2XSA	OGOGA APOSTRUCTURE	3.2.1.52 3.2.1.169
2XSB	OGOGA PUGNAC COMPLEX	3.2.1.52 3.2.1.169
2XSG	STRUCTURE OF THE GH92 FAMILY GLYCOSYL HYDROLASE CCMAN5	3.2.1.24
2XSP	STRUCTURE OF CELLOBIOHYDROLASE 1 (CEL7A) FROM HETEROBASIDION ANNOSUM	3.2.1
2XSQ	CRYSTAL STRUCTURE OF HUMAN NUDIX MOTIF 16 (NUDT16) IN COMPLEX WITH IMP AND MAGNESIUM	3.6.1 3.6.1.62 3.6.1.64
2XSS	CRYSTAL STRUCTURE OF GAFB FROM THE HUMAN PHOSPHODIESTERASE 5	3.1.4.35
2XSW	CRYSTAL STRUCTURE OF HUMAN INPP5E	3.1.3.36 3.1.3.86
2XSZ	THE DODECAMERIC HUMAN RUVBL1:RUVBL2 COMPLEX WITH TRUNCATED DOMAINS II	3.6.4.12
2XT0	DEHALOGENASE DPPA FROM PLESIOCYSTIS PACIFICA SIR-I	3.8.1.5
2XTH	K2PTBR6 BINDING TO LYSOZYME	3.2.1.17
2XTJ	THE CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH 1D05 FAB	3.4.21
2XTK	CHIA1 FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH ACETAZOLAMIDE	3.2.1.14
2XTU	STRUCTURE OF E.COLI RHOMBOID PROTEASE GLPG ACTIVE SITE MUTANT, S201T IN TRIGONAL CRYSTAL FORM	3.4.21.105
2XTV	STRUCTURE OF E.COLI RHOMBOID PROTEASE GLPG, ACTIVE SITE MUTANT, S201T, ORTHORHOMBIC CRYSTAL FORM	3.4.21.105
2XTZ	CRYSTAL STRUCTURE OF THE G ALPHA PROTEIN ATGPA1 FROM ARABIDOPSIS THALIANA	3.6.5.1
2XU1	CATHEPSIN L WITH A NITRILE INHIBITOR	3.4.22.15
2XU2	CRYSTAL STRUCTURE OF THE HYPOTHETICAL PROTEIN PA4511 FROM PSEUDOMONAS AERUGINOSA	3.5.2.9
2XU3	CATHEPSIN L WITH A NITRILE INHIBITOR	3.4.22.15
2XU4	CATHEPSIN L WITH A NITRILE INHIBITOR	3.4.22.15
2XU5	CATHEPSIN L WITH A NITRILE INHIBITOR	3.4.22.15
2XUA	CRYSTAL STRUCTURE OF THE ENOL-LACTONASE FROM BURKHOLDERIA XENOVORANS LB400	3.1.1.24
2XUC	NATURAL PRODUCT-GUIDED DISCOVERY OF A FUNGAL CHITINASE INHIBITOR	3.2.1.14
2XUD	CRYSTAL STRUCTURE OF THE Y337A MUTANT OF MOUSE ACETYLCHOLINESTERASE	3.1.1.7
2XUF	CRYSTAL STRUCTURE OF MACHE-Y337A-TZ2PA6 ANTI COMPLEX (1 MTH)	3.1.1.7
2XUG	CRYSTAL STRUCTURE OF MACHE-Y337A-TZ2PA6 ANTI COMPLEX (1 WK)	3.1.1.7
2XUH	CRYSTAL STRUCTURE OF MACHE-Y337A-TZ2PA6 ANTI COMPLEX (10 MTH)	3.1.1.7
2XUI	CRYSTAL STRUCTURE OF MACHE-Y337A-TZ2PA6 SYN COMPLEX (1 WK)	3.1.1.7
2XUJ	CRYSTAL STRUCTURE OF MACHE-Y337A-TZ2PA6 SYN COMPLEX (1 MTH)	3.1.1.7
2XUK	CRYSTAL STRUCTURE OF MACHE-Y337A-TZ2PA6 SYN COMPLEX (10 MTH)	3.1.1.7
2XUO	CRYSTAL STRUCTURE OF MACHE-Y337A MUTANT IN COMPLEX WITH SOAKED TZ2PA6 ANTI INHIBITOR	3.1.1.7
2XUP	CRYSTAL STRUCTURE OF THE MACHE-Y337A MUTANT IN COMPLEX WITH SOAKED TZ2PA6 SYN INHIBITOR	3.1.1.7
2XUQ	CRYSTAL STRUCTURE OF THE MACHE-Y337A MUTANT IN COMPLEX WITH SOAKED TZ2PA6 ANTI-SYN INHIBITORS	3.1.1.7
2XV6	CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C-TERMINAL DOMAIN (146- 220) IN COMPLEX WITH A CAMELID VHH.	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2XVG	CRYSTAL STRUCTURE OF ALPHA-XYLOSIDASE (GH31) FROM CELLVIBRIO JAPONICUS	3.2.1
2XVK	CRYSTAL STRUCTURE OF ALPHA-XYLOSIDASE (GH31) FROM CELLVIBRIO JAPONICUS IN COMPLEX WITH 5-FLUORO-ALPHA-D-XYLOPYRANOSYL FLUORIDE	3.2.1
2XVL	CRYSTAL STRUCTURE OF ALPHA-XYLOSIDASE (GH31) FROM CELLVIBRIO JAPONICUS IN COMPLEX WITH PENTAERYTHRITOL PROPOXYLATE (5 4 PO OH)	3.2.1
2XVN	A. FUMIGATUS CHITINASE A1 PHENYL-METHYLGUANYLUREA COMPLEX	3.2.1.14
2XVP	CHIA1 FROM ASPERGILLUS FUMIGATUS, APOSTRUCTURE	3.2.1.14
2XW9	CRYSTAL STRUCTURE OF COMPLEMENT FACTOR D MUTANT S183A	3.4.21.46
2XWA	CRYSTAL STRUCTURE OF COMPLEMENT FACTOR D MUTANT R202A	3.4.21.46
2XWD	X-RAY STRUCTURE OF ACID-BETA-GLUCOSIDASE WITH 5N,6O-(N'-(N-OCTYL)IMINO)NOJIRIMYCIN IN THE ACTIVE SITE	3.2.1.45 2.4.1 3.2.1
2XWE	X-RAY STRUCTURE OF ACID-BETA-GLUCOSIDASE WITH 5N,6S-(N'-(N-OCTYL)IMINO)-6-THIONOJIRIMYCIN IN THE ACTIVE SITE	3.2.1.45 2.4.1 3.2.1
2XWH	HCV-J6 NS5B POLYMERASE STRUCTURE AT 1.8 ANGSTROM	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2XWY	STRUCTURE OF MK-3281, A POTENT NON-NUCLEOSIDE FINGER-LOOP INHIBITOR, IN COMPLEX WITH THE HEPATITIS C VIRUS NS5B POLYMERASE	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2XX6	STRUCTURE OF THE BACILLUS SUBTILIS PROPHAGE DUTPASE, YOSS	3.6.1.23
2XXA	THE CRYSTAL STRUCTURE OF THE SIGNAL RECOGNITION PARTICLE (SRP) IN COMPLEX WITH ITS RECEPTOR(SR)	3.6.5.4
2XXD	HCV-JFH1 NS5B POLYMERASE STRUCTURE AT 1.9 ANGSTROM	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2XXL	CRYSTAL STRUCTURE OF DROSOPHILA GRASS CLIP SERINE PROTEASE OF TOLL PATHWAY	3.4.21.4 3.4.21
2XXM	CRYSTAL STRUCTURE OF THE HIV-1 CAPSID PROTEIN C-TERMINAL DOMAIN IN COMPLEX WITH A CAMELID VHH AND THE CAI PEPTIDE.	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2XXN	STRUCTURE OF THE VIRF4-HAUSP TRAF DOMAIN COMPLEX	3.4.19.12
2XY3	STRUCTURE OF THE BACILLUS SUBTILIS PROPHAGE DUTPASE WITH DUPNHPP	3.6.1.23
2XY9	HUMAN ANGIOTENSIN CONVERTING ENZYME IN COMPLEX WITH PHOSPHINIC TRIPEPTIDE	3.4.15.1 3.2.1
2XYA	NON-COVALENT INHIBTORS OF RHINOVIRUS 3C PROTEASE.	3.4.22.28 3.4.22.29 3.6.1.15 2.7.7.48
2XYD	HUMAN ANGIOTENISN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH PHOSPHINIC TRIPEPTIDE	3.4.15.1 3.2.1
2XYE	HIV-1 INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION-STATE MIMIC AND VARIOUS P2 AND P1 PRIME SUBSTITUENTS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2XYF	HIV-1 INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION-STATE MIMIC AND VARIOUS P2 AND P1 PRIME SUBSTITUENTS	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2XYG	CASPASE-3:CAS329306	3.4.22.56
2XYH	CASPASE-3:CAS60254719	3.4.22.56
2XYL	CELLULOMONAS FIMI XYLANASE/CELLULASE COMPLEXED WITH 2-DEOXY-2-FLUORO-XYLOBIOSE	3.2.1.91 3.2.1.8
2XYM	HCV-JFH1 NS5B T385A MUTANT	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2XYP	CASPASE-3:CAS26049945	3.4.22.56
2XYQ	CRYSTAL STRUCTURE OF THE NSP16 NSP10 SARS CORONAVIRUS COMPLEX	2.1.1 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1
2XYR	CRYSTAL STRUCTURE OF THE NSP16 NSP10 SARS CORONAVIRUS COMPLEX	2.1.1 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1
2XYV	CRYSTAL STRUCTURE OF THE NSP16 NSP10 SARS CORONAVIRUS COMPLEX	2.1.1 3.4.19.12 3.4.22.69 3.4.22 2.7.7.48 3.6.4.12 3.6.4.13 3.1.13 3.1
2XZD	CASPASE-3 IN COMPLEX WITH AN INHIBITORY DARPIN-3.4	3.4.22.56
2XZE	STRUCTURAL BASIS FOR AMSH-ESCRT-III CHMP3 INTERACTION	3.4.19
2XZF	CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE WILD-TYPE LACTOCOCCUS LACTIS FPG (MUTM) AND AN OXIDIZED PYRIMIDINE CONTAINING DNA AT 293K	3.2.2.23 4.2.99.18
2XZI	THE ASPERGILLUS FUMIGATUS SIALIDASE IS A KDNASE: STRUCTURAL AND MECHANISTIC INSIGHTS	3.2.1.18
2XZJ	THE ASPERGILLUS FUMIGATUS SIALIDASE IS A KDNASE: STRUCTURAL AND MECHANISTIC INSIGHTS	3.2.1.18
2XZK	THE ASPERGILLUS FUMIGATUS SIALIDASE IS A KDNASE: STRUCTURAL AND MECHANISTIC INSIGHTS	3.2.1.18
2XZL	UPF1-RNA COMPLEX	3.6.4.13 3.6.4
2XZO	UPF1 HELICASE - RNA COMPLEX	3.6.4.13 3.6.4
2XZP	UPF1 HELICASE	3.6.4.13 3.6.4
2XZT	CASPASE-3 IN COMPLEX WITH DARPIN-3.4_I78S	3.4.22.56
2XZU	CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE WILD-TYPE LACTOCOCCUS LACTIS FPG (MUTM) AND AN OXIDIZED PYRIMIDINE CONTAINING DNA AT 310K	3.2.2.23 4.2.99.18
2Y0B	CASPASE-3 IN COMPLEX WITH AN INHIBITORY DARPIN-3.4_S76R	3.4.22.56
2Y0J	TRIAZOLOQUINAZOLINES AS A NOVEL CLASS OF PHOSPHODIESTERASE 10A (PDE10A) INHIBITORS, PART 2, LEAD-OPTIMISATION.	3.1.4.17 3.1.4.35
2Y1H	CRYSTAL STRUCTURE OF THE HUMAN TATD-DOMAIN PROTEIN 3 (TATDN3)	3.1.21
2Y1K	STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY CBDP (12H SOAK): PHOSPHOSERINE ADDUCT	3.1.1.8
2Y1L	CASPASE-8 IN COMPLEX WITH DARPIN-8.4	3.4.22.61
2Y1P	CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, COMPLEXED WITH CITRATE	3.1.4.37
2Y1T	BACILLUS SUBTILIS PROPHAGE DUTPASE IN COMPLEX WITH DUDP	3.6.1.23
2Y24	STRUCTURAL BASIS FOR SUBSTRATE RECOGNITION BY ERWINIA CHRYSANTHEMI GH5 GLUCURONOXYLANASE	3.2.1.8 3.2.1.136
2Y28	CRYSTAL STRUCTURE OF SE-MET AMPD DERIVATIVE	3.5.1.28
2Y2B	CRYSTAL STRUCTURE OF AMPD IN COMPLEX WITH REACTION PRODUCTS	3.5.1.28
2Y2C	CRYSTAL STRUCTURE OF AMPD APOENZYME	3.5.1.28
2Y2D	CRYSTAL STRUCTURE OF AMPD HOLOENZYME	3.5.1.28
2Y2E	CRYSTAL STRUCTURE OF AMPD GROWN AT PH 5.5	3.5.1.28
2Y2F	CRYSTAL STRUCTURE OF YERSINIA PESTIS YOPH IN COMPLEX WITH AN AMINOOXY- CONTAINING PLATFORM COMPOUND FOR INHIBITOR DESIGN	3.1.3.48
2Y2G	PENICILLIN-BINDING PROTEIN 1B (PBP-1B) IN COMPLEX WITH AN ALKYL BORONATE (A01)	2.4.1.129 2.3.2 3.4.16.4
2Y2H	PENICILLIN-BINDING PROTEIN 1B (PBP-1B) IN COMPLEX WITH AN ALKYL BORONATE (ZA2)	2.4.1.129 2.3.2 3.4.16.4
2Y2I	PENICILLIN-BINDING PROTEIN 1B (PBP-1B) IN COMPLEX WITH AN ALKYL BORONATE (ZA3)	2.4.1.129 2.3.2 3.4.16.4
2Y2J	PENICILLIN-BINDING PROTEIN 1B (PBP-1B) IN COMPLEX WITH AN ALKYL BORONATE (ZA4)	2.4.1.129 2.3.2 3.4.16.4
2Y2K	PENICILLIN-BINDING PROTEIN 1B (PBP-1B) IN COMPLEX WITH AN ALKYL BORONATE (ZA5)	2.4.1.129 2.3.2 3.4.16.4
2Y2L	PENICILLIN-BINDING PROTEIN 1B (PBP-1B) IN COMPLEX WITH AN ALKYL BORONATE (E06)	2.4.1.129 2.3.2 3.4.16.4
2Y2M	PENICILLIN-BINDING PROTEIN 1B (PBP-1B) IN COMPLEX WITH AN ALKYL BORONATE (E08)	2.4.1.129 2.3.2 3.4.16.4
2Y2N	PENICILLIN-BINDING PROTEIN 1B (PBP-1B) IN COMPLEX WITH AN ALKYL BORONATE (E07)	2.4.1.129 2.3.2 3.4.16.4
2Y2O	PENICILLIN-BINDING PROTEIN 1B (PBP-1B) IN COMPLEX WITH AN ALKYL BORONATE (EO9)	2.4.1.129 2.3.2 3.4.16.4
2Y2P	PENICILLIN-BINDING PROTEIN 1B (PBP-1B) IN COMPLEX WITH AN ALKYL BORONATE (Z10)	2.4.1.129 2.3.2 3.4.16.4
2Y2Q	PENICILLIN-BINDING PROTEIN 1B (PBP-1B) IN COMPLEX WITH AN ALKYL BORONATE (Z06)	2.4.1.129 2.3.2 3.4.16.4
2Y2U	NONAGED FORM OF MOUSE ACETYLCHOLINESTERASE INHIBITED BY VX-UPDATE	3.1.1.7
2Y2V	NONAGED FORM OF MOUSE ACETYLCHOLINESTERASE INHIBITED BY SARIN-UPDATE	3.1.1.7
2Y35	CRYSTAL STRUCTURE OF XRN1-SUBSTRATE COMPLEX	3.1.13
2Y3U	CRYSTAL STRUCTURE OF APO COLLAGENASE G FROM CLOSTRIDIUM HISTOLYTICUM AT 2.55 ANGSTROM RESOLUTION	3.4.24.3
2Y3X	CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, COMPLEXED WITH SULFATE	3.1.4.37
2Y4A	UNEXPECTED TRICOVALENT BINDING MODE OF BORONIC ACIDS WITHIN THE ACTIVE SITE OF A PENICILLIN BINDING PROTEIN	3.4.16.4
2Y4S	BARLEY LIMIT DEXTRINASE IN COMPLEX WITH BETA-CYCLODEXTRIN	3.2.1.41
2Y50	CRYSTAL STRUCTURE OF COLLAGENASE G FROM CLOSTRIDIUM HISTOLYTICUM AT 2. 80 ANGSTROM RESOLUTION	3.4.24.3
2Y55	UNEXPECTED TRICOVALENT BINDING MODE OF BORONIC ACIDS WITHIN THE ACTIVE SITE OF A PENICILLIN BINDING PROTEIN	3.4.16.4
2Y59	UNEXPECTED TRICOVALENT BINDING MODE OF BORONIC ACIDS WITHIN THE ACTIVE SITE OF A PENICILLIN BINDING PROTEIN	3.4.16.4
2Y5B	STRUCTURE OF USP21 IN COMPLEX WITH LINEAR DIUBIQUITIN-ALDEHYDE	3.1.2.15 3.4.19.12
2Y5E	BARLEY LIMIT DEXTRINASE IN COMPLEX WITH ALPHA-CYCLODEXTRIN	3.2.1.41
2Y5F	FACTOR XA - CATION INHIBITOR COMPLEX	3.4.21.6
2Y5G	FACTOR XA - CATION INHIBITOR COMPLEX	3.4.21.6
2Y5H	FACTOR XA - CATION INHIBITOR COMPLEX	3.4.21.6
2Y5K	ORALLY ACTIVE AMINOPYRIDINES AS INHIBITORS OF TETRAMERIC FRUCTOSE 1,6- BISPHOSPHATASE	3.1.3.11
2Y5L	ORALLY ACTIVE AMINOPYRIDINES AS INHIBITORS OF TETRAMERIC FRUCTOSE 1,6- BISPHOSPHATASE	3.1.3.11
2Y64	XYLOPENTAOSE BINDING MUTATED (X-2 L110F) CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE	3.2.1.8
2Y6C	THE DISCOVERY OF MMP7 INHIBITORS EXPLOITING A NOVEL SELECTIVITY TRIGGER	3.4.24.23
2Y6D	THE DISCOVERY OF MMP7 INHIBITORS EXPLOITING A NOVEL SELECTIVITY TRIGGER	3.4.24.23
2Y6E	STRUCTURE OF THE D1D2 DOMAIN OF USP4, THE CONSERVED CATALYTIC DOMAIN	3.1.2.15 3.4.19.12
2Y6G	CELLOPENTAOSE BINDING MUTATED (X-2 L110F) CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE	3.2.1.8
2Y6H	X-2 L110F CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE	3.2.1.8
2Y6I	CRYSTAL STRUCTURE OF COLLAGENASE G FROM CLOSTRIDIUM HISTOLYTICUM IN COMPLEX WITH ISOAMYLPHOSPHONYL-GLY-PRO-ALA AT 3.25 ANGSTROM RESOLUTION	3.4.24.3
2Y6J	X-2 ENGINEERED MUTATED CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE	3.2.1.8
2Y6K	XYLOTETRAOSE BOUND TO X-2 ENGINEERED MUTATED CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE	3.2.1.8
2Y6L	XYLOPENTAOSE BINDING X-2 ENGINEERED MUTATED CBM4-2 CARBOHYDRATE BINDING MODULE FROM A THERMOSTABLE RHODOTHERMUS MARINUS XYLANASE	3.2.1.8
2Y6T	MOLECULAR RECOGNITION OF CHYMOTRYPSIN BY THE SERINE PROTEASE INHIBITOR ECOTIN FROM YERSINIA PESTIS	3.4.21.1
2Y6U	PEROXISOMAL ALPHA-BETA-HYDROLASE LPX1 (YOR084W) FROM SACCHAROMYCES CEREVISIAE (CRYSTAL FORM II)	3.1.1
2Y6V	PEROXISOMAL ALPHA-BETA-HYDROLASE LPX1 (YOR084W) FROM SACCHAROMYCES CEREVISIAE (CRYSTAL FORM I)	3.1.1
2Y72	CRYSTAL STRUCTURE OF THE PKD DOMAIN OF COLLAGENASE G FROM CLOSTRIDIUM HISTOLYTICUM AT 1.18 ANGSTROM RESOLUTION.	3.4.24.3
2Y7C	ATOMIC MODEL OF THE OCR-BOUND METHYLASE COMPLEX FROM THE TYPE I RESTRICTION-MODIFICATION ENZYME ECOKI (M2S1). BASED ON FITTING INTO EM MAP 1534.	3.1.21.3
2Y7H	ATOMIC MODEL OF THE DNA-BOUND METHYLASE COMPLEX FROM THE TYPE I RESTRICTION-MODIFICATION ENZYME ECOKI (M2S1). BASED ON FITTING INTO EM MAP 1534.	3.1.21.3
2Y7X	THE DISCOVERY OF POTENT AND LONG-ACTING ORAL FACTOR XA INHIBITORS WITH TETRAHYDROISOQUINOLINE AND BENZAZEPINE P4 MOTIFS	3.4.21.6
2Y7Z	STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS	3.4.21.6
2Y80	STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS	3.4.21.6
2Y81	STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS	3.4.21.6
2Y82	STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS	3.4.21.6
2Y8C	PLASMODIUM FALCIPARUM DUTPASE IN COMPLEX WITH A TRITYL LIGAND	3.6.1.23
2Y8I	STRUCTURAL BASIS FOR THE ALLOSTERIC INTERFERENCE OF MYOSIN FUNCTION BY MUTANTS G680A AND G680V OF DICTYOSTELIUM MYOSIN-2	3.6.4.1
2Y8V	STRUCTURE OF CHITINASE, CHIC, FROM ASPERGILLUS FUMIGATUS.	3.2.1.14
2Y8W	STRUCTURE OF CRISPR ENDORIBONUCLEASE CSE3 BOUND TO 20 NT RNA	3.1
2Y8Y	STRUCTURE B OF CRISPR ENDORIBONUCLEASE CSE3 BOUND TO 19 NT RNA	3.1
2Y91	CRYSTAL STRUCTURE OF CLASS A BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS BS3 WITH CLAVULANIC ACID	3.5.2.6
2Y96	STRUCTURE OF HUMAN DUAL-SPECIFICITY PHOSPHATASE 27	3.1.3.16 3.1.3.48
2Y9E	STRUCTURAL BASIS FOR THE ALLOSTERIC INTERFERENCE OF MYOSIN FUNCTION BY MUTANTS G680A AND G680V OF DICTYOSTELIUM MYOSIN-2	3.6.4.1
2Y9H	STRUCTURE A OF CRISPR ENDORIBONUCLEASE CSE3 BOUND TO 19 NT RNA	3.1
2Y9N	CELLOBIOHYDROLASE I CEL7A FROM TRICHODERMA HARZIANUM AT 2.9 A RESOLUTION	3.2.1.91
2Y9Y	CHROMATIN REMODELING FACTOR ISW1A(DEL_ATPASE)	3.6.4
2Y9Z	CHROMATIN REMODELING FACTOR ISW1A(DEL_ATPASE) IN DNA COMPLEX	3.6.4
2YA4	CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4)	3.2.1.18
2YA5	CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH SIALIC ACID	3.2.1.18
2YA6	CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH DANA	3.2.1.18
2YA8	CRYSTAL STRUCTURE OF STREPTOCOCCUS PNEUMONIAE NANA (TIGR4) IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE	3.2.1.18
2YAY	THE CRYSTAL STRUCTURE OF LEISHMANIA MAJOR DUTPASE IN COMPLEX WITH SUBSTRATE ANALOGUE DUPNPP	3.6.1.23
2YAZ	THE CRYSTAL STRUCTURE OF LEISHMANIA MAJOR DUTPASE IN COMPLEX DUMP	3.6.1.23
2YB0	THE CRYSTAL STRUCTURE OF LEISHMANIA MAJOR DUTPASE IN COMPLEX DEOXYURIDINE	3.6.1.23
2YB1	STRUCTURE OF AN AMIDOHYDROLASE FROM CHROMOBACTERIUM VIOLACEUM (EFI TARGET EFI-500202) WITH BOUND MN, AMP AND PHOSPHATE.	3.1.3.97
2YB4	STRUCTURE OF AN AMIDOHYDROLASE FROM CHROMOBACTERIUM VIOLACEUM (EFI TARGET EFI-500202) WITH BOUND SO4, NO METAL	3.1.3.97
2YB9	CRYSTAL STRUCTURE OF HUMAN NEUTRAL ENDOPEPTIDASE COMPLEXED WITH A HETEROARYLALANINE DIACID.	3.4.24.11
2YBH	NITRATE X-RAY INDUCED REDUCTION ON HEWL CRYSTALS (2.31 MGY).	3.2.1.17
2YBI	NITRATE X-RAY INDUCED REDUCTION ON HEWL CRYSTALS (6.62 MGY)	3.2.1.17
2YBJ	NITRATE X-RAY INDUCED REDUCTION ON HEWL CRYSTALS (12.31 MGY)	3.2.1.17
2YBL	NITRATE X-RAY INDUCED REDUCTION ON HEWL CRYSTALS (17.9 MGY)	3.2.1.17
2YBM	NITRATE X-RAY INDUCED REDUCTION ON HEWL CRYSTALS (23.3 MGY)	3.2.1.17
2YBN	NITRATE X-RAY INDUCED REDUCTION ON HEWL CRYSTALS (28.6 MGY)	3.2.1.17
2YD0	CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF HUMAN ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1 ERAP1	3.4.11
2YD1	CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF DROSOPHILA RECEPTOR PROTEIN TYROSINE PHOSPHATASE DLAR	3.1.3.48
2YD2	CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGMA	3.1.3.48
2YD3	CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGMA	3.1.3.48
2YD4	CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF CHICKEN RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGMA	3.1.3.48
2YD5	CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE LAR	3.1.3.48
2YD6	CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE DELTA	3.1.3.48
2YD7	CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE DELTA	3.1.3.48
2YD8	CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-2 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE LAR IN COMPLEX WITH SUCROSE OCTASULPHATE	3.1.3.48
2YD9	CRYSTAL STRUCTURE OF THE N-TERMINAL IG1-3 MODULE OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGMA	3.1.3.48
2YDB	CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, SOAKED WITH 2',3'-CYCLIC NADP	3.1.4.37
2YDC	CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, SOAKED WITH GTP	3.1.4.37
2YDD	CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, SOAKED WITH 2',3'-CYCLIC AMP	3.1.4.37
2YDG	ASCORBATE CO-CRYSTALLIZED HEWL.	3.2.1.17
2YDM	STRUCTURAL CHARACTERIZATION OF ANGIOTENSIN-I CONVERTING ENZYME IN COMPLEX WITH A SELENIUM ANALOGUE OF CAPTOPRIL	3.4.15.1 3.2.1
2YDP	STRUCTURE OF THE E242A MUTANT OF THE ALPHA-L-ARABINOFURANOSIDASE ARB93A FROM FUSARIUM GRAMINEARUM IN COMPLEX WITH AN IMINOSUGAR INHIBITOR	3.2.1.55
2YDQ	CPOGA D298N IN COMPLEX WITH HOGA-DERIVED O-GLCNAC PEPTIDE	3.2.1.52 3.2.1.169
2YDR	CPOGA D298N IN COMPLEX WITH P53-DERIVED O-GLCNAC PEPTIDE	3.2.1.52 3.2.1.169
2YDS	CPOGA D298N IN COMPLEX WITH TAB1-DERIVED O-GLCNAC PEPTIDE	3.2.1.169
2YDT	STRUCTURE OF THE ALPHA-L-ARABINOFURANOSIDASE ARB93A FROM FUSARIUM GRAMINEARUM IN COMPLEXE WITH AN IMINOSUGAR INHIBITOR	3.2.1.55
2YDU	CRYSTAL STRUCTURE OF YOPH IN COMPLEX WITH 3-(1,1-DIOXIDO-3- OXOISOTHIAZOLIDIN-5-YL)BENZALDEYDE	3.1.3.48
2YEQ	STRUCTURE OF PHOD	3.1.3.1
2YET	THERMOASCUS GH61 ISOZYME A	3.2.1.4
2YEU	STRUCTURAL AND FUNCTIONAL INSIGHTS OF DR2231 PROTEIN, THE MAZG-LIKE NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE FROM DEINOCOCCUS RADIODURANS, COMPLEX WITH GD	3.6.1.19
2YF0	HUMAN MYOTUBULARIN RELATED PROTEIN 6 (MTMR6)	3.1.3 3.1.3.95 3.1.3.64
2YF3	CRYSTAL STRUCTURE OF DR2231, THE MAZG-LIKE PROTEIN FROM DEINOCOCCUS RADIODURANS, COMPLEX WITH MANGANESE	3.6.1.19
2YF4	CRYSTAL STRUCTURE OF DR2231, THE MAZG-LIKE PROTEIN FROM DEINOCOCCUS RADIODURANS, APO STRUCTURE	3.6.1.19
2YF9	STRUCTURAL AND FUNCTIONAL INSIGHTS OF DR2231 PROTEIN, THE MAZG-LIKE NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE FROM DEINOCOCCUS RADIODURANS, NATIVE FORM	3.6.1.19
2YFC	STRUCTURAL AND FUNCTIONAL INSIGHTS OF DR2231 PROTEIN, THE MAZG-LIKE NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE FROM DEINOCOCCUS RADIODURANS, COMPLEXED WITH MN AND DUMP	3.6.1.19
2YFD	STRUCTURAL AND FUNCTIONAL INSIGHTS OF DR2231 PROTEIN, THE MAZG-LIKE NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHOHYDROLASE FROM DEINOCOCCUS RADIODURANS, COMPLEXED WITH MG AND DUMP	3.6.1.19
2YFN	GALACTOSIDASE DOMAIN OF ALPHA-GALACTOSIDASE-SUCROSE KINASE, AGASK	3.2.1.22 2.7
2YFO	GALACTOSIDASE DOMAIN OF ALPHA-GALACTOSIDASE-SUCROSE KINASE, AGASK, IN COMPLEX WITH GALACTOSE	3.2.1.22 2.7
2YFY	SERCA IN THE HNE2 STATE COMPLEXED WITH DEBUTANOYL THAPSIGARGIN	3.6.3.8 7.2.2.10
2YG1	APO STRUCTURE OF CELLOBIOHYDROLASE 1 (CEL7A) FROM HETEROBASIDION ANNOSUM	3.2.1
2YGK	CRYSTAL STRUCTURE OF THE NURA NUCLEASE FROM SULFOLOBUS SOLFATARICUS	3.1
2YH2	PYROBACULUM CALIDIFONTIS ESTERASE MONOCLINIC FORM	3.1.1.1
2YHW	HIGH-RESOLUTION CRYSTAL STRUCTURES OF N-ACETYLMANNOSAMINE KINASE: INSIGHTS ABOUT SUBSTRATE SPECIFICITY, ACTIVITY AND INHIBITOR MODELLING.	2.7.1.60 3.2.1.183
2YHY	STRUCTURE OF N-ACETYLMANNOSAMINE KINASE IN COMPLEX WITH N- ACETYLMANNOSAMINE AND ADP	2.7.1.60 3.2.1.183
2YI1	CRYSTAL STRUCTURE OF N-ACETYLMANNOSAMINE KINASE IN COMPLEX WITH N- ACETYL MANNOSAMINE 6-PHOSPHATE AND ADP.	2.7.1.60 3.2.1.183
2YIG	MMP13 IN COMPLEX WITH A NOVEL SELECTIVE NON ZINC BINDING INHIBITOR	3.4.24
2YIH	STRUCTURE OF A PAENIBACILLUS POLYMYXA XYLOGLUCANASE FROM GH FAMILY 44 WITH XYLOGLUCAN	3.2.1.4 3.2.1.151
2YIJ	CRYSTAL STRUCTURE OF PHOSPHOLIPASE A1	3.1.1
2YIK	CATALYTIC DOMAIN OF CLOSTRIDIUM THERMOCELLUM CELT	3.2.1.4 3.2.1
2YJ2	CATHEPSIN L WITH A NITRILE INHIBITOR	3.4.22.15
2YJ3	CONFORMATIONAL CHANGES IN THE CATALYTIC DOMAIN OF THE CPX-ATPASE COPB- B UPON NUCLEOTIDE BINDING	3.6.3.10
2YJ4	CONFORMATIONAL CHANGES IN THE CATALYTIC DOMAIN OF THE CPX-ATPASE COPB- B UPON NUCLEOTIDE BINDING	3.6.3.10
2YJ5	CONFORMATIONAL CHANGES IN THE CATALYTIC DOMAIN OF THE CPX-ATPASE COPB- B UPON NUCLEOTIDE BINDING	3.6.3.10
2YJ6	CONFORMATIONAL CHANGES IN THE CATALYTIC DOMAIN OF THE CPX-ATPASE COPB- B UPON NUCLEOTIDE BINDING	3.6.3.10
2YJ8	CATHEPSIN L WITH A NITRILE INHIBITOR	3.4.22.15
2YJ9	CATHEPSIN L WITH A NITRILE INHIBITOR	3.4.22.15
2YJB	CATHEPSIN L WITH A NITRILE INHIBITOR	3.4.22.15
2YJC	CATHEPSIN L WITH A NITRILE INHIBITOR	3.4.22.15
2YJQ	STRUCTURE OF A PAENIBACILLUS POLYMYXA XYLOGLUCANASE FROM GLYCOSIDE HYDROLASE FAMILY 44	3.2.1.4 3.2.1.151
2YKG	STRUCTURAL INSIGHTS INTO RNA RECOGNITION BY RIG-I	3.6.4.13
2YKK	STRUCTURE OF A PAENIBACILLUS POLYMYXA XYLOGLUCANASE FROM GLYCOSIDE HYDROLASE FAMILY 44	3.2.1.4 3.2.1.151
2YKM	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE, A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)	2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1
2YKN	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE, A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)	2.7.7.49 2.7.7.7 3.1.26.13 3.4.23.16 3.1.13.2 2.7.7 3.1
2YL6	INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS	3.2.1.52
2YL8	INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS	3.2.1.52
2YL9	INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS	3.2.1.52
2YLA	INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS	3.2.1.52
2YLK	CARBOHYDRATE-BINDING MODULE CBM3B FROM THE CELLULOSOMAL CELLOBIOHYDROLASE 9A FROM CLOSTRIDIUM THERMOCELLUM	3.2.1.91 3.2.1
2YLL	INHIBITION OF THE PNEUMOCOCCAL VIRULENCE FACTOR STRH AND MOLECULAR INSIGHTS INTO N-GLYCAN RECOGNITION AND HYDROLYSIS	3.2.1.52
2YLM	MECHANISM OF USP7 (HAUSP) ACTIVATION BY ITS C-TERMINAL UBIQUITIN-LIKE DOMAIN (HUBL) AND ALLOSTERIC REGULATION BY GMP-SYNTHETASE.	3.4.19.12
2YMK	CRYSTAL STRUCTURE OF THE HEXAMERIC ANTI-MICROBIAL PEPTIDE CHANNEL DERMCIDIN	3.4
2YNA	CRYSTAL STRUCTURE OF THE MAIN PROTEASE OF CORONAVIRUS HKU4	3.4.22.69 3.4.22 3.4.19.12
2YNB	CRYSTAL STRUCTURE OF THE MAIN PROTEASE OF CORONAVIRUS HKU4 IN COMPLEX WITH A MICHAEL ACCEPTOR SG85	3.4.22.69 3.4.19.12 3.4.22
2YNF	HIV-1 REVERSE TRANSCRIPTASE Y188L MUTANT IN COMPLEX WITH INHIBITOR GSK560	2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1
2YNG	HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK560	2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1
2YNH	HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK500	2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1
2YNI	HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK952	2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 3.4.23.16 2.7.7 3.1
2YOC	CRYSTAL STRUCTURE OF PULA FROM KLEBSIELLA OXYTOCA	3.2.1.41
2YOJ	HCV NS5B POLYMERASE COMPLEXED WITH PYRIDONYLINDOLE COMPOUND	2.7.7.48 3.4.22 3.4.21.98 3.6.1.15 3.6.4.13
2YOK	CELLOBIOHYDROLASE I CEL7A FROM TRICHODERMA HARZIANUM AT 1.7 A RESOLUTION	3.2.1.91
2YOL	WEST NILE VIRUS NS2B-NS3 PROTEASE IN COMPLEX WITH 3,4- DICHLOROPHENYLACETYL-LYS-LYS-GCMA	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2YOZ	CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, CRYSTALLIZED WITH 2'-AMPS	3.1.4.37
2YP0	CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, CRYSTALLIZED WITH 2'-AMPS	3.1.4.37
2YPC	CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION H309S, CRYSTALLIZED WITH 2',3-(SP)-CYCLIC-AMPS	3.1.4.37
2YPE	CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION H309S, CRYSTALLIZED WITH 2',3'- CYCLIC AMP	3.1.4.37
2YPH	CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION H230S, CRYSTALLIZED WITH 2',3-(RP)- CYCLIC-AMPS	3.1.4.37
2YPJ	NON-CATALYTIC CARBOHYDRATE BINDING MODULE CBM65B	3.2.1.4
2YPT	CRYSTAL STRUCTURE OF THE HUMAN NUCLEAR MEMBRANE ZINC METALLOPROTEASE ZMPSTE24 MUTANT (E336A) IN COMPLEX WITH A SYNTHETIC CSIM TETRAPEPTIDE FROM THE C-TERMINUS OF PRELAMIN A	3.4.24.84
2YQ9	CATALYTIC DOMAIN OF MOUSE 2',3'-CYCLIC NUCLEOTIDE 3'- PHOSPHODIESTERASE, WITH MUTATION V321A, CRYSTALLIZED WITH 2'-AMP	3.1.4.37
2YQP	SOLUTION STRUCTURE OF THE ZF-HIT DOMAIN IN DEAD (ASP-GLU-ALA-ASP) BOX POLYPEPTIDE 59	3.6.1 3.6.4.13
2YRN	SOLUTION STRUCTURE OF THE CH DOMAIN FROM HUMAN NEURON NAVIGATOR 2	3.6.1 3.6.4.12
2YS0	SOLUTION STRUCTURE OF THE SOMATOMEDIN B DOMAIN OF HUMAN ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE FAMILY MEMBER	3.1.4.1 3.6.1.9
2YS1	SOLUTION STRUCTURE OF THE PH DOMAIN OF DYNAMIN-2 FROM HUMAN	3.6.5.5
2YSX	SOLUTION STRUCTURE OF THE HUMAN SHIP SH2 DOMAIN	3.1.3.86 3.1.3.56 3.1.3.36
2YTW	SOLUTION STRUCTURE OF THE PDZ-DOMAIN OF HUMAN PROTEASE HTRA 1 PRECURSOR	3.4.21
2YU6	SOLUTION STRUCTURE OF THE YTH DOMAIN IN YTH DOMAIN-CONTAINING PROTEIN 2	3.6.4.13
2YU7	SOLUTION STRUCTURE OF THE SHP-1 C-TERMINAL SH2 DOMAIN COMPLEXED WITH A TYROSINE-PHOSPHORYLATED PEPTIDE FROM NKG2A	3.1.3.48
2YV0	STRUCTURAL AND THERMODYNAMIC ANALYSES OF E. COLI RIBONUCLEASE HI VARIANT WITH QUINTUPLE THERMOSTABILIZING MUTATIONS	3.1.26.4
2YV5	CRYSTAL STRUCTURE OF YJEQ FROM AQUIFEX AEOLICUS	3.6.1
2YVB	HIGH RESOLUTION X-RAY CRYSTAL STRUCTURE OF TETRAGONAL HEN EGG WHITE LYSOZYME	3.2.1.17
2YVM	CRYSTAL STRUCTURE OF NDX2 IN COMPLEX WITH MG2+ FROM THERMUS THERMOPHILUS HB8	3.6.1
2YVN	CRYSTAL STRUCTURE OF NDX2 FROM THERMUS THERMOPHILUS HB8	3.6.1
2YVO	CRYSTAL STRUCTURE OF NDX2 IN COMPLEX WITH MG2+ AND AMP FROM THERMUS THERMOPHILUS HB8	3.6.1
2YVP	CRYSTAL STRUCTURE OF NDX2 IN COMPLEX WITH MG2+ AND AMPCPR FROM THERMUS THERMOPHILUS HB8	3.6.1
2YWD	CRYSTAL STRUCTURE OF GLUTAMINE AMIDOTRANSFERASE	2.6 4.3.3.6 3.5.1.2
2YWE	CRYSTAL STRUCTURE OF LEPA FROM AQUIFEX AEOLICUS	3.6.5
2YWF	CRYSTAL STRUCTURE OF GMPPNP-BOUND LEPA FROM AQUIFEX AEOLICUS	3.6.5
2YWG	CRYSTAL STRUCTURE OF GTP-BOUND LEPA FROM AQUIFEX AEOLICUS	3.6.5
2YWH	CRYSTAL STRUCTURE OF GDP-BOUND LEPA FROM AQUIFEX AEOLICUS	3.6.5
2YWJ	CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN FROM METHANOCALDOCOCCUS JANNASCHII	2.6 4.3.3.6 3.5.1.2
2YXO	HISTIDINOL PHOSPHATE PHOSPHATASE COMPLEXED WITH SULFATE	3.1.3.15
2YXP	THE EFFECT OF DEUTERATION ON PROTEIN STRUCTURE A HIGH RESOLUTION COMPARISON OF HYDROGENOUS AND PERDEUTERATED HALOALKANE DEHALOGENASE	3.8.1.5
2YY2	CRYSTAL STRUCTURE OF THE HUMAN PHOSPHODIESTERASE 9A CATALYTIC DOMAIN COMPLEXED WITH IBMX	3.1.4.35
2YY6	CRYSTAL STRUCTURE OF THE PHOSPHOGLYCOLATE PHOSPHATASE FROM AQUIFEX AEOLICUS VF5	3.1.3.18
2YYV	CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN FROM THERMOTOGA MARITIMA	3.1.3.71
2YZ2	CRYSTAL STRUCTURE OF THE ABC TRANSPORTER IN THE COBALT TRANSPORT SYSTEM	3.6.3 7
2YZ3	CRYSTALLOGRAPHIC INVESTIGATION OF INHIBITION MODE OF THE VIM-2 METALLO-BETA-LACTAMASE FROM PSEUDOMONAS AERUGINOSA WITH MERCAPTOCARBOXYLATE INHIBITOR	3.5.2.6
2YZ5	HISTIDINOL PHOSPHATE PHOSPHATASE COMPLEXED WITH PHOSPHATE	3.1.3.15
2YZJ	CRYSTAL STRUCTURE OF DCTP DEAMINASE FROM SULFOLOBUS TOKODAII	3.6.1.23
2YZO	CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN FROM THERMOTOGA MARITIMA	3.1.3.71
2YZS	CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN FROM AQUIFEX AEOLICUS	3.1
2Z00	CRYSTAL STRUCTURE OF DIHYDROOROTASE FROM THERMUS THERMOPHILUS	3.5.2.3
2Z0B	CRYSTAL STRUCTURE OF CBM20 DOMAIN OF HUMAN PUTATIVE GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE 5 (KIAA1434)	3.1 3.1.4.2
2Z0D	THE CRYSTAL STRUCTURE OF HUMAN ATG4B- LC3(1-120) COMPLEX	3.4.22
2Z0E	THE CRYSTAL STRUCTURE OF HUMAN ATG4B- LC3(1-124) COMPLEX	3.4.22
2Z0J	CRYSTAL STRUCTURE OF UNCHARACTERIZED CONSERVED PROTEIN FROM THERMUS THERMOPHILUS HB8	3.1.3.71
2Z0M	CRYSTAL STRUCTURE OF HYPOTHETICAL ATP-DEPENDENT RNA HELICASE FROM SULFOLOBUS TOKODAII	3.6.4.13
2Z12	STRUCTURE OF THE TRANSFORMED MONOCLINIC LYSOZYME BY CONTROLLED DEHYDRATION	3.2.1.17
2Z18	PHASE TRANSITION OF MONOCLINIC LYSOZYME CRYSTAL SOAKED IN A 10% NACL SOLUTION	3.2.1.17
2Z19	PHASE TRANSITION OF MONOCLINIC LYSOZYME CRYSTAL SOAKED IN A SATURATED NACL SOLUTION	3.2.1.17
2Z1A	CRYSTAL STRUCTURE OF 5'-NUCLEOTIDASE PRECURSOR FROM THERMUS THERMOPHILUS HB8	3.1.3.5
2Z1G	CRYSTAL STRUCTURE OF E.COLI RNASE HI SURFACE CHARGED MUTANT(Q4R/T40E/Q72H/Q76K/Q80E/T92K/Q105K)	3.1.26.4
2Z1H	CRYSTAL STRUCTURE OF E.COLI RNASE HI SURFACE CHARGED MUTANT(Q4R/T92K/Q105K/Q113R/Q115K/N143K/T145K)	3.1.26.4
2Z1I	CRYSTAL STRUCTURE OF E.COLI RNASE HI SURFACE CHARGED MUTANT(Q4R/T40E/Q72H/Q76K/Q80E/T92K/Q105K/Q113R/Q115K)	3.1.26.4
2Z1J	CRYSTAL STRUCTURE OF E.COLI RNASE HI SURFACE CHARGED MUTANT(Q4R/T40E/Q72H/Q76K/Q80E/T92K/Q105K/Q113R/Q115K/N143K/T145K)	3.1.26.4
2Z1K	CRYSTAL STRUCTURE OF TTHA1563 FROM THERMUS THERMOPHILUS HB8	3.2.1.41
2Z1S	BETA-GLUCOSIDASE B FROM PAENIBACILLUS POLYMYXA COMPLEXED WITH CELLOTETRAOSE	3.2.1.21
2Z24	THR110SER DIHYDROOROTASE FROM E. COLI	3.5.2.3
2Z25	THR110VAL DIHYDROOROTASE FROM E. COLI	3.5.2.3
2Z26	THR110ALA DIHYDROOROTASE FROM E. COLI	3.5.2.3
2Z27	THR109SER DIHYDROOROTASE FROM E. COLI	3.5.2.3
2Z28	THR109VAL DIHYDROOROTASE FROM E. COLI	3.5.2.3
2Z29	THR109ALA DIHYDROOROTASE FROM E. COLI	3.5.2.3
2Z2A	THR109GLY DIHYDROOROTASE FROM E. COLI	3.5.2.3
2Z2B	DELETION 107-116 MUTANT OF DIHYDROOROTASE FROM E. COLI	3.5.2.3
2Z2D	SOLUTION STRUCTURE OF HUMAN MACROPHAGE ELASTASE (MMP-12) CATALYTIC DOMAIN COMPLEXED WITH A GAMMA-KETO BUTANOIC ACID INHIBITOR	3.4.24.65
2Z2E	CRYSTAL STRUCTURE OF CANINE MILK LYSOZYME STABILIZED AGAINST NON-ENZYMATIC DEAMIDATION	3.2.1.17
2Z2F	X-RAY CRYSTAL STRUCTURE OF BOVINE STOMACH LYSOZYME	3.2.1.17
2Z2I	CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM MYCOBACTERIUM TUBERCULOSIS	3.1.1.29
2Z2J	CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM MYCOBACTERIUM TUBERCULOSIS	3.1.1.29
2Z2K	CRYSTAL STRUCTURE OF PEPTIDYL-TRNA HYDROLASE FROM MYCOBACTERIUM TUBERCULOSIS	3.1.1.29
2Z2X	CRYSTAL STRUCTURE OF MATURE FORM OF TK-SUBTILISIN	3.4.21.62 3.4.21
2Z2Y	CRYSTAL STRUCTURE OF AUTOPROCESSED FORM OF TK-SUBTILISIN	3.4.21.62 3.4.21
2Z2Z	CRYSTAL STRUCTURE OF UNAUTOPROCESSED FORM OF TK-SUBTILISIN SOAKED BY 10MM CACL2	3.4.21.62 3.4.21
2Z30	CRYSTAL STRUCTURE OF COMPLEX FORM BETWEEN MAT-TK-SUBTILISIN AND TK-PROPEPTIDE	3.4.21.62 3.4.21
2Z37	CRYSTAL STRUCTURE OF BRASSICA JUNCEA CHITINASE CATALYTIC MODULE (BJCHI3)	3.2.1.14
2Z38	CRYSTAL STRUCTURE OF CHLORIDE BOUND BRASSICA JUNCEA CHITINASE CATALYTIC MODULE (BJCHI3)	3.2.1.14
2Z39	CRYSTAL STRUCTURE OF BRASSICA JUNCEA CHITINASE CATALYTIC MODULE GLU234ALA MUTANT (BJCHI3-E234A)	3.2.1.14
2Z3A	CRYSTAL STRUCTURE OF BACILLUS SUBTILIS CODW, A NON-CANONICAL HSLV-LIKE PEPTIDASE WITH AN IMPAIRED CATALYTIC APPARATUS	3.4.25 3.4.21
2Z3B	CRYSTAL STRUCTURE OF BACILLUS SUBTILIS CODW, A NON-CANONICAL HSLV-LIKE PEPTIDASE WITH AN IMPAIRED CATALYTIC APPARATUS	3.4.25 3.4.21
2Z3C	A MECHANISTIC VIEW OF ENZYME INHIBITION AND PEPTIDE HYDROLYSIS IN THE ACTIVE SITE OF THE SARS-COV 3C-LIKE PEPTIDASE	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2Z3D	A MECHANISTIC VIEW OF ENZYME INHIBITION AND PEPTIDE HYDROLYSIS IN THE ACTIVE SITE OF THE SARS-COV 3C-LIKE PEPTIDASE	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2Z3E	A MECHANISTIC VIEW OF ENZYME INHIBITION AND PEPTIDE HYDROLYSIS IN THE ACTIVE SITE OF THE SARS-COV 3C-LIKE PEPTIDASE	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2Z3G	CRYSTAL STRUCTURE OF BLASTICIDIN S DEAMINASE (BSD)	3.5.4.23
2Z3H	CRYSTAL STRUCTURE OF BLASTICIDIN S DEAMINASE (BSD) COMPLEXED WITH DEAMINOHYDROXY BLASTICIDIN S	3.5.4.23
2Z3I	CRYSTAL STRUCTURE OF BLASTICIDIN S DEAMINASE (BSD) MUTANT E56Q COMPLEXED WITH SUBSTRATE	3.5.4.23
2Z3J	CRYSTAL STRUCTURE OF BLASTICIDIN S DEAMINASE (BSD) R90K MUTANT	3.5.4.23
2Z3W	PROLYL TRIPEPTIDYL AMINOPEPTIDASE MUTANT E636A	3.4.14 3.4.14.12
2Z3Z	PROLYL TRIPEPTIDYL AMINOPEPTIDASE MUTANT E636A COMPLEXD WITH AN INHIBITOR	3.4.14 3.4.14.12
2Z4G	HISTIDINOL PHOSPHATE PHOSPHATASE FROM THERMUS THERMOPHILUS HB8	3.1.3.15
2Z4O	WILD TYPE HIV-1 PROTEASE WITH POTENT ANTIVIRAL INHIBITOR GRL-98065	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2Z4U	CRYSTAL STRUCTURE OF WILD TYPE PD-L4 FROM PHYTOLACCA DIOICA LEAVES	3.2.2.22
2Z53	CRYSTAL STRUCTURE OF THE S211A MUTANT OF THE RIBOSOME INACTIVATING PROTEIN PDL4 FROM P. DIOICA LEAVES	3.2.2.22
2Z54	THE INFLUENCE OF I47A MUTATION ON REDUCED SUSCEPTIBILITY TO THE PROTEASE INHIBITOR LOPINAVIR	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2Z56	CRYSTAL STRUCTURE OF G56S-PROPEPTIDE:S324A-SUBTILISIN COMPLEX	3.4.21.62 3.4.21
2Z57	CRYSTAL STRUCTURE OF G56E-PROPEPTIDE:S324A-SUBTILISIN COMPLEX	3.4.21.62 3.4.21
2Z58	CRYSTAL STRUCTURE OF G56W-PROPEPTIDE:S324A-SUBTILISIN COMPLEX	3.4.21.62 3.4.21
2Z5G	CRYSTAL STRUCTURE OF T1 LIPASE F16L MUTANT	3.1.1.3
2Z62	CRYSTAL STRUCTURE OF THE TV3 HYBRID OF HUMAN TLR4 AND HAGFISH VLRB.61	3.2.2.6
2Z63	CRYSTAL STRUCTURE OF THE TV8 HYBRID OF HUMAN TLR4 AND HAGFISH VLRB.61	3.2.2.6
2Z64	CRYSTAL STRUCTURE OF MOUSE TLR4 AND MOUSE MD-2 COMPLEX	3.2.2.6
2Z65	CRYSTAL STRUCTURE OF THE HUMAN TLR4 TV3 HYBRID-MD-2-ERITORAN COMPLEX	3.2.2.6
2Z66	CRYSTAL STRUCTURE OF THE VT3 HYBRID OF HUMAN TLR4 AND HAGFISH VLRB.61	3.2.2.6
2Z6B	CRYSTAL STRUCTURE ANALYSIS OF (GP27-GP5)3 CONJUGATED WITH FE(III) PROTOPORPHYRIN	3.2.1.17
2Z70	E.COLI RNASE 1 IN COMPLEX WITH D(CGCGATCGCG)	3.1.27.6 4.6.1.21
2Z71	STRUCTURE OF TRUNCATED MUTANT CYS1GLY OF PENICILLIN V ACYLASE FROM BACILLUS SPHAERICUS CO-CRYSTALLIZED WITH PENICILLIN V	3.5.1.11
2Z72	NEW STRUCTURE OF COLD-ACTIVE PROTEIN TYROSINE PHOSPHATASE AT 1.1 ANGSTROM	3.1.3.48
2Z79	HIGH RESOLUTION CRYSTAL STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 11 XYLANASE OF BACILLUS SUBTILIS	3.2.1.8
2Z7F	CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN NEUTROPHIL ELASTASE WITH 1/2SLPI	3.4.21.37
2Z7G	CRYSTAL STRUCTURE OF ADENOSINE DEAMINASE LIGATED WITH EHNA	3.5.4.4
2Z7J	STRUCTURAL INSIGHTS INTO DE MULTIFUNCTIONAL VP3 PROTEIN OF BIRNAVIRUSES:GOLD DERIVATIVE	3.4.21
2Z7X	CRYSTAL STRUCTURE OF THE TLR1-TLR2 HETERODIMER INDUCED BY BINDING OF A TRI-ACYLATED LIPOPEPTIDE	3.2.2.6
2Z80	CRYSTAL STRUCTURE OF THE TLR1-TLR2 HETERODIMER INDUCED BY BINDING OF A TRI-ACYLATED LIPOPEPTIDE	3.2.2.6
2Z81	CRYSTAL STRUCTURE OF THE TLR1-TLR2 HETERODIMER INDUCED BY BINDING OF A TRI-ACYLATED LIPOPEPTIDE	3.2.2.6
2Z82	CRYSTAL STRUCTURE OF THE TLR1-TLR2 HETERODIMER INDUCED BY BINDING OF A TRI-ACYLATED LIPOPEPTIDE	3.2.2.6
2Z83	CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF JAPANESE ENCEPHALITIS VIRUS NS3 HELICASE/NUCLEOSIDE TRIPHOSPHATASE AT A RESOLUTION 1.8	3.4.21.91 3.6.1.15 3.6.4.13 2.1.1.56 2.1.1.57 2.7.7.48
2Z84	INSIGHTS FROM CRYSTAL AND SOLUTION STRUCTURES OF MOUSE UFSP1	3.4.22
2Z8G	ASPERGILLUS NIGER ATCC9642 ISOPULLULANASE COMPLEXED WITH ISOPANOSE	3.2.1.57
2Z8I	CRYSTAL STRUCTURE OF ESCHERICHIA COLI GAMMA-GLUTAMYLTRANSPEPTIDASE IN COMPLEX WITH AZASERINE	2.3.2.2 3.4.19.13
2Z8J	CRYSTAL STRUCTURE OF ESCHERICHIA COLI GAMMA-GLUTAMYLTRANSPEPTIDASE IN COMPLEX WITH AZASERINE PREPARED IN THE DARK	2.3.2.2 3.4.19.13
2Z8K	CRYSTAL STRUCTURE OF ESCHERICHIA COLI GAMMA-GLUTAMYLTRANSPEPTIDASE IN COMPLEX WITH ACIVICIN	2.3.2.2 3.4.19.13
2Z8X	CRYSTAL STRUCTURE OF EXTRACELLULAR LIPASE FROM PSEUDOMONAS SP. MIS38	3.1.1.3
2Z8Z	CRYSTAL STRUCTURE OF A PLATINUM-BOUND S445C MUTANT OF PSEUDOMONAS SP. MIS38 LIPASE	3.1.1.3
2Z94	COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH TDT	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2Z9G	COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH PMA	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2Z9I	CRYSTAL STRUCTURE OF RV0983 FROM MYCOBACTERIUM TUBERCULOSIS- PROTEOLYTICALLY ACTIVE FORM	3.4.21 3.4.21.107
2Z9J	COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH EPDTC	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2Z9K	COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH JMF1600	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2Z9L	COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH JMF1586	3.4.22 3.4.19.12 3.4.22.69 2.7.7.48 3.6.4.12 3.6.4.13 2.1.1 3.1.13 3.1
2ZA4	CRYSTAL STRUCTURAL ANALYSIS OF BARNASE-BARSTAR COMPLEX	3.1.27
2ZA5	CRYSTAL STRUCTURE OF HUMAN TRYPTASE WITH POTENT NON-PEPTIDE INHIBITOR	3.4.21.59
2ZAE	CRYSTAL STRUCTURE OF PROTEIN PH1601P IN COMPLEX WITH PROTEIN PH1771P OF ARCHAEAL RIBONUCLEASE P FROM PYROCOCCUS HORIKOSHII OT3	3.1.26.5
2ZAK	ORTHORHOMBIC CRYSTAL STRUCTURE OF PRECURSOR E. COLI ISOASPARTYL PEPTIDASE/L-ASPARAGINASE (ECAIII) WITH ACTIVE-SITE T179A MUTATION	3.4.19.5 3.5.1.1
2ZAL	CRYSTAL STRUCTURE OF E. COLI ISOASPARTYL AMINOPEPTIDASE/L-ASPARAGINASE IN COMPLEX WITH L-ASPARTATE	3.4.19.5 3.5.1.1
2ZAM	CRYSTAL STRUCTURE OF MOUSE SKD1/VPS4B APO-FORM	3.6.4.6
2ZAN	CRYSTAL STRUCTURE OF MOUSE SKD1/VPS4B ATP-FORM	3.6.4.6
2ZAO	CRYSTAL STRUCTURE OF MOUSE SKD1/VPS4B ADP-FORM	3.6.4.6
2ZAV	ARGINASE I (HOMO SAPIENS): NATIVE AND UNLIGANDED STRUCTURE AT 1.70 A RESOLUTION	3.5.3.1
2ZBD	CRYSTAL STRUCTURE OF THE SR CALCIUM PUMP WITH BOUND ALUMINIUM FLUORIDE, ADP AND CALCIUM	3.6.3.8 7.2.2.10
2ZBE	CALCIUM PUMP CRYSTAL STRUCTURE WITH BOUND BEF3 IN THE ABSENCE OF CALCIUM AND TG	3.6.3.8 7.2.2.10
2ZBF	CALCIUM PUMP CRYSTAL STRUCTURE WITH BOUND BEF3 AND TG IN THE ABSENCE OF CALCIUM	3.6.3.8 7.2.2.10
2ZBG	CALCIUM PUMP CRYSTAL STRUCTURE WITH BOUND ALF4 AND TG IN THE ABSENCE OF CALCIUM	3.6.3.8 7.2.2.10
2ZBH	CRYSTAL STRUCTURE OF THE COMPLEX OF PHOSPHOLIPASE A2 WITH BAVACHALCONE FROM AERVA LANATA AT 2.6 A RESOLUTION	3.1.1.4
2ZBM	CRYSTAL STRUCTURE OF I115M MUTANT COLD-ACTIVE PROTEIN TYROSINE PHOSPHATASE	3.1.3.48
2ZC1	ORGANOPHOSPHORUS HYDROLASE FROM DEINOCOCCUS RADIODURANS	3.1.8.1
2ZC5	PENICILLIN-BINDING PROTEIN 1A (PBP 1A) ACYL-ENZYME COMPLEX (BIAPENEM) FROM STREPTOCOCCUS PNEUMONIAE	2.4.1.129 3.4.16.4
2ZC6	PENICILLIN-BINDING PROTEIN 1A (PBP 1A) ACYL-ENZYME COMPLEX (TEBIPENEM) FROM STREPTOCOCCUS PNEUMONIAE	2.4.1.129 3.4.16.4
2ZC7	CRYSTAL STRUCTURE OF CLASS C BETA-LACTAMASE ACT-1	3.5.2.6
2ZC9	THROMBIN IN COMPLEX WITH INHIBITOR	3.4.21.5
2ZD1	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE), A NON-NUCLEOSIDE RT INHIBITOR	2.7.7.49 2.7.7.7 3.1.26.4 3.4.23.16 3.1.26.13 3.1.13.2 2.7.7 3.1
2ZD8	SHV-1 CLASS A BETA-LACTAMASE COMPLEXED WITH MEROPENEM	3.5.2.6
2ZDA	EXPLORING THROMBIN S1 POCKET	3.4.21.5
2ZDK	EXPLORING TRYPSIN S3 POCKET	3.4.21.4
2ZDL	EXPLORING TRYPSIN S3 POCKET	3.4.21.4
2ZDM	EXPLORING TRYPSIN S3 POCKET	3.4.21.4
2ZDN	EXPLORING TRYPSIN S3 POCKET	3.4.21.4
2ZDV	EXPLORING THROMBIN S1 POCKET	3.4.21.5
2ZDZ	X-RAY STRUCTURE OF BACE-1 IN COMPLEX WITH COMPOUND 3.B.10	3.4.23.46
2ZE0	ALPHA-GLUCOSIDASE GSJ	3.2.1.20 3.2.1.1
2ZE1	X-RAY STRUCTURE OF BACE-1 IN COMPLEX WITH COMPOUND 6G	3.4.23.46
2ZE2	CRYSTAL STRUCTURE OF L100I/K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE), A NON-NUCLEOSIDE RT INHIBITOR	2.7.7.49 2.7.7.7 3.1.26.4 3.4.23.16 3.1.26.13 3.1.13.2 2.7.7 3.1
2ZE4	CRYSTAL STRUCTURE OF PHOSPHOLIPASE D FROM STREPTOMYCES ANTIBIOTICUS	3.1.4.4
2ZE9	CRYSTAL STRUCTURE OF H168A MUTANT OF PHOSPHOLIPASE D FROM STREPTOMYCES ANTIBIOTICUS, AS A COMPLEX WITH PHOSPHATIDYLCHOLINE	3.1.4.4
2ZEC	POTENT, NONPEPTIDE INHIBITORS OF HUMAN MAST CELL TRYPTASE	3.4.21 3.4.21.59
2ZEJ	STRUCTURE OF THE ROC DOMAIN FROM THE PARKINSON'S DISEASE-ASSOCIATED LEUCINE-RICH REPEAT KINASE 2 REVEALS A DIMERIC GTPASE	2.7.11.1 3.6.5
2ZET	CRYSTAL STRUCTURE OF THE SMALL GTPASE RAB27B COMPLEXED WITH THE SLP HOMOLOGY DOMAIN OF SLAC2-A/MELANOPHILIN	3.6.5.2
2ZF0	EXPLORING THROMBIN S1 POCKET	3.4.21.5
2ZFF	EXPLORING THROMBIN S1-POCKET	3.4.21.5
2ZFP	THROMBIN INIBITION	3.4.21.5
2ZFQ	EXPLORING THROMBIN S3 POCKET	3.4.21.5
2ZFR	EXPLORING THROMBIN S3 POCKET	3.4.21.5
2ZFS	EXPLORING TRYPSIN S3 POCKET	3.4.21.4
2ZFT	EXPLORING TRYPSIN S3 POCKET	3.4.21.4
2ZFY	CRYSTAL STRUCTURE OF HUMAN OTUBAIN 1	3.1.2 3.4.19.12
2ZG0	EXPLORING THROMBIN S3 POCKET	3.4.21.5
2ZGA	HIV-1 PROTEASE IN COMPLEX WITH A DIMETHYLALLYL DECORATED PYRROLIDINE BASED INHIBITOR (HEXAGONAL SPACE GROUP)	3.4.23.16 2.7.7.49 2.7.7.7 3.1.26.13 3.1.13.2 2.7.7 3.1
2ZGB	THROMBIN INHIBITION	3.4.21.5
2ZGC	CRYSTAL STRUCTURE OF ACTIVE HUMAN GRANZYME M	3.4.21
2ZGH	CRYSTAL STRUCTURE OF ACTIVE GRANZYME M BOUND TO ITS PRODUCT	3.4.21
2ZGJ	CRYSTAL STRUCTURE OF D86N-GZMM COMPLEXED WITH ITS OPTIMAL SYNTHESIZED SUBSTRATE	3.4.21
2ZGK	CRYSTAL STRUCTURE OF WILDTYPE AAL	3.1.21
2ZGL	CRYSTAL STRUCTURE OF RECOMBINANT AGROCYBE AEGERITA (RAAL)	3.1.21
2ZGM	CRYSTAL STRUCTURE OF RECOMBINANT AGROCYBE AEGERITA LECTIN,RAAL, COMPLEX WITH LACTOSE	3.1.21
2ZGN	CRYSTAL STRUCTURE OF RECOMBINANT AGROCYBE AEGERITA LECTIN, RAAL, COMPLEX WITH GALACTOSE	3.1.21
2ZGO	CRYSTAL STRUCTURE OF AAL MUTANT H59Q COMPLEX WITH LACTOSE	3.1.21
2ZGP	CRYSTAL STRUCTURE OF AGROCYBE AEGERITA LECTIN AAL MUTANT I25G	3.1.21
2ZGQ	CRYSTAL STRUCTURE OF AAL MUTANT L33A IN P1 SPACEGROUP	3.1.21
2ZGR	CRYSTAL STRUCTURE OF AAL MUTANT L33A IN C2 SPACEGROUP	3.1.21
2ZGS	CRYSTAL STRUCTURE OF AGROCYBE AEGERITA LECTIN AAL MUTANT L47A	3.1.21
2ZGT	CRYSTAL STRUCTURE OF AGROCYBE AEGERITA LECTIN AAL MUTANT F93G	3.1.21
2ZGU	CRYSTAL STRUCTURE AGROCYBE AEGERITA LECTIN AAL MUTANT I144G	3.1.21
2ZGX	THROMBIN INHIBITION	3.4.21.5
2ZHD	EXPLORING TRYPSIN S3 POCKET	3.4.21.4
2ZHE	EXPLORING THROMBIN S3 POCKET	3.4.21.5
2ZHF	EXPLORING THROMBIN S3 POCKET	3.4.21.5
2ZHQ	THROMBIN INHIBITION	3.4.21.5
2ZHR	CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH OM99-2 AT PH 5.0	3.4.23.46
2ZHS	CRYSTAL STRUCTURE OF BACE1 AT PH 4.0	3.4.23.46
2ZHT	CRYSTAL STRUCTURE OF BACE1 AT PH 4.5	3.4.23.46
2ZHU	CRYSTAL STRUCTURE OF BACE1 AT PH 5.0	3.4.23.46
2ZHV	CRYSTAL STRUCTURE OF BACE1 AT PH 7.0	3.4.23.46